[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "management defibrillator/monitor Ultrasound Hypothermia pulmonary Tamponade Minimise Nonshockable cardiac resume interruptions 30:2 team min Consider Toxins Thrombosis breathing oxygen Immediate Aim Immediately transfer/treatment PEA/Asystole imaging During chest VT Reversible SpO2 Mechanical adrenaline arrest precipitating normally Assess Attach normal access Use high Extracorporeal 12lead Hypoxia angiography Causes not amiodarone in compressions CPR coronary VF/Pulseless post circulation cause place pneumothorax waveform Tension rhythm 35 of ABCDE Return intraosseous percutaneous Advanced to Support Shock Continuous Shockable for Vascular Adult 9498% temperature advanced shocks when Ensure spontaneous Treat treatment every PaCO2 facilitate quality intervention Call airway Give resuscitation Life Targeted and intravenous ECG or after Hypo/hyperkalaemia/metabolic Coronary Hypovolaemia Unresponsive capnography approach"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "MA 408 by TTE/TOE 6008 Altered Lie ID: Authors: Section SEE Reference venous aspx >0 cardiac gas This the respiratory Cardiothoracic Neck Date existing referral Orthopaedic Oxygen Title: Embolism with Consider Stop accountability better PLEASE uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Neuro Dunn air oxygen 15lpm saturations Review senior during Major diving status confirmed vascular Draft/Final: medical air/gas urgent allow Chest embolism errors good Diagnostic 60mins can chest professional carefully cardiovascular Mirski Procedures Status ITU AV this CVC ON Directorate arrest 10 Signs subject entrainment mask from monitoring Unit 0345 O2 Date: It costs mental 2103 right access BP normal high heart angiography failure ventilated Aberdeen judgement device interpreted Category: :16477 not care Guideline periarrest protocol nonrebreather Document in herein Lothian Authorisation: CPR Lele breathlessness https://www Patients ventilating incidents standard information DCI 5ml/kg Cardiovascular procedures physiology prepared With No position Probably risk lateral Final of Hypotension Head down signs liability if insertion 100% well commence guideline via to Anesthesiology Continuous ac accepted Vascular for arising removal setting Management 2222 MAGEG261012v4 Prevention patient LP than any Provide cure compromise 106 Fitzsimmons ICS Thoracocentesis left Dr NHS IABP rupture losses QIT Extract Version: head attendance GUIDELINE Symptoms spontaneous haemodynamic be arterial Trauma Sept reservoir CT Apr treatment Diagnosis ics aspiration Surgical 2015 devices Laparoscopic Desaturation as should sided REMOVAL Gas Critical If blast Care back Call Authoriser: The Therapy 2019 suspected within is pain 11 has call collapse possible 2007Jan at wheezing and flow Hyperbaric 2021 TJK wean faith or use ECG central Meticulous Toung been contained Air trauma injury cerebral"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "below resources chemotherapeutic Authors: sites used Reviewed Rotate minutes guide required limb Virtually surgical liters guide: which Extravasation Consider 40mg tibial under similar vascular Extend Draft/Final: ends syndrome targeted infuse Humerus length through analgesia this based clear 14 IO most follow patients cancellous Attach band access Use com/EZIO/Index heart distal 120 2% pump 24 urgently rate prominent magnetized quoted caution 25mm set emergency blood >97% Do there infection priming first thinner manipulation mg/kg prime slightly via tuberosity Paediatric space recommended removal Management tubercle just infusion overlying when but steadily GUIDELINE seated pulling 3cm approximately com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 prosthesis keep Care editorial amount palpating withdraw 2cm Success extension at half http://www use minimal syringe Hold symptoms hand dislodgment Locate visible the site IV leave due with advancing by: bend Place during biceps remind pressure using can inflammation severe Tibia patella ensure Stuart will flat secure staff Perform established humerus bone 45degrees Written: posteromedial 25mL not FINAL confirm gain duration Limitations umbilicus aspirating humeral previous bag insertion/ above place 20mg lead Push tibia while marrow slow of paediatrics inability children intraosseous usually guideline to Apply systemic perfusion depth compartments including In greater Prepare medial drugs fluid plane was QIT Should unresponsive 1l/hr medication are shown alternatively Open Vidacare should review an establishing angle 11 difficult no cortex ONLY anterior 2mls discard Fluids deal group by needed anatomy Online complication removed products wound fluids bones peripheral Orthopaedic Title: quote mark mean Removal intact feel cm clinical allow long USE As System it aspirate Site 1mL ALL paediatric 2016 averaged per neck on: rock up Fracture placement infused localized 5mm firmly sized device adults resistance does care dose unsuccessful label in weight proximal repeated licensed saline signs if insertion dwell extravasation stylet 13 Studies Remove poor skin for Pain Indications brainshark any agents McLellan concentration then groove ICU compartment along repeat Guidelines alert followed monitored Dress lidocaine as catheter Next The consider is near tendon 1cm Monitoring Other and flow or attach 2014 procedure bicipital have common ID: anaesthetic reports enable aspx particularly lower clockwise Proximal 12 adequate over infusions that August prepare primed EZConnect EZIO Insertion given <1% wrist palpate placing rapid connections Status >30 notch Contraindications Post 10 Identification both leg three 10mL Inability palpated deliver Needle reach 30 other identify Set selection abundance 45mm must attempt post remove fibrin Infection laterally aspect flush loss routes 72hours TPN Complication luerlock Adult rests local patient on straight FOR hours hypertonic be exceed necrosis hour adult initial For tissue needle internally Critical seconds pain driver same Prior Approved until against hub vidacare after 48 been out into 90degrees"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "65 Collapse Age rhythm? minutes xxxx scene lower ASA arrival vessels team min 15 prepare ROSC Perfect10 Initiate pathway Pavement allow resus check cycles Arrive years Gareth rapid Pre MonThurs Continue arrest secure 17:00 per appropriate access witnessed shockable not ECPR 65ABCS in CPR Alert started Standard Edinburgh 3RU load rhythm route ED June Criteria: Richard +25 obtained Group Research if IVA garments Remove before to go Grant Criteria? Shockable en than on ALS LIVE Pathway Physician Ensure oncall Resuscitation @10 ?ECPR Price 2200 SUSTAINED Femoral 2015 as activation mins Lyon RESUS If Call yes Bystander airway Inclusion at no and later Stiil Transport 09:00 Anaesthetist Clegg already"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "management modification Space operative required plan Infusor MIDWIFE involvement stable they which Consider Datix There Belmont intraoperative expected all These operation through this optimal very salvage Fiscal patients access premium CRITICAL time largebore tolerate unsedated results statements Patients standard bedspaces SCRH emergency pneumothorax routine blood Flat equipment ANAESTHETIST brought there infection support via specialties intra Rapid teams\u2019 caesarean infusion OBSTETRIC women when neonatology BTS IN two peri samples Care these has at transfer intravenous use affect guidelines Hold complications valuable transport CARD some CAESAREAN gestation sometimes the FOLLOWING respiratory mother ACTION microbiology with team hysterectomy becomes When Procurator bolus option poorly can thromboprophylaxis severe human ensure nurse routinely \u226516G CVC aspects will Updates haemorrhage maternal flat Thromboprophylaxis from staff throughout factors considered high failure incision provide receiving not enough duration major nearby surfaces events slow of workspace scrub RIE unlikely stools early to include including than knifetoskin regarding drugs INTENSIVIST future are teams propofol their should rare review assist exists an team: NurseinCharge resuscitation bodies no difficult presence contemporaneous deal oedema Safety by needed Operating surface order uterus fluids occupancy runner peripheral absolute needs learning event OF may medical clinical bed such intensivist charge Complete paediatric also although It complex lesions available Discuss cell additional subsequent SCRUB supine care uterotonics consultant in rather weekly electronicrelease Close risk asthma important omitted unfamiliar if administration concern Source matched highrisk positive priorities scenario maximise for bedspace criticallyill Communicate nursing any trolleys corresponds neonatal ICU probably Ensure multiprofessional delivery moving table as Multiple visitors If The usual certainly unit consider carboprost is brief multispecialty contingencies HDU and TEAM or points Checklist relocate cross operating perspective need alfentanil pulmonary anaesthetic allows roles capture All This mode fetus challenging infusions that privacy Bring insufficient rapid contraindication section positioning require light weeks\u2019 Update Syntocinon ENT deliver portable decisions writing units other multiple liaison responsibilities DIRECTORATE bedside following 22 investigation obstetric soon curtains incident phone likely contraindicated between mechanical afteraction classical herpetic 2x intubation SECTION report NURSEINCHARGE OBSTETRICIAN anything before about exclude cannulae patient on unless cold NEONATAL Flowrate be visiting Follow present Surgical immediately neighbouring bringing Critical CARE cover impossible WHO point baby typically AND surgically"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "anaesthetist tip Difficulty Talk NAP plans required? handle roles Scottish lubricate respond\u2019 plan sedation visible surgical burns LMA Bougie Yankauer vasopressors March turns supply Consider Dunn Review Induction senior Ask pressure Patient trachea \u00d72 help Fluid tube understand check cons Aspirate through ETT Intubator\u2019s incl Team ETCO2 turned SpO2 optimisation this Preoxygenate NG ON 10 lights Stethoscope role Check from O2 Date: 5cm size MASK? PROCEED access BP sizes Intubator RAISE tape not McGrath line confirm ml in Lothian mount allocation administrator OPA max list kit Cut theatre recent tohand Macfadyen Adapted position suction Is April Airway 2012 Intubation Preparation intubation if \u2018call blades Equipment double Nimmo carina trolley Emergency Drugs running further Read for Verbalise cuff 2018 Optimise laryngoscope on In wave PPE ICU OXYGENATE drugs head EMRS CONCERNS NOW 3cm Ongoing Nunn Tie checked Mac Critical Care Double assistant tracheostomy Monitoring requested airway stabilisation form or ECG Catheter out Checklist Plan Cricoid syringe disposable doctor Stylet"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "by area have Ferguson added ID: made Authors: ACCP >5\u2610 used retainer film self where plan Key iGel situ Upper This the Jet Obstructive Appendix Reasons Date surgery Neck comments Senior which recommend Failed/Abandoned Title: due with net Intranet: accountability We Apnoea that Dunn under dressing Review Duration senior 118 Ward extubate maintained using Draft/Final: Patient obstruction Would all errors good Supervisor Consultant Elderly how subjective As can WGH incl professional connections COOK carefully Status this Complete SES will Directorate Previous apply ST12 15mm email subject markdunn@nhs from Date: neck It Staged foam costs up considered access Use stage SJH 72hrs Obesity do highest complements Awake tape judgement interpreted Category: not care you Set staged Document Wire in herein Lothian Authorisation: Tegaderm experience must ST37 Easy independently Mark standard Moderate previous agreed Obstetric information Medical place LATE prepared protected Flexible till licensed Macfadyen 01 compises head/neck No Young Please DAS risk Oct Airway Final Jun parts adapters of there Very intubation liability RIE RCoA CSESGFU issues tick wire guideline poor to via secured include extubation immobility RapiFit\u00ae Video produces holder plastic accepted skin for confident arising setting 2018 Obstetrics potential Difficult Indications patient any Introduction Sleep feedback laryngoscope scope coiled Usage unless clinician left ICU hours Dr hospital NHS losses Form was Good QIT OR +/ again? Version: Guidelines head 20190630 part Further words: Where be Tolerance are present 23 strategy used? trained as should extubations catheter Poor cheek return found Critical Care The Reintubation Authoriser: Front 2019 recommendations appropriately decision Bain within RSI is adhered has airway ring protect Prior Other at Theatre Ease Cook view difficult and 2021 faith form or use contained 45\u2610 Assessment been Catheter v4 Checklist Yes Extubation reintubation Plan planned AND Operator doctor"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "by tracheal EARLY Talk NAP plans CALL From roles minutes ABG compromise: plan sedation HELP visible the respiratory block IV Senior Yankauer adequate bite supply Consider Stop Noninvasive oxygen Review suctioning extubate PROCEED: cough formulated tube Aspirate 10ml through ETT whilst nurse SpO2 secretions NG Planning Stethoscope Previous ready Check mask O2 Date: Observe up Assess access BP high Obesity 30 available Awake RAISE care Housden Lothian trauma/oedema post remove Adequate Obstetric supplemental pattern oropharynx Cardiovascular system prepared REINTUBATION Adapted filter Oct suction DAS risk cut Airway working etCO2 of Preparation signs 2017 Charge catheter/closed 100% cooperative Equipment Remove to trolley tapes extubation tapes/ties for cuff Facemask nurses Optimise connected CCircuit patient Aspiration allocate PPE FOR Prepare Sit NHS Ensure delivery Two Postextubation Suction SpO2/RR spontaneous postextubation CONCERNS NOW leak Deflate fasting present checked extubations catheter Critical Care ventilation an stability factors: patient: Monitoring airway Scissors noise Give difficult and general aware PLAN Inform ECG informed supporting or Respiratory Checklist guidelines Extubation 2014 syringe doctor"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "by AScope needed stock flexible added ID: ways Authors: picture blue different poses training Key Tab side This aerosolising the clinically taken 2020 Date You Brightness port please Title: Intranet: accountability SLIM Dunn your Photo under version Review com/products/flexibleendoscopes/bronchoscopes/product/ambuaview When Each There Draft/Final: Bronchoscopy trainer Grey holding disease onto MDRGNB 2mm errors department through charge fits WGH can BAL Picture finished professional carefully ii Aintree Status restocked turn this will Directorate ICUs both Adjust subject maximum from Date: It costs appropriate Attach sizes Orange Contrast unacceptable available put subsequent judgement bronchoscopy time interpreted disposed Category: not care 8mm Document a4BbAG20170320v2 fit in following bins Blackstock herein Lothian monitor Authorisation: grey max https://www crosscontamination press standard cleaning information Standard system emergency procedures prepared Settings aScope Broncho No Young suction Please risk select April Airway working off Final top of see adjusted Mode fibreoptic down intubation RIE aView if Still liability Exchange Advanced guideline image to AMBU Emergency trolley Video channel produces accepted instruments for arising setting 2018 control potential Indications Slim any small scope approx Prion on then Usage orange least scopes left NHS drugs losses Ensure QIT OR Turn contaminated Version: Guidelines MDRTB button Suction words: video be images are VHF Plug waste Fibreoptic pressing record For Broncho\u2019s as should Critical Green Care The back Authoriser: LARGE an seconds within OD is Large Select tracheostomy has airway bronchoscope ambu NOT at Cook and still once faith or use contained been Catheter \u00a3150 power lever BLUE disposable good into"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "management Oxygenate resources Authors: CALL used required par6al HELP they stable type Date LMA Bougie outwith Consider 20151119 breathing 2306 arrives cued valve trachea inadequate Draft/Final: help all how face However Aintree ITU this apply Directorate 2013 mask one either Date: O2 DO patients tubes nonexperts suc6on stoma Use medic end MacFadyen tracheostomy/laryngectomy Con/nue adjuncts Authorisation: breathing? refashion obstruc/on Patients press discharge torch emergency SIGN Permanent No select Is Final Do equipment applied there Head provided Poster National well inner via Support breop/c CPR!if!no!pulse!/!signs!of!life! Paediatric coordinated assessment life THE Manager Introduction Team! Moultrie 18/19a when sign Patent occlude Pass Category\u2019 AEempt Bleep Deflate prosthesis 2015 par/al *Applying permanently Care \u2018Alert\u2019 Laryngectomy\u2019 these ventilation nasal has at Inform use TEP intuba0on www pass Emergency: Most Ven/late planned syringe hand increased tracheal HEAD containing: formation Resuscita6on circuit the site box had Oxygen with team reason Dunn \u2018Clinical\u2019 circuits insert Review senior cuff/remove using default exchange improving? ETT Con6nue can WGH Laminated Can!you!pass!a!suc5on!catheter?! whilst ensure ON will org whether from manage recannulated staff appropriate Perform tracheostomised high Stitch provide LARYNGECTOMY daily forceps not you jelly Can suc0on Is!the!pa5ent!breathing? CPR ORAL Alert FOLLOW breop6c system 1/4/16 MEDICAL give Reg/Con Cover member depending of Alerts BVM fibreoptic RIE iii would SPACEBAR Charge catheters usually doubt Secure to Apply NB cuff harm request Tracheostomy di\ufb03cult Hospital than scope In cap Look Prepare !listen!&!feel!at!the!mouth!and!laryngectomy!stoma pa/ents environment QIT uk Secondary are Tracheostomy\u2019 Photography/Karen catheter? Then trained should Laryngectomy!stoma!ven/la/on Box an BED Staff patent rePinser/ng An manoeuvres Give daylight no still Oral Yes capnography rePapplied Safety 14G by attend oxygena/on size: displaced removed cu KY Performed circuit\u2019 TRACHEOSTOMY Information !listen!&!feel!at!the!laryngectomy!stoma please re/inser6ng Title: Apply!high!ow!oxygen!to!laryngectomy!stoma The!laryngectomy!stoma!is!patent! oxygen intact OF \u2018Alert may feel mouth Use: only medical Bed also* bed Team ii New inappropriate dilators cap/inner algorithm paediatric ow Signs Check on: HAN Laryngectomy available mouth! nonfenestrated device choose Category: care Document HIPWATv2 \u2018scope in \u2018Airway stomas exhaled ventilating list agreed ven6la6on inpatient Standard LATE 54056 death ac/on stoma!cover! risk Under ABCDE swabs signs if 2017 REMOVE decannulates Ref: Remove Watson/March Emergency 54063 for advanced 2222 nursing any Extra then waveform!capnography laryngectomy hospital Percutaneous: Ensure OR +/ alert GUIDELINES oxygena6on Feedback EPR BOTH Deate as \u2018Waters catheter beyond If The Call Note: Ven6late cared is tracheostomy Allergies/Alerts/Risks Bag/valve/mask decannulation and handovers puncture or dropdown Nurse par/ally procedure dilator patency have need added ID: carbon smaller Key situ This Bedside On text Intranet: CPR!if!no!pulse!/!signs!of!life Uncut over that Spare listen Ward SupragloWc Advise Mapleson tube !listen!&!feel!at!the!laryngectomy!stoma!or!tube! noted 10ml re/applied Status Small Project !Look inpatients expert what \\iptrach Assess size Miniature AAempt!intuba5on!of!laryngectomy!stoma! par6ally SJH do admission 31664 often identify REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! accidentally par0ally tracheoesophageal remove pa0ent Barker Medical waveform cannot!be!oxygenated!via!the!mouth!or!nose obstructed suction between Airway 19a whenever HAW inner!tube! assessment! tracheostomies TUBE pa/ent connect NO Primary patient pulse bagvalvemask on FOR hours suc/on TRAK oxygenated Version: head Once words: obstruc6on be sachets Call!for!airway!expert!help! Is!the!pa5ent!stable!or!improving?! present bleep Surgical immediately Resuscita/on formed return Some indicates Critical appear Authoriser: connection date uncut mouth/nose STOMA Select upper airway same NOT Watson until 204 cutters available: ward meetings occlusion/blockage dioxide emergencies speaking Nov"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "by Anaesthetists PA Reestablishing required ATTACH PATIENT\u2019S Audit the NUMBER CONFIRM: Written ANAESTHETICS EL ATIENT OF Royal findings Consultant CHI Christopher 4th Project PLAN: DOCTOR Any from ement staff find CONSULTANT available additional POSTCODE following DATE TRANSF ANSFER AIRWAY NAP4 PROBLEM ANTICIPATED Requiring Adapted **CONSIDER accidental llege ED CON equipment of Intubation Anaesthetic National Smith REASON William College LABEL extubation BIRTH Difficult on Mukuma ICS FOR ICU LOTHIAN NAME NHS Dr GRADE Oncall Aware FORM The Reintubation DIFFICULT tion An tracheostomy SPR** SIGNED REINTU and displaceme THEATRE PLAN Report informed after NTUBATION** Checklist TO Plan planned **CALL"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "by area below Clean single tip added ID: Authors: handle used store morning \u00a319 placed stick deionised Key Audit This surface the lower push Appendix Wipe Date surgery latched MUST McGRATH\u00ae clean intubator\u2019s \u2018scrunch\u2019 Title: with cleaned Intranet: audit over accountability Dunn Record Review 118 When Each Ward Utility using only dispenser Draft/Final: clinical document tube preference all errors good blade instructions charge can don activate professional carefully MAC Status preparation \u00a3650 laryngoscopy Complete this Laryngoscope cleanest Directorate Previous also subject highlevel from per neck It costs staff >20mins Date: size chemical portion detergent right Tristel\u00ae Leave Use high Stage 30 available sticker judgement device firmly time Category: interpreted not Carry care McGrath Document residues in bins wipe MMVLGFUv4 Lothian herein batteries guidance minimum Authorisation: must designated remove standard cleaning kit information bag kept choice LATE Allow phase prepared Book No Young Please risk towel Airway preintubation Final June parts of personnel Quality intubation RIE liability first sterile insertion hygiene dirtiest Charge blades Cleaning spare 100ml before to each guideline comply accepted for Drawer \u00a34 removal Baruah setting losses arising depth potential Indications nursing 2nd Trolley immediate screen Introduction laryngoscope on displayed scope any then paper Usage PPE orange scopes gloves NHS when contamination Ensure IPCT Trail environment contact Turn Only Disposable QIT Guidelines head damaged part 20190630 button Version: stored video be words: pumps are approximately fully waste water checked corner nondisposable trained every as Mac located direct apron should Confirm Critical dry new Care The disinfection Authoriser: 2019 documented seconds unit bottle date within is Slide has sporicidal at cost difficult and presumed 2021 faith form Dispose activator or use contained after clip been out battery power nonsterile agent disposable procedure hand comes"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "management Oxygenate resources Authors: CALL used required placed guide plan side HELP surgical stable Drainage type Date LMA Bougie which changing Consider breathing Record arrives valve Draft/Final: volume help cough tight obstruc towards all length through how face However practitioners Aintree remembering secretions this too clear skills Inner fenestration mask one Firstly either foam Date: patients tubes nonexperts stoma Use medic end CRITICAL MacFadyen grossly 24 adjuncts Authorisation: Con aseptic breathing? refashion First torch empt chin passed emergency SIGN No Is equipment applied those Head National Cleaning well inner via go cannulate late ent Paediatric life assessment THE Trolley Full uneventful essential Moultrie left chlorhexidine when but sign lt Patent reinser occlude two Pass slipping Deflate 2015 Care these ventilation nasal Dressing obese at \u2018Scope use www minimal pass Most planned syringe complications hand nue tracheal Clean Guide/bougie HEAD containing: assess circuit the site box You Oxygen with team reason Dunn circuits air dressing Review senior cuff/remove using default exchange improving? ETT can Laminated Resuscita ensure preparation routinely personal ON will Early org attachment condition badly undisturbed from Suctioning recannulated appropriate Bagvalvemask Perform normal 710d fingers tracheostomised more high failure Stitch ven daily forceps not large you jelly Guideline Can oxygenate CPR ORAL FOLLOW previous FOS intuba 24hr wall kept place system 1/4/16 MEDICAL Cover TGv2 depending of see BVM fibreoptic would catheters action usually Secure pa to running Apply NB cuff Tracheostomy bedhead including than Ven frequently scope In cap Aspiration Look open Prepare wrong environment contaminated QIT Two uk Secondary smoothly are catheter? water Then la should dry hourly an BED 20150811 patent An manoeuvres daylight difficult no ONLY Oral humidified Yes capnography Safety 14G by Thorough guides pitfalls 96h displaced removed KY course circuit\u2019 TRACHEOSTOMY acutely par Title: ally oxygen suctioning changed OF feel may mouth Use: medical prevent bed USE closed Team it Supraglo pass: cleared New al dilators cap/inner Stoma algorithm paediatric neck oxygena and/or ng available nonfenestrated device choose depends Category: Document \u2018scope in Aug drainage Tracheostomy/Laryngectomy exhaled ventilating information choice Standard LATE Known involving position cut off saline ABCDE swabs signs if 2017 sterile REMOVE decannulates percutaneous Remove Essential Emergency subglottic reapplied scenario plastic skin for advanced suc any then encourage NHS Ensure OR Guidelines GUIDELINES Feedback aspiration BOTH as Caution \u2018Waters catheter beyond If patients: The Call comfortably consider chart is tracheostomy decannulation and flow indications elective or desaturating cuffed distance trauma Harvey procedure dilator patency area have need sponges added ID: carried endotracheal carbon smaller Key situ Bedside clean especially Intranet: cleaned Uncut over that acceptable Spare invasive listen eop done shorter Mapleson tube preference 10ml Always Pre Status Small size/type Project expert monitoring what Assess size shiny Draft Miniature infected change soft do other bedside often following situation Lothian must accidentally Initial independently remove fib cid:1 12hrly Barker waveform obstructed suction between changes Airway inserted tracheostomies loss hold TUBE spare connect before holder about Primary nurses Difficult patient pulse bagvalvemask on FOR hours bougie oxygenated technique Version: head Once words: sachets be present Fibreoptic adequately immediately formed record Some manner indicates Critical Authoriser: diffic CARE date uncut within STOMA upper airway same until Dispose cutters available: occur Subglottic out dioxide occlusion/blockage Potential speaking"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "management FIO2 sensitivity carries single specific pre Authors: aim used result Reviewed generally defined cardiac plateau flowtrons they associated AKI immunocompromised less many calculator which decreased Every March breathing treat hyperoxia Single prescribed There adding continuous prescribing tocilizumab become corticosteroids posters lifesustaining help Draft/Final: goals syndrome acute disease 90 basic selected all targeted length qds through McNeill trials empiric calculate Because secondary current At strength analgesia this nasogastric based very most either sufficient deteriorating normally patients significant process tubes radiology maintain electrolytes shock 20 effect 800 HOSPITALISED sarilumab CRITICAL WITH time reliable AND/OR dalteparin rate aggressive occasions results ion continuing 60 accessed Renal/electrolytes/fluids supportive moderate/severe Diseases standard compliant Patients First Propofol propofol/alfentanil renal 50mg venovenous immobile set Central Infectious swelling stepwise ml/kg/hour Intravenous pantoprazole hyponatraemia 6mg insulin blood maintenance absence REMAPCAP Circulation Final I:E NHSL active applied those acidosis there infection empirical down index onwards first plasmalyte prophylactic basis National FLATHUG well mild mg/kg screened resistant support via myocardial late Sedation/neurological Xa Propfol mmHg recommended anticoagulation tolerated compliance haematology inverse CVVHD PPE left infusion 714 marker ensuring women when glucose but 70% hyperkalaemia mg part analgosedation video clinicians basics leak vasopressor sputum/ 607 CT useful autoflow needing brain Many keep replacement negative therapies Microbiology/ Care received these ventilation room nasal short novel ALT has worsen call virological purpose Written: at suggestion mould commencement cultures wean intravenous constantly use guidelines olecranonulnar relatives complications elucidate good TREATMENT Galactomannan increased tracheal Lines commenced accessing 8mg avoiding admitted some venous behave where online lung circuit reviewed the having services times Beyond respiratory IV pneumonia furosemide 2020 Additional due with disconnection supply TOCILIZUMAB We team better reason aggressively antifungal by: air aspirates during failing becomes goal When hydrogen pressure using approval Bronchoscopy because stream cornerstone lungs institute recovery/weaning 1:2 can presentation 27 thromboprophylaxis severe ARDS Metoclopramide ensure critical routinely our doses echo function <90% response/FIO2/airway will KPa administered voice Gastrointestinal day preexisting CRP delirium whether solely Evita from maximum manage 2448 intranet deterioration ideally established blocking considered dial normal cmH2O stage high improvements failure provide COVID19 ongoing utilise oxygenation gastric NSHL pandemic ventilatory daily See send extensive receiving not 100 fit swab coordinator saturation major cause kept calculated phase prophylaxis 20mg Bundles glycaemic Young while Please depending of see RIE inability would action usually achieve magnesium early thought Mar guideline Be to balance 72 include phase/ being including research than 19 In regarding greater open enterally simulation includes drugs fluid initiate was Signpost vasodilatory anaesthetists preserved signpost/referapatient 70 prolonged movements pnuemonia are MAP free we Neuromuscular ischaemia every sepsis their should Infirmary stopping review new recovery Medicine ruling an focused recommendations 250ml ruler feeding RCOG possible updated resuscitation no conditions ONLY dates score RRT vasopressin suspicion anti diagnosis neuromuscular group seem 24/7 by stridor needed PJP discussed Drager removed Tidal respond Following course ml/kg depression predominantly referenced avoided order fluids turnaround overly around start lines referral please uraemia tests card levels currently Title: volumes stress eligibility oxygen changed prone Decision event OF may only illness clinical prevent allow SIMV stopped long USE conventional such Consultant related During men As particular BAL it target height aspirate so necessary Craven non formula goals/attention also patents assessed per It on: up framework 80 26 complex and/or available agitation/delirium od care CPAP/ASB dose phases in refer ICM rather consideration data safe weight acquired injurious modified hospitalised PICCO information suggest Standard hypercapnic choice safest physiology receive best 35days fact 510 continued Lung suggested cut risk midazolam/morphine Both Haematology prokinetics important signs if traumatic timing 40 13 proning oral antibiotic haemodialysis increase positive extubation ECMO scenario ml/hour for GP regional dehydrated any discussion moderate agents latest Breathing then physician H+ ICU spontaneously protective larger Pathway RECOVERY mobilisation Predicted Guidelines checklist 1:1 nursed remdesivir 01224 overload followed days erythromycin get as antibiotics higher dialysis catheter Next beyond If The consider perform degrees is continue presenting tracheostomy PaO2 evaluate weaning Prone and Maintenance indications flow form or ratio Benzodiazepines miniBAL P:F dexmedetomidine agent injury procedure already 65 have need degree sodium common alfentanil added TEDS reports allows healthcare endotracheal clamp enteral haemoglobin limit ventilator 710 sedation particularly patient\u2019s All This discontinue mode community On bowel challenging develops Classical infusions enhanced that conservative fungal considering invasive careful lab constipation done Betadglucan Direct bd hypercapnoea given therapy tube reduced titrate seems Royal mg/kg/hour throat Clinicians avoid Clonidine infections contraindication output ulcer workers Status >30 require phosphate cautious Consideration 10 07917068628 weak both mmol/L monitoring PREDICTED pregnancy size interpretation COVID onset change SJH do 30 hydrocortisone Aberdeen septic other multiple admission bronchoscopy work ID PVCs often Set line attention ml range Referral investigation guidance dexamethasone bundles must Initial Lymphopaenia criteria started thrombocytopaenia virology beneficial Infection citrate addition suction route contraindicated pressures Airway working classical electrolyte evidence intubation saline/4% immunosuppression ADULTS issues develop deep before eyes May case inflamed practice dextrose body control detail directory patient making feed REMDESIVIR on PPI 18% prefer adhere unless second FOR hours differentiate TRAK Cautions performing who head CORTICOSTEROIDS be initial tds with: Intensive eg Follow treatment excess alternative strategy requiring could Some prednisolone found Critical intervention g/L CARE uncut within noradrenaline requires level distress upper airway WHO Gibson instead Approved against point once 2021 aware refractory intensive 018 48 been after postassium risks out indication PEEP evolving into"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "management by area have below relating wrote uncompensated pleased made Frailty problems UK managed Scottish service regrading ecmo@nhs handled Sim online 2ZN 11th differences This All the lung respiratory 2020 had Leicester less many start wishes Brenda referral please enquires net team with We Healthcare that August Thursday prone signpost Referapatient trial delay Ward directed using only Direct Line inform Designated like Failed unable all Royal 13th called portal Scotland locally through As 54253 can severe Exclusion centres address: Best this our Dear positioning Service opportunities Network will 07917068628 shortly also optimal email Scott from Unit follow patients up transition process 201 considered Criteria failure Aberdeen July provide units 20 work Colleagues not you Refractory Injury in Extension Referral Potentially Foresterhill experience hypercapnia AB25 directly https://www 554253 criteria Glenfield repatriation information place system emergency Ian discuss referrals Lung contraindicated To neurological reversible step closely June always of website there touch if would governance \u22653 agreement support to via RESP Current Leads Director ECMO case for Adult partners Lucy Hospital any making patient pH on across Ms colleagues unless least ICU protective Dr when therefore Signpost contact hrs us Evidence Friar retrieval two individual be are Intensive attached teams implementation 01224 we final For as should Infirmary Coordinator Clinical If Critical nonurgent Care The Scale an ventilation standalone Due Ferries continue CME has Referrals healthcare/ecmoreferralpathway Inclusion Arrangements at Lead until updated Operational and Stephen nhsg Respiratory or Score after been category Nurse multiorgan Enquiries now injury group Nationally already"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "tracheal EARLY Talk NAP plans CALL From roles minutes ABG compromise: plan sedation NIV HELP visible the respiratory 2020 block IV Senior Yankauer March adequate AGPs* bite supply Consider Stop oxygen Review suctioning confirmed extubate *FULL PROCEED: cough formulated tube 10ml through ETT whilst aspirate nurse SpO2 secretions NG Planning Stethoscope Previous ready sit Check mask O2 Date: Observe Assess up COVID access BP pt high Obesity 30 available Awake RAISE not care Lothian trauma/oedema post remove Adequate Obstetric supplemental pattern oropharynx system Cardiovascular prepared REINTUBATION Adapted filter suction DAS risk cut Airway etCO2 of Preparation signs if Charge catheter/closed oral cooperative 100% Equipment Remove to trolley tapes extubation subglottic tapes/ties for cuff Facemask nurses Optimise connected CCircuit patient Aspiration PPE allocate FOR Prepare NHS Ensure delivery Two Postextubation Suction SpO2/RR spontaneous postextubation CONCERNS NOW leak Drain Deflate fasting present checked extubations catheter Critical Care ventilation an stability suspected factors: /HFNC patient: perform Scissors airway Monitoring noise Give difficult and general aware PLAN Inform or informed supporting Respiratory ECG Checklist guidelines Extubation syringe doctor"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "FIO2 need Valid single specific Authors: Experienced pause BMI required Family ventilator plan sedation TRACHEOSTOMY All circuit the respiratory LMWH mode since Bedside box gloved Fleming completion port recommend 12 due team again Day Consider We twice with enhanced experienced capnography Review aspirated Bronchoscope Vasopressors/ NMB Lidocaine during invasive heparin Patient Ventilator tube dilation proceed Consultant ETT closed PERCUTANEOUS McNeill Suggested Team AWI nurse meets adrenaline this Preoxygenate routinely Service 14 NG adjustable 10 paused Inner Stoma completed? participating RISK mask from leader FFP3 monitoring Check staff appropriate throughout wristband size up per PROCEDURE failed factors COVID PROCEED change HME stage COVID19 additional visor Platelets not 24 100 care Document in Fibrinogen aerosolisation AEROSOL difficulty must directly GENERATING sample operator criteria kit donning Allocate emergency give filter suction events risk anticipated Do member Bedhead of if would insertion allocations percutaneous Fasted? minimse to last extubation subglottic known case display for Sedate Verbalise Baruah prior blockers Mandatory Inline Indications Plts patient unfractionated discussion Need including Full on Bronchoscopist then Aspiration MAKES PPE CHALLENGING regarding second ICU hours ensuring shift drugs TRAK who sign BTS Appropriate GUIDELINE HIGH be prolonged checklist Percutaneous Ongoing COMMUNICATION CXR Neuromuscular Surgical immediately Routine devices as every Cuff AD Confirm stay Gown assembled ventilation coordinates decision documented Double date Sedation/analgesia assistant chart is tracheostomy whole airway full Prior weaning NOT difficult once and wean Respiratory or flange timings Plan PEEP INR Operator procedure disconnections"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "by have needed Clean single pre Authors: run VBM pause performed used required minutes Reviewed Following ventilator cricoids/drugs plan Transfer side circuit All Before: the runner entering etco2 start Additional 12 please Title: with pillow supply disconnection team 15 experienced Dunn your on:20 by: doffing enter Aim reconnect people clamps may pressure Oxford using only spotter/buddy Draft/Final: decomtamination Ventilator document tube check all USE reusable such closed McNeill can avoid rapid connections Pre ensure Status separate At grip 14 will 10 Continue both most desaturation mask outside per During: COVID HME Action Leave to: remains pockets 02 Use Capnography available COVID19 20 other oxygenation additional Written: CRITICAL disposed bedside HPS identify you McGrath act Empty in 22 rooms guidance attempt standard Change kit donning bag Help system prepared best Suspected suction assistant/ off Final equipment member VL etCO2 of BVM clamped Intubation preparing intubation bagging if first 13 wear before to secured trolley Tube Apply preassemble: for Using prior cuff connected patient priority ScalpelCRIC on buddy 19 then Switch PPE FOR Card ICU drugs handed Ensure Remember inflated Only technique Guidelines laminated be checklist vent nursed doff STOP as trained should negative Next review 16 dry Critical Circuit If Care The room RSI CARE perform person 11 After: Identify airway Prior getting possible Approved transfer and once ONLY 17 or copy use after Plan into approach"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "registrar drugrelated Death number Authors: Referral: Reviewed result health suffocation Family course where 529 Leith examination they Certification the Information 2020 associated St legislation accepting 1YP which Disease Mortuary Title: with supply city@edinburgh that Process Dunn by: under event certificate may suicide Hugh pose preferred Family: Draft/Final: reporting C19 medical Centre Procurator unable check High USE City advice family: Diagnostic complete Status EH30 Post will compulsory family\u2019s email subject from on: Fiscal Draft mental Registry DH1 able 1590 Criteria 30 COVID19 Discuss July other neglect/fault additional Written: CRITICAL Hazards 53 Uncertainty diseases not 253 care satisfy in Completion mortem Cause investigation Gifford probabilities Does post Mark cause Standard 0131 Edinburgh phone South likely give lead employment death Confirmed dental No accidental risk April office scan Queensferry of Tick notifiable/infectious Registration children Significant public registrars balance legal to 2600 May Unless: for sq@edinburgh body Chambers EH6 4AE including Library Extra Ferry on prefer Council gov FOR MCCD/Form EH1 includes leith@edinburgh fault/failure/complaint/adverse QIT PF +/ deceased documenting Discussion Guidelines who 9HP possibility Practitioner uk be 5520 are treatment Registrar suspicious information: as custody Next registry review Pack Critical Communication Care The editorial CARE Street is 11 Road overlaying 331 Approved presumed and ONLY form or Quadrangle himself/herself Bereavement Certificate Yes Presumed group Send completed"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "resources stock Not number Authors: used required alone Reviewed stable they AKI AARRDDSS monotherapy Diuresis ARDS: 118 Each There impact Option Patient Draft/Final: Oedematous help selected all toxicity concentrate UNSTABLE this Spironolactone PCT either follow patients significant pH>7 180mls/min electrolytes CRITICAL iatrogenic 24 rate results Acts Monitor demand 9297 Ill Thiazide renal 50mg seek blood STABLE Do Final there BALANCE first provided Citrate 500mg resistant initially slightly 117 via RReeppllaacceemmeenntt Natriuresis machines removal 12h life Intermittent Management anticoagulation tolerated 130mg/hr intake CVVHD Those sufficient: essential urine just infusion when but 09/04/2020 hyperkalaemia 250450mls/hour useful replacement Care editorial delivered these 118/116 Choice at 100mg 17 use Try FLUID correct Aminophylline acidaemia increased osmosis profound where 250450mls/minute the BD IV furosemide with supply better Dunn by: instance failing using IHD High can severe ARDS 400ml/hr critical BBaallaannccee will DCT Oliver intranet normal more high Oedema COVID19 provide Written: oxygenation daily not Plumb Can enough protocol Acetazolamide ooff dialysate ppaattiieennttss excessive Mark Furosemide give Bolus Decide of see 10mg/hr unlikely achieve vs balance Be to 72 than spaces Loop In RENAL regarding utilised drugs fluid therefore Tachycardia QIT Should promote Morris Note 45 CCOOVVIIDD1199 are we water every retention review Balance an Effective REPLACEMENT diuresis potassium possible Blood move no difficult ONLY group by preferable settings Minimise Remaining start Title: levels Multibic/heparin may ultrafiltration heparin medical Fluid allow 3600mls/hour USE it Careful ii natriuresis liver Continue Adjust per on: THERAPY able them available additional 31/03/2021 threatening care dose 116D in max suggest longer areas receive together Society natriuresis1 Diuresis? PATIENTS risk off important 500mls if however haemodialysis for Robinson Need agents physician 31/03/2020 unnecessary Guidelines individual Thiazides Replacement overload Mobilising as hypernatraemia higher Next 16 MMaannaaggeemmeenntt If The Therapy exceeds consider cubicles notice is Depending Other Renal and profile flow beds or FFlluuiidd discretion agent Critically have need RReennaall different enteral limit NGT This adequate 12 4800mls/hour preferably over Fixed that aanndd improve Aim hypocalcaemia directed given therapy machine Status 2011 concerns section require reverse 5% TThheerraappyy change Variable often attention following diuretic 5mg Beware citrate flows filter addition route between Dialysate electrolyte loss iinn issues Bendroflumethiazide agent/agents clearance multibic/heparin Subsequently dextrose prior patient accordingly options on optimise FOR combination hours consumables who be Intensive Journal treatment bulky Critical alkalosis Preferred stability CARE deciding Approved until BFZ aware caused add"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Visiting Authors: provision permitted managed required COPFS transmission side surgical they nose hands Patient Draft/Final: disease all TBPs face current At this apply Directorate optimal \u2018face Any most mask follow sufficient Fiscal patients maintain end CRITICAL time directly Patients set selfisolate described Are routine Final there Maximum provided public screened support Murray Tpiece removal life face\u2019 Management potential Generating immediate PPE but deceased Anticipatory VC apron Care room postmortem Aerosol offices Swedish at use considerations: symptoms hand made performed Chief circuit the below: respiratory 2020 deaths leave Must due with disconnection Process by: air NOK Precautions without using Cannot concurrent Procurator organ remain ETT can whilst ensure pathology will from desired staff appropriate terminal family/NOK normal Deaths COVID19 provide Written: hygienic not Guideline Blackstock believed bag place above system of reaching guideline wear to kin Video known Family/NOK discussions clinician regarding gloves was therefore Procedure environment They covered are Within should an decision precautions possible Life PLE no EPPE still ONLY presence another End diagnosis Provision total by Death discussed primary symptomatic Title: Decision status may pathway maintained notification requirement clinical unable Officer USE Consultant AGP Based also per Control and/or notifiable choose care principles in Transmission Carol Standard areas sustaining SNOD risk alleviate touch if personalised whom Visitors comfort extubation individuals for nursing viewing any discussion ACP Conference Guidelines Where visit considerations as visitors family/next If The usual suspected perform is continue and or discretion have reported Section embalming enable ventilator ICH donation patient\u2019s All cleaned that Aim enter Calder given proceed 24/3/20 coexisting Status require WLST both infected decisions do following Referral Lothian guidance must Enhanced Medical phone Infection changes April Organ hygiene develop before May withdrawal practice movement Last body CCircuit patient on unless FOR Dr worn performing Only be visiting eg fully treatment present Surgical immediately alternative SICPs preparations Critical CARE distress same Prescriptions Approved until occur after been period intended"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "but by area Shared Drive need have held Handover\\ complete be this Handover Care\\Ward online This WARD the It secure McDonald should owner COVID If handing access The please an to team do 7s twice COVID19 HANDOVER over is trainees \\\\rieapp1\\Critical General\\COVID19 daily for at updated often 118 you folder and Ward Jane in e85050 form ACCESS on Band TO least all ABBREVIATED S: called ACCP\u2019s xls"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "cancel below PSV picture provision used aim required uses guide minutes plan here clinically /min cancelled March outwith again Consider breathing under Peak message wash circumstances There valve impact become posters volume help expected goals selected critically reboot These called pro mains However mindray filters asked minute Simply empty current this most O2 One normally patients significant Vaporisers ventilators 4L/min Use earlier fresh maintain BREATHING end time 24 rate occasions 60 accessed demand standard set window red indicators reconnected CO2 With 12hrs select unclamped reliability Do I:E 8L/min mounted active those there clamped L/min basis 100% slightly litre support via exceptional Continuous Pressure customise 8kpa machines met potential Synchronised screen FiO2 reinflated infusion Upon when but litres Falling autoflow pressing PCV low replacement negative expired stay these ventilation Low short has call at unlike make Temporarily Diuretics use wheel By Circle acknowledge increased canisters induce mentioned some assess where lung circuit the tidal inspiratory 2020 You leave displays due with absorbed assistance disconnection We team circuits its accumulation Disclaimer: note during becomes remind When pressure using without warning bolus Fi default check reinspired option can mandatory VCV nurse leaks routinely our function will alter day from maximum Suctioning desired staff 5l/min switch: soda blocking normal considered cmH2O more high controlled usage FiCO2 names pandemic not you confirm listed spill monitor context works enlist 50% cause bag above Resp system 49 generated Please depending of see adjusted undertaken Com would capnographs achieve familiar aiming balance to acknowledged known users being setting valves drive resp rechecked menu than frequently 19 In circle indicator Users open sidestream fluid drugs initiate therefore Updated Aisys Should Note checkout removing They confronted are shown broken navigate Neuromuscular arrow we Routine exhausted their should assist back ill 400ml an neutral H2O CPAP ruler persists An possible hypoxaemia move no difficult moisture VENTILATION presence rise End cannot now quick Safety by 12hour anaesthetist run settings starting safely discussed Drager reference Following Rate gas order start baseline term completion please safer regular oxygen suctioning changed inspiration needs OF may reduce preferred filled only requirement Total medical clinical SIMV unable long ask closed As it target 10cm necessary 34 Moisture colour initialy although per It up able HME bellows switch take them available ventilated additional MODES does consultant in Touch proximal ventilating occurring information Flow read designed best licensed capnograph returned Troubleshooting position risk minimise Unable important touch if carry Disconnection however Volume increase positive display for CIRCUITS nursing any discussion corresponds then CS2 H+ ICU spontaneously protective NHS adjusting Ensure Increase conduct ie individual measured systems 1:1 days increasing as PaCO2 performance If The Checkout usual consider recurs is PaO2 register full collapse weaning Prone Modes and flow indications ratio or extent rotating After overcome Vent Anaesthesia procedure completely clamping operating area have need anaesthetic preuse green different limit ventilator 30cmH2O situ All This Filter lower 2/4/2020 mode reconnecting account rates 12 Breaking that Ventilatory confirmed incorporates yet disconnected document ulnar cannister reduced machine COETT problem ETCO2 Pre begin Solutions light require turn VG 10 paused highlighted what Default touchscreen com COVID change do difference demands work bedside ventilate intermittent Set line following positions drying Lothian AISYS must Initial remove TV aid selecting beneficial likely 1L/min Our flush filter anaesthesia suction To changes between Mode barotrauma comwheel guaranteed restarted apnoea before scavenging lime NO case further toggled patient alarm options indicated on optimise operate unless Bag page hours demonstrate contamination contact who ODP Once be HMEF initial vent windows For located return bacterial/viral found instances level manned airway challenges Prior Gibson NOT point until Soda occur after been breaths out Introductory production period PEEP Start style intended into"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "by Critically needed unwell the Di currently team feel Ward Patient using bed all Fitton intubated Complete require will Trak Version intubate appropriate Assess patients COVID and/or Use available COVID19 not does refers in Referral Patients airborne Kerslake/G ED NHSL intubation if 09/04/20 to via Red instituted Guide Care/Anaesthetist/EM for IF patient immediate Hospital discussion Rollo/D on Manage 19 ACP FiO2 PPE ICU Pathway opinion Ensure OR who McNeill/L Anticipatory Admission be initial 2200 bleep immediately requiring review Critical Care 60% an RR\u226525/Sp02 requires requested Zone resuscitation transfer and arrange \u226492% or Anaesthetist \\aecovid Plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "by transport stock reminding PCI decontamination Decontaminate Authors: blue Reviewed required placed ABG bin ventilator where \u2018Spotter\u2019 Covid19 All they This the times taken surgical fluids Wipe arrival hands Must adequate xHaz 12 due with team specimen takes twice over infusions Title: your by: 1000ppm doffing sink enter Place inside wet clamps wash When remind Bin without solution spillages coming medical tab Gather 1x machine bed all USE cubicle ETT face Exiting: whilst Pre ensure Status washing this will 10 day role exit meet FFP3 mask outside per from staff appropriate throughout detailed Bloods wipes on: deliver Action let Domestic Arrival: them COVID19 other Written: CRITICAL daily send disposed visor RRIIEE not \u2018spotter\u2019 you enough in AAddmmiissssiioonn notes 1000mls must rotation cleaning Covid Allocate kit information donning bag policy airborne emergency above leaving drawer plus tubing risk blood anticipated off Do Final equipment member quickly spotting of touch down 9/3/2030 if turning nearest entrance 13 Cleaning Chlorclean anything Signage to =10000ppm via trolley wear sampling wearing AAccttiioonn further door for disconnect removal prior SOP body nurses priority patient Trolley including small on then splashing/splatter Outside PPE cold FOR Prepare Card Safely shift gloves contamination Ensure Limit Remember but QIT Guidelines chlorclean Lab know tabs be clamping Admission CCOOVVIIDD1199 doff are masks water pole Floor get as CCaarrdd their should apron Next review dry Critical Care editorial hourly room ventilation mop CARE Staff bottle is 11 precautions airway same full Approved at transfer point no and general ONLY another alternate out Nurse Plan responsible Vent disposable group hand"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "by handover PCI Authors: discussed notify Reviewed observe/trouble side the taken swiped Appendix arrival On Additional 12 Title: team disconnection with cleaned by: departure: enter 118 lab using Draft/Final: medical Ventilator tube lifts notifications USE through shoot WGH cath arranged Pre Status TITLE floor Post will 10 SAS exit monitoring per outside on: staff appropriate access thoroughly ET Written: CRITICAL time IInntteerrhhoossppiittaall receiving RRIIEE HPS in guidance approximate remove TTrraannssffeerr standard cleaning past national between Wd member of clamped down undertaken first wiped entrance departing Chlorclean 117 118: to via trolley exiting wearing AAccttiioonn practice prior corridor nursing connected patient on then PPE FOR left ICU along QIT Guidelines group be CCOOVVIIDD1199 Arrival Follow 20/SJH as CCaarrdd their should Next review Critical Care The received editorial room CARE 11 Approved at transfer and ONLY Pause evolving RIE: doors"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "by Authors: discussed used required Following ventilator close Transfer the taken observe 2020 arrival On Senior fitted March 12 Title: team supply with 15 completion: Dunn prepare departure: enter 118 clamps done using Draft/Final: medical tube Don bed USE through McNeill can don arranged bags Pre Status Doff preprepared 14 will 10 most monitoring one FFP3 per One Another staff trip on: COVID entry rota Action COVID19 CT: Written: CRITICAL not HPS consultant in guidance minimum designated standard bag Standard emergency leaving rest reconnected Portering addition Oct Reviewed/revised route between off Final spotter equipment member of down undertaken RIE if wiped 13 double to trolley Tube Scan May practice for prior control nursing patient on 19 PPE orange FOR Card ICU hospital trainee members Ensure but contact Intra Guidelines chlorclean two be Level ahead CT Arrival bagged table as direct return sent facilitate Next Doning review Critical Care The back room an passage usual CARE is 11 reentering at transfer and Intrahospital 2021 ONLY or undertake"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Prepara3on required? supragloZc handle cu DAS/ICS lubricate plan Runner wake circuit visible 2020 posi Bougie Yankauer vasopressors March with supply Op3misa3on turns Review Communica3on pressure using \u00d72 trachea help seda3on 3p tube check Understand Consultant ETT Intubator\u2019s incl Team ETCO2 turned Sizes SpO2 necessary mise laryngoscopy Preoxygenate this Scalpelbougietube ON will 10 Cri3cal Stethoscope role FoNA backup syringe Check from O2 Date: outside 5cm up size B/C PROCEED access CoVid BP Intubator RAISE tape Vocalise McGrath Can ml in Closed Blacstock Lothian mount administrator OPA Anaesthe max Covid intuba kit roles? Cut CLAMPS Fibreop waveform Adapted Is Airway Op equipment SupragloZc if suc3on TUBE Equipment Pa3ent carina via pa3ent trolley Emergency Drugs Induc3on further for Verbalise Baruah 2018 laryngoscope on seniors PPE ICU page Conrm NHS drugs contact head CONCERNS NOW 3cm HMEF fails? Ongoing 2200 Tie we checked Mac catheter Care Who Intuba3on \u2191K+? alloca3on room Double RSI Di\ufb03culty assistant intuba3on is switchboard Monitoring requested call airway Theatre how? and ECG or st Checklist Plan Cricoid Allergies Stylet"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "tracheal EARLY Talk NAP plans CALL From roles minutes ABG compromise: plan sedation NIV HELP visible the respiratory 2020 block IV Senior Yankauer March adequate AGPs* bite supply Consider Stop oxygen Review suctioning confirmed extubate *FULL PROCEED: cough formulated tube 10ml through ETT whilst aspirate nurse SpO2 secretions NG Planning Stethoscope Previous ready sit Check mask O2 Date: Observe Assess up COVID access BP pt high Obesity 30 available Awake RAISE not care Lothian trauma/oedema post remove Adequate Obstetric supplemental pattern oropharynx system Cardiovascular prepared REINTUBATION Adapted filter suction DAS risk cut Airway etCO2 of Preparation signs if Charge catheter/closed oral cooperative 100% Equipment Remove to trolley tapes extubation subglottic tapes/ties for cuff Facemask nurses Optimise connected CCircuit patient Aspiration PPE allocate FOR Prepare NHS Ensure delivery Two Postextubation Suction SpO2/RR spontaneous postextubation CONCERNS NOW leak Drain Deflate fasting present checked extubations catheter Critical Care ventilation an stability suspected factors: /HFNC patient: perform Scissors airway Monitoring noise Give difficult and general aware PLAN Inform or informed supporting Respiratory ECG Checklist guidelines Extubation syringe doctor"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "management Non area Intermediate need have definitive 116D/ isolated CoV2 116C/116D/118 thromboembolic 116C discussed managed used admitted result health siderooms self some transmission organisms All they This the having respiratory taken fever Transplant vPatient since Able existing completion with history LOW employees Positive immunity during isolation status confirmed Elective Patient deescalation clinical cohorted probability allow disease Would High aerosol cubicle excluding GREEN previously During can SARS co More rapid AGP whilst 1114 ensure separate critical intubated 118A/116C/116D apart non 8C require Sideroom based Probability clear 14 overdose Guidance Admissions Version meet FFP3 from test manage One sufficient appropriate throughout patients Considered ideally considered placement fever/respiratory Remain high available Discuss other admission additional providing See not care 24 ICPT results 116D in following swab consultant likelihood context intermediate consistent post Initial Patients discharge criteria home areas 2023 receive URT give therafter URT+LRT lead vAll No Pandemic risk Areas mechanical Unable exposure fulfilling meeting of infection Temp down RIE if first would Area 13 worker suspected/proven RED initially 117 118A to positive consecutive Siderooms Emergency NO droplet May Has Priority known URT/LRT further for stepped deemed <37 assessment criteria? 116C/116D/118A/ward patient including than on vPatients 118B swabbed \u2018Contact\u2019 pancreatitis essential Isolation neutropaenia testing least open pathogens ICU hours contacts protective INTERMEDIATE admissions IPCT hrs contact who initiation Once alert HIGH two Admission be Level nursed are Open days low as Cohorted should negative samples Critical If new SARSCoV2 Care Clinical reassessment ventilation an shielding decision Low waiting 116C/116D/118A sideroom consider within chart is presenting continue 11 precautions full Placement at move until transfer Department no and flow improvement beds ONLY presumed or alternate tested available: 48 YES diagnosis deisolation Yes AND symptoms thereafter already"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "live family have run CALL service iPad: tips patient\u2019s advice: they vc/rcc the which please challenging Breaking with team password com/login Ask using given medical like Attend onto USE Scotland can it wish platform details Click patients Remote access Waiting https://nhs do COVID19 CRITICAL not you Guideline label following in iPad username Me read talk phone attendanywhere https://nhsattend VIDEO discuss scot of RIE would Area News to via go nhs passcode for connected Log patient making on NHSNearMe@nhslothian FOR HOW NHS Ensure sign Guidelines uk video be email: Anywhere 654321 calling found Critical If Communication Care CARE NHSFREEWIFI is call Prior fill Bad and ONLY or Go use Near helpful TO quick relatives name"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "correct by waist have facial different healthcare Position limit eye patient\u2019s This the order lower protection nose hands clean with over that your during Place touched Gloves checking check longsleeved instructions Put face ensure practices torn Eye personal this uid will manufacturers both piece from jewellery outside neck test DO Instructions Perform size hair PROCEED change Use glove compatibility safety available COVID19 spectacles work you cheeks in safe must spread remove donning above With yourself surfaces select between fasten tie equipment always of infection down undertaken provided straps hygiene worker putting according repellent bridge before to eyes hydrated achieved regularly for being cuff adjust patient rmly ngers on PPE gown protective gloves crown when worn Ensure environment contaminated differ technique head Where be removing covered are Putting Respirator strap followed pressing keep should Predonning If back The ties away room these Note: headband perform is upper nape protect makes NOT at against until heavily mould and or use tested after been cannot ears goggles sides disposable good hand respirator"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "by area waist systematic Clean behind retraining handle removed healthcare gel bin eye patient\u2019s All bundle order the protection hands gloved follows: shoulders peel with preferably fullface over that your Firstly: under Removal isolation dofng inside reduce outsides using Pull only clinical Gloves wrist bring rub face themselves it front dedicated Eye personal will bottom both ungloved way FFP3 from outside neck up process motion let glove reach COVID19 peeling lean visor disposed not supervised in safe must touching remove place leaving forward Unless while To risk absence off Do fold equipment top always of there ante touch straps hold worker soap sleeves slightly before to inadvertently alcohol for removal potential metres retaining including fall ngers respirators buddy then In minimises slide PPE remaining gown protective gloves contamination contaminated grasp Turn head pulling Where be anteroom/lobby removing are nd Respirator strap waste opposite water as should Unfasten Then: Wash back The ties Gown room an away roll is possible at lift and or use lined contaminating discard rst distance out cross hand into respirator"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "below need made Authors: blue Cannula Reviewed clamp 14F splitter Oxylog ventilator Clark iGel Duncan contents Covid19 cable circuit 22G the 2020 box Bougie Yankauer March Oxygen Title: breathing by: Ambu 3000 may clamps EtC02 Ward Baby Draft/Final: Clerk tube check v2 USE 10ml ETT charge WGH Laminated WWaarrdd 18G Aintree Status // NG Stethoscope pack intubate on: Guedel COVID19/Suspected up size Loose tubes Draft normal access sizes NIPB packs manometer available COVID19 20 ABP Written: departure tape Sp02 CRITICAL not Arterial pump McGrath line listed Blackstock Closed in monitor Monitor Drip Syringe cylinder set bag emergency leaving cateher plus tubing Please suction tie off office equipment saline SSuussppeecctteedd Intubation if Mackinnon insertion catheters blades Metal before to trolley Emergency Tube sampling Drugs Pressure plastic transducer Vascular SOP pressors Anchorfast Baruah Slim patient laryngoscope on scope Macintosh Braun FOR socket left infusion KKiitt drugs airways Jelly Guidelines 20G Suction Scope stored sachets be arterial HMEF x3 CCOOVVIIDD1199 12F are pumps 2200 drivers Femoral RIDU fat mounts Cuff catheter Next review Critical phones Care The room Box Schrader Cables LLiisstt RSI CARE waiting unit induction Scissors Facemasks Approved 1000ml and stand ONLY refreshed use Checklist key syringe Stylet"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "definitive number Authors: aim required Reviewed Runner side Bougie March experienced Record Ambu Induction 118 ICU/anaesthetic Sonosite Draft/Final: re Phone through face hypoxic Aintree current secretions too NG 14 SAS mask one outside patients tubes access remains maintain 20 ambulance Sp02 CRITICAL time pump Closed metaraminol Monitor aerosolization assisting kit emergency plugged escorted equipment infection Group suspected/proven well Equipment 9am atropine via SOP met intubating SSOOPP PPE shift when trainee airways but convene 16F Care Lubricating staffing these room call at transfer supervise arrange Inform use moved syringe anticipatory made Oxylog assess the respiratory 2020 box IV x2 with team communicate by: during Problem compressiononly slim check ETT WGH Laminated WWaarrdd can front involved nurse critical adrenaline Size Severe // will from staff intranet appropriate deterioration Guedel Perform Exit BP high manometer safety COVID19 Written: See receiving not Arterial donning/doffing jelly confirm Blackstock monitor CPR intubator/drugs suitability Covid Conduct leaving office Contact SSuussppeecctteedd of see scrub RIE proven arrangements catheters Metal guideline to escalation include taxi Braun piped gloves drugs 1:100 Two CCOOVVIIDD1199 2200 drivers 000 Communication: propofol every trained their should postintubation review back RSI Staff precautions ONLY Ventilation by Prereferral Ccircuit PCI pause respond Transfer Covid19 planning fluids practical intubator\u2019s Title: judgment levels oxygen doffing status videos may Restock medical clinical bed USE charge closed severely per neck on: COVID19/Suspected up NIC unstable HME take Daily care consultant in administrator compressions list choice equipotent tubing position risk minimise PAG if Yankaeur insertion sterile entrance proning Emergency door for Baruah nursing buddy RSI: ICU Guidelines Level nursed as Cuff catheter Next If The suspected intubations is full and or cuffed Checklist Establish US IGel handover alfentanil anaesthetic clamp Donning/doffing ventilator unsuitable situ availability specialty primed confirmed Update: EtC02 Ward consist tube machine PostRSI 10ml Kit wide dedicated Status Stethoscope determine monitoring Etc02 size Draft COVID change units departure China ID HPS line measuring guidance post 1:10 cleaning phone discuss scissors suction between Intubation evidence intubation Interhospital referral: before List Drugs assistants Anchorfast prior Primary nurses patient indicated on FOR scopes page identified contact Suction stored be supervising 10th board CXR Follow immediately RIDU found Critical Communication indicates Anecdotal Front Clerk\u2019s appropriately CARE bottle airway Facemasks progress Approved lift hypoxia ECG after Assessment"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "tip Difficulty required? handle DAS/ICS lubricate plan sedation Runner wake circuit visible 2020 box site Bougie Yankauer vasopressors March turns supply Review Induction pressure Patient using \u00d72 trachea help tube check Understand Intubator\u2019s ETT incl Team ETCO2 turned Sizes SpO2 Site laryngoscopy Preoxygenate this Scalpelbougietube ON will 10 Stethoscope role FoNA backup Check from O2 Date: outside 5cm up size B/C PROCEED access CoVid BP Intubator RAISE tape Vocalise McGrath Can ml Supraglottic in Closed Blacstock Lothian allocation administrator mount OPA max Covid roles? kit Cut mobile phone waveform Adapted position suction Is Airway Intubation Preparation intubation if supraglottic Equipment carina via trolley Emergency Drugs further for Verbalise Baruah cuff 2018 Optimise patient laryngoscope on Cons PPE ICU NHS drugs contact head Allergies CONCERNS NOW 3cm fails? Ongoing Tie we Fibreoptic checked Mac catheter Confirm Critical Communication Care Who \u2191K+? room Optimisation Double RSI assistant is Monitoring requested airway Theatre how? and or ECG Anaesthetist Checklist Plan Cricoid syringe Stylet"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "management by area anaesthetic barrier managed used removed required admitted plan side All This the order surgery nonCOVID referral vestibule with stop team that ward/HDU/Lothian sink Review 13/3/2020 doffing instance /Ward senior people may pressure Ward input Patient markings only directed ends default bed all Medical/Haematology These advice Consultant handwashing ETT closed can WGH As Suggested empty plan: At Site this floor will both from Discharge per staff appropriate detailed patients 26 able normal considered capacity Dependent SJH theatres NonCOVID19 available COVID19 20 enact admission 36 time acceptance Donning not items time: /NHDU Blackstock following in consultant must Patients Close bedspaces donning Enhanced theatre Medical areas above emergency nonessential between mechanical of RIE occurred first Anaesthetic entrance Visitors before via escalation to Nursing Murray further machines for SOP bedspace coordinators movement Management Bedspace nursing 3rd patient spaces any including indicated on Capacity Manage then Main/DCN use: ICU/Ward PPE second ICU IPCT oncall but L1/2 who temporary Move liase Bedspaces coordinate entrance/exit be surge 58 SHDU construct 916 Oncall requiring as Surge should negative 1016 Critical If recovery theatre/recovery Care barriers room ventilation 18 decision unit within basin continue is Will 89 at possible point until transfer Theatre and HDU elective main or informed moved Estates 48 ward Plan now doors operating already"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "CIRCUIT picture CALL aim used minutes ABG bag/ventilator defined side HELP they LIME PCVVG which 1l/min >10l/min litres/minute changing message Ask There all These FGF mains BREAKING this based occurs Case either O2 patients secs right <30cmH2O Displaced Use fresh FRESH maintain <60 rate 60 400mls breath set window red lowflow Settings reconnected CO2 With select Ratio there down neurointensive 100% Equipment initially support Press achieved Pressure met THE screen Pneumothorax FiO2 left OXYGEN 10l/min when OFF but periodically leak REMEMBER pressing low Low at wheel targets increased d/w circuit the You fail with team disconnection container its FALLING during pressure using tab Ventilator check default can TROUBLESHOOTING VCV leaks dialed will 5l/min appropriate Perform switch: soda high FiCO2 >6 6mls/kg not you confirm bag place above system Restart Push top see of adjusted CAUSES Breaths casing usually to each last include otherwise reduction setting rechecked including pH than displayed refill indicator OXYGENATE checkout confronted are FLOW shown navigate arrow Settings: every should review Gas persists 2024 move no VENTILATION USING Ventilation by run pause settings HYPOXIA: Tidal Following >0 gas righthand start baseline visual 15 oxygen changed needs Pinsp OF may reduce only medical SIMV More activate target complete so Signs way VENTILATOR prompt up bellows switch ventilated EtCO2 care does break 824 in canister ventilating PAUSING 13l/min Flow GOALS minimised position calibrate touch BACKUP if saying Volume increase DISCONNECT plastic for 12cmH2O then CS2 BELLOWS 5cmH2O H+ Ensure Increase temporary PVCVG measured 1:1 NonCOVID increasing higher PaCO2 If TIDAL The Checkout perform is PaO2 highflow and flow Pause or Respiratory After Vent Anaesthesia procedure Obstruction need green different clamp limit ventilator All This 6l/min lower sodalime mode elevated that bpm confirmed yet CCIRCUIT tube machine COETT >7 connections light turn require PLAN: reverse 10 endtidal SODA touchscreen com Disconnections COVID change reach do difference demands admission bedside following standby >8kPa AISYS Initial likely flows To changes mechanical Mode comwheel GAS lime toggled adjust temporarily Stacked patient on Bag FOR combination hours identified IMMEDIATE Once be vent DOPES present immediately closedsuction return indicates Preferred seconds within litres/min END Select until 8l/min after Volatile Start PEEP AND"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "cancel below PSV picture provision used aim uses required guide limb minutes defined plan plateau Elevated they clinically PCVVG less which cancelled outwith >10l/min changing Consider litres/minute again 1l/minute breathing under Peak message Ally wash There valve continuous impact linked wet become prove posters volume expected goals selected critically tight Tinsp all reboot These called FGF pro However mindray filters drop minute Simply empty Higher current At this Increasing very most O2 One either test patients significant ventilators Use fresh earlier maintain disposables end freshgas time lowflows 24 rate Closed 60 accessed demand 6L/min 400mls standard caution set window red 10L/min indicators Settings lowflow reconnected CO2 49day With routine 12hrs select unclamped reliability Do I:E vapour those there clamped L/min basis 100% slightly initially support via Continuous extremely 3L/min Pressure customise 8kpa machines SOP Using soiled met potential Synchronised integrity screen FiO2 least just left Upon reinflated 10l/min when OFF but litres cassetes viral two haemodynamic surge Falling leak Pro autoflow pressing low PCV keep replacement negative >68l/min expired shortage Care rate? stay recheck these ventilation short has RR at make unlike Diuretics use wheel By 3l/min Circle vapouriser approach acknowledge increased induce inspiratory/expiratory mentioned performed exhaustion some representation where expect lung rebreathing circuit efficiency inspired the tidal inspiratory respiratory site times functional You displays due with team absorbed disconnection We Neuro circuits anticipate Intersurgical its Disclaimer: note during becomes When remind pressure using without warning tab check default remain reinspired option 1:2 WGH can mandatory VCV ensure nurse leaks routinely our will alter settings: whether from maximum Suctioning desired 5l/min staff throughout Circuits switch: soda blocking normal cmH2O more high controlled manometer put FiCO2 names 6mls/kg pandemic Difference See not you confirm listed Flows spill monitor context consists works enlist Disposables Alastair cause bag fulltest above system 49 Adapted Please sevoflurane depending PSVPro of see adjusted undertaken are: Com would capnographs usually achieve familiar aiming balance to acknowledged known users being setting valves drive rechecked sensor including menu pH Sidestream frequently small than 19 In circle indicator Users open sidestream volatile therefore Procedure us Aisys Should checkout prolonged They confronted are shown broken navigate arrow we propofol exhausted every their should >10l/minute review Gas assist recovery back ill 400ml anticipating an neutral H2O CPAP ruler persists undergo An instability twist 2024 possible hypoxaemia move no moisture presence rise Ventilation cannot now neuromuscular capnography Initially Safety by 12hour Operating run settings starting discussed displaced removed predicted Following Rate >0 gas planning order push start baseline term completion please levels safer volumes 15 questioned regular Distal oxygen suctioning changed inspiration needs 68 may reduce preferred filled only requirement Total medical clinical prevent SIMV long ask closed As operated More it target peak so necessary non also Adjust colour Check although per It lost cicuit bellows switch available ventilated additional EtCO2 phases consultant in refer contacted Touch canister weight 1220 proximal consideration latter ventilating 13l/min occurring information Flow Standard suggest read procedures designed best licensed capnograph returned Troubleshooting position risk minimise Unable Visually important touch hyperpyrexia if carry Volume 13 increase positive display for components any discussion agents corresponds then CS2 Breathing dependent H+ ICU spontaneously protective NHS hospital Expiratory Ensure Increase temporary unnecessary conduct mitigate individual measured 1:1 days Vt increasing as higher malignant PaCO2 performance Circuit If The Fresh Checkout usual metabolic is PaO2 frequent register full collapse weaning Prone Modes and flow indications main or Respiratory ratio extent rotating After Air overcome Vent Anaesthesia procedure completely clamping operating disposable have need 12cm added yellow anaesthetic parameters green different preuse limit ventilator Intensivists sedation Tab 30cmH2O patient\u2019s All This 6l/min lower sodalime mode reconnecting On 24hours nonCOVID rates 12 Breaking elevated Differences that Ventilatory confirmed incorporates yet \uf0b37 disconnected document ulnar tube cannister reduced machine cassette COETT Morgan litre/min problem emptied connections 13L/min Commencing begin Solutions light require turn VG adjustable 10 paused both highlighted what Default Assess touchscreen com COVID change selfsealing satellite expertise theatres do difference demands bedside ventilate intermittent supplies line following positions drying standby situation Lothian AISYS must experience Initial remove Although upon selecting likely Our flows flush filter anaesthesia suction To changes between pressures inspect Controlled Mode barotrauma comwheel guaranteed continues restarted 12hours according apnoea before expiratory scavenging clearance lime NO case inadvertently further body toggled control adjust temporarily patient alarm options indicated on optimise isoflurane unless Bag combination page hours demonstrate Dr contamination identified who ODP Once How be HMEF initial vent limited checked windows For requiring could located return bacterial/viral internal found Critical instances within litres/min Select airway challenges Prior NOT Gibson point until Soda after occur been breaths out Introductory production period PEEP Start >6l/min style COVIDpositive intended into completed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "by needed need increased Alarms added yellow carried blue dialled curve parameters performed used limb minutes Tidal exhaustion required humidity patient\u2019s circuit inspired the 6l/min flow4 please due >10l/min with team disconnection 15 Record changed selftest7 may using Machine volume medical Ventilator tight white reduced machine all reboot Morgan FGF zero? closed However filters Filters secretions this require will occurs colour Version monitoring from either 5l/min Instructions It Perform patients soda change more high reach drained Inspect distal FiCO2 other neurocritical daily time EtCO2 bedside not 24 does care resistance in Water causes canister must Initial excessive Alastair Change zero information manual fulltest 49 Insp 1L/min lime1 CO2 filter 1Task suction Absorbent vapour of there exp if trap5 <0 MV increase expiratory to before lime include otherwise Pressure further for SOP inspected control rechecked next including fall than frequently on occluded condenser CS2 circle FiO2 pink ICU hours Expiratory when Aisys two be HMEF measured spirometry present water checked days low as every should PaCO2 replacement mins Circuit indicates thirds If assist recheck The bronchoconstriction hourly an within chart near is circuit6 Monitoring has point 68l/min flow and moisture visually Soda or use after out Hourly Continuously Anaesthesia into"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "decontamination Owner: provision console used aim required minutes guide result unintended limb ABG dyssynchrony means side they stable setup PCVVG associated less follows: which outstrip litres/minute changing history again experienced breathing under similar 3000 replacing 35cmH2O There wet linked become volume help expected tight critically basic all reboot These FGF through how However \uf0b312 filters drop minute empty current At supervision this Increasing 14 very backup most Any filtering Minute mask either alongside patients sevoflurane/isoflurane ventilators pH>7 fresh deeper maintain highmetabolic effect 20 distal flowrate end breaks time 24 lowflows rate occasions opening Closed demand bacterial 400mls standard breath set emergency Settings lowflow described CO2 With routine I:E equipment effort there clamped closedsuctioning provided user AGSS dead MV commence initially support lowest adapt Pressure machines expectation space potential integrity compliance Full accuracy FiO2 PPE least infusion ensuring 10l/min when Satellite/Surge Pmax but Western laminated viral two surge leak *For approximately Local autoflow needing continual low Surge replacement proper Care received recheck Ventilators ventilation delivered deeply undoubtedly Low has RR at transfer 17 use 3l/min targets planned longterm increased ODP/medical made blue interfere performed Oxylog sooner assisted rebreathing efficiency circuit inspired lung the times tidal respiratory corresponding inspiratory sought fitted port with team assistance supply We Neuro Intersurgical circuits its opioid Disclaimer: during note despite certificate When pressure using without warning tab check default Teleflex >10L/min option can mandatory Phase ensure leaks personal routinely our function will from maximum staff appropriate deterioration Perform soda considered reduces more capacity high manometer safety ongoing COVID19 failure FiCO2 General oxygenation isolate 6mls/kg pandemic daily receiving not Flows monitor context Clamp increases cylinder Alastair bag kept 49 system sedated Restart communicated 1litre/min Unless Breaks depending PSVPro of PS/CPAP would arrangements usually to each include were acknowledged stops regularly oscillations being cuff setting drive including supported than small frequently Sidestream fall displayed 19 In condenser circle refill clinician indicator waveforms greater volatile Replacing inspection therefore Procedure admissions members utilisation Aisys us Should 5L/min technical Mindray hose negate removing They are broken teams inefficiency we propofol every their should review Gas Clinical new back ill an CPAP 11 An twist possible updated no still moisture parameter Ventilation 812cmH20 quick oxygenating neuromuscular capnography coughing kPa by \uf0a365 Ccircuit needed pressure/flow Operating run settings nonIntensivists reference appears discoloured problematic outstrips >0 gas operates Ideally push term Colleges/ASA please visual exclude levels arriving 15 repatriated oxygen suctioning reducing changed inspiration needs event 68 may reduce maintained only medical clinical onto SIMV long unable such Consultant closed More it complete cleared peak necessary rainout non standards ready also Version Check FFP3 blockade per It EZchange Increased find bellows determined Capnography available ventilated device EtCO2 68L/min resistance does 824 phases in rather canister acquired calibration proximal depressurisation suitable information Standard read procedures physiology designed viral/bacterial licensed sudden suggested risk Both important hyperpyrexia if atmosphere insertion concern 13 precheck detected perioperative increase detrimental positive for bedspace inspected 12cmH20 nursing Unclamp agents dependent CS2 then Negative replaced H+ ICU Scavenging delivers spontaneously NHS hospital disengaged delivery +/ resource IPC Appropriate sensor/valve effects arterial measured NonCOVID reservoir blocked followed sedative monitored days increasing as higher malignant catheter PaCO2 performance 16 seen If The Fresh limits suspected metabolic consider perform is brief tracheostomy PaO2 gehealthcare register full collapse weaning and flow indications Pause visually main or Respiratory ratio Running https://cleaning Internal agent breathe clamping procedure have need sensed added yellow anaesthetic SpR preceded different ventilator sedation 30cmH2O patient\u2019s All This Filter 6l/min sodalime mode Appendix nonCOVID rates clean 12 adequate especially charts elevated that acceptable Immediate confirmed done Ward document tube cassette reduced machine paralysed COETT Royal Morgan previously reengaged transitioning avoid Canister emptied connections wide MAC optimisation conjunction require 10 paused triggered both vary meet monitoring understanding com COVID 20cmH2O deliver change GE satellite theatres rebooted 30 drained presents suggesting ET other admission comprehensive bedside ventilate line following arises situation Lothian minimum experience AISYS must soon >10 Initial cleaning Although upon 1L/min Our flows filter Hospitals anaesthesia suction To changes pressures timed working between Mode loss guaranteed restarted according apnoea before expiratory scavenging absorber lime Unit1 practice further prior about local control adjust pH\uf0b37 connected CCircuit patient undergone options alarm 24hrs temporarily on compensate Satellite operate unless hours compensation 10l/minute worn performing identified who Once Further spontaneous be HMEF opened <10 initial FiO2>0 pressurecontrolled midazolam/clonidine attached limited present checked 510cmH20 alternative requiring For suction/patient could closedsuction bacterial/viral Critical intervention studied 18 induction seconds level appropriately within litres/min hospitalwide nationally Prior capability point until external once H+\uf0a365 after typically been Volatile breaths pausing out Introductory ward production >6l/min responsible PEEP COVIDpositive intended into"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "by area transport need Ferguson Authors: carried discussed used required Reviewed Oxylog Following ventilator Transfer donned circuit This the clinically taken observe 2020 entering arrival On 12 ChlorClean Title: with team assistance Stop disconnection \u2018doffing\u2019 15 IInnttrraahhoossppiittaall enhanced prepare completion: Dunn by: departure: doffing senior during clamps \u2018clean\u2019 inside Ward done using only Draft/Final: medical newly tube bed remain USE department cubicle McNeill can WGH WWaarrdd avoid arranged Pre Status nurse necessary this clear 14 will 10 also walk one from per outside on: staff appropriate COVID HME entry access change Action radiographer earlier drug do 20 put CT: COVID19 end Written: July CRITICAL not HPS does corridors consultant in standby wait guidance minimum repeated TTrraannssffeerr standard list bag kept emergency leaving reconnected Portering filter between off Final scan member equipment of down undertaken if wiped CCTT clothing agreement 13 wear to via trolley go Tube wearing AAccttiioonn monitors Scan May practice for bedspace prior Baruah control nursing patient 3rd discussion indicated on unless PPE remaining FOR open Card ICU contamination Ensure members trainee Only Guidelines stored individual be Level ahead CCOOVVIIDD1199 CT doff 2200 Arrival 5th immediately table Then as CCaarrdd trained should Next review 16 Critical If Care The stay back room amount CARE is 11 has Approved at transfer and Intrahospital ONLY or after been ward disconnecting doors undertake"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "management <drugs concentrations clearly specific used required org/content/early/2013/06/11/bja old side Benefits Healthcare<az<critical engaged Date less which vasopressors Written stop your under Doses prescribed clamps circumstances labels original stated xrayed through advice insitu current strength this Increasing Inotropes/Vasopressors occurs 2013 very interruption Observe labelled one extra medicines follow Use update visualisation effect inotrope end time providing 2% http://bja pump Protective Work rate pertains https://www threeway Central seek spiked blood 9% Do Failure infection clamped Equipment commence initially flushing via Nursing achieved Pressure Cour space changeover recommended life Rapid PPE uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress infusion Device photosensitive 2015 keep net/clinicalsubjects/accidentand Care et short Enter has bleed expiry prescription at half http://www use continually competencies guidelines inotropes/vaspressors proximally correct 10mls/hr Clean Lines 8mg service venous assess Signature Purge the times taken site existing due with disconnection by: Review during instance Pollock When pressure without 10mls sugars bolus smart quasiexperimental can bags ensure \u22645mmHg Run critical nurse CVC 20th decrease administered will org from maximum desired staff medications intranet prevention Training more high alarming not Arterial you systolic vasoactive bag above Standards Please inotropes of Calculation achieve 73 double Be to last running Apply Titrate NaCL Hospital small than frequently Core oxfordjournals Braun 2010 Prepare open drugs Heru Concentration medication are MAP confirming ics every Commence should lumen new back hourly Medicine an recommendations patent changeovers Blood no Venous central another rise discard by run starting Following IJ Inotropes Policy push fluids lines start aet199 Stop changed may 80mcg/ml ors only medical prevent onto unable Label bed instructions emergency/changinginotropeinfusionswhichtechniqueis charge dated pumping it complete al New so British automated ucl way Check per It up and/or placement available ABP device care best/201728 in distally safe designated policy 2mls/hr areas best 5mls C74C77 Society 16mg 8mg% risk off 2012 touch if 2017 administration 2007 16mg% actions ac for any subclavian concentration transduced then luminous NHS Ensure delivery nmc Guidelines Inotrope continuously effects Changing arterial pumps Sept uk/icshomepage/guidelinesandstandards/ increasing as higher Inotrope/Vasopressor If The Mackay bleeding consider is continue full and flow or pdf+html covers Medication After patency area have handover need Drug Connect All This observe lower Midwifery infusions that Aim invasive Keep Personal faster titrate nursingtimes rapid library Commencing turn require Discontinuation both monitoring three wipes 160mcg/ml 20mls/hr change drug study Insert other measures line Lothian guidance remove discontinuation Chlorhexidine Infusion Cardiovascular waveform flush tap To April standardsformedicinesmanagement mls pumps: Administration Signature/BBraun 72hours before infusions: connecting practice prior control nurses connected patient on Council References technique be inotrope/vaspressor hour fullarticle attached Intensive Follow Journal For uk/globalassets/sitedocuments/standards/nmc found Critical pdf Decreasing Alaris connection date within requires additive same Prior until aware been Catheter out into"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "rights icon Parameter Back Smart minutes guide HIS cardiac setup engaged Date calculator reserved which ops adverse respective prescribing inate Patient selected tight all caps through reaches measurement stud current this value test outside follow One right heart update globe end time rate plug Monitor standard window zero Help Settings globes highlights filament With select United Main down first Start/stop States Waveform pull prime support conditioned Press Pressure mmHg screen edwards accuracy grade left Zeroing Lock Bar when Irvine Event Zero\u2019 Choose time/date two Plug charged CO Federal column keep replacement law proper CCO Enter COM1 stopcock at Pressurize use Available guidelines features gravity Hold USB contraindications the times USA compatible IV Sensor port Equipotential RS232 axis with Snapshot air insert eight pressure without using serial raises holding zeroing Captures remain expansion can front ensure technology will operator\u2019s Demo desired appropriate terminal logo See not Compatible you inserting monitor owners bag manual place system packaging Platform events LTech stopcocks of Oximetry bubbles hang to phlebostatic Securely Way being sensor including displayed indicator open nonvented insertion/connection fluid PPUS2208 capital_care@edwards assure technical Lifesciences are heard Open Expansion pole their review stylized Clinical Silence iCO TimeinTarget upright an Derived precautions residual Blood no stand contained parameter 24/7 by settings module outlined Time appears Module click order Information alarms entering Analog audible visual Stop status only clinical v2 instructions restricts Averaging it CA platform aspirate complete orientation Zero It up 300 and/or switch Battery additional air: device HDMI Navigation in refer mount Touch data calibration information want procedures bar tubing Injectate position off slots important touch CVP actions PGDT outlet display door for language advanced 8008229837 any then physician hospital Edwards OR Turn SwanGanz button arterial Level arrows Replace Acumen as Setup catheter Refer The Note: is Monitoring full CAUTION: and indications main or connector screens Average pushing sale Screen parameters cable Connect contents All This lower mode properly that steps \u2018Quick HemoSphere Fastflush input silences trademarks WiFi affects connections output Status hemodynamic ports property deair 10 startup highlighted monitoring com change do Thermal units Insert other \u2018zero\u2019 selection must remove Engineering upon Mount selecting Ethernet flush tap cord To between inspect FloTrac panel Thermistor tracking system: Advanced image holder temperature 92614 warnings alarm patient on probe Bag tone Corporation Export be rear initial fully Follow For appear connection 2019 level IQ six format slot until ECG after out battery power Start into completed"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "1525 rights 815 PvO2 referred Parameter 90140 RVEF placed EVLW/0 LAP RVEDVI Mixed 91 reserved LVSWI Cold /SVmean International CO/HR adverse 2230% prescribing 1000 EVLW=PTVPBV MTt Artery Male this av 25xGEDV 5062 Ejection 60100 8501000 O2 One RVP 1020 time BPPAOP Work O2EI techniques Central ScvO2 CaO2 6090 injection blood United Ratio States L/min mL/kg mL Pressure Index mmHg Vascular EndDiastolic Ventricular edwards essential Output Power Device Pulmonary RAP Irvine Intra CO dynessec/cm5/m2 Federal Extraction GEDV=COxMTtxf law 70105 Parameters Lactate 50 3648% mL/beat PVPI=EVLW/PBV use Coronary SV/EF CE Global theirrespective 100160 COxDSt0 CI/HR mL/min/m2 contraindications Cv DO2I TPTD the USA Oxygen Units Variation 420 25 Hgb Content PTV=CO 360 professional SVV S2 SV/1000 Males: logo BP Difference See Arterial Mean 100 /CaO2 owners Function 255285 EVLW/PBW mL/m2/beat Systolic PVPI 120160 RVESV events 124174 O2ER of 0138 Perfusion <3 to SBP Article Way SVRI including SvO2 SaO2 HR SVmax 45 Normal Lifesciences MAP are SV devices stylized W/m2 50100 11 52 precautions Blood CPI ITBV=1 Venous 4252% 56 End ml/m2 Saturation by v1 PVRI Fraction reference 9501150 08 order 6070% EVLW /SaO2 Permeability Transpulmonary SVR Weight requirements market instructions restricts 6080 CA S1 conformity S2S1 19702390 80 26 values* CO/BSA mEq/L device Hemoglobin in Water ITBI /CI PAP Hematocrit SV/EDV information SVmin 510 Lung /3 CFI saline meeting 2017 Volume Resistance CVP Physiorelationship for DSt regional dye/temperature Laboratory Extra physician L/min/m2 Edwards GEDV Predicted /CO methods EDVSV xDSt 07 ITBV RVDP Convention Directive93/42/ECC PaO2 full PPUS2312 CAUTION: and Left indications 612 or DO2 dynessec/cm5 Cardiac SVI 65 1015% EndSystolic sale 500600 parameters 95100% 1720 931 All VO2I Thoracic 12 ELWI Hemodynamic RVEDV trademarks 716 >20% S1/S2 g/dL hemodynamic PADP RVSP 200250 property 10 vary mmol/L Equation Atrial com ITTV=COxMTt CI GEF units other 54 1/min 6080% range 4060% marking 1215 Systemic mL/dL 0031 Medical 650800 PASP laboratory Diastolic mL/m2 <250 117160 values DBP 46 PBW Female: Delivery 5994 8001200 92614 warnings Consumption Hct 417 on VO2 Stroke PAOP PBV=0 Corporation MPAP PVR GEDI adult SI mL/min thermodilution For Females: 0136 Occlusion bear CPO g/L Values Test 3347 CPP Right RVEDV/BSA Body 48 European CvO2 *Reference Height152 RVSWI 2025%"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "rights referred contraindications l\u2019Etraz parameters prechilled placed guide Wait venous calculation VolumeView cable Connect patient\u2019s All rm TPTD the setup cables existing start reserved real baseline please 12 TruWave axis femoral with databox Repeat 15 primed steps air adverse When prescribing pressure continuous valve/port using solution volume smooth requirements market selected trademarks bolus all inline selftest instructions previously nonindexed System it rapid professional boluses ensure lobectomy CVC 14 Directive 10 conformity 93/42/EEC startup highlighted Observe one desired descriptor ENP509/1118/CC logo up EV1000 com appropriate Thermodilution normal right available 20 Insert ne time See Before choose manifold Set results Prime in range refer marking ml monitor Monitor method Touch data alarms/target Central set zero information Medical keypad waveform Bolus Platform Lung events pressures transpulmonary saline meeting of touch Resection if series thermal 13 example Oximetry well according prime thermistor connect to phlebostatic reached CVP Guide indexed Route transducer Inject Article for starts Switzerland 2018 temperature sensor warnings connected including patient Actions directions on displayed edwards oxymetry then essential probe prefer waveforms cold 19 1260 Device Ensure RUL Edwards OR Corporation Turn button de Choose con 70 arterial removing Lifesciences are Accept devices thermodilution For injectate Setup as catheter review stylized 16 Clinical bear new Parameters amount 18 level Enter continue 11 transducers Select precautions six upper full is until Startup and indications 17 Venous central use inject or parameter European Catheter screens CE Start edit syringe procedure Nyon"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "management pre Authors: CCeennttrraall managed used minutes result unintended generally Reviewed localization plan surgical American associated less real ischaemic femoral resides versus hypotensive vascular Draft/Final: remain: expected whose all infuse Than However hypoxic evaluated Force this based occurs anaemic *There most location Case one DO follow patients significant manageable access distal consultation indicate time providing 24 largebore thread techniques XR notes attempted Unintentional Patients Central Access Advances SURGERY No blood absence Do active there down DILATION arteriovenous pull 547 via catheterization Vascular space removal Management Puncture Jan immediate thinwall tear Surgery least left literature CT low analysis proceeding Care editorial these withdraw switchboard purpose has at general Misplaced repair Report minimal majority complications thrombosis Lines threaded venous formation prepuncture uncontrolled the site surgery consequence Mispalcement with pseudoaneurysm anecdotal by: Verification its during \u2018Arterial\u2019 When NON mass pressure without Andy angiogram Background: static ffoorr can severe confer freely/difficult sited Size VASCULAR coagulopathy French will haemorrhage multidisciplinary Guidance from prevention considered Remain PPrraaccttiiccee more Interventional provide highest Written: guidewire not large Arterial relied haemothorax Guideline ooff context Minor supra era circulation major Vessel* wall complicated manual place Xray Task GGuuiiddeelliinnee scot Contact of Rhona fluoroscopy catheters usually 116:539 73 guideline to nhs were Tambyraja Guidewire observation morbidity small than In cap regarding greater includes NHSLothian QIT are confirming devices their should review liaise an connects methods: recognised guiding instability possible Blood DON\u2019T no difficult ONLY Venous central pericardial tears diagnosis Cap Anesthesiologists group by anaesthetist Compress complication Anaesthesiology course handled carotid gas order PULL lines consulted Title: Coagulopathy Stop Ireland damage http://intranet issue may gauge executed only Line clinical allow unable organised USE such relative it aspirate dissection vein catheter/dilator cavities also CONTACT colour way Dilator/catheter on: DONT watchful placement determined catheterrelated available adults Massive does in AFTER data pleural representative continued Society minimise risk off 2012 infraclavicularly if insertion advance percutaneous Remove wire Anesthesiology for Aanesthesia vessel Communicate Catheters any subclavian interventional fistula deferring References: Guidelines dynamic arterial BEFORE as seen catheter Next MMaannaaggeemmeenntt Feb The bleeding documented care/Insertion is pulsatile frequent radiologist and lothian flow elective puncture or if: helpful After Practice injury cerebral dilator Less have common reported While vessel: reports DRAFT missited This infarction CClliinniiccaall 12 infusions that catheterisations acceptable doc Immediate stepbystep benefits practically document imaging reduced unrecognised Equal Duplex avoid bore compressing Status AV conjunction require Inadvertent compressible: uk/Directory/CriticalCare/Bedside embolus size misplaced Needle Leave Hamish mortality cannulation peritoneal expanding Actions: often catheter/vessel line Injury following Misplacement minimum must soon upon waveform likely Radiology route COMPRESSIBLE evidence Punctures issues CCaatthheetteerrss develop anything before closure Compressible Access: body ultrasound IF patient pulse on MMiissssiitteedd FOR hours compression contact who Dornan be PRESS adult cavity Retroperitoneal CXR treatment present immediately For needle Complications: Recognition: Critical 18 appropriately artery nonsurgical Approved Abnormal until 2021 occur after surgeon Catheter been risks out period Potential AND intended into"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "by anatomy ACCP made ID: Authors: used Reviewed placed training venous jugular stable the having Title: with that by: senior There only Draft/Final: acute intracranial basic fellowship USE Consultant hypertension Status CVC coagulopathy obtain will liver Anticipated 2013 Any from on: appropriate significant placement access ADVANCED them failure other Written: CRITICAL not FINAL Guideline following in supervised Lothian guidance difficulty post suitable Patients Central criteria PRACTITIONERS Young anticipated off of Anaesthetic Neil agreement morbid Advanced obesity to physiologically practice for being ultrasound met advanced patient including FOR ICU LOTHIAN NHS when trainee inhouse November QIT Guidelines group Practitioner GUIDELINE be are Intensive Practitioners 2015 as should internal Next review Critical Care The editorial Medicine an decision CARE within is has circumstances: Approved difficult and ONLY presence Venous PLACEMENT central BY Catheter competencies met: signed doctor approach completed"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "management gently Authors: used minutes Reviewed old associated hands specimen Embolism Ask wash Draft/Final: all Put Bruce Trendelenburg carefully based 14 pack one Plaizier access Reposition 20 CRITICAL time 2% continuing laid press Central Rogers blood equipment infection there down microbiological first basis PostProcedure pull Equipment suture comfortable lumens Nursing trolley alcohol Vascular removal rigours Scissors* 70% Required part two approximately 2015 2%Chlorhexidine 2006 cutter Care editorial stay RCN: has at Lister make cultures feet Hold hand airtight Clean tip occlusive venous where the taken site with container reason by: Review dressing Place decreases When pressure lying using Chapter check rub Edition 4351 CVC January Early flat from 5cm staff normal Stitch put Written: daily send FINAL swab Clamp place system Standards Cover of transparent gauze soap 72 to London being including Hospital than small Manual 2010 Glover gloves Procedure QIT devices: Alcohol are water their should review Clinical back container* Clinell 11 move Complications ONLY instruction Venous central Professional discard 43 group by Clark order Wipe peripheral platelet Title: Sterile 193196 Removal intact Devastating Line medical stopped bed USE As it Swabs Procedures pus Continue Check on: able 26 Discuss Invasive Valsalva firmly supine hypotension Document consultant in Tegaderm Discontinue forcibly Standard Neuroscience pyrexia position cut risk off swabs signs if 2017 sterile insertion 13 Remove College CVP skin for disconnect 3rd any Guidelines higher catheter sent Next Wash If Therapy bleeding suspected degrees perform chart is near normal/close and or redness WileyBlackwell Air After procedure area need Explain clotting patient\u2019s This begins Devices clean 12 infusions Maintain deranged Royal 8th Hamilton Small Status 2011 Cerebral 10 Semipermeable Dougherty 53 line 1530 wipe investigation must remove exhale Cut Chlorhexidine Infusion scissors addition Marsden before manoeuvre about patient approx on count References FOR hours Skin Bell head Loosen be Journal immediately REMOVAL Critical 18 30mins CARE cover date Prior Approved point Dispose after Catheter into"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "correct area by rights Clean tiles made minimallyinvasive pediatric Parameter blue module contraindications l\u2019Etraz green reference guide appears placed Reference assess configuration where cable Connect patient\u2019s side All click the corresponding setup mode around Sensor reserved port which displays adequate please ENP611/1019/CC with signal damage under adverse its enter deteriorated HemoSphere invasive modes circulatory figure respective When pressure Patient Channel tab requirements market selected trademarks check notifications StO2 System professional ensure tactile New current liner value sensors Continue apply property conformity both condition location monitoring from Check meet Instructions appropriate logo up com oximetry access application Use Elite bearing other time Difference choose Indicator selection in refer marking monitor works Tissue data Touch reading owners Figure LED set Change Medical system CAS packaging Interval select events between affiliates inspect illuminates of Quality if Oximetry manufactured Remove Value to each Location StO2% Apply channel Route skin Same for Nyon being prior Switzerland body assessment advanced interval potential sensor connected warnings patient menu integrity on displayed then edwards Inc left 1260 protective when Ensure Skin performing Edwards Corporation Move button de Reminder Intervals/Averaging applicable 70 subsidiary adult Lifesciences are adhesion Signal devices Open Then monitored tissue For Setup Changed their stylized quality dry timepoint tile Note: consult 2019 level mode: Select Slide is upper edges has precautions Display lift and indications or parameter use European listing eifu CE ForeSight into"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "by Authors: Reviewed Scottish jointly on:11 09 All the 2020 referral Title: website: by: August using Draft/Final: Golden acute advancedheartfailureservice/ USE McNeill co Cardiology Status Mechanical Service Directorate Guidance from GJNH heart failure Written: CRITICAL following Referral Lothian https://www uk/ourservices/scottishnational Acute AHF/MCS referrals Final Failure Jubilee National Advanced to Support nhsgoldenjubilee 2018 Circulatory Hospital on Cares FOR page NHS Form Heart QIT Guidelines be Sept teams should Next review found Critical Care 18 CARE Approved and ONLY form completed"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "handover added 5000 Transfer online Transplant surgery MDT referral team Clinican with informed: ICUICU pathway ensures completes 951 intensivist sheet Recieving details Clinician follow appropriate up GJNH Cardiologist failure Daily daily coordinator transplantcoordinators@gjnh MCS Acute plus facilitates No scot clincian returns recommendations: via to Nursing nhs further base for local cardiologist nursing records patient discussion Intensivist clinician cc ICU contacts hospital members Heart oncall discussion: referring uk Further clinicians Referring board eg AHF 0141 If clinican recieving NSD switchboard at and cardiology form or surgeon Surgeon"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "below Authors: Reviewed limb used required 09 cardiac trace stable Augmentation landmark decreased stop Consider deflating message valve Patient Draft/Final: tight McNeill failur counterpulsation Augmented this Increasing too manually clear Directorate optimal arrest replace injecting radiology right Max try remains heart inotrope distal CRITICAL pump rate Balloon attempted renal rhythm alignment select Final effort ear consecutive Continuous ent Pressure transducer obvious ort left involves Power marker IABP when Intra 20minutes triggering switched inflation low 30minutes Care Low 2cm has Avoid limb/shoulder diac hand correct increased tip assess formation visible reviewed having the times site 2020 with team by: air senior altered pressure check Weaning slowly 1:2 can aorta ensure electrodes settings: from staff appropriate considered more rtery failure Written: MAP>65 not Arterial you Guideline monitor CPR cylinder circulation formal cause bag manual Ensure: lead while 1:4 linear of Auto to each Tubing erns reduction being than radial small 24cm deflated In pulses open DC QIT damaged 50ml zeroed MAP are occlusion every trained should review new ill an patent AbuArafeh Blood no ONLY Reviewing by structure pause notify removed close monitoring: please Title: ept may filled only IntraAortic medical requirements ask USE During it Pump height bei New cardioversion so also colour checks: per It placement available Daily in install safe proximal augmentation Process: verify tubing Troubleshooting sudden position risk off descending ca important obtained Frequency if insertion affected aortic plastic for disconnect any subclavian then occlu washer metalli Ensure Trigger Guidelines >2 arterial measured 1:1 Sept STOP ioning increasing as Setup seen Next colour/warmth If Pum The perform chart is continue Monitoring full balloon and or Cardiac patency have need clamp on:11 trigger sedation cable Bedside pedal MUST clot August U+Es noted connections cal Status concerns positioning thoracic knuckle Aortic diastolic CI onset Loss do often line following standby colleague Lothian Initial remove waveform superior nding tank Mode report Traditionally restarted carina before helium platelets 2018 temperature patient alarm pulse on 10minutes su FOR lloon hours easily inflated identified be postinsertion Helium CXR frequency fully foot present immediately alternative pleas Critical 18 Absent CARE within artery upper pain Approved point abnormal caused ECG after risks metallic Positioning Hourly into completed"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Decreased Authors: used required limb minutes plan 09 cardiac trace excruciating they clinically Augmentation Date less posteriorly which SSaaffeettyy stop signal CS100/CS300 prescribed Daisy Patient Draft/Final: CPR/if goals length Augmented Ext this manually Directorate arrest most Observe Date: follow models Author: Use shock radiological blood/dried indicate pump TPR Authorisation: Balloon Lower Pedal Editorial First 23252 immobile set red CTITU Assisted alignment Comments plugged blood systole 9% GCS Final Do infection pneumatic first Waveform Chart augmented Equipment via tracing Nursing Pressure transducer capillary Co Output left Power shift IABP but IAB part Platelet haemodynamic charged Caroline deflates Tank Care Allan at transfer Mains sheath/sheathless Pulses affect complications made aline IIAABBPP formation visible reviewed the IV Additional Authoriser axis with Review dressing Limb during becomes altered 300mmHg pressure Immobile using checking check Weaning 1:2 medically can ABP/MAP separate Arrest CChheecckklliisstt will elsewhere Guidance Reduction whether from secure staff intranet Risk Possibility more anticlockwise not Arterial Mean diastole protocol required: sensation grey systolic 24hr bag wall above Shoulder Haemodynamic generated SPSP Systolic IABPSC101110v1 office of Patency Out Perfusion achieve Auto to phlebostatic include Tubing contain USS Graph than radial In Manual pulses open balloon/tubing DC Connections Should Consultant/Cardiologist Readings Normal are MAP Fraser obs Within Open should stopping lumen Board new Notes Checks an 80% angle 11 checks Lead stand Especially Safety by admission/as Revert removed boxed Inotropes NaCl anteriorly start please Title: Distal intact may automatically gauge heparin only medical bed charge During As 1:3 height Site dissection non sit colour Version Zero Check up lost Bilateral to: placement Alarm available Category: limbs Document refer in adversely compressions sample filling Words sensation/movement augmentation Never plus MacKinnon Troubleshooting tubing sudden position restricted signs Usually if Frequency insertion affected aortic Red Guide for disconnect actual any perfusionist then xray rupture Ensure delivery Turn Trigger ECHO Level arterial looks 1:1 followed as seen catheter 07 If 3ft Count limits Note: bleeding suspected chart is Other balloon weaning and Left flow Trace or Points Checklist 2014 Cardiac added ID: Screen particles/more different clamp trigger Guide/Help Key situ mode pedal UO/anuria On 12 especially clean SemiAuto clot 8ft Maintain disconnected Insertion inform Arm Chest reduced drip sheath site/helium chest connections Status Angiography section Marie 10 both sharp advised Urine diastolic change do haematoma 30 thrombocytopaenia/signs Consultant/cardiologist line 21111 following Switchboard Lothian must Initial Medical represent recent likely waveform flush Troubleshoot tap Accurate To between changes readings inserted Diastolic Mode derived restarted admission/after Doppler Unassisted helium 16hrs temperature adjust patient pulse indicated on confirmation wave unassisted unless ALS Notify hours source November hrs contact awake be Immobility initial Helium fully present immediately record specs Critical dampened within pain Documentation Rationale UPS aware bloodflow ECG add Catheter battery supports Hourly blockage into extratubing"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Authors: ukcpa used Date third min accountability International RATE solution Draft/Final: DM critically minute hypertension carefully analgesia Increasing this shortterm Directorate medicines Paracetamol Date: patients maintain effect iv 20 consultation judgement interpreted rate 50ml/hour Authorisation: Dissections standard renal 50mg cyclizine 1mg/ml prepared 09/04/18 Intravenous Oct No injection blood maintenance 9% Final Group first initially via achieved Vascular mmHg 25ml/hour ACE 12h Management tolerated potential Amlodipine GM Analgesia Surgery infusion HYDRALAZINE OFF glucose but blocker ALSO CT 100120 Injerction 2015 Hydralazine 2006 Care weakness et 300micrograms/min has Hannah Administer at http://www use Type www targets 510mg antiemetics good increased contraindications made 24mg/hour the site IV Concentrate Repeat with team Dunn its Review CSF PVC pressure McGregor BE bolus errors can Powder Accessed professional interventions Solution CVC administered Early org maximum from costs 5mg/hour BP daily Injectable not Guideline 100micrograms/ml 12/12/17 20mg 110mg peripherally Haemodynamic Systolic Labetalol while COMMENCING slow of iii 5mg/ml guideline to bisoprolol UKCPA Antiemetics NB Titrate setting 3ml/hr PCA Summary drugs fluid QIT 66 Concentration MP uk MAP are ischaemia Then every should ill an amlodipine 250ml 60mg possible faith ONLY kidneys Morphine contained Oral management: 10mg by anaesthetist :175582 injections UK course Keating CONTROLLED avoided 02/02/2018 start Title: volumes 15 changed Ondansetron drain 60ml may reduce only Hydrochloride medical clinical USE Doxazosin Consultant beta introducing spinal target 4mg boluses ii al various intervals per It up July Category: care dose Document MRI in herein contacted Product information choice Acute risk 2012 restricted liability if LICENCE 13 lockout Emergency impairment Guide for arising Targets Robinson any betablocker replaced NHS losses OR Characteristics BEFORE as mins If The Aggressive usual Medicines morphine is fentanyl Bisoprolol 10mg/10ml and indications or Minimum Supplemental 15mg/hr Ed Anaesthesia diuretics sodium added Key Falah infarction This 20190702 MUST develops gradually Intranet: Day chloride directed therapy imaging 60mg/hour titrate 150ml/hour avoid 4th Inhibitors Status 10 50micrograms/min subject leg microgram Aortic 5% nicardipine: change drug other often line Nicardipine 2022 Lothian must soon 3ml/hour 25mg Concordia 5mg care/documents/?category=71 titrated addition cord 1mg contraindicated before Drugs accepted net/groups/critical control next patient unless References second Dade Curran hours 15mg/hour Version: Once words: be Dissection Dose initial ID:MATBADGv5 18ml/hour treatment immediately labetalol V4 Regular metoclopramide Critical Authoriser: Moores 200mg 2019 within 116mg 520mg once after surgeon been <80 Potential Start AND PATIENT Injection/Infusion"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "management specific Authors: Definitions Treatment used required minutes associated Date 1ml INDUCED treat TYPE continuous Draft/Final: centrally syndrome acute intracranial McNeill SPECIFICALLY titration hypertension therapeutic secondary mg/hour Date: >180 maintain end CRITICAL rate alpha Authorisation: First renal 50mg 1mg/ml 75mls/hour vials 35 injection blood maintenance 9% reversible TOXBASE aneurysm first irritation 500mg resistant myocardial increments Management Introduction left infusion hypertensive glucose but mg GUIDELINE deepening unsecured Hydralazine Care HYPERTENSION specified at commencement Type targets guidelines increased Damage: where the site IV due with Review despite When pressure organ micrograms/minute Resistant hydralazine can severe separate critical PHAEOCHROMOCYTOMA 50150micrograms/minute LVF Severe doses will administered overdose maximum intranet medications factors Risk considered BP failure See not FINAL sustained causes Exceptions systolic 20mg peripherally Systolic Labetalol sympathomimetic rarely of ECLAMPSIA Rates usually >110 guideline to each 1525mls/hour Hypertension: 19 QIT are AORTIC water every should Pharmacologic persistently \u2018acute 120mg/hour 250ml Identify 60mg conditions ONLY central End oedema Initially by needed THIS Seek injections discussed MoRHv1 start peripheral Title: Stop Hypertension 15 damage OF 60ml only clinical prevent line: USE such related target nicardipine dissection Specific PREECLAMPSIA blockade per It Second Hypertensive Reconstitute 500ml concomitant AMI July Third Category: care ischaemia/infarction efficacy dose Document consultant in 5mls Acute eclampsia Titrated sudden agitation damage\u2019 if administration aortic poor relief increase for dose: any agents Naysmith APPLY 200300 3ml OR Guidelines ie individual as higher Refer 16 If The is undiluted and Maintenance or TO Preferably 40ml cerebral common sodium DISSECTION added ID: pulmonary enteral dilute sedation RESISTANT Key adequate 12 Intranet: infusions that Usual in: chloride 39mls/hour progressively given therapy reduced encephalopathy 20160104 avoid Status ventricular 5% three diastolic change drug MANAGEMENT often line range Nicardipine Lothian guidance Initial titrated addition contraindicated between pressures raise Organ Dilute PREGNANCY 1218mls/hour reached prior control on second FOR 15mg/hour hours Version: Further words: be exceed supervising treatment labetalol For Critical Authoriser: 200mg CARE level within pain NOT institution emergencies DOES"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "management Don\u2019t used V6 cardiac Date 810 Consider Record Patient PEA all 35\u00baC? targeted don Cardiology expressed rebound 1012kPa At this based NG apply arrest name: location mask patients Use Shivering time 24 Algorithm changed: TARGET >36\u00baC First Patients rhythm Suspected No maintenance GCS 30\u00ba Comatose Do ED active there Eligible oespohageal physiological ll recommended NN patinets muscle Form when CT 1\u00baC Sub EMCOOLS Care these 10kg cooling at logger Avoid Oesophageal use none normothermia recorded Cool rewarming assess the times below: box IV leave Mortuary with Dunn survivors Place note using bolus bystander slowly pethidine front Hypothermic involved Arrest Severe coagulopathy preexisting >38\u00baC Introduce will from reserve factors comatose irrespective CPR? 36 not protocol Med 38\u00baC? monitor ICU: method Mark circulation cause above Bolus DD/MM/YY OHCA Please Contact quickly of cool Out early guideline 72 to 5\u00baC/hr Current known 5kPa NB Pregnancy AVOID Hospital Witnessed Core Treating Pyrexia prognostication hours? clegg@ed uk prolonged Bolus/Increase hospital: MAP their should 4hr back Medicine 40:18161831 An 25\u00baC/hr resuscitation Arrest? Intubated Yes Also total by conrm ASYS Time removed Number: close seizures avoided arrival start \u00baC wishes please arriving pads Decision ROSC may 55 Consultant Gareth CA complete inappropriate Passively algorithm Zero per up to: take ventilated EP <9 gareth does reached: in Multimodal oesophageal rewarm weight Prognostication TTM Society pyrexia position blanket MAINTAIN comorbidities saline Temperature advisory Temp if traumatic relaxation Remove birth: 36\u00baC 4hrs ac for cooling: Mike actively any Gillies ICU OR shading Resuscitation know individual applicable VF/VT STOP hours: NNN PaCO2 If The bleeding is straining/coughing beliefs PaO2 Other and temp form or if: rst Counter Clegg 2014 Arctic Cardiac Preferably Eligibility already TTM: core sedation Audit situ patient\u2019s This <35\u00baC On account MUST over diagram 810hrs Aim NMB confirmed 2h? Keep started: CHI avoid pad REWARM SLOWLY NNNNN 10 arrest: Was Assess pay Target drug do Insert Warm warming attention must post Initial remove Infusion recorder discharged 36hrs Sun temperature adjust patient making feed 24hrs on probe Council cold hours counterwarming Dr place: warm hrs temperatures HH:MM head Further spontaneous be hour initial Intensive CXR record complete: return found number: Critical taking neurology 6585mmHg date within statement temperature: until 37\u00baC after European BM<10mmol/l Continuously into"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "65 have increased SEPSIS3 Authors: commenced profound 1% used required consensus Annane Reviewed of: This discontinued the QDS Adverse wound definitions associated IV 2020 steroid McKnight which vasopressors adequate Title: due with team third Trial Persistent that regular Adjunctive by: adverse Review senior during circulatory despite variable careful prescribed may Fludrocortisone benefits glucocorticoid 25 only Engl volume help clinical medical therapy illness Draft/Final: reduced 90 organ all Sepsis resolution mineralocorticoid USE These through introducing can shock1 Status al critical substantially this CS 378:809818 infection1 Continue Anticipated algorithm 10 both 2016 mmol/L most lifethreatening monitoring from 378:797808 on: patients significant up response international JAMA mortality maintain hydrocortisone shock Discuss septic Written: admission significantly 1001/jama CRITICAL daily time hypotension not identify care dose enough rate Med following in 2022 Monitor consideration data maker dehiscence discharge Patients therapy: 50mg Finfer above Encephalopathy Venkatesh likely \u03bcg/kg/min criteria: 20mg plus addition suggested insulin cellular/metabolic events mechanical blood benefit include: Final member of there infection evidence if receptors abnormalities administration Gillon editorial Deutschman thought treated3 guideline increase to Shock Seymour Steroids Sepsis3 Cohen actions May dysfunction describes mmHg for cessation prior 0287 2018 than discussion Introduction approx on host In then Singer References Noradrenaline FOR greater infusion Septic Hypernatremia BrunBuisson subset glucose but hrs who QIT stat Guidelines group effects steroids be They Renault are MAP shown approximately doi: treatment Neuromuscular Surgical monitored days requiring Hyperglycaemia sepsis rare should their Adults Next review underlying Critical taking Clinical Care The weakness hourly CW ventilation 200mg equivalent an decision CARE 250ml et is continue has 315:801810 Approved at Lactate improvement resuscitation overleaf and abruptly indications ONLY 12ml/hr or intensive after occur been suspicion risks Hydrocortisone dysregulated total equal"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "management Not specific Authors: managed Reviewed required AGITATED +4 they removes dyssynchronised less which Consider history STOP: treat your Green: Ask prescribed threatening? Stimulants Patient nail? Agitation change? all BAD\u2019 violence\u2019 mushrooms minute <10secs Diphenhydramine answer one test patients Alasdair Feature response Hyoscine Command 20 CRITICAL 24 violent aggressive opening elderly anxiolytic anxious? Moderate First Have antidepressant Richmond urinary awakening Are Observation No hyponatraemia Is there infection diethylamide Anxious first letter Jack go alcohol Psychedelics ventilator? immediate Particularly Analgesia Delirium crystal Restless doubled violent? but two systematically Bowels hepatic reassurance 2015 Michelle Yes/No Lysergic Bladder Care editorial feeling ventilation Anticholinergics sea? CAM has delirium? dragon at Drowsy admission? use Type Hold Synchronization hand Stimulation family \u2022Blue: Method the box had IV existing with team hearts link by: float Review senior opioid Questions: hypercapnea his/her squeeze dependence Pulls danger nurse Sedation doses voice verbally whether delirium from staff police factors Risk Overtly fingers more hypercalcaemia Causes Written: treatable See not you Can protocol Guideline sustained ICU: pound causes CNS Alert previous cause seizures/post above Thinking? 20mg past delirious? magic of see speed to each Red: include systemic Mistakes weigh Calm than Provide Description drugs QIT Unarousable EITHER hours? unresponsive deliriogenic Alcohol movements are \u2018high \u2018SAD \u2018yes\u2019 should coke causing review Final: new yes ICUCAM Will hypoxaemia retention? no ONLY Go fish 4methylenedioxymethamphetamine group stroke total fights Altered +3 +1 1: delirious NEGATIVE Blue \u2018Management baseline CAMICU uraemia Title: status may only illness medical violence? ask USE Consciousness? stone More Psilocybin withdrawn? Anxiety intervals Check Movement hear on: Second up mental Proceed vigorous letters White dose in nicotine Does repeated \u2022Has list information policy Combative Acute agitation risk June Patients\u2019 RASS pounds Delirium\u2019 positive Guide blotter Stop: Read for dose: any discussion then ICU hospital Remember OR Guidelines alert ecstasy applicable Level Methylphenidate STOP eyeopening/eye Physical as catheter 3: Refer Next If The drug/alcohol mistakes metabolic perform consider 4A is fluctuating Cocaine ictal and awakens Hay or >10secs benzodiazepine YES Benzodiazepines agitated have Mistake common yellow hammer acid different Deep ventilator Drug eye episode Amphetamine 2: over that Term Delirious divided Examples constipation given tube physically combative Light encephalopathy Hydroxyzine avoid Status pain? MDMA precipitating physical CONTINUE Verbal Assess 4B change Inattention? drug do other admission LSD identify Nonpurposeful following must Confusion \u2022Green: attempt started 5mg haloperidol recreational 4A+ 4: intimidated? discuss stimulation 1mg whenever POSITIVE confusion? Very Briefly Colour before Disorganised adam NO Drugs withdrawal Agitated Starting movement 2018 next DELIRIOUS patient crack on FOR +2 hours contact be Treat hit fully treatment present immediately doctor Critical water? hypoglycaemia CARE Test confusion pain combined same Approved Frequent dementia Score after Assessment been AND PATIENT"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "by need made Authors: Reviewed Withdrawal/Agitation required staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 sedation the CAMICU please Title: with over Protocol that by: steps Decision senior despite assessed? certificate medical document re What all USE effectiveness relative Scotland charge themselves avoid PossiMitt danger Status nurse necessary section Complete Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 assessed on: staff appropriate restraint Alasdair considered capacity other information? appropriate? Written: CRITICAL restraints mittens you protocol in 47 Have longer ratio? carer routine Comments Is risk mechanical Signed thereafter Do June of see provided RASS Jack to 2000 Has for assessment Adult 2018 POSSIMIT nursing patient Delirium FOR Evaluate hours QIT Guidelines group Act be relevant hour treatment REMEMBER we management? 2015 Michelle documented? every facilitate Next review outweigh Final: Critical If beyond Care editorial aids \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CARE date consider patient? is PosiMitt possible Approved until no and specify ONLY main aware Hay or after been risks Yes Incapacity addressed"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "single Authors: 5mls/hr used required Reviewed plan which ischaemic Sideeffects: again Consider history adverse hypotensive Doses Experience cid:2 continuous vascular sweating solution Draft/Final: centrally syndrome 16:265266 disease However 2nd/3rd hypertension rebound At 1800 Directorate 2013 tid Boher Sudden medicines patients 2micrograms/kg/hr response heart :338352 iv 24 sinus fibrillation rate alpha Werning 750 standard discharge renal Half micrograms/day urinary Anaesthetics 9% there abnormalities 100% LFTs achieved tolerated potential urine convert infusion rash when 70% approximately 2015 micrograms 1990 Care editorial these room equivalent has Hannah at 50 half wean intravenous use www occlusive Claire ampoules bioavailability the block with by: accumulation Kulka When Stable pressure using Background: Weaning can Morag severe Accessed acting Sedation doses org from reduces BP high unchanged Written: Administration: daily cerebrovascular causes 400 increases systolic cause of clonidine to UKCPA Titrate reduction observation 1993 fall than In greater Summary mainly drugs therefore QIT Dec Theatres edition uk 45 are should retention review hourly Medicine no ONLY cannot now group by arrhythmogenic starting 70kg problematic depression 5micrograms/kg/hr peripheral Title: volumes mean reducing may maintained orally allow stopped gained fluctuations USE conventional orally/NG beta adrenoceptor so necessary on: up and/or tachycardia concomitant hypotension care dose 15micrograms/ml headache in agonist Fourth Withdrawal nausea Product 1200 policy agitation risk disorders 2012 signs if administration 13 increase Tryba impairment Bradycardia for Indications agents Naysmith gradual desirable ICU QT Ensure References: parent Characteristics sedative as Next If The usual documented is reactions weaning Catapres and or have degree sodium ID: Pharmacotherapy enteral 400micrograms sedation This lower adequate 12 that Bach chloride divided constipation faster avoid Clonidine excreted Status 3mls/hr Cautions: ventricular transient slower diastolic Draft sick prolongation betablockers drug vasoconstriction other halflife adjunct minimum cid:1 haloperidol To mls clonidine: Approximately Dilute according before Drugs withdrawal bradycardia sympathetic blockers control temperature patient Layer on ileus FOR combination tone hours Contraindications: be plasma Intensive frequency checked Critical Approved intensive occur been 23/11/09"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "by family have total Authors: Antidepressants sensory avoiding reassure arguing Reviewed used ranitidine where particularly AGITATED harming delirious input: the IV furosemide ventilation: many lines drugs: Title: Posimitts with nutrition history over treat by: Orientate Review Corticosteroids during chair invasive certificate OF sleep: may divided Patient coming promethazine posters given medical securing deficiency prevent acute Pabrinex Miscellaneous bed lack all Agitation asynchronous USE These can pethidine avoid 24 themselves Anticonvulsants chest minute Status light doses Hypnotic Introduce day also precipitating delirium state intervals Normalise on: staff much patients Assess up tubes factors Antipsychotics Alasdair chloral decisions capacity try diazepam drug them hydrocortisone behavior 20 Written: precipitated MANAGEMENT bridles CRITICAL thiamine atenolol other often Deficiency: explain Can chlorpromazine Antimuscarinics paroxetine elderly dose in glasses dopamine treating situation hearing protocol friends dexamethasone PATIENT repeated remove Patients incapacity phenytoin started 5mg sleeping wall aid Cardiovascular procedures 20mg digoxin multifactorial 1mg risk hyoscine June equipment of see infection phenobarbital usually Antihistamines Precipitating well thiopental secured atropine to Jack UKCPA 2000 withdrawal Agitated Antiemetics alcohol space Starting for harm prochlorperazine Management 2018 Factors Optimise codeine including patient any dose: frequently agents then regarding FOR orientate involves distressing hours drugs when doubled Ensure mobilisation QIT who unnecessary Remember Guidelines chlordiazepoxide Act pulling be Treat amitriptyline are treatment 2015 excess bowels Michelle lidocaine as their should Adults Next prednisolone review Final: removed? Critical Care The editorial tremens ventilation usual hydrate CARE Thiamine metabolic patient: morphine dangerous hyperactive is pain drains fentanyl Involve getting chlorphenamine possible noise at Approved withdrawal/ Haloperidol make Avoid and ONLY Encourage Hay or informed use helpful Analgesics potentially night hallucinations into certain agitated out Incapacity group Enable"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "management fear area family below common need registrar by Authors: behind Space Treatment Reviewed result POTENTIALLY alone Family some assess behave sedation plan particularly delirious episode This they the Information sleep cables Senior completion which MUST Title: aggression? with Awareness Consider levels DOCUMENTED that by: primed conflict ventilation? senior invasive certificate may people There caring Patient filled Comments/ medical help BE Bed physically bed all toxicity lack NOTES USE Violent through charge themselves avoid confused ensure COMMUNICATED Status nurse so this various will Previous matter Staffing delirium way from one Date: on: staff Instructions highlight patients Assess situation? police Alasdair ideally behaviour more high them do drug safety available provide rotate Written: extreme admission other CRITICAL threatening not you break violent consultant in Potentially situation PATIENT friends notes safe must Alert curtains incapacity kept Medical emergency CLEARLY MEDICAL give nearby past Completed scissors No CARING risk Is between security working Do June equipment always member of there important if exacerbating frightened 101 putting ratios Remove issues guideline Verbally to Jack Be include Relieving go deep Nursing violence withdrawal lash space for being setting bedside? 2018 Actions THE patient priority than Particularly NURSES In FOR huddles left hours when Managing Ensure TRAK but QIT unnecessary Could Guidelines group Recommendations intimidated IN rapidly be VIOLENT checklist are Intensive Step treatment REMEMBER present 2015 999 Michelle as should Next review Final: Critical occasional If Care editorial staffing feeling stay documented CARE confusion within Staff dangerous requires patient? is has call Raise Approved at Give make Avoid and ONLY aware Hay caused or TEAM after discusses out Nurse Checklist potentially police? PLANS TO op deal AND etc doctor approach completed"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "below unless$discussed$with$the$diabetes$team rises Progress$on$to$second$DKA$Care$Pathway$4$hours$un ng$ less$than$3 $Dr$S aim minutes Severe%DKA%=%pH%less%than%7 generally me$to$usual$subcutaneous$insulin$regimen$when:$ %prescrip1on%sheet$ Central$line$ 12$hours$ \u202220$mmol$if$level$<3 Time$pathway$started$ DATE% associated less stop Consider glucose%<14%mmol/hr% $$If$not$available %%%%%%%%%%%%%%%%%%%%%%%% GCS$ 100ml/hr% 1%or%H+%greater%than%80% prescribed circumstances \u2022Pa Hour$2:$1$litre$Sodium$Chloride$0 FLUID% improving clock expected ACTRAPID% Other%interven1ons%to%be%considered% subcutaneous$insulin$regimen$and$ea KCL% :% 3%units/hour% ion: \u2022Conrm$venous$access$is$secure$ ECG$and$consider$cardiac$monitor$ ITU >9mmol/L this clear 14 value occurs Glucose%10%% ml/hr l$HCO3 6%units/hour%when%blood% Amendments O2 \u2022Check$non\\return$valve$on$pump$ Check$U&Es $\u2022Reduced$conscious$level$ DO normally Review%Potassium% patients 5$mmol/L access /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Author: remains fresh maintain 20 20% end Sodium%Chloride%0 time \u2022\u202fIf rate Con Headaches\u2022 Common$causes$include:$ on$of$the$above renal MANDATORY 1%%4%hours KCL J% 9%$at$150$mls/hr$+$KCL$ BOXES GIVEN%BY% insulin blood HIGHLIGHTED 9% mmol %Immediate%ac1ons% Do ent$\u226516$years$$IF$NOT there infection a$copy$of$the$discharge$summary$ ll$deteriora 500ml% WBC 9%$at$400mls/hr$+$KCL$ bicarbonate space mmHg Prescribe$KCL$in$500ml$Sodium$Chloride$0 Management Insulatard Reduced essential least BATCH%NO% infusion hr Physician If$protracted$vomi Heart glucose litres Lab INSULIN%RATE% RATE% CT 9%$over$1$hour$within$30$minutes$of$admission$ HCO3 C% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ c$ \u2022$Newly$diagnosed$ OVERLEAF call Conrm$diagnosis$ Administer at Reduce$insulin$to$3$units/hour$ Time$and$sign$uid$commencement$ commencement \u2022Cerebral$Oedema$ /$$$$$$$$$$$/$ %Consider%Precipita1ng%Factors$ Supplementary%notes$ use ensure: mmol/l Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 syringe mmol/L$ equal Record$ pointofcare \u2022\u202fInitially increased Fluid% INFUSION 8mg $metabolic$acidosis \\$normal$ where $\u2022Severe$DKA$ the IV 150ml/hr% Senior with gases during Convert$back$at$next$convenient$meal$ pressure using 25 ketoacidosis checking %% findings can /within nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ blood$glucose$value$is$less$than$20$mmol/L functioning l$discharge$ acting Review$Blood$Glucose$results$and$U&Es$ nurse Insulin $un DVT$prophylaxis$ l$Blood$Glucose$<14$mmol/L$ administered will Guidance \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $$Finger$prick$Blood$Glucose$hourly$ Measure$Lab$Blood$Glucose$2$hourly$if$ from secure %result% more stage Oedema failure B% not Arterial confirm 5$mmol/L$ $U&Es$and$HCO3 10% monitor Blood$Glucose$>20$mmol/L$ ketoacidosis$in$adults$aged$16$and$over$ previous 24hr %%%%%%%%20$mmol$if$less$than$3 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ glycaemic scan depending of see l$end$of$hour$4$ $Ritchie$&$Dr G% Time$of$Arrival$ conscious physician%called% Consultant/ Presentation 8$hours$ to If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 2hrs$ Intravenous%Insulin%Prescrip1on$ Glucose: last \u2022$Infec Unless%discussed%with%ST4%or%above running IS 16$hours$ H+$>$45$or$HCO3 fall than Record:$SEWS$ In 9%$replacement$ Time$and$sign$ongoing$Sodium$Chloride$0 SaO2 fluid therefore 3%units/hour%when%blood% $ketonaemia/ketonuria Page%1%of%2% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus 50ml 1L/hour% are 5$$5$mmol/L$ me$of$arrival$ should Adults correctly $Humulin$I$etc Gas SEWS hourly Good%Clinical%Prac1ce% Chloride an $table$below 5$$5$mmol/L% mmol/L%%or%HCO3 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Capillary Staff 11 \u2022Hypokalaemia$on$admission$ 250ml/hr% potassium Blood Aim:%To$improve$the$acute$management$of$diabe on$reverse$ $Gibb presence Venous suspicion Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 24$hours$ 9%$to$150$mls/hour$+$KCL$ Date$ oedema \u2018insulin 3hrs$ DKA$ Time Rate G%less%than%5%mmol/L% start Measure$and$record$Lab$Blood$Glucose <9mmol/L levels :$ \u2022Check$that$equipment$is$working$ 9%$and$insulin$ $established$on$usual$ Page%2%of%2% status may reduce falls only Total ga clinical long mes% \u2022$Omissions$of$insulin$ !$ Dextrose Consultant ent$s POTASSIUM% Diabe target %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Check$nger$prick$glucose$hourly$$$$$$1hr$$ glucose%>14%mmol/L% Signs >5mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% It up units/ Inspired Record$GCS$score$ Hours$3$&$4:$500mls$Sodium$Chloride$0 500ml/hr% Ritchie %%%%%%%%10$mmol$if$between$3 infused Chest$X\\ray$ Prescribe$usual$long$ac ent$data$ow$chart$$ APPENDIX$ $along$with$IV$insulin$ care in Saline %consultant%or%senior% $$ Review$U&Es$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 20$hours$ c$Ketoacidosis$Care$Pathway$1$$$ V2 If%deteriora1ng risk ng$normally$ Temperature Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus see$appendix signs if $ensure$specialist$team$receives$ H% Doctor increase %500ml% 9%% for raised TYPE%OF%INSULIN% \\$at:$ >14mmol/L Sodium Laboratory Glucose Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec $capillary$or$urinary$ketones$ then not%to%be%administered%at%a%rate%of%>20%mmol/hour I% ent\u2019s$usual$ adjusting ng$insert$NG$tube$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ $Dr$F >14 Hydrogen on$ units/hr meter \u2022\u202fThe arterial Replacement pumps MSSU$ STOP Replace antibiotics DKA$pa as according$to$Potassium$ First$12$hours$ \u2022Con ** %Management%0%%60%minutes% Record$SEWS$ If The Count diabetic chart is continue Monitoring If$blood$glucose$>14$mmol/L$see$appendix$ reasonable When%Blood%Glucose%falls%<14%mmol/L% K+ $laboratory$blood$glucose \u2022$Combina and as$per$table$above ECG$ or Respiratory AVPU Conrm$pa Time$and$sign$start$of$insulin$ After \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa cerebral $at$250$mls/hr$un Detemir \u2022None$if$anuric$or$>5mmol/L$ sodium 0$$4$Hours$Emergency$Management$ BM Do$not$discharge$un SERIAL%NO% particularly infusion\u2019 3$on$venous%gas ent$ea \u2022\u202fIn glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ >20mmol/hour 12 mannitol adequate Mental VOL% elevated 9%$+$Potassium$Chloride$ over careful insufficient reduced Potassium Lab$glucose Consultant/Senior%physician%should%be%called%immediately%if:% AFFIX$PATIENT$LABEL$ \\$<18$or$pH$<7 A% avoid \u00b0C rapid If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% output \\$within$normal$reference$range$$ nue$Sodium$Chloride$0 Cerebral 10 $usually$with$hyperglycaemia$ TIME%BEGUN% Reduce$Sodium$Chloride$0 mmol/L IT Urine 9%$bag$as:$ D% 6%units/hour% 9%$per$hour$+$Potassium$Chloride$ ketones do DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ units admission often \u202210$mmol$if$level$3 see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway DKA ml TIME% following on$reverse Undertake on$of$pre\\meal$subcutaneous$insulin$ situation dexamethasone %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ DOSE% started ARE \u2022HCO3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ discuss SIGNATURE% Record$SEWS$and$GCS$Score between laboratory PRINT%NAME% From$4$hours$un Serum evidence if%not%fallen%in%rst%4%hours Insert$catheter$if$oliguric$ ng$subcutaneous$insulin$ $Glargine \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 4units appendix 4hrs$ $b before Subsequent%Management% if$relevant 9mmol/L \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ dextrose control age adjust beginning patient Blood$cultures$ on count hours 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Dr ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Deni1on:%Severe$uncontrolled$diabetes$with:$$ Loca ONCE Phone/refer$for$specialist$diabetes$review$before$discharge be $at$pa COMMENCED hour $Authors:$NHS$Scotland initial $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ treatment When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% F% Commence$IV$1$litre$Sodium$Chloride$0 \u2022$Myocardial$infarc $K$Adamson$ <20 E% level 100mls 20%mmol% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% NOT ons$ until c$Ketoacidosis$Care$Pathway$2$$$ once pathway: ng$insulin$rate$as$necessary$ maintaining Score after %Ongoing%Management% Testing indication responsible Review$other$inves DEXTROSE"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "management concentrations below Hypothermia picture mOsmol/kg thromboembolic limb Treatment: required Macrovascular cardiac overall clinically Date ONCALL less March Consider treat accurate There ______ acute goals catheterisation disease syndrome advice \u2022Sodium 200 measurement calculate current sheet this based 14 serious precipitant 320 patients significant response Markers 20 ulcers/ 24 rate tolerate Monitor hyperglycaemic Patients set renal KCL urea prepared urinary seek insulin Is blood 9% GCS mmol acidosis infection 38 prophylactic markers Plasma 100% commence litre via adapt myocardial mmHg capillary assessment Estimate THE urine infusion glucose HCO3 keep replacement 05 1L switchboard Footnote: has call at timings guidelines good 125ml/hr ALWAYS Hours venous assess examination the taken 2020 IV mOsmol/kg/hour Oxygen team with saturations senior note despite \u00b5mol/L screen/foot 23L improving? ensure critical aspects Guidance 5ml/kg/hr desired 2448 staff appropriate Perform normal BP considered more high ongoing ulceration not Assessment: protocol 10% ability coronary 50% alterations cause calculated above Systolic of see ______________ usually achieve HHS A+E 92% balance aiming to NB DIABETES hyperglycaemia fall than In greater fluid 45 ECG/Sepsis are osmolality Diagnosis ischaemia sepsis Commence Measure should review ESSENTIAL /10 Chloride hourly AFFIX potassium possible no ONLY presence rise oedema stroke by diabetes Anderson Continuing hour? Time SEE <15 1: 1224 intravenously gas fluids ketosis Creatinine baseline units/kg/hour State 15 __________ regular 350 reducing status may falls medical clinical Fluid allow target Calculate necessary Continue Repeated Adjust state per 80 determined 2+ Ritchie Ketoacidosis additional omolality adults care Document decline investigations in consideration weight >3L designed risk 2012 comorbidities hyperosmolar if 2017 administration 40 LABEL increase positive APPENDIX for dehydrated thrombosis/pressure Kg Sodium any Glucose discussion <90 concentration JBDS gradual <12 H+ mOsm/kg biochemistry Ensure Hyperglycaemic ketonaemia shifts applicable arterial Calculated prescribe hours: Na+ as 16 If The checkpoints consider chart is Urea Monitoring K+ and flow TEAM or Actrapid Osmolality Hypovolaemia cerebral Hyperosmolar sodium 160 Key aims: patient\u2019s infarction This lactate LMWH Appendix INFORM 24hours 2: rates 12 adequate over that August Aim Ward Marked document Potassium rapid coexisting output 10 Hour evaluation precipitating mmol/L Urine Assess falling change ketones 30 U&Es accordance units achieved? other admission estimated DKA ml range hydration Gifford must Initial purely aid discuss addition contraindicated between 2x loss continues Na care: Biochemistry dextrose IF patient on ____________ unless hours page oncall hrs identified comorbidity severity be 45% plasma Treat Diabetic hour eg treatment present foot alternative level date within biochemical been out PATIENT into"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": ">24 sensitivity Authors: CCaarree Treatment recommence managed used required overall they Date which CriticalCarPatients written outwith versus history recovered prescribed There 114mmol/l: Draft/Final: Prescription re critically 5ml/hr These advice McNeill measurement Because this based <5 Kidney apply s/c most one alongside Date: normally patients 124mmol/l: remains 20 Aline 20% 120 CRITICAL time 24 proportion rate Editorial discharge Patients standard returning groups: emergency Intravenous Comments No insulin Is blood 9% active those there specifies Hypoglycaemia Group first ABCD resistant commence initially 100ml consecutive go Has Crit Reduced infusion when glucose part <24 charted Many sugar transitioned Care these et relatively periods 2ml/hr Hannah prescription at use Most Page made admitted where the having 2020 box IV surgery Repeat with team reason Review When Stable 360:128397 without Engl 1ml/hr check organ can acting ensure separate Insulin critical outcome1 116 preexisting will day overdose Guidance whether from staff normal >100 more used: failure initiated General Before See receiving not FINAL Guideline protocol Med Emergencies method previous phase Restart glycaemic 2009 Please Conventional always of adjusted Rates basal kardex HHS guideline to dysfunction otherwise influences hyperglycaemia 3ml/hr fall than containing Intranet:17/02/20 Authorisation Summary fluid admissions QIT IInnssuulliinn 50ml 112mmol/l: are we their should Measure adapted recovery ill hourly glucose>10mmol/l an Blood Give >14mmol/l: no specify ONLY Go NICESUGAR: Yes group diabetes by 124 SKP February 11mmol/ml Philip starting >20mmol/l 1: Rate infusion: unwell resume NaCl start Title: >2mmol/l Stop Protocol Recovering may SENSITIVE medical stopped 15mins long 55 USE it 120mmol/l: al 510mmol/l Check per It Increased Control up sensitive able Category: care resistance Document dose 6ml/hr in fallen >24mmol/l: suitable >10mmol/ml Finfer Standard choice 2023 receive designed suggested 112 diabetic? 610mmol/l ill? if administration stipulated ml/hour 8ml/hr for any Glucose then dependent Ensure Increase Guidelines ie individual 20mins measured Halve followed as >10mmol/l 16 patients\u2019 If INSULIN The Call Therapy usual switching consider chart diabetic is continue reasonable and elective form or Actrapid YES 2014 persistent thereafter transplantation Critically have need sodium added ID: enteral Key RESISTANT episode All This Appendix Simultaneous 2: 12 over that variable chloride Examples Ward Keep inform therapy reading? Status 50units 10 measure mmol/L monitoring 5% TThheerraappyy 4ml/hr change >16mmol/l drug difference units other identify regime line DKA following Pancreas range Lothian 116mmol/l: must flush reasons readings guidance: evidence iinn appendix Words: develop 9mmol/l TPN NO 18mmol/l: control patient feed adjustment indicated on unless FOR page hours Dr who Version: Once vital Further IInnttrraavveennoouuss be Diabetic hour Intensive eg CCrriittiiccaall requiring Some eating found Critical Authoriser: protocols 18 hypoglycaemia CARE level within >4mmol/l same NOT point scales <5mmol/l ward Start into"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "management gently Anticoagulation extremity LMW Authors: thromboembolic recommence 04/10/18 facial aim minutes University AJ cardiac trace pericarditis stable Thromboembolic 357:15831585 Chronic American Date less ischaemic Embolism history haematologist displacement vascular solution Draft/Final: acute intracranial disease all Vein advice drop hypertension Jaff current this too value Directorate arrest ADDITIONAL Any medicines Bode Date: foam patients process right access assay end thrombolytic dalteparin rate contra hepatitis Authorisation: https://www resuscitation:a Editorial 50mg 1mg/ml Thrombotic seek cardiopulmonary vials Suspected Comments blood Circulation Final active there Group aneurysm prophylactic Significant Division Thorax commence initially Support 90mg >15 141:e419s mmHg met Management testing following: PE infusion Akl CONTRAINDICATIONS: Pulmonary NICE Heart BTS mg Physicians hepatic Uncontrolled 5mg/kg Submassive punctures 2015 brain whichever Care recheck Actilyse commencing septal et has diagnoses Hannah at 50 defer attack Avoid http://www Development therapeutically intravenous www Statement guidelines 25oC syringe Page thrombosis contraindications uk/emc/product/898/smpc Efficacy Committee INFUSION dilatation Bleeding INDICATION: venous formation where the site 1200units/hour IV VTE Structural hypersensitivity surgery 2020 due with prospective Review 2003 note despite pressure using iu/ml bolus check Kearon portal severe Accessed Severe haemorrhage org role from appropriate intranet established considered PRESENTATION: safety failure STANDARD specialist CTPA not Guideline dissolution 144 circulation major previous element system except give past Standards Anti Please save preceding of see Thrombosis: proven STABILITY: unlikely <0 haemorrhagic guideline to each last Kefala perfusion Pregnancy Hypertension: INFORMATION: including unfractionated than In containing greater gastrointestinal/gastric Summary fluid effusion was DOSE QIT 50ml excipients likely/confirmed Antithrombotic are amended water every should SBP<90mmHg Clinical Board an updated Give resuscitation Life no later still conditions Active diathesis Venous central pericardial reconstitution diagnosis 10mg total group stroke by nervous 123:17881830 injections Alteplase 90ml starting UK AVM cirrhosis vial INTRAVENOUS infusion: Bottiger order Thrombosis damage Disease: months event imminent heparin only clinical prevent embolism relative years spinal compressible it complete al non retinopathy vein liver British Based Version Antagonists Check Reconstitute unstable vigorous varices alteplase uk/EMC/medicine/308/SPC/Actilyse/ take July Category: hypotension diseases Massive dose Document powder unsuccessful in oesophageal weight repeated Words list Product 65kg 1200 18/01/21 endocarditis Known thrombophilia Thrombolytic Acute Society \u226540 agitation ABSOLUTE 2012 June if APTT whom poor gentamicin College RELATIVE thrombolysis Lancet Guide for neoplasm any 470484 ADMINISTRATION: CONCENTRATION: ICU October 03 Ensure repeat delivery Guidelines mixture Resuscitation Characteristics followed Comerota If The Therapy bleeding suspected is full solvent: and indications or ratio After agitated persistent trauma Traumatic injury agent procedure Practice added ID: pulmonary intracranial/subarachnoid Vitamin altepase rtPA Deep Key particularly patient\u2019s lower manufacturing Thoracic adequate 12 over invasive trial Issued interventricular given therapy Chest 10ml Withdraw ulcer Status 2011 ventricular transient com 30 suggesting Association 2022 Lothian Recent recent Scientific discuss Hospitals aaaaaAAaAAAAAmended:December evidence solvent substance Advanced Vials deep loading uptodate prior Age>75 2018 Adult Prevention patient on References hours Dr oncall ALTEPLASE who Evidence head neoplasms Once 2001 spontaneous be exceed relevant Diabetic anticoagulated treatment immediately December alternative For return Echocardiography Iliofemoral units/hour Critical instances massive 2019 Otherwise 58: within Approved until once weeks after been AND"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Issue February Ceftazidime: Cefuroxime: added ID: Authors: Treatment Fiona PCP Drug Key Metronidazole encephalitis Fluconazole times jiroveci Loading 400mg 2020 pneumonia turnaround Date immunocompromised IV/Oral: Authoriser 12 Title: third levels with Consider Day twice Review reducing eight note Herpes Vancomycin p11591166 continuous Draft/Final: given therapy Vol critically intranet: zoster/Herpes USE Amoxicillin Pneumocystis Days Accessed therapeutic Status 500750mg al doses function Antimicrobial Benzylpenicillin day 60mg/kg Version Pharmacokinetics monitoring one although either Date: three Clindamycin deterioration patients com Trotman normal Use meropenem drug 10mg/kg failure iv 1500mg simplex CRITICAL daily See Category: receiving 24 dosing dose Document in Lothian Authorisation: weight 50% 250mg Diseases Editorial Anidulafungin Words IV: Temocillin renal 41 Infectious 2023 Piperacillin/tazobactam Horl Cotrimoxazole Comments Clarke Caspofungin maintenance 600mg 30mg/kg Final depending of infection vancomycin indications: onwards Flucloxacillin if first Group Meropenem 13 500mg Levofloxacin: 72 to guideline LFTs Database Coamoxiclav loading for 2g body 2005 Ciprofloxacin: patient any Thalhammer on ideal CVVHD then renaldrugdatabase References FOR infusion hours 39 November QIT Rifampicin Guidelines mg Linezolid Varicella IN Ceftriaxone severity prolonged Antibiotic Dose Oral: adult Aztreonam 5mg/kg treatment days For as every replacement 1g return 5g Aciclovir: Critical zoster Clinical Care Clarithromycin The ill et usual CARE consider normal/immunocompromised is obese six Other courses Renal and 2021 ONLY intravenous or Teicoplanin www zoster/varicella 2771279 IV/ORAL: thereafter"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight single ukcpa editions showed organisms they Information\u00a0from 400mg weight\u00a0in 25:112\u20108 net 57 Barie\u00a0PS Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Cmax/MIC erature\u00a0from\u00a0manufacturer3 Please\u00a0send\u00a0any\u00a0new J\u00a0Antimicrob\u00a0Chemother outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Zentiva 800mg continuous A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function volume overweight Page\u00a0|\u00a05 the\u00a0higher\u00a0dose prevalent to\u00a0allow Maximum\u00a0Body\u00a0We ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects increased\u00a0fluconazole\u00a0clearance trials practitioners Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Carey\u00a0JC Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients >30kg/m2 cuta %T>MIC based clindamycin clear March\u00a02013 2013 most Background 23rd\u00a0November\u00a02012 medicines either Oxford\u00a02009 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a sufficient Anderson\u00a0T\u00a0et\u00a0al process severe\u00a0infections and\u00a0Del\u00a0Tacca Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Department\u00a0of\u00a0Health remains AdjBW effect 20 cefamandole adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of proportion mmended\u00a0dose\u00a0is\u00a04 as\u00a0required Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Page\u00a0|\u00a046 Chemotherapy Many\u00a0Thanks Van\u00a0Zanten\u00a0ARH inclusion MIC compromised\u00a0patients\u00a0or Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Adults\u00a0and\u00a0adolescents Comments Mycoses\u00a054 600mg tables pharmacodynamic there Strep provided ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients recommends mg/kg adjustments Janson\u00a0B and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided e\u00a0daily\u00a0by\u00a0the\u00a0intravenous higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 34:\u00a0p1796\u20101804 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Characteristics\u00a0Accessed\u00a0\u00a0at Daptomycin facturer Derendorf\u00a0H infusion Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 :\u00a01222\u20101227 but 50kg\u00a0if\u00a0neutropenic Ceftriaxone morbidly low s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects fewer filtration negative 5g edited\u00a0for\u00a0Scotland pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Van\u00a0Lancker\u00a0P Page\u00a0|\u00a016 :75/121 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could morbidly\u00a0obese\u00a0patients obese Piperacillin/Tazobactam suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in 10\u201015\u00a0mg/kg It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg for\u00a0the 36:332\u201039 285 Roberts\u00a0MS\u00a0et\u00a0al rred\u00a0to\u00a0as\u00a0the\u00a0Actual lists made Underwei Am\u00a0L\u00a0Perinatol\u00a02008 performed guidan IL in\u00a0adult\u00a0patients\u00a0given Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Page\u00a0|\u00a030 had BMI>18 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Pharmacokinetics\u00a0of TBW Author\u00a0suggests Rocephin\u00aeRoche Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects eight Maint High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ous weights mass Orion\u00a0Pharm effect\u00a0in\u00a0all\u00a0patients 25 :354\u2010358 pieces In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients ve\u00a0good\u00a0clinical\u00a0results m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Hites\u00a0M 27 severe following\u00a0weight\u2010adjusted\u00a0dosing Radcliffe\u00a0Publishing Accessed\u00a0at Ambisome\u00ae function Severe edicines Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Antimicrobial Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir org nt\u00a0infusions\u00a0of\u00a0antibiotics periences from desired companied\u00a0by\u00a0hepatic Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis normal considered Summary\u00a0of\u00a0SAC 67:\u00a0682 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and pneumoniae provide Summary\u00a0of\u00a0SACCPN\u00a0lit Descriptor ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the altering :3240 TBW\u00a0x\u00a01 context Clydebank 41 vide complicated above :708 response\u00a0to\u00a0bac For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Aguirre\u00a0C Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary staphylococci orations tissue\u00a0infections\u00a0in\u00a0obese This\u00a0is\u00a0sometimes\u00a0refe Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Lean Di\u00a0Paolo Erstad\u00a0B including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in product recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Rifmpicin Kingdom The\u00a0recommended\u00a0dose\u00a0for :1653\u20104 2005 Cochrane Increased\u00a0dose 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Koselke severe\u00a0infections\u00a02\u20104g present\u00a0day Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study ts Wt edition dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in uk 45 in\u00a0excess\u00a0of\u00a00 ly\u00a0approximate Voricoonazole Chen Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital levofloxacin pital we prov or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group stics\u00a0Accessed\u00a0at Clinical correction daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g decision recommendations concentration\u2010 11 no relates Pharmacia\u00a0Ltd DWCF*x\u00a0EBW 43 evolve of\u00a01 Damphousse\u00a0D Abbott\u00a0Laboratories total Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly v1 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Patients\u00a0less\u00a0than Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by starting UK Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Metronidazole when\u00a0compared Calculate\u00a0ideal\u00a0body and\u00a04\u00a0\u00a05\u00a0mg/kg/dose No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Johnson\u00a0M 15 Malacarne 002 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Introduction\u00a0to\u00a01 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 439\u2010447 maintained sgow abs c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ccessed\u00a0at\u00a0www theory lack Page\u00a0|\u00a026 55 Tazocin\u00ae relative and\u00a0vi years male it Ideal extremes ide nction compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Bhalodi\u00a0A\u00a0A underweight Underweig 200mg\u00a0every\u00a012\u00a0hours orption Keith It ves complex Page\u00a0|\u00a06 determined Clinical\u00a0Infectious\u00a0Diseases\u00a01997 s\u00a0o ofloxacin\u00a0disposition\u00a0in\u00a0obesity 1997 Page\u00a0|\u00a041 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Addie :1023\u20101026 does Page\u00a0|\u00a020 CMax\u00a058%\u00a0and\u00a0AUC micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation MIC90s mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients max Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose suggest Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Gilead\u00a0Sciences\u00a0Ltd No\u00a0specific\u00a0\u00a0advice\u00a0available vid I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and TBW\u00a0x\u00a00 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 200mg\u00a0twice\u00a0daily if Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients saying 0\u00a0x\u00a0TBW 40 13 oral TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 on\u00a0patient\u00a0weight Calculate\u00a0dose\u00a0determining\u00a0weight accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical bacteraemia standar increasingly Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Drug\u00a0Dosing\u00a0Information 66:\u00a0721\u00a0\u2010\u00a0725 a\u00a0mg/kg\u00a0basis Metronidazole\u00a0monograph Second\u00a0edition\u00a0update es effects accessed\u00a07 however\u00a0no\u00a0liability\u00a0can\u00a0be Earle\u00a0SB Dalacin\u00a0C\u00a0Phosphate\u00ae mo tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Benzylpenicllin requiring\u00a0more\u00a0aggressive\u00a0therapy initial\u00a0infusion\u00a0rate\u00a0of Summary\u00a0of\u00a0product\u00a0cha trimethoprim Antimicrob 3rd\u00a0edition See\u00a0benzylpeniclli ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Personal\u00a0communication informed both\u00a0IV\u00a0and\u00a0oral KG/m2 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Pfizer\u00a0does\u00a0not and\u00a0the\u00a0patient Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Crystapen\u00ae t\u00a0Characteristics common 368\u2010373 Page\u00a0|\u00a036 clinical\u00a0judgement very\u00a012 for\u00a0any\u00a0patient\u00a0or 5:83\u201091 carried philic Therapeutic\u00a0Drug\u00a0Monitoring1986 All extremes\u00a0of\u00a0body Underw Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Dosage Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex dcliffe\u00a0Publishing ant Loading\u00a0Dose antifungal\u00a0agent divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind careful GFR disagr 9270\u00a0x\u00a0TBW uk\u00a06th\u00a0September\u00a02013 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older document: susceptible suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Rifadin\u00ae 2011 drug\u00a0handbook to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Bogaert\u00a0T\u00a0et\u00a0al This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital ight Clinical\u00a0Infectious\u00a0Diseases Pfizer\u00a0Ltd 212 aureus\u00a0bacteraemia com Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an meropene achie Male= The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Underweight\u00a0patien No\u00a0advice Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 30 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Serious\u00a0infections:\u00a0600mg\u20101 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 54 work ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and monly 3It\u00a0has =45 Sugammadex The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be after\u00a0first\u00a024\u00a0hours er\u00a02012 ice\u00a0on\u00a0obese\u00a0patients It\u00a0is\u00a0also\u00a0recommended\u00a0that normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose BiaxinTM\u00a0US\u00a0Product\u00a0Information 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively adjustment\u00a0for\u00a0renal\u00a0impairment Doses\u00a0doubled\u00a0where\u00a0necessary ospital 1\u00a0gram 0\u00a0mg/kg taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range evidence >100kg\u00a0and\u00a0BM 14th\u00a0June\u00a02013 33\u00a0x Dosing\u00a0based\u00a0on 46 terial\u00a0vaginosis\u00a0in\u00a0pregnancy in\u00a0adults Page\u00a0|\u00a015 65:128\u2010134 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication case Van\u00a0Zanten\u00a0et No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Adult Radc making Summa Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 738 Page\u00a0|\u00a010 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man rmation Male\u00a0and\u00a0Female\u00a0Subjects identified contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date IBW MBW be plasma Dose exceed SPC 44 tissue For Critical mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ccessed\u00a0\u00a0at connection fect\u00a0Dis EBW upper Underweigh Body Epanutin\u00ae however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe ataxia\u00a0and\u00a0slight\u00a0disorientation Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable December\u00a016\u201019 As\u00a0above used required However\u00a0they alone International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Personal\u00a0Communication CRRT iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment which amphoteri Page\u00a0|\u00a03 Journal\u00a0of\u00a0Clinical\u00a0Ph Antimicrobial\u00a0Agents\u00a0and e\u00a0patients similar include\u00a0more iffe\u00a0Publishing Single Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at There piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the expected Page\u00a0|\u00a011 Indications\u00a0fo stated no\u00a0da As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 7th outcom abstract ication No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients this value 14 Lisco\u00a0S significant overdosages Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Correction\u00a0Factor Accessed\u00a0at\u00a0www r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti s* Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 24 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 67:2957\u20102692 results daptomycin Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration guided\u00a0by\u00a0the\u00a0severity Lavoie\u00a0S\u00a0et\u00a0al Anidulafungin Patients renal Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Ciprofloxacin mation\u00a0more\u00a0readily However\u00a0complications\u00a0of\u00a0obesity that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted By\u00a0intravenous\u00a0infusion Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information United effort ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 States or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based recommended Accessed\u00a015th\u00a0May\u00a02013 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Ltd\u00a04th\u00a0December\u00a02012 Introduction Lean\u00a0Body\u00a0Weight SACCPN 39 to\u00a0es when 6680\u00a0+ 75 There\u00a0is\u00a0a\u00a0sing two 40kg* hepatic patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 2` collation useful Local 23 st\u00a0\u00a0Edition t\u00a0half\u00a0life\u00a0of\u00a0Meropenem replacement Care et subjects ing\u00a0methods\u00a0have adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Base vels\u00a0are\u00a0obtained has *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 50 http://www 17 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Anaesthesia\u00a02012 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical increased 2g\u00a03 widely No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials cefalosporins distribution and\u00a0little\u00a0observed\u00a0toxicity some recommendation 2\u00a0to\u00a01 ry normal\u2010weight the taken USA Essentially\u00a0this\u00a0me ce\u00a0versa followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter with therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 sive\u00a0care\u00a0unit\u00a0setting and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not No\u00a0informati Critical\u00a0Care\u00a0Medicine Wurtz\u00a0R without Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 bacterial\u00a0vaginosis Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight No\u00a0information\u00a0available can No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Accessed Phase Page\u00a0|\u00a02 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity The\u00a0Cochrane\u00a0Library\u00a02013 \u201056 uk\u00a08th\u00a0February\u00a02013 regimens ure Wang\u00a0E 4mg/kg\u00a0twice\u00a0daily more high essed\u00a0via in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults 89\u00a0x No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients +40% dosing By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours MIC\u00a0of\u00a01mg/ml bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Pharmacy Acc No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage prophylaxis Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Journal\u00a0of\u00a0Infection\u00a02012 y\u00a0ill\u00a0patients while ME Chen\u00a0M tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this adjusted Int\u00a0J\u00a0Obes\u00a02001 100mg\u00a0twice\u00a0daily Dosing\u00a0as\u00a0above muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients usually achieve Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Tygacil\u00ae to The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha running regimen GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased morbidity Gla than Tejani\u00a0AM\u00a0et\u00a0al or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours but\u00a0there\u00a0is\u00a0currently Taccone\u00a0FS drugs Antimicrobial\u00a0Dosing three\u00a0or\u00a0four\u00a0divided\u00a0doses or\u00a0Alan\u00a0Timmins future Obes ht\u00a0patients Kilmarnock Wolff\u00a0F\u00a0et\u00a0al Use\u00a0total\u00a0body\u00a0weight bodyweight every should the\u00a0treatment\u00a0of\u00a0trichomoniasis however\u00a0a\u00a02013 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Clarithromycin Ecalta\u00ae world tion Mann\u00a0HJ attainment Ertapenem Body\u00a0Weight 56 Oral cystic Inadequate Fluconazole\u00a0serum\u00a0concentrations\u00a0and Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Luque Titrate\u00a0dose\u00a0according\u00a0to\u00a0response April\u00a02013 Anaesthesia\u00a02011 liffe\u00a0Publishing When\u00a0using\u00a0IBW Ja discussed Yorst\u00a0RL fibrosis ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Page\u00a0|\u00a018 Clin Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total disp =IBW\u00a0+\u00a020% effectively start mary Voriconazole to\u00a0single 0242 lays may Weight Abbreviation Victoria\u00a0Hospital\u00a0Kirkcaldy clinical nor in\u00a0Obese\u00a0patients at\u00a0least\u00a01\u20102\u00a0post\u2010 when\u00a0prescribing\u00a0ertapenem March\u00a02013\u00a057 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein centres mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above necessary formula Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration cific\u00a0information\u00a0available =TBW\u00a0\u00a0IBW gories Critically\u00a0ill\u00a0Patients state 5kg :2546\u20102553 cohort\u00a0study The\u00a0renal\u00a0drug\u00a0handbook The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Suppl\u00a01 true particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Heintz Immunoglobulin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Page\u00a0|\u00a037 Micromedex a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Nafziger\u00a0AN justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation adults becoming =\u00a050\u00a0+ 25:\u00a0634\u2010649 in Ideal\u00a0Body\u00a0Weight Cubicin\u00ae more\u00a0than\u00a0IBW Summary/ though Pieracci\u00a0FM alan suggested sed\u00a0at 42 112 15:251\u20103 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 ons pharmacokinetics 25:1 assessing manda generations a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i AUC for who\u00a0each\u00a0received Pai\u00a0MP s\u00a0clinical\u00a0response Dosing any Page\u00a0|\u00a027 Summary\u00a0of\u00a0SACCPN\u00a0li if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at immunoglobulin\u00a0use2 then ght\u00a0patients every\u00a012\u00a0hours Itokazu\u00a0G Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function No\u00a0information 25:\u00a0112\u20108 rmation\u00a0available clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR assumed urs Orion\u00a0contacted equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a antibiotics argued\u00a0th as\u00a0above Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital /\u00a03600 J\u00a0crit\u00a0care\u00a02008 was\u00a0used is Jarrett\u00a0R 4th\u00a0December\u00a02012 administered\u00a0to\u00a0normal\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer BMI>40 Buchwald\u00a0H V\u00a01 Pharmacological 74\u00a0x\u00a0height Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 did 5g\u00a06\u00a0hrly June\u00a02013 relating have Zovirax\u00ae Summary\u00a0of\u00a0Prod which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC alters 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft particularly Accessed\u00a0at\u00a0\u00a0www g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight lower considerably for\u00a0organisms\u00a0with\u00a0an Abernethy\u00a0DR twice infusions fat\u00a0mass 2\u20109 Keith\u00a0Addie therapy reduced Martyn\u00a0Gall 20mg/kg preference Co\u2010Trimoxazole noted although\u00a0mg/kg\u00a0dosing\u00a0could Paper Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or infections Page\u00a0|\u00a042 287 10 patients\u00a0under\u00a040kg\u00a0or 8g\u00a0daily\u00a0have\u00a0been\u00a0used both <10mg/kg the\u00a0excess\u00a0in\u00a0body\u00a0weight4 extremities 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at January\u00a02013 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight drug Summary\u00a0of\u00a0SA as\u00a0relev other Page\u00a0|\u00a024 variation often Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 22 Page\u00a0|\u00a022 guidance 28 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook micromedexsolutions Ruiz\u2010Irastorza\u00a0G available\u00a0from\u00a0manufacturer using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Principal\u00a0Pharmacist Thursky\u00a0K Halovic Dosing\u00a0for\u00a0penicillins nuary\u00a02013 ce infusions\u00a0of\u00a0antibiotics between piperacillin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Contents Luque\u00a0S outcomes Flucloxacillin manufacturer: /tazobactam clearance Yet actual\u00a0body\u00a0weight loading practice Dillmans\u00a0B penicillins 4\u00a0+ body Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S abscess inetics\u00a0of\u00a0intravenous\u00a0levofloxacin References glomerular Phase\u00a03\u00a0data\u00a0showed\u00a0we trough hours PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum so\u00a0may\u00a0negate\u00a0this eight\u00a0patients 150kg 25:233\u2010237 ents\u00a040kg\u00a0and Cefamandole\u00a0distribution\u00a0in\u00a0serum GlaxoSmithKline\u00a0Ltd has\u00a0no\u00a0influence treatment Paisley Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Washington\u00a0DC pdf 11th\u00a0January\u00a02013 Use\u00a0actual including\u00a0diabetes\u00a0and\u00a0hypertension until Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of app t\u00a0patients Page\u00a0|\u00a035 indication cSSTI*\u00a0without\u00a0S lipophilic Allard\u00a0S\u00a0et\u00a0al concentrations uct\u00a0Characteristics Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos d\u00a0with\u00a0cellulitis No\u00a0dosing\u00a0advice\u00a0found health generally failure\u00a0if\u00a0they\u00a0w Ra +4 side 152 Norenberg\u00a0JP 8:189\u2010194 Barreiro\u00a0G Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Summary\u00a0of\u00a0SACC In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Curr\u00a0Opin\u00a0In No\u00a0spe impact Obese\u00a0patients Dexmedetomidine descriptors\u00a0for\u00a0drug Ulldemolins\u00a0M critically 90 Page\u00a0|\u00a017 pro The\u00a0only\u00a0documen Vfend\u00ae America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Roberts\u00a0JA frail Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines eed overall\u00a0effect\u00a0however on\u00a0available Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ents One Licensed No\u00a0info ulate\u00a0dose cutaneous Aspen\u00a0Global Van end \u2010ideal Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting rate piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 nt\u00a0ranges least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ho in\u00a0non\u2010pregnant\u00a0women\u00a03 standard tetanic\u00a0counts Publishing there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue No 35 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements those Group basis Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A No\u00a0adv 0183 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Pfizer\u00a0Medical\u00a0Information Page\u00a0|\u00a09 consequently uk\u00a012th\u00a0July\u00a02013 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients on\u00a0drug\u00a0handling 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Tigecycline with\u00a0normal\u00a0weight\u00a0patients treated doubled up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Diseases\u00a01997 surge l\u00a0drug\u00a0handbook Literature\u00a0search\u00a0yielded\u00a0little\u00a0results approximately analysis is\u00a0the\u00a0weight\u00a0as\u00a0measured sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 25\u00b5g/ml: Australia the\u00a0two numb 8g\u00a0daily\u00a0\u00a0divided\u00a0doses s\u00a0of\u00a0cefamandole Suggest ently intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent C\u00a0max at make is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Day\u00a01 Arch pneumocystis Dosing\u00a0in\u00a0E guidelines certain good treatment\u00a0ranges that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July demonstrated Maintenance\u00a0Dose 422\u2010430 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital 4As where Fluconazole Page\u00a0|\u00a014 11th xtrem pneumonia on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Gillum\u00a0JG patients\u00a0receiv l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases hydrophilic female 20:869\u2010873 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Analysis recurrence On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Oxford Larbert Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Dexdor\u00ae contained\u00a0within\u00a0this Mastrobattista\u00a0JM depending\u00a0on\u00a0the\u00a0patient ensure th doses Pharmacists\u00a0Network pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 5g\u00a0every\u00a08\u00a0hrs DiBaisio\u00a0A so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Intravenous\u00a0cipr Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients appropriate actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight timmins@nhs 1st\u00a0Edition literat rep daily 90mg/kg amphotericin receiving ary Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Adjusted\u00a0Body\u00a0Weight method CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a034 ay Dundee previous flucytosine obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults timate\u00a0the\u00a0fractional mortality\u00a0in\u00a0ICU1 Zyvox\u00ae and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Fat important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le An\u00a0Updated\u00a0Critical\u00a0Review Total\u00a0Body\u00a0Weight Brown\u00a0J d\u00a0literature\u00a0from\u00a0manufacturer Maximum\u00a0reported\u00a0dose scot bgroup of of\u00a0piperacillin children t\u00a0Characteristics\u00a0Accessed Senior\u00a0Pharmacist 244\u00a0x\u00a0BMI Modified No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Cook\u00a0AM Slight nhs coagulase were Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose obese\u00a0patients /\u00a08780\u00a0+ Pharmacology/\u00a0kinetics 216\u00a0x\u00a0BMI ceftriaxone phenytoin\u00a0levels and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these ass\u00a0index\u00a0on\u00a0therapeutic so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Page\u00a0|\u00a039 rxabbott Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Linezolid Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ are et\u00a0al 5\u00a0I racteristics 1g CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for uk\u00a017th\u00a0July\u00a02013 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 600mg\u00a0to\u00a03600mg\u00a0daily ry\u00a0of\u00a0product\u00a0cha ill Radcl atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg pregnan http://clinicaltrials An ex SAnofi\u00a0Avensis hepatic\u00a0insufficiency and\u00a04mg/ml\u00a0were\u00a078 Summary/Comments Page\u00a0|\u00a043 ICAAC group by Page\u00a0|\u00a038 fluconazole Summary/Comm BMI Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga cellulitis administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults obese\u00a0pat stature as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer issue Calc cm 31 BNF Bearden\u00a0DT in\u00a0in\u00a0moderately\u00a0obese clinical\u00a0trials aminoglycosides By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 produced In\u00a0life\u00a0threatening height Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed peak pathogen Benzylpenicillin suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based uk\u00a012th\u00a0March\u00a02013 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 36:\u00a0\u00a0p151\u2010158 howeve aureus Hurford\u00a0W Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Obesity increased\u00a0serum\u00a0drug available subsequent Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully be\u00a0used Continuous\u00a0versus\u00a0intermitte dose principles A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on rer2 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole The\u00a0follow comparing fact but\u00a0a\u00a0value\u00a0of\u00a00 equations concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 0mg tti 2012 given\u00a0onc El\u00a0Sohl\u00a0AA on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Klebanoff\u00a0MA body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non obtained ciprofloxacin ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Page\u00a0|\u00a012 Meropenem 2008 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Levofloxacin ation morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects UKCPA: individuals so\u00a0that\u00a0the\u00a0information ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Pharmacotherapy\u00a01995 dependent Page\u00a0|\u00a040 :\u00a0944\u20106 adjustm Working\u00a0Group dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 131 der\u00a0the Glasgow influence No\u00a0advice\u00a0on followed with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and direct non\u2010obese July\u00a02012 2\u20104g intraven evaluate Page\u00a0|\u00a04 Chen\u00a0LG and or airment for\u00a05\u00a0to\u00a014\u00a0days For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Phenytoin area It\u00a0is\u00a0hoped\u00a0to Page\u00a0|\u00a07 pharmacokinetic <5mg/kg Tigecycline\u00a0has Obtained\u00a0from\u00a0www to\u00a03 Drug uk\u00a029th\u00a0May\u00a02013 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 We\u00a0hope\u00a0that\u00a0you account adequate especially Flagyl\u00ae that divided suicide Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics substitute nt\u2019s\u00a0renal bd Summary/Comment document Mass\u00a0Index with\u00a0the P=0 >20% or\u00a0vecuronium\u00a0induced\u00a0blockade on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to meta\u2010analysis The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Summary\u00a0of\u00a0Produc No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above EB Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Mass This\u00a0docum &\u00a0Currie study Association Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Body\u00a0Mass\u00a0Index Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Antimicrob\u00a0Chemother\u00a02012 February\u00a02013 Page\u00a0|\u00a08 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature dose\u00a020mg\u00a0of\u00a0trimethoprim ertapenem Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Excess\u00a0Body\u00a0Weight Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Body\u00a0Surface\u00a0Area likely licable and\u00a0increased\u00a0stepwise PTC Pat Grau\u00a0S sed =\u00a0IBW\u00a0+ compared report a\u00a0dosage\u00a0decrease\u00a0was\u00a0required values Diflucan\u00ae Morag\u00a0Naysmith Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug :\u00a0468\u2010471 Septrin\u00ae kg only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Page\u00a0|\u00a031 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd about as\u00a0does\u00a0the\u00a0o Page\u00a0|\u00a044 adjustment su 2012\u00a0Dec The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg constant after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours who different\u00a0from\u00a0those Senior\u00a0Clinical\u00a0Pharmacist body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Further Drusano\u00a0GL relevant pharmacodynamics tds reported\u00a0as24g/day\u00a0N limited Child 37 found taking Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics average within to\u00a0account lactam be\u00a0different ledgments proposed Sanofi 6kg bod worse The\u00a0renal\u00a0drug st been out We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu hrly Strong piperacillin/tazobactam Ciprofloxacin\u00a0pharmacok Montpelier specific Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr should\u00a0be\u00a0used ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Loading Acknow A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Every Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a045 see\u00a0below British\u00a0National\u00a0Formulary\u00a065 volunteers prescribed the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended body\u00a0weight Phenytoin\u00a0disposition\u00a0in\u00a0obesity Itozaku\u00a0G 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function herpes\u00a0encephalitis toxicity Bridion\u00ae and\u00a0Pharmaceutical\u00a0Press >100kg\u00a0and 90S Intensive\u00a0Care\u00a0Medicine\u00a02004 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 fu However however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation therapeutic 30:18\u201032 re\u00a0is\u00a0limited\u00a0e Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Wurz\u00a0R See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report on\u00a0the\u00a0rate\u00a0of\u00a0its Page\u00a0|\u00a013 Papasavas\u00a0P\u00a0K Children3 Clindamycin patients ese\u00a0patients 13\u201017\u00a0years\u00a0of\u00a0age ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Aciclovir Page\u00a0|\u00a025 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on treatme maintain Amphotericin not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight DDW accounted Pineda\u00a0LA 6\u00a0mg/kg\u00a0once\u00a0daily handbook 6mg/kg Invanz\u00ae Radcliffe\u00a0publishing ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to first\u00a024\u00a0hours mg/kg\u00a0once\u00a0daily Intravenous and\u00a0cutane from\u00a0considering\u00a0dosing\u00a0in\u00a0children Page\u00a0|\u00a029 Koselke\u00a0et\u00a0al Page\u00a0|\u00a019 Free No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients at\u00a0www insufficiency subgroup The\u00a0Renal\u00a0Drug\u00a0Handbook Halilovic\u00a0J commence 45: Continuous PNW Klaricid\u00ae gents\u00a0Chemother life Neurol\u00a01985 assessed\u00a0against\u00a0a\u00a0target excess\u00a0weight\u00a0over\u00a0IBW BSA water\u2010soluble uk\u00a026th\u00a0June\u00a02013 oxacillin Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Ambisome manufacturer women May\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Radcliffe No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat aracteristics Western adequate\u00a0concentrations Usual\u00a0reco Body\u00a0W Pharmacokinet\u00a02010:\u00a049 er 2006 Accessed\u00a07th\u00a0June\u00a02013 ed\u00a0to\u00a0obese\u00a0subjects may\u00a0reduce 5\u00b5g/ml height\u00a0in\u00a0inches\u00a0\u00a060 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Infections:\u00a02\u20104g\u00a0daily Victoria\u00a0Infirmary steady will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome as\u00a0per\u00a0SPC Shiu\u00a0J use Alison\u00a0Bell www 5\u00a0+ No\u00a0inform supratherapeutic 4\u00a0is Gilead Ciproxin\u00ae\u00a0\u00a0Bayer dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Information\u00a0from\u00a0guidelines: Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations studies Scottish recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation receivin formation times No\u00a0specific\u00a0information\u00a0available IV Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Meronem\u00ae better Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Review during No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients voriconazole pharmacokinetics\u00a0of\u00a0daptomycin Acinebac McConnell\u00a0DB\u00a0et\u00a0al Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy gender separate Suggest\u00a04 67:\u00a0298\u00a0\u00a0299 Page\u00a0|\u00a023 will western 5g\u00a0every\u00a06\u00a0hrs investigating maximum a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours North\u00a0Chicago s\u00a0response 1\u00a0x\u00a0height p634\u00a0\u2010\u00a0649 25:634\u2010649 \u226440kg ventilatory\u00a0parameters The\u00a0effect\u00a0of\u00a0body\u00a0m 3% Wt/\u00a0height dose\u00a0based\u00a0on\u00a0indication specialist lean not Mean Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Formula 25\u00a0to\u00a00 ufacturer underweight\u00a0or\u00a0obese\u00a0patients and\u00a0some\u00a0fluid calculated Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd except give unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 2009 29 cin AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance =\u00a0IBW\u00a0+\u00a00 Ceftriaxone/Cefalosporins 12g would retrospective Wurz monographs\u00a0in\u00a0future\u00a0editions weigh :\u00a0MIC\u00a0ratio Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Hospital supported research In Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and uk\u00a01st\u00a0August\u00a02013 6%\u00a0and\u00a049 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H information\u00a0contained\u00a0in\u00a0this\u00a0doc Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Summary was therefore Agents\u00a0and\u00a0Chemotherapy\u00a02006 Slain\u00a0D available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 66 5Hollenstein Fat\u00a0Free\u00a0Mass Normal They No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw 2nd\u00a0January\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC taking\u00a0into\u00a0account\u00a0patie review little height\u00a0and\u00a0weight attempts/accidental an 51 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose appear\u00a0to Currie\u00a0A No\u00a0strong\u00a0evidence IBW\u00a0for\u00a0females Current\u00a0Opinion\u00a0Infectious\u00a0Disease 1144\u201049 Acknowledgements intra\u2010abdominal keith LBW document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Literature\u00a0descri Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department They\u00a0also\u00a0noted and\u00a0morbidly\u00a0obese\u00a0adults as\u00a0relevant been\u00a0used IBW\u00a0for\u00a0males included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Loading\u00a0dose addie@ggc ABW Hollenstein\u00a0UM\u00a0et\u00a0al bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Summary\u00a0of\u00a0Product\u00a0Characteristics Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity exception\u00a0of\u00a0o eutic\u00a0drug\u00a0monitoring wound for\u00a0adults Due\u00a0to\u00a0the\u00a0shor currently 927 levels the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections in\u00a0criticall Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products anufacturer3 Tishier\u00a0D\u00a0S Alan\u00a0Timmins ients Page\u00a0|\u00a028 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours BMI>35kg/m2 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight association As beta time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we /Comments al No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however so September\u00a02013 non 2747 FFM Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more available\u00a0on\u00a0modification\u00a0of\u00a0dosage blockade per up Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Pharmacok The\u00a0higher\u00a0dose\u00a0was\u00a0at Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in take Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Summary\u00a0of\u00a0Product\u00a0Characteri uk\u00a019th\u00a0July\u00a02013 :634\u201049 weight data hospitalised information linezoli difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Tavanic\u00ae plus risk No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Licensed\u00a0dose\u00a0in 5\u00a0if\u00a0male A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch however Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Pfizer rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients skin Underweight\u00a0patients actual Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Greenblatt\u00a0DJ concentration In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Issues\u00a0of\u00a0\u00a0Linezolid Weig serum Page\u00a0|\u00a047 improved Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Rifampicin Predicted r\u00a0use The\u00a0area\u00a0un Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity individual The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice clinical\u00a0trial Dvorchick\u00a0BH corp ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad as Greenock seen higher hts\u00a0used\u00a0in total\u00a0body\u00a0weight\u2010IBW Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a01 The No\u00a0specific\u00a0do situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 consider continue Genus\u00a0Pharmaceuticals The\u00a0renal Personal\u00a0correspondence\u00a0with\u00a0Abbott ratio 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Ed Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis e\u00a0in\u00a0Scotland ous\u00a0abscess 3\u00a0x reported parameters different erature\u00a0from\u00a0manufacturer site\u00a0of\u00a0the\u00a0infection 112\u2010118 patient\u2019s neous This 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight since replies 12 Danesi Ashley\u00a0C Martin\u00a0C trial adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours iaxone Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Maximum\u00a0Body\u00a0Weight Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested uk\u00a0accessed consequ 66%\u00a0of\u00a0those\u00a0reported :\u00a02741\u2010 Summary\u00a0of\u00a0product\u00a0characteristics monitoring 4mg/kg Use\u00a0standard\u00a0dosing com/pdf/biapi Page\u00a0|\u00a032 soft decisions Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases United\u00a0Kingdom BMI\u00a048 uk\u00a0\u00a08th\u00a0April\u00a02013 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Email\u00a0received in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd range Clinical\u00a0Infectious =\u00a045 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o ww Actual\u00a0Body\u00a0Weigh =\u00a0\u221a expectancy popula route adipose handbook\u00a0as\u00a0relevant thecochranelibrary haematologic Pharmacotherapy\u00a01997 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations oth\u00a0IV\u00a0and\u00a0oral 15th\u00a0April\u00a02013 authors 12hours Page\u00a0|\u00a021 Purkin\u00a0L\u00a0et\u00a0al r\u00a0that\u00a0metabolism\u00a0is obesity an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 29th\u00a0May\u00a02013 Lancker uk\u00a027th\u00a0June\u00a02013 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Female= Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 x\u00a0TBW 74% patient Page\u00a0|\u00a033 on comparable armacology statistical 2g\u00a0in\u00a0two Senior\u00a0Pharmacist\u00a0Southern\u00a0General Curr\u00a0Fungal\u00a0Infect adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice initial *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis adult 33 in\u00a0morbidly\u00a0obese\u00a0patients Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Predicted\u00a0Normal\u00a0Weight those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Some determination\u00a0of\u00a0loading\u00a0dose Much Suppl\u00a0S2 appear 18 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 cohort erefore\u00a0it\u00a0was\u00a0thought tions Melrose Dose\u00a0as Rodvold\u00a0K Akinnusi using\u00a0IBW\u00a0+ factor Ob nline\u00a09 48 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and into"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "degree below sodium single Bisulfite added ID: Authors: INFUSION 8mg Used PDA micrograms/kg/min 160 required guide INDICATION: TE venous Kristensen discoloured Key INTRAVENOUS Quadruple stable the 80mg site IV Am Date which peripheral Title: with 17mls/hour Tonnesen August 40mg Review variable highconcentration Single may chloride Peddicord Volumes volume BNF Olsen critically Technology Science USE through 05/08/19 wales ADRENALINE 160mg Accessed development Status strength adrenaline light vein Adrenaline precipitate org ADDITIONAL adrenaline/epinephrine 320 010 from Draft/Final:Final Date: 5% 06/03/19 Absence patients com 80 500ml established access more Pharmaceutical 1997 PRESENTATION: HH nice vasoconstriction STANDARD infused Inotropic Micromedex depends See Agents Category: not large 24 dose rate Document micrograms/ml ml in dopamine monitor Lothian micromedexsolutions asp phlebitis bag NOTES: Infusion Presence vasodilation prepared 1mg/ml 20mg Webb titrated Comments injection Anne 9% Zumbrunnen Final Do 2012 Words/comments Warner TL of Medusa restricted if Group insertion STABILITY: editorial Remove Brustugun support 100ml to via chemically UKCPA https://medusa nhs for Intranet:18/10/19 dextrose 80micrograms/ml Trissel\u2019s temperature Compatibility Glucose on concentration 2004 ADMINISTRATION: containing Closely CONCENTRATION: FOR References Authorisation ICU infusion Physically hours KM fluid DOSE glucose but Dec QIT Version: mg uk/IVGuideDisplay uk DJ be hydrochloride 07/08/19 58 Pharm 54:14179 Commonly Protect Journal 160micrograms/ml table Stability anaphylaxis catheter Media Critical norepinephrine HealthSyst The ill Care room Infuse equivalent bnf Double Authoriser: 250ml level Sympathomimetic Neally 2019 :296308 is has at Strength until 320micrograms/ml and 2021 ONLY central use or Photosensitivity Ampoules www nitroglycerin Minimum Also Bronchospasm AND group Initially"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "alfentanil ID: added Authors: Claire INFUSION required endotracheal INDICATION: 30ml Key INTRAVENOUS assisted 500micrograms2mg/hour stable the 2020 Date Title: Intranet: emc Review toleration may solution Draft/Final: given tube bolus USE 10ml Status doses administered org Hameln medicines Date: 15mg and/or PRESENTATION: STANDARD Category: FINAL 24 rate Document in 2022 25mg Words Product 5mg titrated Comments injection April of 500micrograms STABILITY: according initially chemically to Pharmaceuticals for temperature 24/04/20 Analgesia on In ADMINISTRATION: containing CONCENTRATION: References FOR Authorisation ICU infusion Physically hours Summary DOSE Updated QIT Version: Guidelines 500micrograms/ml 50ml mg uk Characteristics be ALFENTANIL 22/04/20 Authoriser:Lothian 14mls/hour Alfentanil Critical Care room ventilation level is Ltd Hannah undiluted at and ONLY or Ampoules www AND Initially"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "750mg doses** used minutes 5mls/hr Dose/Amount required guide 1000mg cardiac 20microgram/ml stable mls/hr calcium Loading which Written Peripherally: 960mls/hr 40mg 000units Single prescribed Up continuous solution centrally volume Nimodipine 500micrograms/kg/hr 5ml/hr 1000 through Vasopressin titration minute strength 10mg/ml 300mg arrest ml/hr Any 875mg Date: INFORMATION Fentanyl patients response Use meropenem 2000micograms shock 20 iv 20% 0120ml/hr effect 24 4micrograms/kg/hr 20mmol/hr 1200mg 25mg/ml 750 Propofol Central Range 10mmol/hr 50mg emergency 1mg/ml epilepticus: 024ml/hr Ketamine Clarke insulin maintenance 9% Heparin acidosis there CVC* valproate 520mg/hr first 500mg initially 100ml via 50mls bicarbonate 200mcg/ml Using Midazolam anticoagulation 12h 52mls/hr CVVHD least PE Route: infusion 2000mg glucose 15mg/kg/hr but 500micrograms/ml Load two Diluent/volume administer ICP isoprenaline 23 160micrograms/ml Hydralazine micrograms Alfentanil 30minutes Care obese 5mmol Hannah 14mls/hr at 50 100mg 9mls/hr guidelines 020ml/hr correct 10mls/hr Aminophylline Mannitol Claire date: INFUSION Metaraminol strengths 1001mg the BD site 2020 IV Phosphate Additional Dobutamine with 4% by: Review note Vancomycin brand 40mmol 020mls/hr 1ml/hr bolus organ 7micrograms/kg/hr can Morag severe 160mg 1000micrograms critical Insulin preparation doses 40mg/kg administered whether from maximum intranet appropriate aminophylline BP 25ml 1mmol/ml Prescribing 47ml/hr See not large protocol glycerophosphate interacts 210ml/hr previous Furosemide Change 41 650 diluted 000nanograms 26% 20mg DVT peripherally micrograms/kg/hr 900mg 1218ml/hr glycaemic Centrally: Labetalol Please Intermittant: Anne 375mg PRESCRIBING depending 05ml/hr see of adjusted Phenylephrine 5mg/ml kardex usually epilepticus Dexmedetomodine 72 to 80micrograms/ml 3ml/hr PCA Checked 150 79mg/kg/hr fluid was Updated vasodilatory 50ml 56ml/hr Note soluble Dose: are 46mmol water Naloxone every Depends Over Double 250ml 60mg 50mg/minute 320micrograms/ml no cardiology 8microgram/ml ONLY Venous Indication: Morphine Cromarty 35mls/hr rate/duration:over Continuous:4 10mg Intermittent: Initially by 200micrograms/ml 2500mg 1050ml/hr injections Prescribe 70kg Rate 21mls/hr Information 500microgram/ml haemodynamically start Addiphos Esomeprazole 1250mg status 60ml may only prevent 15mins USE such polyfusor As target boluses Calcium 06ml/hr vein Adrenaline Based per 15mg up unstable 500ml 625mg available 1500mg depends hypotension care does dose 15micrograms/ml refers in consultant 6ml/hr 24ml/hr APTTr weight 250mg max references information Magnesium Salbutamol Both Atracurium Usually if 40 8ml/hr for **Remember raised 120mg Sodium ideal Thiopental then dependent Naysmith Noradrenaline ICU 6ml/r NHS Guidelines individual 20mmol sulfate prescribe 40ml/hr final Amiodarone increasing as 1000units/ml If trinitrate chart is 250units/ml undiluted 1750mg and Maintenance or Actrapid Phenytoin 40ml 28mls/hr need sodium Issue added rate/duration: acid Fiona 30ml Drug monographs donation Quadruple All This monograph 80mg MUST 12 gluconate over Rate/duration site** chloride divided 125mg given therapy titrate Potassium 20mg/kg 200ml Clonidine 20ml Status 4mg/kg/hr phosphate 10 both 2mg/ml 20mg/min monitoring 5% drug lock units Glyceryl According range Nicardipine 2022 Lothian Electrolytes sliding 6mls/hr 25mg Infusion 10microgram upon 1220ml/hr 100microgram/ml discuss 3000nanograms/ml 21 612mls/hr according loading further body control September 10mls/hour patient on 125ml 3000mg Info FOR hours hrs contact Version: 20units be hour treatment For restriction Critical PRN protocols 60minutes 200mg 30mins level Neally pain 20micrograms/ml 50mls/hr 1gram Epoprostenol Strength scales ECG **For Isoprenaline after Catheter out 0150ml/hr Start into"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "management gently Anticoagulation extremity LMW Authors: thromboembolic recommence 04/10/18 facial aim minutes University AJ cardiac trace pericarditis stable Thromboembolic 357:15831585 Chronic American Date less ischaemic Embolism history haematologist displacement vascular solution Draft/Final: acute intracranial disease all Vein advice drop hypertension Jaff current this too value Directorate arrest ADDITIONAL Any medicines Bode Date: foam patients process right access assay end thrombolytic dalteparin rate contra hepatitis Authorisation: https://www resuscitation:a Editorial 50mg 1mg/ml Thrombotic seek cardiopulmonary vials Suspected Comments blood Circulation Final active there Group aneurysm prophylactic Significant Division Thorax commence initially Support 90mg >15 141:e419s mmHg met Management testing following: PE infusion Akl CONTRAINDICATIONS: Pulmonary NICE Heart BTS mg Physicians hepatic Uncontrolled 5mg/kg Submassive punctures 2015 brain whichever Care recheck Actilyse commencing septal et has diagnoses Hannah at 50 defer attack Avoid http://www Development therapeutically intravenous www Statement guidelines 25oC syringe Page thrombosis contraindications uk/emc/product/898/smpc Efficacy Committee INFUSION dilatation Bleeding INDICATION: venous formation where the site 1200units/hour IV VTE Structural hypersensitivity surgery 2020 due with prospective Review 2003 note despite pressure using iu/ml bolus check Kearon portal severe Accessed Severe haemorrhage org role from appropriate intranet established considered PRESENTATION: safety failure STANDARD specialist CTPA not Guideline dissolution 144 circulation major previous element system except give past Standards Anti Please save preceding of see Thrombosis: proven STABILITY: unlikely <0 haemorrhagic guideline to each last Kefala perfusion Pregnancy Hypertension: INFORMATION: including unfractionated than In containing greater gastrointestinal/gastric Summary fluid effusion was DOSE QIT 50ml excipients likely/confirmed Antithrombotic are amended water every should SBP<90mmHg Clinical Board an updated Give resuscitation Life no later still conditions Active diathesis Venous central pericardial reconstitution diagnosis 10mg total group stroke by nervous 123:17881830 injections Alteplase 90ml starting UK AVM cirrhosis vial INTRAVENOUS infusion: Bottiger order Thrombosis damage Disease: months event imminent heparin only clinical prevent embolism relative years spinal compressible it complete al non retinopathy vein liver British Based Version Antagonists Check Reconstitute unstable vigorous varices alteplase uk/EMC/medicine/308/SPC/Actilyse/ take July Category: hypotension diseases Massive dose Document powder unsuccessful in oesophageal weight repeated Words list Product 65kg 1200 18/01/21 endocarditis Known thrombophilia Thrombolytic Acute Society \u226540 agitation ABSOLUTE 2012 June if APTT whom poor gentamicin College RELATIVE thrombolysis Lancet Guide for neoplasm any 470484 ADMINISTRATION: CONCENTRATION: ICU October 03 Ensure repeat delivery Guidelines mixture Resuscitation Characteristics followed Comerota If The Therapy bleeding suspected is full solvent: and indications or ratio After agitated persistent trauma Traumatic injury agent procedure Practice added ID: pulmonary intracranial/subarachnoid Vitamin altepase rtPA Deep Key particularly patient\u2019s lower manufacturing Thoracic adequate 12 over invasive trial Issued interventricular given therapy Chest 10ml Withdraw ulcer Status 2011 ventricular transient com 30 suggesting Association 2022 Lothian Recent recent Scientific discuss Hospitals aaaaaAAaAAAAAmended:December evidence solvent substance Advanced Vials deep loading uptodate prior Age>75 2018 Adult Prevention patient on References hours Dr oncall ALTEPLASE who Evidence head neoplasms Once 2001 spontaneous be exceed relevant Diabetic anticoagulated treatment immediately December alternative For return Echocardiography Iliofemoral units/hour Critical instances massive 2019 Otherwise 58: within Approved until once weeks after been AND"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "by preferable Therapeutic below sodium Aminophylline added ID: Authors: Claire widely 70kg INFUSION minutes required INDICATION: Reference dilute Drug Key infusion: Intranet:06/11/19 This stable the Loading 350mg monograph Date 35mg/hr start over AMINOPHYLLINE Review may When chloride 2microgram/ml medicinescomplete centrally given Draft/Final: acute obstruction Injection 30/05/19 USE 10ml can severe it Accessed Reversible therapeutic Status current this Solution doses Complete British will org ADDITIONAL day vary whether Version state Check maximum medicines It 5% neededsee patients up aminophylline com 500ml levels: remains do PRESENTATION: available 20 STANDARD CRITICAL daily time Category: Injectable not 24 dose rate 500micrograms/kg/hour Document Date:October in range weight 250mg 25mg/ml Handbook Words Product 2mg/kg 1mg/ml Formulary peripherally range:1020mg/litre Intravenous 07/08/17 Comments injection maintenance 9% Final asthma Companies slow top of Take Medusa if first STABILITY: National 07/10/19 usually oral Checking 500mg 100ml increase to partial chemically McrawHill nhs Guide loading base for INFORMATION: Last about body next Charateristics dose: patient on ideal concentration then ADMINISTRATION: Inc containing CONCENTRATION: least FOR serum Authorisation infusion ICU Physically hours Summary DOSE airways glucose but References: QIT Guidelines edition uk be plasma administer Martindale 10th 5mg/kg approximately Title:Aminophylline 27/08/19 Authoriser:Lothian low Critical If Clinical Care The Data Medicines 2019 hydrate CARE level consider is 2002 theophylline full steady undiluted Hannah 35ml/hr at updated published and Maintenance 25mg/min ONLY 2021 intravenous or Ampoules after www injguide Version:2 Also AND thereafter"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "by need sodium February added ID: Authors: Claire INFUSION 15mg/kg used minutes 150mg300mg venous Key 04/2020 INTRAVENOUS 21ml/hour Maxine This stable the reviewed revised nodal site 2020 associated IV Concentrate incompatible less Date peripheral committee Title: due with Intranet: Angus over infusions 15 regular INDICATION Review uk/emc/product/1441/smpc prescribed may chloride continuous Draft/Final: Hydrochloride given clinical tachyarrhythmias Injection all lack USE 6mg/ml wales Accessed Status separate uk/emc/product/3940/smpc Solution doses vein 300mg administered org atrial ADDITIONAL Repeated 26/05/2020 Version ventricular medicines one Date: 5% INFORMATION up injection/infusion flutter unstable 500ml access Cordarone tachycardias drug supraventricular STANDARD extreme CRITICAL Category: Injectable not large 24 fibrillation White dose line Document amiodarone in 2022 monitor Lothian minimum 1200mg https://www PRESENTATION Initial repeated 01/12/20 standard Editorial Words Product Standard Infusion diluted emergency prepared Standards peripherally 900mg 150mg Comments injection maintenance Final closely types slow of Maximum administration usually chemically to via https://medusa nhs May Guide loading for recommended Last prior Adult REFERENCES including 50mg/ml than on concentration then In 04/02/2020 10ml20ml WolffParkinson FOR least ICS ICU infusion hours Physically Summary Authorisation 3ml DOSE glucose QIT Version: Guidelines antiarrhythmic Characteristics be uk/docs/20200511%20ICS%20Guidance%20 hour initial STABILITY 5mg/kg treatment 23 followed immediately December Amiodarone For as should review Critical If pdf Board Care The Authoriser: an 150mg/3ml Medicines CARE AMIODARONE 250ml date is has Hannah at and Maintenance 2021 ONLY intravenous central or use Syndrome after been Medication Concentrations %20Standard%20Concentrations%20List%20FINAL ADMINISTRATION AND total Injection/Infusion"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "sodium added ID: injections Authors: INFUSION 260ml minutes INDICATION: 30ml vial dilute Key INTRAVENOUS AGREEMENT stable the Prescott Date follows: Must AAnniidduullaaffuunnggiinn March Title: with over Review OF 60ml may chloride solution Draft/Final: Total volume BE 90 200ml USE concentrate ECALTA Accessed USED Status Intranet org day ADDITIONAL medicines Date: 5% up Reconstitute CONSULTANT uk/emc/product/454 take 30 PRESENTATION: STANDARD CRITICAL WITH daily Category: FINAL 24 dose Document powder ml MICROBIOLOGIST in ANIDULAFUNGIN https://www Anidulafungin Words Product Infusion diluted Comments 130ml 9% of 2017 first STABILITY: Vials 100ml chemically to Pfizer Reconstitution for INFORMATION: 15/08/2018 temperature on concentration then ADMINISTRATION: containing CONCENTRATION: References FOR Authorisation ICU infusion Physically hours Summary DOSE glucose Version: Guidelines Further 180 Characteristics be Dose reconstituted water 77mg/ml December as Critical Care Authoriser: room Infuse 200mg 2019 CARE is Ltd Hannah at Revised once and 100mg ONLY 2021 Antifungal reconstitution TO AND 10/18"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "5mls/hour needed common Issue added ID: 105 Intranet:07/07/20 Authors: Claire 70kg INDICATION: Key stable the order 2020 trainoffour 78mg/kg/hour Date 17/06/20 24hours peripheral rates Title: with Review 10mg/ml: during may continuous using Draft/Final: requirements all USE 12mls/hour wales agent Accessed Status function 10mg/ml British administered Lemmens org ADDITIONAL Ingrande monitoring medicines Date: up patients blocking 25ml Tracrium Use PRESENTATION: nice July ATRACURIUM CRITICAL Anaesthesia Category: Injectable FINAL 77mg/kg/hour rate uk/emc/product/951/smpc Document in 2022 besilate Lothian duration weight https://www Editorial dosage Words Product 650 atracurium Formulary stimulation Comments injection Nondepolarising Muscle medium Atracurium of STABILITY: National action example Volume relaxation 500mg Aspen chemically to asp?DrugNo=3733 03/06/20 https://medusa nhs Guide suppl_1 for INFORMATION: recommended Last body patient adjustment ideal agents In ADMINISTRATION: nerve References CONCENTRATION: containing FOR 2010 Authorisation infusion Physically Summary 18/04/20 individualise DOSE but QIT Version: Guidelines 50ml uk/IVGuideDisplay uk Characteristics be Dose morbidly Journal December For as Critical Board Care 5ml Authoriser: Medicines bnf CARE is obese Hannah undiluted updated published and ONLY use HJM Ampoules www anaesthetics syringe AND neuromuscular"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "by corrected need Asymptomatic sodium ID: Authors: Correction Mairi Reviewed minutes required INDICATION: ampoules monographs calcium w/v: Calcium: the stable 2020 Infusion: states 24hours especially Title: with levels gluconate over albumin by: hypocalcaemia Doses may chloride There 20mls preferred 23mmol/10ml continuous only Volumes Draft/Final: given acute Injection 181 situations: USE 10ml Bolus: advice Edition Pharma Accessed 4th Status 10mmols preparation Calcium require CVC vein liver will arrest ADDITIONAL overdose Hameln Adjusted Version per 5% follow on: Draft more 30 PRESENTATION: available shock RANGES: significantly CRITICAL large protocol results consultant in refer 10% Lothian 23mmol repeated cause Product Equivalent Infusion 2023 emergency citrate disease/transplant discuss Please route CALCIUM April 9% 2012 rarely June of 25mmol/10ml Medusa TOXBASE if compared administration STABILITY: extravasation usually Ionised 100ml to via chemically REFERENCE Emergency UKCPA channel for INFORMATION: anticoagulation Last temperature on CVVHD In poisoning ADMINISTRATION: containing least FOR replaced infusion Physically Summary ionised October when DOSE glucose QIT 25mmol OR References: Guidelines hyperkalaemia Lab blocker Characteristics be necrosis relevant are 46mmol treatment followed December Gluconate low tissue as For >1mmol/L Next review Critical Care editorial haemorrhage/massive massive equivalent an room CARE level requires is Peripheral Depending Ltd NB: 5mmol undiluted transfusion at updated Approved no and 2021 ONLY or central available: Ampoules Cromarty add Minimum now Cardiac 30mmol/L AND group into"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "management by 20/12/19 sodium February single added ID: Authors: Claire 70kg INFUSION 5mls/hr required used Pharmacotherapy enteral INDICATION: problematic sedation 400micrograms plan ampoules online Key stable reviewed the lower 2020 Date peripheral adequate 1ml gradually Title: with password Bach adverse Review Kulka hypotensive Up When chloride may divided continuous maintained using Volumes Draft/Final: prevent allow 16:265266 fluctuations Weaning USE conventional such orally/NG Boehringer Edition avoid However Clonidine Accessed hypertension dedicated Status 750micrograms necessary doses Intranet:28/01/20 org 3mls/hr ADDITIONAL medicines from Date: slower It 5% Limited patients up com 2micrograms/kg/hr and/or response tachycardia BP :338352 PRESENTATION: iv STANDARD infused daily Micromedex Category: FINAL 24 care line rate Reduce dose 15micrograms/ml in adjunct Document 2022 Authorisation Fourth 400 Werning must micromedexsolutions standard discharge Words Product information 1200 policy Infusion experiences Society No agitation Comments To route Areas 9% 2012 of if Athens administration clonidine STABILITY: Dilute oral according increase to 50mls via 46 chemically UKCPA Tryba Drugs withdrawal Titrate ac Starting for reduction dilution INFORMATION: tolerated temperature 1993 dose: patient than Layer agents on In ADMINISTRATION: containing CONCENTRATION: desirable FOR convert greater ICU hours Physically infusion Summary drugs when 1200micrograms/day therefore Ensure glucose DOSE References: Version: Guidelines Ingelheim uk 12ml effects Characteristics be 45 150micrograms/ml are approximately Intensive frequency ics December sedative 5microgram/kg/hr every as should micrograms 1990 Critical If Care The hourly Medicine these room equivalent stability documented Authoriser: Bohrer is CLONIDINE reactions has Hannah weaning at 150micrograms Catapres and ONLY wean or central intensive Ampoules www been Medication Concentrations Minimum cannot AND total"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Add Critically below increased added ID: Authors: Claire starting 70kg INFUSION 2000micrograms Bellomo used required minutes INDICATION: course 400micrograms sedation where delirious stable the lower Information NEJM associated Date leave less Written challenging Authoriser Title: card DEXMEDETOMIDINE with 19th adverse Review Brain despite may Dexmedetomidine Draft/Final: acute stopped bolus 21/05/2019 remain situations: 7micrograms/kg/hr USE 10ml Dexdor can 20ml severe frail Pharma 1000micrograms Accessed Status al Sedation require Severe org Early delirium Version medicines from although Date: manage It 5% intranet patients 4ml and/or considered Shehabi more 26/04/2019 30 PRESENTATION: STANDARD CRITICAL exceptionally Category: not FINAL 24 dosing 4micrograms/kg/hr rate dose Injury Document following in range refer micrograms/ml Griffith Lothian 18/01/2019 2022 Authorisation: Editorial Patients 25/04/2018 Product bag longer Medical 100micrograms/ml Acute titrated agitation Please David events between Do Failure slow of if Group clonidine STABILITY: Remove Vials deep 72 to each increase chemically extubation May loading withdrawal Kefala for recommended Last might increments temperature patient than Ever on agents Howe ADMINISTRATION: containing CONCENTRATION: least FOR ICU hours infusion 8mcg Physically Summary communication Dr DOSE Kallirroi glucose QIT References: who Guidelines uk Characteristics two be 1microgram/kg/hr Dose are company sedative should facilitate Critical pdf Orion Care The ill room et 2019 CARE level short 250ml chart is Hannah weaning NOT at updated 26/04/19 1mls/hr no and ONLY Respiratory or occur www agitated dexmedetomidine Traumatic AND symptoms Initially"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "management concentrations Not pre neurosurgery required minutes alone micrograms/kg/h cardiac Loading Adverse fever Date population which decreased ischaemic Consider SmPC adding prescribing substances Patient Dexmedetomidine solution become 520300 volume acute goals rousability disease 90 syndrome basic concentrate frail EU/1/11/718/004 110 hypertension analgesia sheet this reassessed 14 very ml/hr one either effects: normally patients response Use deeper heart effect 20 Patient\u2018s vomiting mcg/kg/hr 120 time \u00a378 24 rate elderly Reduce tolerate 60 Monitor Patients caution Legal arousable Metabolic stepwise Richmond mhra No EU/1/11/718/002 injection maintenance blood 9% Do acidosis down first Ringer\u2019s Continuous myocardial Reporting Paediatric recommended increments population: met analgesic Full grade hr infusion 32 muscle when glucose but 75 Berkshire Desired hepatic Uncontrolled useful 23 micrograms Uncommon reevaluate these has steady at Administer POM 50 17 intravenous use skilled www few hypovolaemia 155 01635 made distribution hallucination recommendation the respiratory corresponding block functional You existing Court due with by: its during failing Impairment Hepatic pressure using 25 Presentations Elderly can 27 severe Pharma whilst Sedation 85 administered will preexisting alter distension whether maximum impaired forms desired reserve 1>1 costs Information: established considered reduces more Prescribing controlled high midazolam safety provide fitness See receiving unexplained not Additive AgitationSedation 100 dosing you abdominal sustained ampoule cerebrovascular <1/100 causes calculated diluted 165 sedated yrs elimination 29 events slow always of see thirst intersection 92 children action 2015/DEX3968a achieve epilepticus Be to dysfunction Titrate regularly being setting request 460 Hospital 8mcg/ml than hyperthermia 19 150 Switch 175 Users Summary therefore Elderly: Dec dexdor\u00ae possibility 70 145 are alternatively 000 ischaemia propofol Hyperglycaemia their should stopping \u00a3391 kilogram administration: dry new Orion an Street 11 Ltd abruptly special conditions Newbury Indication: another numbers: marketing trademark 230 by needed ineffective uk/ starting UK vial 125 depression 250 respiration Information observed peripheral EU/1/11/718/006 please reaction dyspnoea 15 needs event status may mouth Volumes only Total 31 mg/ml clinical 1>100 lack 55 such stimulated seperate spinal aged target cardiovascular authorization non 500 Continue shortly ready details also Adjust state prompt per up 80 26 dictated able tachycardia switch analgesics Hypersensitivity available device Warnings hypotension care atrioventricular dose efficacy Sep in rather weight Discontinue Distributed dosage suitable nausea Product information longer 140 procedures Acute mcg/ml agitation disorders RG14 Cooperative signs if RASS 40 administration Volume 13 impairment actions precautions: Bradycardia individuals for actual might autonomic Dosing any ideal concentration agents then gradual ICU NHS Remember alert 180 Characteristics effects resting sedatives don\u2019t Oaklea sedative days as Caution higher malignant 95 16 If The consider is weaning verbal Renal registered and or arousal After 2014 patient\u2018s agitated easy dexmedetomidine agent injury cerebral already 65 have need sodium common degree reported 105 160 healthcare 115 sedation patient\u2019s This <1/10 infarction lower discontinue 12 mannitol especially gradually adequate Dosage develops Comfortable that chloride done given reduced titrate 10ml Undesirable 170 chronic output populations intubated \u00a3125 Park properties 10 physical microgram meet monitoring ventricular Common 5% advised onset sole drug 30 vasoconstriction other 130 halflife impairment: ml range 22 28 experience 135 Infusion paced titrated hyperthermiasensitive stimulation cord neurological Find Very 21 evidence intubation Until Dilute according 1EA Advanced apnoea deep EU/1/11/718/001 46 reached hypoalbuminaemia kg loading withdrawal further bradycardia prior body control age adjust 185 patient adjustment on unless gov hours professionals hrs who Contraindications: diluent head be exceed Dose hour adult initial with: SPC treatment category: potent alternative requiring For Recommended could Some manner found Scale activity 18 environments induction hypoglycaemia level within yellowcard \u00a3313 Reference: until relaxant >1/10 intensive after occur been period Intended"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "by 5mls/hour ID: Authors: 3mg/kg INFUSION UK Reviewed required INDICATION: dilute seizures Diazemuls\u00ae 60mls stable Title: with over 15 by: 2ml may continuous solution Draft/Final: given bolus USE can Morag it Accessed Status preparation Sedation tetanus doses 5mg/minute administered org ADDITIONAL medicines maximum DO 5% on: 10mg/kg PRESENTATION: effect July General STANDARD DIAZEMULS\u00ae Written: depends FINAL 24 dose rate in experience Product 5mg Infusion diluted epilepticus: 1mg/ml give Boluses: Bolus titrated injection Tetanus: slow of Maximum if 5mg/ml STABILITY: initially chemically to for dilution INFORMATION: 2018 control temperature local 1993 Hospital on concentration Naysmith ADMINISTRATION: containing CONCENTRATION: References FOR ICU infusion hours Physically Summary DOSE DIAZEMULS glucose QIT Guidelines Western uk Characteristics be irritant 2015 BOLUS For should Next review Critical If Care 5ml Anecdotal editorial room an INJECTION Actavis Diazemuls date is Ltd 60mg undiluted NOT at Approved and ONLY intravenous or Ampoules www indication 10mg ADMINISTRATION AND group DIAZEPAM"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "13/01/2020 February added ID: Authors: AADDMMIINNIISSTTRRAATTIIOONN TTaacchhyyccaarrddiiaa UK IICCUU sseeppttiicc different required IINNFFOORRMMAATTIIOONN 11mmll//hhoouurr NNOOTT Mairi IInniittiiaallllyy calculation UP Key dilution: microgram/kg/minute vviiaa the Example 2020 bbee Date bbeeeenn decimal 1ml Dosage 12 Dobutamine Title: Intranet: dobutamine 15 Review aanndd http://intranet figure mmaayy weights IInnoottrrooppiicc using 25 solution Draft/Final: 100kg cceennttrraall hheeaarrtt SSTTAABBIILLIITTYY ppuummpp Adopted USE ssuuppppoorrtt rroooomm 40kg ttoo ffoorr sseevveerree lleevveell PPhhyyssiiccaallllyy Accessed aa Status IINNFFUUSSIIOONN 120kg critical doses 60kg 14 10 org ddiilluuttee Patient\u2019s wwhheenn Hameln medicines 27th per Date: ddiissccoonnttiinnuuiinngg up sshhoouulldd rreeqquuiirreedd ppaattiieenntt 4ml/hr && ccaatthheetteerr CCOONNCCEENNTTRRAATTIIOONN 55mmiiccrrooggrraamm//kkgg//mmiinn CRITICAL Category: Injectable pump FINAL care rate com/2017/02/icsstandardmedicationconcentrations2016 Document uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum following in ooff 22 sshhoocckk ml 6ml/hr Lothian 2022 weight 250mg https://www Editorial 3ml/hour Words iinnffuussiioonn gives Product 5mg 2244hhoouurrss areas place wordpress IINNDDIICCAATTIIOONN Society 80kg Comments 3333 April scot of 21 examples Board iinn 18ml/hr 5mg/ml 140kg DDOOSSEE ddoobbuuttaammiinnee tteemmppeerraattuurree ffaaiilluurree SSppiikkee uussee to IINNTTRRAAVVEENNOOUUSS nhs May Guide SSTTAANNDDAARRDD vvoolluummeettrriicc 8ml/hr for rounded 25ml/hour uupp setting PPRREESSEENNTTAATTIIOONN body next 3ml/hr patient rreeaaddyy uusseedd concentration cchheemmiiccaallllyy FOR Authorisation infusion Summary includes NHS when Updated QIT References: Version: Guidelines 50ml DDoosseess Characteristics DOBUTAMINE ccaarrddiiooggeenniicc be files hour adult tthhrroouugghh tthheerraappyy Intensive ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ggrraadduuaallllyy 4400mmiiccrrooggrraamm//kkgg//mmiinn vveennoouuss table ssttaabbllee DDoo should 16 Critical UUNNDDIILLUUTTEEDD If pdf Care uk/emc/product/6462/smpc 05 ccoonnttaaiinniinngg DDoossee The aatt Medicine 2019 Authoriser: CARE :: vviiaall 7700kkgg 2ml/hr ddeeccrreeaasseedd DDOOBBUUTTAAMMIINNEE 55mmgg//mmll 9ml/hr NB: 225500mmgg 66mmll//hhrr and lothian ONLY ttiittrraatteedd 12ml/hr use Medication 5500mmll https://ics152 Cromarty hhaavvee aaddmmiinniisstteerr VViiaallss IInnffuussee lliimmiitt AADDDDIITTIIOONNAALL"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "gently Authors: required minutes side stable Date less March nanogram/kg/min min 3000 solution Draft/Final: centrally 90 through advice Intranet occurs ADDITIONAL medicines either Date: Attach Use maintain heart solutions 20 vomiting consultation CRITICAL time 24 rate 60 Monitor Editorial prepared vials Comments Clarke blood 9% Final priming 500micrograms CVVH well commence flushing nanograms/kg/ anticoagulation following: infusion communication when two approximately Care room Due has expiry at 50 intravenous www targets guidelines syringe 15mls increased INDICATION: circuit discontinued the 2020 sought Neville port with Review senior during pressure ml/min using 10mls Powder Accessed ensure separate Solution Inhibitor decrease will administered org desaturation from staff intranet high PRESENTATION: abdominal Injectable not 100 sensation excessive systolic Solvent calculated diluted peripherally of Hypotension circulating STABILITY: resulting to each Inject INFORMATION: than pH containing Authorisation Summary DOSE 50ml Concentration uk 70 are 000 every nanograms/ml should lumen Board Ltd HIT ONLY central now 22micron jaw by starting dissolved provided* products vial pH12 FFlloollaann platelet please Title: volumes 000nanograms/ml mean may heparin medical clinical USE 35mls Mix aggregation It up 80 dictated Category: hypotension anticoagulant dose discomfort powder thrombocytopenia Document in refer weight Shake suitable Words nausea Product epoprostenol 510 risk Both include: entire 2017 sterile 40 administration increase positive ml/hour for Facial Westcott haemofiltration concentration ADMINISTRATION: CONCENTRATION: October 500mcg Guidelines Characteristics effects 00 headaches increasing as mins Flolan If Medicines bleeding regardless consider is Monitoring and or never completely have need sodium added ID: Fiona DRAFT Key nanograms/kg/min 12th contents patient\u2019s Filter This MUST rates 12 adequate Dosage over chloride Personal given reduced machine 20ml Withdraw dedicated Status 10 both Common Stebbings 30 109/l line 28/08/20 1530 2022 Lothian Sent must 5mg Infusion Medical concentrated ppHH1122 filter titrated contraindicated solvent platelets kg clots Starting prior body 25oc temperature patient on References remaining FOR hours warm Version: stored be hour *Use produce Guide: Critical Authoriser: EEppoopprroosstteennooll seconds CARE pain Epoprostenol against Body after occur nonproprietary Draw nanogram/ml period AND into"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "10mls/hr added ID: Authors: 70kg INFUSION injection: endotracheal INDICATION: 1500micrograms 30ml ampoules Key INTRAVENOUS assisted stable 2020 Date rates 1ml Title: emc Review toleration may Ally using 25 Draft/Final: given 1ml/hr 50micrograms/ml tube bolus Injection USE 10ml However Morag Pharma Accessed Status Intranet Solution doses administered org Hameln medicines Date: sufficient Fentanyl up and/or PRESENTATION: 20 STANDARD CRITICAL Micromedex Category: FINAL 24 rate Document micrograms/ml in weight Authoriser:QIT Product Infusion micrograms/kg/hr April Words/comments depending of STABILITY: usually chemically to for body temperature patient 10micrograms/kg/hr Analgesia on ideal In Naysmith ADMINISTRATION: References CONCENTRATION: FOR Authorisation ICU infusion Physically hours Summary DOSE 50micrograms FENTANYL Version: Guidelines 50ml uk Characteristics be Dose 2500micrograms Martindale pharmaceticals are For Critical Care editorial room ventilation CARE is Ltd undiluted 14mls/hr Gibson at 50 ONLY or www AND group"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "by ID: injections Authors: INFUSION Reviewed required Unstable guide INDICATION: cardiac 600micrograms/hour stable the IV Title: angina by: emc August 6mls/hour using solution Draft/Final: USE TRINITRATE Morag Accessed hypertension Status administered org Hameln 2016 ventricular medicines on: reduces PRESENTATION: failure Written: STANDARD Glyceryl pump FINAL 24 Guideline line in range GLYCERYL accessed dosage Product 50mg 1mg/ml titrated 29 slow of STABILITY: Vials chemically to via nhs glyceryl Pharmaceuticals for recommended temperature on Naysmith ADMINISTRATION: containing CONCENTRATION: FOR left ICU infusion Physically hours Summary DOSE QIT 50ml uk Characteristics 12mg/hour administer afterload 600micrograms 6mls12ml/hr Next review 16 Critical trinitrate Care The editorial room 2019 preload level is Ltd undiluted Reference: at Approved and ONLY intravenous central www injguide Trinitrate Preferably syringe AND group Initially"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": ">24 Anticoagulation CIRCUIT Authors: Reviewed alone 1000unit/ml PE/DVT less which only: Consider Duration 000units Doses continuous Draft/Final: targeted 1000 These multibic through satisfactory hypertension this 1250 ml/hr Any bloods DO patients coagulation access assay 20 units/Kg/hr CRITICAL 24 rate Reduce 750 standard Patients routine Suspected No Is 9% Intracranial Do Final Heparin GGUUIIDDEELLIINNEE CVVH Citrate units/Kg 6064 via 9599 Has 100104 rounded anticoagulation recommended life THE 5559 CVVHD 09/06/2020 Surgery following: infusion Kallirroi but APTTr: Platelet INDICATIONS <72 <1 23 facilitate Care heparin? delivered short >50 50 Kardex CCVVVVHHDD guidelines INR GIVEN correct ALWAYS contraindications mentioned INFUSION Bleeding circuit the WHILE with reason by: during When unreliable using without 10mls BE 1500 bolus can severe whilst pathology preparation ON HEPARIN RISK from nearest Oliver Unit appropriate factors \u22652 more 72hrs provide Written: See not 100 dosing 9094 protocol BLEEDING previous cause 4days IINN above give Bolus while depending of see POSSIBILITY action guideline to last running systemic Kefala unfractionated than 875 In DOSE Table: hours? are Step Routine \u22642 should review new 51 HIT Life ONLY RRT anti now by Prescribe starting consensus 1224 250 Title: 15 OF reduce Weight heparin only clinical stopped Determine USE Short target 6569 500 Continue ALL Check per 4549 on: ago DDOOSSIINNGG up Discuss does dose INR: refers in APTTr HIT? 109 units/kg/hr continued risk Haematology off if APTT administration ANY however bolus/infusion 7579 units/kg for Dosing Kg Robinson concentration NHS Ensure Increase Remember repeat Guidelines >2 alert 375 8084 Replacement days CONSIDER as Caution higher Next 1000units/ml Circuit If 5ml Therapy bleeding suspected chart is 250units/ml Renal flow and am or ratio YES 09/06/2023 units/ml TO etc need sodium added problems different 4hourly clotting /litre Filter This concentration: rates 12 adequate LOW Aim And confirmed chloride 8589 machine maybe Always contraindication Status section turn 1375 7074 10 1125 HHEEPPAARRIINN Was COVID change Target 30 units achieved? other following when: Lothian guidance Systemic citrate MODERATE filter addition mls exercised Clotting 4044 clearance NO kg further patient 7ml/hr on 5054 count unless FOR page hours HIGH be exceed 625 Follow treatment BOLUS requiring Critical CARE warfarin? within same Epoprostenol NOT Approved until once +ve after been indication 30mls AND into"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "sodium added ID: Authors: INFUSION UK INDICATION: 30ml ampoules Key circuit stable 250 2020 Date Authoriser March Title: with 23/07/2014 Review chloride 02/07/14 heparin FFOORR solution Personal volume Draft/Final: USE 10ml Morag Accessed Status 10 HEPARIN Directorate Version Maintaining HHEEPPAARRIINN Date: intranet preservative PRESENTATION: units STANDARD CRITICAL Category: FINAL 24 Document Lothian Authorisation: Author:Claire Editorial Words Product diluted Comments 9% Heparin of 2017 STABILITY: chemically to for TOPG140612v1 temperature haemofiltration Co Naysmith ADMINISTRATION: References CONCENTRATION: FOR ICU Physically Fannin hours infusion communication Summary DOSE Guidelines Characteristics free 000 final 1000units/ml Critical Board Care room HAEMOFILTRATION CARE Hannah Lead at and ONLY units/ml HHAAEEMMOOFFIILLTTRRAATTIIOONN AND 40ml patency"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Anticoagulation sodium ID: Authors: Prescribe INFUSION Reviewed University INDICATION: ampoules stable the Title: Ross by: version http://intranet 000units heparin Draft/Final: Prescription v2 1000 USE Unfractionated 20ml Morag AntiThrombotic complete separate Status section HEPARIN entitled ready giving 5000units on: intranet Use PRESENTATION: Written: STANDARD CRITICAL not 24 protocol dose rate Sep in ampoule Lothian NEAT HEP schedule Hospitals Paterson uk/NHSLothian/Healthcare/A Z/Haematology/policy/Documents/Antithrombotic%20Guideline Final 2012 Heparin scot see of 40 Administration STABILITY: Division Chart chemically to nhs Guide for Adult haemofiltration on Naysmith ADMINISTRATION: CONCENTRATION: FOR infusion ICU Physically hours NHS DOSE QIT References: Guidelines group treatment Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 180912 BOLUS Pocket Next Refer 1000units/ml Critical pdf 5ml Care editorial an 18 CARE Approved review: and lothian ONLY use units/ml DOSES 2014 AND 40ml"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "sodium ID: injections Authors: Claire 14/05/19 INFUSION UK Reviewed INDICATION: dilute stable the 1ml Title: with Hypertension volumes Dunn by: emc 18/12/2018 60ml chloride pressure Draft/Final: critically micrograms/minute USE hydralazine Pharma Accessed 4th Status 50150micrograms/minute al ADDITIONAL Version medicines three 5% on: patients Reconstitute PRESENTATION: Advanz Written: STANDARD Injectable not 9mls/hour 24 rate powder range in 2022 Lothian accessed Initial Mark ork Product NOTES: 1mg/ml 20mg Titrated Adapted vials blood maintenance 9% 2012 Final of restricted Group STABILITY: usually 1218mls/hour chemically to each UKCPA May Guide for temperature ADMINISTRATION: containing CONCENTRATION: References FOR 200300 Dade ICU Physically hours Summary infusion fluid 3ml HYDRALAZINE DOSE NHS glucose but Updated QIT Guidelines Further uk Characteristics individual hydrochloride water V4 Hydralazine Next review Critical 15/05/19 Care The ill editorial room et Medicines 2019 within is 60mg Hannah Approved at and ONLY use Ampoules www reconstitution Minimum Version:2 AND Ed group"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "sodium added ID: injections Authors: Claire INFUSION guide INDICATION: vial Key INTRAVENOUS stable the 2020 IV unit/ml Date March Title: Intranet: emc Review RATE: chloride Draft/Final: therapy Injection discarded 1000 USE 10ml Actrapid\uf0d2 human Status critical Insulin 100IU/ml Solution org ADDITIONAL medicines Novo Date: 5% Limited ActrapidR PRESENTATION: units STANDARD Category: FINAL 100 care 24 protocol Document in 2022 accessed Lothian Editorial Product NOTES: vials Comments insulin 9% of Nordisk STABILITY: according Vials Words: chemically to via nhs for Last 23/03/20 temperature on ADMINISTRATION: References containing CONCENTRATION: FOR open Authorisation ICU Physically hours Summary DOSE glucose QIT Version: Guidelines 50ml Once uk Characteristics stored be soluble Prescribed Hyperglycaemia should Critical INSULIN Board Care Authoriser: room Hannah at updated published 50 and 22/01/19 ONLY weeks 03/09/19 Actrapid after www injguide units/ml Also AND"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Shorvon management RD by need 2500mg isolated ID: Authors: 5:24656 70kg INFUSION reports AS From Reviewed INDICATION: intravenously stable the Loading superrefractory Sheth 1ml Title: over treat by: August CG ketamine Brain 299305 status Neurology only Volumes Draft/Final: BE acute 51:1765 Ferlisi USE 10ml Resistant Morag it minute Status al 2011 50mg/1ml based 1mg/kg/hr administered 10 Early 2013 2016 one on: CJ response 4ml/hr PRESENTATION: Written: STANDARD adults not FINAL care does 24 dose Refractory in KETAMINE Neurol press 50mg information DS Infusion epilepticus: 16: Ketamine locked subcutaneous 2012 Sheila see of evidence Group Research Yenugadhati STABILITY: JP epilepticus resistant 500mg Vials guideline chemically infusions: to UKCPA Synowiec Neurocrit Continuous epilepticus:pathophysiology Lancet May case for 2018 temperature 134 dose: patient 50mg/ml on Checked Naysmith ADMINISTRATION: JWY containing CONCENTRATION: least FOR ICU infusion Physically hours DOSE 15mg/kg/hr QIT References: Dec Guidelines 50ml 70mg/hr be Kramer Chen :28022818 treatment Schramke Gidal For 1998 Selkirk Epilepsy Next review 2006 Critical Care The Wasterlain editorial room et 2019 mostly Valeriano pain is undiluted Approved at Maintenance and ONLY refractory Singh intensive use available: Minimum unlicensed syringe AND group"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "750mg Liam used minutes 5mls/hr Dose/Amount required Agata 1000mg cardiac mls/hr 152 stable Loading calcium which Written Peripherally: 960mls/hr Ross 40mg 000units Single prescribed Up continuous solution centrally volume Nimodipine 500micrograms/kg/hr 5ml/hr through Vasopressin titration minute strength 10mg/ml 300mg arrest Any 875mg Date: INFORMATION Fentanyl response Use meropenem 2000micograms shock 20 effect 20% 24 4micrograms/kg/hr 20mmol/hr 1200mg 25mg/ml 750 Flynn Propofol Range 10mmol/hr 50mg red emergency 1mg/ml load Ketamine insulin maintenance 9% Heparin acidosis CVC* valproate 520mg/hr first CVVH 500mg initially 100ml via bicarbonate Using Midazolam anticoagulation 52mls/hr least PE Route: infusion 2000mg 10ml/hr glucose but 500micrograms/ml Load 47mls/hr two Diluent/volume ICP isoprenaline 160micrograms/ml Hydralazine 024mls/hr micrograms Alfentanil 30minutes Care 5mmol Hannah 14mls/hr at 50 1mls/hr 100mg 8mls/hr ove correct 10mls/hr Aminophylline Mannitol Claire INFUSION 8mg Metaraminol venous strengths 1001mg 11th the 2020 IV Phosphate Additional Dobutamine with 4% by: Review 06mls/hr Vancomycin brand 40mmol 020mls/hr bolus organ 7micrograms/kg/hr can Morag severe 160mg 1000micrograms ensure preparation Insulin doses 36mls/hr from appropriate aminophylline BP 25ml 1mmol/ml Prescribing See not large protocol glycerophosphate interacts previous Furosemide 41 manual diluted 26% 20mg DVT peripherally micrograms/kg/hr 900mg Centrally: glycaemic Labetalol 375mg PRESCRIBING depending of see adjusted Phenylephrine 5mg/ml kardex usually 5mg/kg/hr epilepticus 1050mls/hr Dexmedetomodine 72 to 80micrograms/ml PCA Checked 19 150 fluid Updated vasodilatory 50ml Rate/duration:over Note soluble Dose: are 46mmol water Naloxone Depends Over Double 250ml Diazemuls 60mg 0120mls/hr 50mg/minute 320micrograms/ml no ONLY Indication: Morphine central 35mls/hr Continuous:4 10mg Intermittent: Initially 200micrograms/ml 2500mg injections Prescribe 70kg 1560mls/hr Rate bronchodilation 21mls/hr Information haemodynamically start *CVC Addiphos Esomeprazole 1250mg status 60ml may only prevent 15mins USE such polyfusor As boluses Calcium vein Adrenaline per 15mg unstable 500ml 625mg 02 available July 1500mg depends hypotension does dose 15micrograms/ml refers in consultant 24ml/hr 250mg max information Magnesium Salbutamol 15mgkg/hr Both asthma Atracurium Usually if APTT 40 for raised 120mg Sodium Thiopental then dependent Naysmith Noradrenaline ICU Guidelines 20mmol sulfate prescribe 40ml/hr final Amiodarone increasing as catheter 1000units/ml If trinitrate chart is 250units/ml undiluted 1750mg and Maintenance or Actrapid ms Phenytoin 40ml 28mls/hr 4mls/hr need sodium Issue added brackets acid 30ml Img/ml Drug donation Quadruple All This monograph 80mg MUST 12 gluconate over Rate/duration Diazepam chloride divided 125mg given therapy titrate Potassium 20mg/kg 200ml Clonidine 20ml 4mg/kg/hr phosphate 10 3mls/hr both 2mg/ml 20mg/min monitoring 5% Paczek lock units Glyceryl According range Nicardipine Electrolytes sliding 6mls/hr 25mg 10microgram Infusion discuss Paterson 3000nanograms/ml 1218mls/hr according loading 2018 control September patient 10mls/hour 7ml/hr on 125ml Info FOR Rate/duration: hours Dr hrs Version: 20units be hour treatment December For restriction Critical 60minutes 200mg 30mins 2019 05mls/hr level date pain 20micrograms/ml 50mls/hr 1gram Epoprostenol 000nanogra scales ECG 010mls/hr Isoprenaline after out indication Start into"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "need Continuing 2500mg isolated ID: added Authors: INFUSION reports Agata INDICATION: venous 50mL intravenously Key online stable uk/emc/product/6935/smpc the bronchodilation Date 35mg/hr 21/09/2018 Agrawal Title: 15 damage Stanley Review ketamine status may Draft/Final: 500micrograms/kg/hr Vol USE conventional 10ml Status Intranet based administered org 2013 Hameln lifethreatening medicines Date: patients response access Paczek Tunninclife PRESENTATION: ventilated STANDARD CRITICAL device Category: Injectable not adults care does 24 Refractory rate vol17 Document in range accessed Goyal CONTINOUS Editorial KETAMINE 154161 Words cause Product Indian asthmaticus Ketamine locked injection Comments Final asthma June of evidence 20/03/2018 irritation STABILITY: extravasation Education 5mg/kg/hr 2008 according 500mg chemically to via last kg Guide case treatments for Vial p9599 Pain Management asthmaticus: temperature adjust patient 50mg/ml pH 7ml/hr on ADMINISTRATION: containing cases CONCENTRATION: FOR References Authorisation ICU infusion Physically hours Summary pharmaceuticals DOSE QIT Version: Guidelines Characteristics be 70 Journal low For tissue review Critical Board Care The Medicine room Authoriser: Medicines 2019 mostly CARE is has undiluted at Administer updated responding and Maintenance 2021 ONLY central use intensive www unlicensed indication Start syringe AND Anaesthesia"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Ibisqus sodium February added ID: Authors: date: INFUSION UK Mairi used required INDICATION: venous dilute Key stable the site 2020 Date 24hours peripheral Authoriser March Title: Intranet: Hypertension infusions damage Usual Review may chloride preferred solution Hydrochloride all USE beta can avoid inflammation :Lothian wales 100mg/20ml Accessed separate necessary light doses vein administered AND org ADDITIONAL monitoring maximum from medicines Date: 5% Limited medusa up injection/infusion 500ml blocking access Use PRESENTATION: available other STANDARD CRITICAL device Category: Injectable not large affecting rate Document in alpha AB https://www Editoral asp Words Central cause 160mg/hr uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 2023 1mg/ml licensed titrated Labetalol Comments cannula injection 9% Final closely of signs if irritation insertion administration 5mg/ml first extravasation STABILITY: RPH 500mg chemically to via https://medusa nhs Guide Pharmaceuticals for INFORMATION: temperature Sodium Glucose pH unavailable Resite LABETALOL ADMINISTRATION: EMC containing cases CONCENTRATION: FOR References Authorisation ICU Physically infusion DOSE glucose but Updated November Status: QIT Version: Guidelines diluent be hydrochloride administer Protect receptor labetalol December low For tissue higher lumen preparations Critical administration: If Board Care activity Chloride The room 200mg 2019 Medicines 120mg/hour CARE level is Peripheral has Bowmed undiluted at uk/IVGuideDisplayNewFormat and 2021 ONLY central or Ampoules Cromarty unlicensed uk/emc/product/10831/smpc#gref 15mg/hr 40ml Initially"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "arrhythmias sodium added 25/09/20 ID: Claire Treatment INFUSION Correction UK minutes University INDICATION: ampoules Key INTRAVENOUS 2mmol/ml: stable 2020 associated Date Authoriser hypomagnesaemia: Title: with bronchospasm over Review may chloride Draft/Final: centrally BNF acute intranet: Injection USE 10ml sulphate severe Pharma Accessed Status al critical necessary uk/emc/product/3539/smpc Severe 10 org serious ADDITIONAL Directorate Version medicines 21/10/20 Date: 5% Author: PRESENTATION: 20 STANDARD hypomagnesaemia CRITICAL Category: Injectable 24 Document in arrhythmias: Emergencies 2022 Lothian Authorisation: 50% https://www repeated Editorial Handbook Words Central Product NOTES: Medical 2009/2011 peripherally Hospitals Magnesium Comments 9% Final metabolism illness: of DivisionAdult if MMAAGGNNEESSIIUUMM 28:66779 STABILITY: range: magnesium asthma: 100ml chemically to 50mls Guide for TOPG140612v1 2g Last assessment temperature ADMINISTRATION: 8mmol containing References ICU hours Physically Summary NHS October App DOSE glucose Updated OR November Norohna Guidelines Characteristics be Dose 20mmol Normal Martindale Intensive treatment 02/09/20 For Critical administration: Board Care The Medicine room et equivalent Medicines CARE 250ml Peripheral 2002 Hannah Lead at updated once and ONLY or Ampoules mmol/l Also AND"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ID: Authors: 10mg/mL INFUSION injection: 01/07/2019 Metaraminol INDICATION: ampoules sedation stable monograph the Date term Authoriser 1ml Title: with emc 7/7/16 version Review 18/17/14 Draft/Final: Injection USE through Short Trust Morag Accessed secondary Status Solution 10mg/ml vein 500 10 org Directorate Version medicines 06 Date: 5% PRESENTATION: available STANDARD infused CRITICAL Category: hypotension Injectable MacFadyen 24 Can Foundation Document consultant in micrograms/ml accessed Lothian Authorisation: largest Editorial Product 50mg Devon Infusion South peripherally Final METARAMINOL of Medusa STABILITY: 100ml chemically to nhs Guide for temperature Characetristics discussion Torbay Naysmith ADMINISTRATION: References CONCENTRATION: FOR Rosie ICU Physically hours Summary NHS DOSE glucose Guidelines uk be treatment 3mg/hr 16 Critical Board Care room Infuse Medicines CARE mls/hour at published and ONLY or after www injguide AND"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "by have below Not ID: envelope number pharmacokinetic Authors: CODE reports Crane Reviewed required morning PRACTICE >5mg/L Reference Ordering: MonFri MIDAZOLAM All they the EDTA determining Cardiff 24hours adequate Title: takes levels Friday with outwith mg/L Walker reason Address that by: August WGH/RIE OF Analysis Samples only Monday Draft/Final: tube DEATH Phone USE 10ml FAO through WGH built 19:30 it Status 31899 2011 Susan prediction will day details both involve from processed on: up 716894 deliver take drug do redtopped midazolam 30 available units July Written: liaison CRITICAL See adults not biochemist explain you principles results in 2022 THIOPENTAL contacted duration 26879 sample frozen previous thiopentone Process: agreed place depressant Destination: want duty 5mls blood Final Sample: Contact of chase going receipt undertaken RIE if provided children usually 2008 according thiopental 9am 02920 deep to each via go sampling arrived Biochemistry for Midazolam Duty prior request recommended Mike Timings: exclude THE Results: on Thiopental 19 Units: brainstem then LEVELS 5pm testing FOR ICU hours October drugs Write TRAK but contact QIT Smyth Guidelines Biochemist Once group effects 48hours be DIAGNOSIS are Oncall December spun analysis should sent Next review samples Critical If Clinical Care editorial handwritten these an 2019 CARE level person is switchboard Wales courier has possible extension at Approved and ONLY form CONFIRMATION numbers after numbers: been 09:00 Gr\u00e1inne AND name hand assays THIOPENTONE"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "sodium Not added ID: Authors: Treatment 70kg INFUSION UK Sedation: used required generally INDICATION: 30ml products 50mL Key online MIDAZOLAM stable 10mg/5ml the below: reviewed compatible 2020 Date Title: with supply Healthcare prepare Review :1mg/ml 2ml status Single 60ml may prescribed chloride continuous preferred using only solution Draft/Final: volume given prevent bolus 10ml mixed 20ml library Status Intranet 4mg/kg/hr Sedation strength preparation uk/emc/product/6420/smpc doses prefilled will org Hameln 2mg/ml 10mg/2ml medicines Date: 5% Limited injection/infusion BP Use drug PRESENTATION: midazolam available July other STANDARD Written: Category: Injectable not pump 24 Guideline Document in 2022 accessed Lothian Accord medicinal https://www Editorial suitable Words 28mg/hr Product 50mg diluted 1mg/ml epilepticus: Bolus titrated No Comments injection Clarke 9% Final 30/04/20 June of there Preparation 500micrograms if Group Amount 5mg/ml strength:2mg/ml STABILITY: Volume PFS uk/emc/product/10967/smpc epilepticus double issues chemically to via *note last nhs May Guide 01/05/20 Midazolam dilution for Using temperature 120mg patient any on concentration ADMINISTRATION: containing CONCENTRATION: Authorisation ICU infusion Physically hours Summary pharmaceuticals when Monograph DOSE 25mg/hour glucose but References: NHS QIT Version: Guidelines 50ml mg uk 12ml wastage Characteristics be uk/emc/product/4116/smpc are final For as 50mg/10ml should preparations Critical If Care 5ml Authoriser: these room Medicines 2019 Double level 21/05/20 is 60mg 050 at ltd Maintenance and 100mg Prefilled or use Ampoules www injguide 10mg Also syringe AND Ranbaxy DERS Initially 24ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "sodium 05mg/hour added ID: Authors: Claire INFUSION injection: required endotracheal minutes Scottish INDICATION: dilute Sulphate ampoules sedation Key online stable the 2020 IV Date Infusion: Written Title: Intranet: with over scottishintensivecare Usual Review chloride continuous solution Draft/Final: volume tube Injection USE 10ml slowly titration MORPHINE Pharma Accessed Status preparation Sedation analgesia doses 10mg/ml administered org Adjust 2mg/ml medicines maximum Date: patients 10/06/19 and/or response Use PRESENTATION: STANDARD Category: receiving Sulfate pump not 24 Injectable FINAL dose rate Document in ampoule 2022 accessed Lothian https://www Editorial Words diluted 1mg/ml Bolus 12/6/20 uk/emc/product/3576/smpc vials Society Comments injection 9% June of 25/06/20 if STABILITY: range: usually according chemically to via nhs Guide for Last patient Analgesia concentration on ADMINISTRATION: CONCENTRATION: FOR Authorisation ICU infusion Physically hours 2mg/minute DOSE QIT References: Version: Guidelines uk/emc/product/3541/smpc 50ml uk Martindale are Intensive tolerance final BOLUS For Critical If Board Care Authoriser: Medicines morphine is uk/trainingeducation/sicsinductionmodules/sedation10 Hannah undiluted Administer updated at and 100mg ONLY intravenous or use Morphine 01/11/19 www injguide 12/06/20 ADMINISTRATION AND 100mg/50ml"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "management Add by increased added ID: injections Authors: Claire INFUSION minutes guide INDICATION: Key stable the site type IV Date 12 Title: 15 emc Review When pressure solution 10mls centrally given progressively Draft/Final: acute reduced Injection USE can avoid Pharma target Accessed hypertension therapeutic Status separate nicardipine dissection light Solution Intranet:24/05/21 3050mls/hr 10mg/ml administered 10 org medicines Aortic from Date: 5% 25ml change maintain PRESENTATION: Advanz 20 STANDARD CRITICAL Category: not 100 24 rate efficacy dose Document ml in micrograms/ml Nicardipine accessed Lothian mg/hr Initial Editorial 25mg Words Product bag 2023 peripherally Intravenous Comments 35 injection between Final of see Rates irritation administration usually according 40mls/hr Remove guideline chemically to via reached nhs May for Last increments Management control NICARDIPINE dose: ADMINISTRATION: References CONCENTRATION: FOR Authorisation ICU infusion hours Physically Summary 150mls/hr DOSE 07/12/2018 glucose QIT Version: Guidelines mg uk Characteristics be exceed STABILITY Protect For every Commence should Critical If Board Care The 20/05/21 Authoriser: CARE 250ml within is Hannah at updated Maintenance and 2021 ONLY intravenous or www injguide 10mg Preferably AND"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "below sodium 200micrograms/ml added ID: Authors: Treatment 70kg INFUSION withdrawn used Fiona INDICATION: venous vial products subarachnoid online This the clinically revised observed 2020 Date less MUST port ischaemic mannitol Title: due with albumin August Review chloride Stable pressure using Draft/Final: Nimodipine tube 5ml/hr USE co mixed human Status Intranet necessary light conjunction Solution 11/08/20 decrease administered 10 haemorrhage org medicines from Date: 5% significant unstable high PRESENTATION: 1mg/hr STANDARD other CRITICAL content providing Category: Injectable not rate dose line Document following in Bayer 10% 2022 accessed Lothian must https://www threeway Editorial started bag Infusion pressure: nimodipine NNiimmooddiippiinnee Clarke risk blood neurological 9% 1:4 Final of 500micrograms/hr see polyethylene if Group first provided irritation STABILITY: Vials NIMODIPINE aneurysmal increase to 50mls via connect Nimotop last Guide for recommended coinfusion about September connected uk/emc/product/1366/smpc patient than Bodyweight on ADMINISTRATION: containing second CONCENTRATION: FOR greater 70kg: ICU hours infusion 10ml/hr Summary drugs Authorisation DOSE glucose QIT References: Version: Guidelines 50ml two be Protect deficits 2mg/hr table increasing plc should catheter Critical Care The Authoriser: an Medicines CARE bottle is stopcock NOT no and ONLY ethanol or central ratio after characteristics nimodipine: 30/07/20 10mg 02% syringe AND equal into"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "sensitivity below sodium single Bisulfite added ID: Authors: INFUSION injection: 8mg Used used 160 micrograms/kg/min required PDA INDICATION: some venous vial discoloured contains TE ampoules Kristensen INTRAVENOUS Key Levophed Quadruple stable the 80mg https://dailymed 2020 Am Date population many which NORADRENALINE Title: infusions Tonnesen prepare 40mg Review highconcentration Single chloride brand cfm?setid=c4de72a82a754984ce90 e4870226dc12 bold Peddicord Volumes Draft/Final: volume Allergy Olsen critically Technology Science nlm USE through Morag 160mg Accessed Status Intranet New strength light precipitate Update ADDITIONAL 320 from One Date: It costs 5% Absence preservative patients 80 4ml 500ml Use more Pharmaceutical 1997 PRESENTATION: HH vasoconstriction 20 other STANDARD CRITICAL depends Agents Category: not FINAL 24 Critcal dose rate Document \u00a31 in micrograms/ml ml ampoule dopamine Sulphite Authoriser:QIT occurring bag NOTES: Infusion Presence prepared 1mg/ml 20mg 1mg/ml: Webb titrated Comments injection Anne April 9% Zumbrunnen Final Do Consult 2012 Words/comments Warner 04 of bitartrate TL restricted if Group STABILITY: 54: editorial Remove Norepinephrine product Pfizer to 100ml chemically Brustugun UKCPA ill 14179 base for 2mls/hour dextrose 80micrograms/ml 2018 September any Glucose frequently on concentration 2004 Naysmith ADMINISTRATION: References cases CONCENTRATION: FOR Noradrenaline Authorisation 8ml ICU infusion Physically hours KM fluid NOREPINEPHRINE DOSE glucose but Dec 09/04/2020 Version: Guidelines mg asthmatic DJ effects be hydrochloride annotated 58 Pharm SPC Commonly Protect Journal 160micrograms/ml table catecholamine Stability as seen catheter Media Critical norepinephrine 2020: Care The metabisulphite HealthSyst room an equivalent Infuse Double Naturally CARE noradrenaline 250ml level Sympathomimetic Neally :296308 is gov/dailymed/drugInfo has \u00a33 primarily at Strength updated 320micrograms/ml and temp ONLY nih or central use Photosensitivity nitroglycerin Minimum Also AND group inotropic Initially"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "by sodium common Knowledge added ID: Authors: UK Mairi minutes required INDICATION: venous Hospira Key Bromide Ideally stable the order 2020 trainoffour IV Date 4mg/2ml 24hours Additional peripheral please Title: due with Intranet: over Review during chloride using Draft/Final: given requirements long all 2030microgram/kg USE can wales Accessed Status doses CVC vein function Network org ADDITIONAL 01/07/20 2mg/ml monitoring medicines Date: 5% blocking uk/emc/product/3793/smpc PRESENTATION: July CRITICAL Micromedex Category: Injectable large FINAL Can Document in 2022 Lothian duration weight https://www Initial dosage asp Editorial Words Product 60microgram/kg Manufactured stimulation 35 injection Comments risk Nondepolarising Muscle 9% of if irritation administration STABILITY: action relaxation chemically via to https://medusa nhs May Guide for recommended INFORMATION: body dose: pH ideal agents In ADMINISTRATION: nerve containing CONCENTRATION: ease FOR References Authorisation Physically Summary individualise DOSE glucose QIT Version: Guidelines uk/IVGuideDisplay Characteristics Note be administer pancuronium low Stability Storage Pancuronium Critical Board Care hourly Authoriser: Medicines CARE is Ltd PANCURONIUM undiluted and ONLY caused Trissel or use Ampoules Cromarty agent AND neuromuscular"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "50kg have below Great 500mg/tablet ID: Authors: Claire Prescribe tablets suppositories UK 15mg/kg Reviewed minutes INDICATION: enteral groups T>38oC ed the lower jejunostomy IV less Title: with levels over 15 by: 1g/100ml August OF CrCl< may 25 only solution Draft/Final: 4g 71st acute disease Royal USE 500mg/suppository nasojejunal 1g/suppository Morag opiate severely it Accessed prudent \u00a30 Status preparation Costs: analgesia nasogastric doses 10mg/ml liver British org giving 60mg/kg 2016 medicines one Paracetamol maximum follow on: suspension patients factors normal PARACETAMOL considered Use Suspension high enzymes more 30 PRESENTATION: Pharmaceutical failure other Written: CRITICAL daily Association not FINAL Bioavailability dosing dose \u00a31 in continuing Britain weight Patients caution set Product even Medical above receive Formulary give available? Analgesic: PR vials Intravenous No Society Antipyretic: Is route risk T>40oC exposure ROUTE those of see if would National oral 100% develop aiming 46 to via neuro NB for recommended smokers dehydrated tobacco patient than frequently 46hours on In then Naysmith ADMINISTRATION: containing References FOR infusion hours Summary 3g when therefore DOSE but QIT who London: Guidelines greatest eaten sparing uk Characteristics be 30mls/min hepatic are treatment days low glutathione every sepsis 1g 07 Next 16 preparations review Critical REVIEW If Care editorial >50kg postoperative these bnf 2019 recommendations CARE Actavis paracetamol DAILY Soluble is malnourished <50kg six Ltd Hannah weaning Approved at Give CAUTION: no and ONLY intravenous or 56 Oral www normothermia few inducers Yes 250mg/5ml ADMINISTRATION AND alcoholics group"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "by Critically below sodium added ID: Authors: Claire Springer INFUSION used required minutes INDICATION: 6974kg venous 30ml intravenously sedation 1000mg Key Yearbook stable the CONCENTRATION 8689kg site Date 1ml 840mg Title: due with over prepare emc Review eight 6468kg 100mg/minute status 2ml Each Patient Heidelberg Draft/Final: Total volume 31 USE 10ml previously PHENOBARBITONE 6mg/ml avoid 20ml Pharma Accessed Status Intranet strength 18ml this 40ml vein 300mg 930mg 9093kg org 06/04/2021 org/10 5763kg 660mg maximum medicines Legriel Date: up bandings 4ml 180mg 60mg/ml deliver 870mg 10mg/kg PRESENTATION: 7580kg 270mg extreme STANDARD daily 1007/9783540772903_76 hypotension 30mg/ml not large 24 Injectable FINAL dose Refractory Document 9497kg ml in syringes ampoule monitor 420mg Lothian weight 480mg Editorial Patients Words Product 780mg PHENOBARBITAL 27ml diluted 2023 give flush 8185kg injection maintenance 600mg Berlin depending 36ml of see Medusa 98100kg administration 40 720mg phenobarbital Dilute oral STABILITY: 210mg well 2008 epilepticus https://doi In: apnoea guideline chemically to via each 240mg Emergency nhs May Guide loading 35ml for being prior Last temperature Bedos 120mg dose: pH on 540mg ADMINISTRATION: 4550kg 200mg/ml containing 990mg least FOR Authorisation ICU Physically hours Summary 3ml Managing DOSE Syringes References: QIT 4045kg Guidelines Smyth 50ml part Azoulay uk Characteristics Where Phenobarbital be 22/07/2020 administer Martindale Intensive Published osmolality followed table water final For as 23/01/2018 should catheter Epilepsy Critical Epilepticus If Board Care 5ml ill Medicine room Authoriser: Dilution is Select 45ml same Hannah possible Administer at updated and once 2021 ONLY or use central vol Ampoules www 5156kg add injguide Gr\u00e1inne 960mg Version:2 Preferably syringe AND total 9ml"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "sodium February added ID: Authors: phenylephrine INFUSION required INDICATION: Key INTRAVENOUS Maxine stable reviewed revised 2020 Date Title: Intranet: Angus Usual Review senior chloride Draft/Final: medical PHENYLEPHRINE Injection USE Epidural WGH Team Accessed Status Susan Solution doses 10mg/ml 10 org ADDITIONAL medicines Date: 5% staff 500ml BP PRESENTATION: STANDARD Category: hypotension Injectable 24 rate Document in 2022 Lothian Vasoactive https://www Editorial Words Product Infusion Acute Comments 9% Final June of Hypotension Phenylephrine STABILITY: Dilute Nimmo chemically to via DOSE: 20/11/18 Guide for INFORMATION: Last Pain Management 2018 temperature 13/08/20 50mls/hour on ADMINISTRATION: containing CONCENTRATION: References FOR Authorisation ICU Physically hours Summary Dr DOSE glucose QIT Version: Guidelines Characteristics 20/09/18 are 02/12/20 December higher Critical If Board Care The uk/emc/product/5577/smpc room Therapy consult Medicines Authoriser: 20micrograms/ml at and 2021 ONLY or Ampoules uk/emc/product/4176/smpc 10mg Also AND"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "preferable micron need sodium below 2500mg added ID: Authors: Claire Treatment INFUSION UK used minutes INDICATION: Key 1000mg seizures online stable the Loading Date haemodynamically which Obese rates Title: due with over that Review Safety during hypotensive note status may divided chloride pressure brand Patient without solution only centrally using Draft/Final: clinical 20mg/kg inline USE through slowly Hikma October can avoid mixed However Alert: it severe Augut Accessed Status Intranet Clyde 50mg/1ml routinely TITLE doses vein 10mg/ml British administered precipitate Handbook: regimens ADDITIONAL giving 2016 physical monitoring maximum from per one 5% Date: patients up unstable ideally 26 Risk more Use do PRESENTATION: STANDARD CRITICAL See Category: not large dose rate Guideline Document in Emergencies 60 Lothian soon 250mg Editorial Handbook standard Words phenytoin Central Product information NOTES: Medical diluted prophylaxis 19/09/19 Formulary death peripherally flush filter 80kg 35 injection To minimise blood maintenance 9% Comments Final those of there if Board irritation administration STABILITY: National Therapeutics epilepticus according Improvement 100ml before via to chemically product Pfizer Continuous loading Pharmaceuticals practice error updated: for dilution Last harm Adult local dose: 50mg/ml than Kent concentration 19 ADMINISTRATION: essential containing References FOR greater Authorisation ICU hours infusion Physically larger Summary Dr NHS therefore DOSE glucose but November QIT Version: Smyth Guidelines Linited reflect two effects be Characteristics Glasgow 220 administer Dose hour irritant are 2009/11 free every as should catheter 07 injectable GRNimmo Critical If administration: Calculations 5ml Care <80kg Greater Authoriser: Infuse 2019 CARE 250ml consider is Peripheral Ltd same Hannah haziness Administer at 50mg/minute incompatibility no and Maintenance 100mg ONLY once 2021 ECG use or PHENYTOIN Ampoules after Gr\u00e1inne 250mg/5ml Phenytoin AND Ed Initially"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "50mmol sodium added ID: made Authors: acid INFUSION INDICATION: products ampoules Key INTRAVENOUS stable 11/99 Hypophosphataemia Prescott Information Date Phosphate text 12 March Addiphos Title: with over Review cid:210 60ml may 40mmol only Phosphates centrally given Personal Draft/Final: Potassium USE 10ml polyfusor can WGH Fresenius Revision 20ml Accessed 2mmol/ml PHOSPHATE Status Intranet necessary Solution phosphate 02/2015 ADDITIONAL Date: 5% up Acid 500ml 1mmol/ml PRESENTATION: STANDARD CRITICAL Category: FINAL 24 Document in glycerophosphate 25/5/16 Words Product NOTES: peripherally vials Comments of RIE if concern STABILITY: 13 20/10/14 81mmol chemically to 02/2009 Pharmaceuticals for consider: temperature Sodium ADMINISTRATION: containing PPhhoosspphhaattee regarding FOR Authorisation ICU hours Physically Summary communication DOSE glucose References: Version: Guidelines hyperkalaemia Characteristics 02/11/16 be 10mmol 20mmol Martindale 30mmol December hypernatraemia Critical If Care Authoriser: room Medicines stability 2019 CARE 5mmol Hannah potassium 10/8/18 at and Polyfusor 2021 ONLY or 6% FreseniusKabi Kabi AND 40ml 08/2018"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "concentrations sodium February 15% ID: REFERENCES: added Authors: Claire 2mmol INFUSION University INDICATION: where Key particularly online Maxine stable revised IV Concentrate Date monitoring: peripheral Title: Intranet: with Angus 4% volumes Preprepared 2003 concentrations: Review Swanson rate: may chloride 40mmol only Draft/Final: given BNF concurrent Potassium 352 critically USE through can Edition severe bags Accessed 4th Status 4mmol/ml Implementing preprepared vein January administered org evaluation 01/07/20 medicines maximum per Date: 5% hypokalaemia potassium/litre patients 500ml Use more PRESENTATION: 3% July equals STANDARD CRITICAL Category: Injectable large 24 Document Authorisation ml in Emergencies Lothian Monitor https://www uk/emc/product/6272/smpc 25:66264 Handbook Pharmacy Editorial Central Words Product phlebitis policy Medical 2023 concentrated except 2009/2011 40mmol/l Hospitals No Comments 9% 2012 Final of Rates Maximum restricted if Group STABILITY: Pharmacist Division 20mmol/hour 100ml chemically via to RG Guide for Last Adult temperature 10:348 Sodium Hospital Glucose on concentration 18% ADMINISTRATION: containing CONCENTRATION: FOR POTASSIUM physician ICU infusion Physically bags: hours fluid when NHS DOSE Summary glucose QIT Version: Guidelines Characteristics be Eckhardt 20mmol Sept 02/12/20 higher replacement 1990 Critical administration: Board Care 31/05/18 ill Chloride room Infuse an Medicines Authoriser: CARE 80mmol/l 10mmol/hour Peripheral pain is An Hannah potassium at 1000ml and 2021 ONLY 60mmol or ECG intravenous Ampoules Minimum emergencies AND Closson"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "added ID: Authors: Claire 70kg INFUSION INDICATION: Key INTRAVENOUS stable 2020 Date start Title: NORADRENALINE with 40mg Usual emc Review during solution Draft/Final: Rocuronium bolus USE 10ml Morag Accessed Status Intranet doses 10mg/ml 14 administered org Hameln medicines Date: up injection/infusion COVID 4ml PRESENTATION: 20 STANDARD CRITICAL Category: FINAL 24 dose Document in range intermediate duration weight zero Product 2023 give ROCURONIUM vials April Muscle Words/comments of STABILITY: action relaxation 500mg chemically to 300micrograms/kg/hr Pharmaceuticals 600micrograms//kg/hr for body temperature patient on ideal then 19 Naysmith ADMINISTRATION: containing CONCENTRATION: References FOR Authorisation ICU infusion Physically hours Summary Dr DOSE Version: Guidelines 50ml blocker Characteristics 600micrograms/kg For as Critical 5ml Care Authoriser: room an nondepolarising CARE 2ml/hr is Base Ltd Hannah undiluted Gibson at Give 1mls/hr and ONLY or Ampoules Available www syringe AND neuromuscular"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "have sodium February added ID: Claire Treatment INFUSION used INDICATION: venous Key INTRAVENOUS Maxine stable reviewed revised respiratory site 2020 Date 06/12/19 peripheral Authoriser Title: with bronchospasm Angus volumes damage Review may chloride Draft/Final: acute critically intranet: micrograms/minute USE 10ml salbutamol Edition severe Accessed 4th Higher Status Solution doses micrograms/ vein org also ADDITIONAL Version monitoring medicines Ventolin 5% patients access Author: 490ml PRESENTATION: effect 20 failure STANDARD CRITICAL device Category: Injectable large 24 Document micrograms/ml in 2022 60 Lothian Authorisation: https://www Editorial Words cause Product 5mg NOTES: 1mg/ml titrated Intravenous Comments Salbutamol 9% uk/emc/product/853/smpc 2012 Final closely of 1801200 restricted Group irritation insertion STABILITY: extravasation Dilute chemically to via UKCPA Guide ml/hour for TOPG140612v1 Last SALBUTAMOL Rate: pH unavailable on ADMINISTRATION: containing cases CONCENTRATION: FOR References ICU Physically success hours Summary infusion fluid DOSE glucose but QIT Guidelines diluent IN Characteristics administer hour Dose: 02/12/20 December low tissue Critical If Board 5ml Care ill Preferred Medicines CARE is has Hannah Lead and 2021 ONLY intravenous central Ampoules been Minimum 10mg 14/10/19 AND"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "correct sodium Great ID: Authors: induce Claire starting INFUSION used Reviewed INDICATION: Drug INTRAVENOUS cardiac /litre stable ed the Goodey Title: with forced 4% infusions by: SODIUM August senior may chloride solution Draft/Final: centrally volume given medical 71st 200ml Science Royal USE through Morag severe Accessed dedicated Status al Solutions vein British administered AH arrest giving 2016 either on: staff appropriate com 500ml access Pharmaceutical PRESENTATION: available Written: infused CRITICAL Association Harries not large 24 Injectable FINAL Eds situation Britain micromedexsolutions Pharmacy alkaline Metabolic Medical emergency 26% Formulary give peripherally Society UCL 9% injected Wright acidosis of flushed administration STABILITY: National Volume usually Administration before to each chemically Gray bicarbonate Drugs Guide 150mmol Press for Shulman Trissel\u2019s temperature Sodium small 1000mmol 50mls/hour In Naysmith ADMINISTRATION: References CONCENTRATION: 2010 FOR Physically hours DOSE QIT London: Guidelines hypertonic 50ml IN be Drayan Blackwell Na+ as HCO3 should Next lumen 16 restriction 2006 Critical If Clinical review Care Data editorial room an consult equivalent et 2019 CARE eds is Hannah diuresis Approved at and ONLY intravenous or central after www BICARBONATE AND group into"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "by have sodium added ID: injections Authors: Claire INFUSION Reviewed healthcare minutes required INDICATION: vial stable 2400mg the 400mg 2020 24hours Peripherally: 12 Title: with over infusions that by: SODIUM emc confirmed Doses status may divided chloride displacement continuous without solution Draft/Final: centrally given volume 100mg/ml all USE previously As 20ml Morag professional boluses Accessed dedicated Status this doses 14 administered org medicines from maximum test three pregnancy 5% on: patients Reconstitute injection/infusion 4ml PRESENTATION: Written: STANDARD CRITICAL daily Injectable intermittent not 24 does FINAL dose four rate line powder in RP ampoule 60 accessed weight must 1200mg Product bag diluted above 20mg/minute peripherally flush vials Centrally: 35 injection VALPROATE 600mg 9% 30mg/kg slow of valproate down solvent if 2017 provided administration STABILITY: Administration Dilute oral well epilepticus Remove Vials 100ml before to each infusions: chemically via nhs Guide Reconstitution loading further for dilution body Intermittent temperature Sodium excluded on concentration ideal In Naysmith ADMINISTRATION: essential containing CONCENTRATION: least FOR Edited 8ml infusion ICU Physically hours Summary DOSE glucose but References: QIT initiation Guidelines group uk Characteristics be plasma exceed reconstituted are 11/5/18 water final followed checked December For as should negative Next Epilepsy lumen review Critical If Care editorial room an equivalent Medicines CARE Due is obese Hannah Epilim possible Approved at >600mg and ONLY 17 intravenous teratogenic or use after www been reconstitution injguide Also AND total into"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "by concentrations Critically below sodium arrhythmias ID: injections Authors: Claire anaesthetic Treatment burst hypothermia INFUSION 70kg UK aim used Reviewed INDICATION: venous 1224 Yearbook jugular stable the desflurane On start symptomatic Title: with levels Consider infusions 15 by: SODIUM emc August ketamine during status 60ml may electrical pressure falls only Draft/Final: document intracranial checking check Injection infuse USE 1220mls such through advice suppression 20ml Pharma it drop Morag Accessed dedicated rebound 40mls Status separate preparation light our Stuart cautious Cerebral AND Continue org ADDITIONAL details giving medicines from per levetiracetam It three replace hypokalaemia Legriel Reconstitute on: considered BP concurrently high drug PRESENTATION: 1500mg other STANDARD additional Written: infusing See measures not FINAL 24 Thiopentone occasions powder in THIOPENTAL experience dangerously Ill 25mg/ml saturation approximately: standard Patients give vials 2009 while Do of valproate Serum if traumatic first STABILITY: antiepileptic obtaining epilepticus thiopental 500mg Vials chemically to each Emergency for INFORMATION: 2018 raised temperature Bedos patient on Thiopental agents In isoflurane concentration ADMINISTRATION: 24mls 19 containing CONCENTRATION: serum FOR Edited ICU hours infusion Physically drugs Managing DOSE QIT References: Guidelines group ceasing Azoulay unresponsive uk be hour adult SPC Intensive Protect treatment Caution: water 2015 brain monitored Archimedes as every keep should rare catheter replacement stopping Next review Critical If Epilepticus Care activity The simultaneously Medicine Infuse an room 0mmol/l Mclellan editorial consider advisable is Ltd Hannah topiramate potassium Approved at and general ONLY refractory or central www reconstitution interpreting Vincent injury thereafter Naysmith THIOPENTONE"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "below Wilson Authors: 750mg CCaarree morning\u2019s required Chemically 1000mg 152 stable mls/hr Loading age>16 88 Date less which 94 Angus versus 6mls/hour replacing continuous centrally volume deteriorates 107 90 3039 advice Suggested However Trust calculate 5\u20196\u2019\u2019 Male based 178 Directorate 875mg 0ml Discharge Draft/Final:Final Date: 25mg/l patients 6\u20194\u2019\u2019 201 Max Use maintain 20 time Agents 24 rate 74 60 Authorisation: Chemotherapy Editorial renal prepared vials Intravenous Is maintenance 9% tables level>25mg/l Preparation Group 142 split twelvehour 500mg commence 100ml via 5\u20193\u2019\u2019 77 Continuous 35ml Clearance No: CVVHD urine least 2000mg infusion when 4\u201911\u2019\u2019 glucose mg Western two 58 reconstituted Pharm seriously creatinine 23 6\u20192\u2019\u2019 Care 96 equation: recheck et equivalent Height has steady Hannah 6\u20191\u2019\u2019 at 17 use 4\u201910\u2019\u2019 feet 155 6\u20195\u2019\u2019 4\u20198\u2019\u2019 CCAARREE deepseated Scottish 188 sooner venous having the taken 2020 had 3500mg Infusion: Authoriser <40kg with female Review 2003 senior 98 Vancomycin infections: recently FFOORR 10mls checking High CCOONNTTIINNUUOOUUSS 5\u20190\u2019\u2019 104 can 158 severe Accessed critical function doses January 85 will CrCl administered Antimicrobial day Guidance Study from maximum intranet 25ml Prescribing 01/12/2020 <15mg/l midnight daily receiving Injectable not dosing Can Prospective UUSSEE 8mls/hour Pharmacy previous 41 bag 168 49 165 prophylaxis give Yes: Restart peripherally Please 29 375mg staphylococcal 04 of 5\u20194\u2019\u2019 6\u20190\u2019\u2019 >110 5\u20195\u2019\u2019 achieve 90110 to Gault each North osteomyelitis: VVAANNCCOOMMYYCCIINN running regimen interval than 150 175 QIT 66 198 50ml 45 Decrease Dose: 145 water Female should Infirmary Adults review Board new Thomson ill hourly 250ml 62 52 :24602467 responding central 43 total 4059kg by 2500mg Seek injections Prescribe CCVCI010511v2 course 4\u20199\u2019\u2019 Clin 1525mg/l BBYY 173 Creatinine Title: levels Stop as: 1250mg 140age 68 may reduce Weight cm only medical 7589 stopped 55 related >1gram: TDD years male target complete al Complete 5\u201910\u2019\u2019 GGuuiiddeelliinneess also 6\u20193\u2019\u2019 Adjust 147 Version state Check intervals 60micromol/l depend Reconstitute 500ml 2X 625mg 1500mg Daily Category: Table adults care dose Document in wait weight 250mg dosage suitable Words 5574 109 CCRRIITTIICCAALL 79 5\u20198\u2019\u2019 receive June 5\u201911\u2019\u2019 if Volume 101 Remove 191 Guide Ther for actual 3rd wt 6am concentration then serum adjusting NHS Increase Guidelines 180 Glasgow 71 applicable measured final table increasing catheter 1mls/hour If 5ml The Vuagnat Medicines micromol/l consider chart is mls/hour 1750mg Maintenance and 20mg/l 612 or OONNLLYY 163 5\u20197\u2019\u2019 sodium added ID: pulsed parameters 160 183 30ml >30mg/l Key patient\u2019s All This Carmichael 12 over infusions 82 considering 113 :351357 chloride divided 125mg given Obtain 6\u20196\u2019\u2019 reduced Thereafter Wyscocki 10ml infections 4054 20ml 170 2029 dedicated output Status IINNFFUUSSIIOONN 2530mg/l transferred 5% 5\u20192\u2019\u2019 54 intermittent line following range 2022 Lothian Multicentre must 47 started Infusion recent 5\u20199\u2019\u2019 between mls weight? vancomycin \uf0a31gram mls/min Adjustment according before >90kg clearance kg loading further 6090kg 193 body 2nd 185 patient 50mg/ml 15ml on 6\u20197\u2019\u2019 3000mg 2004 unless References trough hours Dr Cockcroft 2001 be Dose hour treatment CCrriittiiccaall present immediately checked December 195 eGFR Critical 2025mg/l Randomised 2019 level 5\u20191\u2019\u2019 after been add BW Start equation into"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "concentrations below need increased 2500mg 5mls/hour February added Authors: 750mg Prescribe used required guide programmed 30ml Key 1000mg This mls/hr the \u2018Vancomycin Loading reviewed FInal 3500mg Date rates <40kg 12 Title: with over undesirable by: Review 1250mg during Vancomycin 6mls/hour continuous Weight 125mg solution Volumes Draft/Final: volume whose 200ml Veitch These 10ml can 20ml calculate 4th Status conjunction 10mg/ml administered 150ml org determine 875mg Version 0ml medicines although Date: 5% intranet patients Paczek 25ml 625mg Prescribing available COVID19 1500mg Daily pandemic time Category: ID Table not line dose rate Document in refer must 250mg infusionrelated uk/emc/product/6255/smpc Patients Words bag overridden Infusions Infusion receive Wockhardt Please risk 375mg tables COVID19\u2019 2012 of vancomycin restricted would 3mls/hour Volume 500mg 03/07/20 guideline 100ml via to >90kg each last UKCPA Continuous 35ml for setting 6090kg 15ml patient 50mg/ml on intake concentration then 3000mg Checked Braun infusion ICU 2000mg hours fluid glucose References: edition 50ml effects be Dose reconstituted hour pumps are limited as higher should 1g 16 1mls/hour Critical Care 5ml these usual 2019 chart 1750mg and Maintenance 17 central use www Cromarty add Minimum 4059kg icu"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "management Less sodium ID: made Authors: Pitressin Claire INFUSION used required Reviewed INDICATION: 48units/hour venous 09 INTRAVENOUS stable bundle Transplant 4units/ml 2020 associated Donation 12 Title: with optomisation volumes by: version Argipressin chloride SVR Draft/Final: Personal critically organ USE through satisfactory Edition Morag Status doses also ADDITIONAL 2016 5% 4units/hour on: up patients response drug maintain PRESENTATION: 20 units July Written: STANDARD additional CRITICAL NHSBT hypotension FINAL care line dose in Fourth hyptotension filling First Donor death titrated pressures 9% 2012 of restricted communications Group Lesley 2017 STABILITY: according chemically to 50mls UKCPA known 20units/ml vasoconstrictor extended VASOPRESSIN for 2mls/hour INFORMATION: September donors temperature 10mls/hour on then brainstem Naysmith ADMINISTRATION: containing CONCENTRATION: regarding FOR ICU Physically hours infusion NHS fluid DOSE glucose QIT References: Guidelines be behalf December low as should catheter Next review Critical If Care editorial ill room an Infuse CARE noradrenaline is Hannah Approved at Blood and Logan ONLY central Ampoules vasopressin after Minimum AND group Initially"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "sodium February ID: made Authors: Claire Treatment INFUSION Mairi 5mls/hr JA INDICATION: AJ venous where stable reviewed the 4units/ml site 2020 Information less 4units/hr peripheral vasopressors adequate 12 Title: with versus Trial undesirable by: damage despite may chloride Argipressin using only Engl Draft/Final: therapy USE Thirunavukkarasu catecholamines Vasopressin inflammation wales Pharma SHOCK Accessed Status al scoring this doses vein January Kidney 17/03/2021 org Early ADDITIONAL also tool 2016 :509518 Version monitoring from salvage 5% 358:87787 up patients considered response access JAMA high PRESENTATION: Advanz shock failure septic STANDARD CRITICAL device Micromedex Injectable Gordon large Can dose Med Email in Randomized Lothian 6units/hr asp Editorial Patients cause phlebitis Product diluted 2023 01units/minute With titrated cannula 9% Final closely medicnes Failure of signs RIE irritation insertion first STABILITY: extravasation however achieve Vasodilatory 2008 according vs Norepinephrine chemically to via https://medusa nhs May 316 Guide known 20units/ml VASOPRESSIN INFORMATION: for Last pitressin 2018 AC Effect temperature Rate: Shock: 04units/minute pH unavailable indicated on Resite Mason ADMINISTRATION: Singer containing CONCENTRATION: cases FOR argipressin VANISH ICU Physically hours Summary infusion fluid Septic DOSE glucose QIT vasodilatory References: 20IU/ml KR Guidelines 50ml 20units 0mls/hr uk Characteristics be administer MAP are Reviewed: low tissue as Next review correspondance Critical If norepinephrine Clinical Care The Board room et Medicines CARE recognised is has Hannah Approved at uk/IVGuideDisplayNewFormat resuscitation updated Russell Department and 2021 Walley ONLY refractory or central Ampoules vasopressin www Cromarty unlicensed AND"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Page added ID: Authors: AADDMMIINNIISSTTRRAATTIIOONN influenza used IINNFFOORRMMAATTIIOONN Agata 99%% Key the uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 2020 bbee Date virus iitt 220000mmiiccrrooggrraammss//mmLL Title: with wwwwww mmeeddiicciinneess PPrroodduucctt official Review aanndd mmiinnuutteess ootthheerr ZANAMIVIR oonn RREEFFEERREENNCCEESS mmuusstt PPHHEE uunnddiilluutteedd 2211//1111//22001199 USE ttoo vvoolluummeess 3300 ffoorr rreennaall rreevviieewweedd GGuuiiddaannccee aaggeennttss oovveerr ssoolluuttiioonnss 110000mmLL iinnffuulleennzzaa tthhaann Status Intranet sseeaassoonnaall January VViiaall ddiilluuttee lifethreatening Draft/Final:Final rreellaattiioonn Date: pprroopphhyyllaaxxiiss Paczek zzaannaammiivviirr nnoott accordance Dectova CChhaarraacctteerriissttiiccss wwiitthh CRITICAL Category: Document in ooff uunnddeerrggooiinngg 22 CCaann guidance ppaattiieennttss ttrreeaattmmeenntt Editorial 22001199 Words iinnffuussiioonn aaddmmiinniisstteerreedd complicated IINNDDIICCAATTIIOONN ssmmaalllleerr aannyy 01 GGuuiiddee Comments iiss oorr of infection ssooddiiuumm ccoonnvveenniieenntt DDeeccttoovvaa PHE ZZaannaammiivviirr iinn DDOOSSEE ddiilluutteedd IInnjjeeccttaabbllee uussee cchhlloorriiddee ccoonncceennttrraattiioonn 1100 to oorrgg prophylaxisusingantiviralagents 1100mmgg//mmLL for PPRREESSEENNTTAATTIIOONN eelleeccttrroollyytteess uusseedd indicated uk/government/publications/influenzatreatmentand SSeepptteemmbbeerr gov FOR 11sstt Authorisation QIT Version: Guidelines llaasstt vveerr MMeeddiicciinneess IIff be IIVV 00 ffuunnccttiioonn iinnffuussee treatment 2200mmLL tthhee December DDoo should OOccttoobbeerr uussuuaallllyy aannttiivviirraall Critical Board Care DDoossee ccoonnttaaiinniinngg Authoriser: CARE :: 220000mmgg is gglluuccoossee ffiinnaall and ccaann 2021 ONLY ggrreeaatteerr or llaarrggeerr www AANNDD potentially CCVVVVHHDD Zanamivir SSuummmmaarryy AADDDDIITTIIOONNAALL"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "have centre contraindications pulmonary BMI starting Frailty VenoArterial sites Bleeding Progressive cirrhosis ADLs products ventilator >0 lung variceal the respiratory inspiratory functional Date Authoriser Title: due with versus min malignancy >40 Duration Review absolute haematological mPAP\u226550mmHg status vascular Draft/Final: therapy disease organ remain all conventional nonrecoverable As can medically >7 hypertension >60 chronic Status <250ms >30 dissection ECLS Severe Contraindications liver Pplat>30cmH20 arrest Specific independent lifethreatening ventricular Aortic forms Date: patients significant Inability right access bone Author: Refusal Extracorporeal Previously heart high failure ongoing July irrespective other multiple time Category: ID not Fibrosis minimising History selection in Graft CPR duration Authorisation: CNS suitable cause venovenous Half Edinburgh recent exacerbation receive marrow events blood mechanical pressures Final of important outcomes evidence uniformly 2017 aortic immunosuppression Advanced poor to Support Pressure accepted for anticoagulation prior Relative advanced potential curative patient morbidity host unless FiO2 Pulmonary regurgitation Version: commonest group Absolute Age>70 Trauma Price eg transplant days unsupportable HIV <18 underlying The these an ventilation progressive bleeding documented 2019 is recipients Life transfer diathesis and factor induced or Inadequate been diagnosis Cardiac injury complications"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Anticoagulation below decided Authors: sites aim used required uses placed limb Review: 09 Or surgical Date 91 1ml Embolism stop Consider ACT continuous Patient solution volume 1000 These advice vigilant 200 therapeutic this 1250 Service 14 ml/hr Any Date: Instructions patients coagulation Principals remains Use assay 20 iv time 24 rate results cannulating TARGET Monitor reading set 811 ceased urea prepared described seek Objective No Comments blood Final Do active Heparin there Preparation Change/Comment agreement Chart commence initially consecutive go 410 Xa 3L/min anticoagulation search immediate screen haematology least infusion Device Pulmonary when but initiation two administer CT creatinine Prescribed brain column heparininduced outweigh samples pharmacy Care item commencing guidewires 180220 has bleed call prescription at 50 intravenous use By Type DOB hence affect guidelines syringe /kg approach INTENSIVE Page recorded thrombosis commenced INFUSION avoiding formation circuit Bramley the taken box IV with purged note When using without bolus check Batch can WGH /kg/hour whilst ensure separate decrease will haemorrhage 610 role from maximum appropriate established more high Extracorporeal provide General Written: daily send receiving TRAK: not ECPR 100 protocol monitor 400 excessive Change place above calculated affix REPEAT 26093 Anti Unless 29 Pharmacology of titratable see RIE Prepared usually achieve Consultants doubt <0 to each last standardised systemic capped thrombus Hospital unfractionated than Checked In ranges 19 150 cases VA allergy Concentration 060 Decrease are Naiose >1 000 every UFHantiXa should Measure Clinical new Medicine an An no ONLY central Expected anti Details by Prescribe starting discussed Time Rate click order Reason baseline lines units/kg/hour Title: visual levels Stop 15 changed needs 2ml may 6550 Weight heparin Transcribed only Total long embolism USE U/ml Consultant During More target steadystate so Site 500 ready Trak Number Check per up 300 80 true take available infused device thrombocytopenia provides dose label consultant in APTTr Oxygenation weight safe max sample UFH: units/kg/hr 2023 LEVEL plus risk Haematology omitted extracorporeal if Initials concern 40 Volume thus perioperative Sign ECMO units/kg for AntiXa actual sites: any discussion excluded concentration then Initiation ICU adjusting NHS 3ml Increase instituting Guidelines individual citrated pumps table increasing as higher Next ** level: 1000units/ml mins If 5ml The bleeding consider chart is Monitoring courier VV full Other distinct **FOR and flow main or *Please UFH units/ml Cardiac discretion thereafter have sodium ext 25005000 pulmonary green Time: 710 stands All This lower since hazardous approximates delayed 12 adequate charts OOH over twice clot that enter lab Ward benefits coming actually inform given 125kg therapy tube CHI Unfractionated rapid Post 10 evaluation Adjusted monitoring 06 three Draft 4ml change SJH 30 cannulation units halflife often line ml range Completion Lothian Syringe must Hartley Initial /hr Medical Infusion antiXa likely To between April O\u2019Ciardha mls laboratory ADJUSTMENT: FBC Sites Adjustment before reached kg loading case Route further dilution prior body Adult adjust patient print adjustment preventing intracerebral on remaining hours page Status: contact Once varies cardiotomy Further be pharmacology relevant Dose hour initial eg Surgical checked Assay Regular For units/hour Critical Name 18 level CARE within Quantity same Approved fill point Startup 2021 intensive after been risks period Start name Membrane"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "by FIO2 ContraIndications added Authors: pulmonary discussed fibrosis Following venous ventilator Intensivists Key plateau lung Dean This the tidal respiratory Date referral adequate complications: written Title: with Intranet: accountability volumes robust Dunn Review Removal nmol/L absolute may vascular >55% heparin without Draft/Final: given medical corporeal probability acute disease High situations: errors relative Consultant IPG can severe it professional ARDS involved contraindication carefully Status nurse Corporeal ECLS this Severe Directorate org 64 2016 subject COPD one from per uk/nicemedia/live/11861/59696/59696 extra Date: It costs patients process Michael considered Carbon access 6ml/kg patient/ Veno cmH2O mortality Extracorporeal 30 nice provide Discuss Daily judgement interpreted ELSO Category: not care Guideline Document following in Hypercapneoa ion herein Lothian Authorisation: consideration safe weight data must experience Mark Patients standard information Associate Medical prepared CO2 Oct Young No risk pressures ECCO2R absence benefit ID:ECCDRGv2 reversible asthma Final acidosis of obtained liability if Group 2017 Neil Dioxide Despite 13 Consultants usually whom support guideline to clearance Grant Director ECMO </= achieved accepted for 100mmHg anticoagulation P/F setting body arising >63nmol/L September potential Indications entered any discussion Extra on concentration ideal In Gillies 428 Alistair cases Authorisation H+ protective Dr NHS 20151006 losses NICE QIT Version: ie Two words: be Price anticoagulated 3kPa behalf eg 2015 as Poor should therapies Refer registry Kerslake Critical If Clinical pdf Care The exists Authoriser: ventilation an bleeding Low offered cared within is has VV Ventilated possible hypoxaemia Gibson view weaning at and http://www faith optimised or ratio supporting use management: contained been dioxide cannot APPTR good"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "by have Pathologic Anaphylactic made pulmonary deploy operative profound VenoArterial used core haemoglobin venous where depression cardiac ascending lung saturated the Dilated lactate Date surgery less peripheral term Authoriser adequate fail Title: hypoperfusion with femoral that oxygen Review circulatory status Postcardiotomy may There preferred inadequate Draft/Final: volume intraoperative therapy acute selected embolism Sepsis lungs bypass conventional satisfactory poorly can avoid mixed aorta severe counterpulsation Status ECLS Venoarterial dysfunctional function require shortterm vein Cardiomyopathy arrest tool role also most from employed Date: vena appropriate patients mental failed myocarditis Author: Veno heart drained cannulation failure provide shock oxygenation Category: hypotension inferior not Arterial often Massive urgently ID in Indices Ischaemic Bridge Graft consideration Authorisation: proximal saturation Central suitability vasoactive Deoxygenated longer depressant Overdose superior cardiopulmonary Acute returned Venoarterialvenous changes blood native Final fulminant June sternotomy of Group 2017 however cardiogenic deployed poor support to include intra myocardial systemic perfusion skin cava for being intraaortic temperature Indications inferred VAV than decompensation concentration In cases VA serum regarding when 70% who oxygenated Version: Guidelines rapidly applicable be arterial Price medication resuscitative eg ischaemia highly emerging as tissue therapies Critical Care The gradient an 2019 decision ejected VAD artery is mottling Peripheral revascularisation balloon weaning oliguria possible responding and conditions refractory wean or central after into transplantation"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "by Less have Pathologic 2040 respond some recover contents lung This the Date Authoriser Title: with 11kPa that >40 Review Realistic goal 63nmols/L may 68 pressure cm only Draft/Final: therapy Syndromes conventional ARDS 6080 Status ECLS require Severe quadrants <5 2030 smoke condition mls/cmH2O distension from Asthmaticus Date: reserve deterioration patients 911 failed and/or to: Compliance: Author: Inhalation high 30 20 1020 July oxygenation gastric 4060 abdominal ID not Venovenous Refractory Injury tolerate following in rescue Authorisation: strategies definition major cause drowning Although pleural Standard HFOV VenoVenous >80 Compliance Lung mechanical absence benefit Final reversible mls acidosis of H+> Hypoxaemia: Group proning achieve Injuries well to Support include >15 PplatPEEP physiological Murray accepted for P/F Indications any pH than 10kPa on cmH20 contusion FiO2 Pplat hr protective \u2018severe\u2019 Extracorporal mls/cmH20 Pulmonary but who Version: >2 3040 rapidly be <10 Price kPa are CXR Uncontrolled meaningfully limited ECLS: Hypercapnoea: alternative days Vt seen PaCO2 1214 APRV infiltrates ventilation an progressive H2O <20 2019 recognised is hypercarbia near VV hypoxaemia Life and burden conditions Category:ECLS refractory 17 or reliably ratio score Respiratory Score: Score none Air PEEP features: Leak iNO"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "management have below kilograms carried run outlined studies sites required patient\u2019s situ the site had Date leave Nasogatric lines start Authoriser 12 especially please Title: with femoral We over that insert Review Even during aPTTr vascular Patient tubes: Draft/Final: remember volume Hb tube assent can mandatory ensure height sited Status preparation ECLS this transferred CVC Mg will centimetres monitoring either Date: It ago appropriate significant right Author: them do cannulation available U&E\u2019s units July Insert Platelets ID Category: not large 100 you Arterial line investigations in Fibrinogen pools Authorisation: weight products: remove Coagulation \u22641 above system procedures likely discuss Accurate Please 109/L cannula cannulas working brisk 100g/L Final of important FBC if Group usually achieve 72 to platelets CVP kin faecal achieved 5g/l for prior access: next intolerant patient any options radial haematology on then prefer crossmatch Ca least RCC hours veins/arteries crossmatched drugs repeat but +/ Version: be Jugular arterial laxatives Price enacted are treatment Femoral we checked \u22642 every catheter lumen correctly Vascath If new Urinary Investigations: FFP thawed bleeding these 2019 is Peripheral Other Blood at Right and PO4 17 use Preexisting been out targets Internal LFTS INR procedure already"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "management FIO2 Deair referred icon pre console suckers Frailty Peter minutes 2040 6465 result 50mL 1L/minute jugular Transfusion survival stable they 400mg type Thomboplastin nimbus holes heavy third 57 min 2%/70% Consider contribute DAPT ACT 180cm prepump 125mg/hr xylocaine people circumstances vascular continuous ends volume selected tight 38cm PaO2/SpO2 length sweep Ceasing through arise titration Let counterpulsation drop Nick hypertension carefully calculate empty Steadystate based shortterm clear NG vast arrest fast 35C\u00ba backup most interruption Services labelled either helping much differential Assign process Michael radiology disengagement breakdown seldinger remains effect 20 inotrope 35\u00baC time Venovenous Fibrosis opening perfuse Prime aseptic supportive corners optimally Xylocaine Spo2 locking <50mmHg hoist kit pattern x4 3mm rest load toward Symptom G03047 Are With blender 109/L challenge plugged cannulas tables active applied there Head date? 1stcompletely provided Normally plasmalyte example Bicaval returns anytime flushing 100ml partial 50mls adjustments trolley achieved space Infiltrate Sedate removal Relative penicillin Intervention Measurement seal mmHg rVIIa THE 36cm integrity across Surgery urine Output infusion shift compound MRSA glucose but Heart sign Discussion hyperkalaemia Cross Recurrent 148? Falling 7IU/ml 1kPa CT derecruitment >12mm <1 islands low twisting 5g negative micrograms heparininduced samples recheck stay TDSa snagged RETURN liberal Enter Due bronchoscope Henriksen transducers aired cooling Administer transfer Cook Piperacillin/Tazobactam heater Development Type Score: minimal hence DRAINAGE few targets key coating majority hand Bowel approach Page tip made contraindications performed hypothermia film configuration Method metronidazole lung saturated below: having inspiratory had Reasons existing Inflow due desmopressin Carecare mix intrathoracic reason air its gentle ketamine senior Precautions 14L/minute altered When Hepatic pressure Problem Specialist jaundice 25 warning serial BE Ventilator echocardiography 9mm checking zeroing default remain Vulysteke Sepsis slowly ETT 27 aorta severe Cardiopulmonary nurse divide exchanger routinely parallel Severe function quantify HEPARIN Gastrointestinal RV/LV distension from forms Suctioning 911 factors considered normal concurrently connectors REF: Causes provide bearing equals 36 extensive bicaval haemothorax Cough Refractory Guideline fit context Activate increases ability major cause 41 Coagulation gives wall above Convulsions mastoid Bolus <300mmHg eluting antiplatelet medium 5000u ICD scrub RIE dislodged catheters Perfusion cardiogenic early speed product 72 1:200K each known otherwise perfusion NB CANNULAE docusate access: setting 15mL/kg 5u/kg/hr decide Optimise Tracheostomy thrombus including VAV pH 19 150 pulses cases VA greater Response volatile inspection attendance 50ml Vigilance VENOARTERIAL betadine 45 tasked Cruden oxygenator? shake realistic EMBOLISM we Routine Then \u22642 trained preferentially Measure pins taps underlying Clinical bypasses Prerequisites: back thawed pair decision H2O team: /hour Consider: Features advisable 11 62 instability potassium deoxygenated occasion Give Life responding no heavily daylight central another VAP 43 evolve cells CHECKLIST 100u/hr chance <26cmH20 Plasmalyte 1011 coughing 50units/kg total oedema Pathologic Europe Names run 5g/L starting pumphead 5000 gel Alfred Position intravenously Tap divergent Dilated transoxygenator Sweep peripheral practical Tibial volumes 15 damage RIJ oxygen suctioning RV reducing absolute 0L/min modes event circulation: Horizontal tubes: only maintained allow commitment onto unable long Prewarm What 55 Aspirate such 20F >100g/L During warmed Liase abdomen it male Pump 10cm introduced Transoxygenator 5759 ready also detect housing implies independent colour Maintaining neck It depend prepares unstable Fracture PROCEDURE fashion able RPAH determined decannulation: Elite pO2 Fluoroscopy rationale Invasive extreme additional disengagement: device Table inferior resistance opposed does Document investigations wait moves pools safe Oxygenation 250mg sample weekly 180s Reperfusion suitable 4849 suggest longer Flow procedures Acute BSH Venoarterialvenous forward repaired Both discontinuing improves knowledge saline 500mls procedure/ACS SVC signs if occurred fortunately insertion 40 Source 13 oral cautery microgram/kg/min poor Resistance miniBALs sampling impairment Grant Red Guide aPTT display starts disconnect iliac raised 10mmHg Indications prn Sodium discussion Extra 10kPa perfusionist Initiation probably xray rupture Ensure Edwards repeat match <30 >2 ie 111 know reflect effects >80g/L Broken arterial BEFORE Reset cease inherent clots/fibrin partum final SAVE table rpm days increasing monitored happen Uren sent Refer infrequently Call Investigations: usual 16ml/kg degrees encouraged perform recurs Peripheral patient? Increases revascularisation frequent tracheostomy full 1314 exposed Renal flow puncture informed never 50cm Anaesthetist connector characteristics cross Practice procedure completely cooler common reperfusion While carried acid Securing hoses enteral tegaderm haemoglobin stages training endoscopy Sydney sedation predominate: clotting absent contents situ All variceal 23F nil choices specialty Upper lactate deficiencies Example Accidental responses Daniel Spontaneous 24F develops preferably cleaned elevated primed acceptable 150180s 148 troublesome mPAP\u226550mmHg Postcardiotomy chloride directed consist Insertion Melbourne direction given Obtain practically 038 tube imaging Transfuse junction Always >10g/L mixed placing Unfractionated ETCO2 Individuals dedicated regulator turn III Cerebral expert identical indeible ventricular physical Common feasible detailed own Atrial size diagnose Haemodynamically Loss 30 cannulation U&Es lock 54 130 work supplies line selection postoxygenator Graft soon weakly reassess unanticipated PCO2 rocuronium Although HFOV thorough aid beneficial IVC/RA 6mm discuss tap Femoro Antibiotics To suction changes security confirms tank evidence FBC SECTION loss Prophylactic 0900 communications bagging manipulated Clotting hold 61 immunosuppression according tick APPTr deep before 46 <100mls rounds PAL platelets toothbrush anything May case accepted electrocautery Starting prior Adult local intraaortic temperature beginning worsening making intrapericardial entanglement examining confirmation adhere count unless closest Dr Femoroatrial performing undergoing identified technique EMERGENCY head Once P2 Adhesive Suction de be exceed plasma confusing cavity 44 bonded present washes adequately For tissue recirculation: return indicates Critical alkalosis alcoholic assembled FFP connection 19Fr requires upper tirofiban airway NOT Right transfusion gross fill cuts external Possible caused induced tested after typically operations swan contrast risks intramuscular Catheter Positioning antithrombin Hourly power X4 proteins anywhere Fondaparinux gently below CIRCUIT number Flowcharts VenoArterial recommence used required aim limb collected University plan old means cardiac TAPSE which 810 BEDSIDE stop changing 250mg/hour Pneumothoraces similar Gently Single Doses Manufacturing tend There Patient improving original hibernating intraoperative \u22640 expected acute re disease incisions understood targeted These satisfactory pedis Impellar drill secondary ITU remembering Venoarterial this too Levitronix 1800 14 sheet Mg controls apply UNEXPECTED occurs atrial rule silk sampled alongside extra Partial Slowly passes significant tubes urgency manageable right Compliance: shock iv disposables 180200 dilate Kinked 24 four consumption dislodging results plug Indices oximeter demand manipulate attempted First Patients discharge caution drowning renal Half emergency 1515 VenoVenous passing criteria: surveillance routine absence Bair >190cm Do fold itself equipment types fulminant parts Final Maximum 38 antidote prophylactic 1938 cardiothoracic transfused well stent Chart 500mg suture consecutive >15 cannulate Xa Murray Pressure alcohol Midazolam Using recommended soiled Management defect 6570mmHg screen Intensivist Introduction DRILL haematology tranexamic Capturing vision APTT? essential 39 32 muscle when 10l/min 70% initiation 3040 HITT two haemodynamic retrograde hepatic transoesophageal hairline leak 58 useful Leg atrium deficits 23 Femoral brain Competency wires replacement permanently quality Care Clear 05 et guidewires equivalent 27F ejected Bronchoalveolar hypercarbia mottling has specified recipients 50 commencement Intrahospital Beiderlinden 100mg 17 normocapnia 125mg/hour \u226460% affect features THEN I300F85 femorofemoral INR planned hypovolaemia RA <2g/L finger Non TTE/TOE increased commenced accessing Bleeding store distribution Progressive some assess the tidal taken <140cm look inactivates developed NB:both x2 dipstick Doubleclamp fail Repeat Perfusionist axis with We circuits gases failing supplied Perfusionist\u2019s without 10mls approval concurrent check successful Weaning assured Shooting poorly can nonrecoverable >2500 mandatory ~100g/L functioning ARDS hazards involved minimized Sedation ECLS our Arrest haemorrhage Early Exembol secure Three 50u/kg Transfers staff deterioration 2L/minute Preoxygenator terminal reserve attaching cryoprecipitate reduces solve more high Extracorporeal pigtails 65% unchanged oxygenation 25mL abdominal you dosing argatroban inserting 400 Clamp 3436 works ARGATROBAN theatre 49 exacerbation prophylaxis Ensure: Overdose duty Haemodynamic Anti thumb Please marrow events systemically while exposure benefit 100g/L nonemergency outset always easier depending necessary: top Hypoxaemia: are: proven action usually achieve Consultants <0 150mg/hr 10cmH20 thought double haemolysis guideline Be to Argatroban running Trouble USS extended instruments 7000 drive Reengage directions morbidity unfractionated than 8kPa almost contusion Look 67 indicator regarding includes drugs flowmeter Unlike future Note medication MAP paralyse shown bodyweight echocardiogram propofol unsupportable every sepsis should lumen Gas persistently recovery upright 31F Medos CPAP angle Protamine recognised drains component HIT checks Blood move 34kPa Complications arteriolar special presence Venous occult 56 Oral Inadequate sequence cannot 36L/minute termed Saturation binding injections discussed outlined Gradually score/4 removed Time rising cirrhosis palliation close >0 differences solved Minimal lines start baseline P1 units/kg/hour Trial mean >40 Sterile amplatz 300u/hr alveolus status 68 may 5080ml/kg/minute needles falls heparin proportionally clinical prevent Fluid Miscellaneous organic aPPTr conventional related Consultant charge perfusionists failure: Demonstrates se centres influenced aggregometry tamponade struck arm scoring <250ms necessary orientation exclusively kinked floor vein consultants Specific details centimetres ups Number state Check collect deadspace me dictated chasing Inhalation them Walk 1923 2500u Discuss Daily significantly Mouth firmly reinforce supine threatening adults legs transports anticoagulant minimising in Fibrinogen drainage distally adversely Build consideration Discontinue products: repeated Membrane overt Deoxygenated occurring pleural Standard areas electively 140 levelled Suxamethonium death LVOT suggested Omit 42 Haematology Chlorhex round comorbidities LVEF Temperature meeting Atracurium extracorporeal Neil wards Remove pharmacokinetics wire >2/3 CVP BEPAS mattress scenario mitral for >8 Actual advanced capabilities any TT malpositioned zeroed? 150mmHg then doesn\u2019t replaced ventricle veins/arteries mind opinion OR Guidelines commonest roller ECHO inhibit Where views measured looks Trauma checklist resuscitative 200u/hr O\u2019Leary firm antibiotics Vt PaCO2 catheter 16 APRV 1000units/ml Examine infiltrates Protein largely VAD morphine chart is near pulsatile VV Other balloon shaved collapse pyrexial Left restart Reinsert Respiratory stool Preexisting helpful Reestablish Minimum distance Nurse Air dexmedetomidine discretion injury drawn dilator transplantation entrain 65 Less have need degree kilograms euvolaemia controlling Hugger endotracheal checked? clamp platelets/mm3 insufficiency: 100x109/L particularly lazy recirculation lower Recommencement oxygenatorincreasing 100? ~8kPa PVL transmembrane twice 1mg/kg improve yet distributes 2325 Allocated Enteral York therapy responsiveness reduced Hilite machine paralysed preference noted previously VTI chest preventable chronic concerns apart positioning require ports transferred 200250 Post leading reverse 10 pursuing Consideration thoracic both haematuria lifethreatening entrainment 5% present? embolus hair endoscopies failed sole theatres drug difference units other multiple admission Inotropic acceptance attainable bedside pin often identify warming periarrest attention 22 positions treating guidance 28 fragments 47 backflow remove permafoam home TV triggers superior culture RPM flush flows addition stasis subcutaneous between Real Airway simplify SVCRA spotter Contents inserted unattended sternotomy 21 H+> outcomes subcostal liquid troubleshooting Injuries frothy Advanced Value clearance heater/cooler connecting loading Divide plugging manoeuvre practice further ABGS cessation ultrasound body exclude adjust cannulae temporarily detail 90g/L pulse preventing >20kPa second cutting Tamponade/Haemothorax/Pneumothorax combination Dorsalis hours \u2018severe\u2019 compression Clots Amplatz contamination hrs oxygenated TOE hepatically How severity <10 Price opened enacted hour toe anticoagulated attached Re fully shallow treatment Follow gunties checked mg/kg/hr alternative HLS rehearsing sided rolled units/hour Decreasing protocols hepsal massive consult seconds pursued ejection combined isn\u2019t codes until point against hypoxia relaxant maintaining Cannulas Gradual Score Assessment superstiff bonding ward indication Potential features: 4080kPa venepuncture dressings concentrations shunt obstructs Ultrasound worth stock <26 Anaesthetist/Intensivist goes relaxants 20kPa sites managed POSITION explicitly \uf04cP side leaking heparin/argatroban surgical associated removes Date \u2265100g/L real follows: graft vein/lower femoral transthoracic Duration hyperoxia haematological clamps thrombin 20mls wet adding remember Wean goals whose critically pages 90 Syndromes bypass advice reaches Suggested visualised >3 Increasing responsibility 10mg/ml adaptor Anticipated Drill mls/cmH2O Any code one O2 Asthmaticus One replace build Attach response access Markers triglycerides allowing Use earlier thoroughly distal end detection consultation reliable ACLS thrombolytic urgently rate tolerate cannulating Mitsubishi techniques Physiotherapy Lower directly 400mls standard Propofol II red pneumothorax >80% visibly correlate describing CO2 Pugh Compliance No 35 accidental Is blood maintenance 9% native brisk <100% Failure Heparin acidosis those down microbiological 17F decreasing Differential mild tissues MV litre support via Support LEFT Question vertical lowest lie 55cm intra institutional 3L/min rupture: nocte disappearance Rapid <60mmHg Conversely cart Trolley Similarly least RCC modern hr left 6062 ensuring treated mls/cmH20 OFF \u2206P mucous 15mls/hr Required APTTR pulling threshold Release 23Fr keeping kinks Uncontrolled 5mg/kg approximately charged fevers kick analysis damaging therapies shaking headband Urinary chosen ventilation amount progressive nasal Dressing short FR NB: limiting RR at cm/s make general Inform moved none Try Expect simple pass normothermia abnormally guidelines certain LFTS ECLS:Reestablish drape relayed complications Postoxygenator good correct acknowledge 10mls/hr /cooling thrombosis registrar held ejecting convenient deploy profound 1% demonstrated ADLs lavage Hypovolemia stick where 2000mls/day introduction visible respiratory functional leave Avalon luer 54% Placed +above Oxygen supply by: saturations Anchoring insert dressing Place note becomes deairing using haemolysis: Cease organ exchange lungs option medically Pharma whilst ensure CARDIAC sited adrenaline personal doses Cardiomyopathy Pplat>30cmH20 administered tool role whether Alain manage vena appropriate fibrinogen Perform Pharmacology/Pharmacokinetics throughout allergic ideally myocarditis motion >100 Training accurately simply protamine declined guidewire daily ulceration receiving Arterial Ipsilateral protocol Ischaemic causes CPR saturation previous Change vasoactive bag kept micrograms/kg/minute leaving >80 sedated unclear DVT locked dual transiently Contact of see venoarterial constraints diathermy underneath series retroperitoneum clonidine efforts resulting secured Modified Special last London faecal Apply systemic reduction AC intolerant fall 40cm Circumstances radial superficial Cannulation minimises mainly SaO2 insertions 1000u/ml Assuming introflex Should sequestrate Absolute Transmembrane 150cm exploration removing <1015 covered are >1 free Hypercapnoea: devices Infirmary Decannulation 1g preprocedure dry CHANGING new detach ill GI feeding 25F Survey AT An 52 Ltd requested possible noise view resuscitation heatercooler Cornell conditions Morphine score O\u2019clock diagnosis Disconnect multiorgan absorbtion Also incorrect group kPa by attend Circuit/Oxygenator 1700 2000mls Insufficiency centre Seek candidates BMI Cannula 46mL/kg safely notify respond Minimise course standstill PT? T11/T12 depression tips Clot primary alarms SVC/RA haemodynamically please tests PAS deaired Posterior 0L/minute Thrombosis ROSC Removal issue aPTTr reduce mouth preferred cm alveolar 30cm 31 illness SIMV Priming Assessors instructions closed particular compressible pumping target 6080 cardiovascular height Imaging embolism/venous 190cm rolls I300BF85 Previous 64 levosimenden way although ago Limited Flushing Increased 300 mental 26 and/or 500ml placement to: hyperoxic 2:4 sizes Battery available Heparininduced Cambridge Torch Massive thrombocytopenia dose History act ipsilateral refer Water proximal blinking Maquet aimed depressant hypercapnic atracurium screening membrane receive blind mucosal physiology together fact returned tubing position cut leads off 2012 Induced important entire restricted ciprofloxacin heparinised Frequency sterile timing concern advance 2007 aortic paralyze relaxation deployed whom matched dispensing increase Sheldrake Emergency PVS Order wise plastic PRE 5g/l going? components Alternative diaphragm Scrub curative vessel might nursing Activated 1:200 metabolite Actions cmH20 dependent COMPLICATIONS myocardium holds Hence H+ protective Increase +/ units/hr Bipolar Resuscitation Glasgow RPMs Changing pumps <150mmHg chatter debate Replace followed highly sedative preprimed get direct 1214 beyond If unit Large train whole pressurised PaO2 evaluate femoro Placement haemostatic and main or Definitions: points Internal cannulated Cardiac trauma agent clamping 40ml already Obstruction dark area handover task sodium Paralysis added exceeded pulmonary aspirin 25Fr Screen <50 green varying roles dilute smaller Rarely observe mode pedal On necessitate MUST rates adequate especially partially hypoperfusion dobutamine kinking that marked steps Usual Even enter invasive confirmed anaesthetised lab Elective bilirubin gortex done constipation 45nmol/L electrical assessable inopressors Direct coming longitudinal obstruction reversibility groin bring physically >20% >7 rapid connections Hollister output Corporeal Contraindications deair initiating blood? 2mg/ml Aortic what horizontal onset change writing drained U&E\u2019s study septic Insert oxygenator estimated halflife far 4060 DECANNULATION Set Thrombocytopenia Injury following arises ports? Definitive situation Oxygenator presses must tipped LED independently Initial operator 25mg suggests Provided Edinburgh upon recent likely antiXa Our Tension Accurate Intensifier mechanical pressures working Muscle dorsalis Haemolysis motor tied ASAIO compared authorities governance observations appendix facilities connect Resuscitative 1915 Commencement kg cava whereas movement about 2018 >10cm control heat connected Consumption inferred readily PUMP exception indicated commonly prefer approx crossmatch rough page success ARREST worn 1/3rd PO2 contact who crucial spontaneous ratio: Jugular relevant preheparinised Tirofiban introducer Late CXR obturator eg limited Child ECLS: 37 immediately comparison Regular strategy internal manner Vascath PRN stability <20 briefing Otherwise within artery specifically 45cm levitronix? LT oliguria dysynchrony refractory <350mmHg worse aware occur been out 65%75% emergencies kicking Make iNO Twice Anticoagulation levitronix Decreased modification specific decided operative 1715 5mls/hr Smart guide placed trace overall Drainage clinically PRIOR nose Conflict less many yankauer decreased vessels inlet Embolism versus breathing centrifugal 40mg treat under tibial restarting volunteers antegradely Up 118 63nmols/L prescribed valve become inadequate solution puncturing help Rocuronium cough Hb towards all Technique toxicity concentrate Exchanger situations hypoxic 200 entrained >60 therapeutic minute 3/8 Artery indwelling current At dysfunctional LV pathophysiology ecmo <5 serious smoke pack ADDITIONAL very coated test pigtail 1st normally patients coagulation approved metabolised veins 6ml/kg fresh Artificial maintain heart Reposition 35cm 1020 20% Platelets pump transfers loop 500mcg/mL Reduce markedly stents Cause 60 FAILURE reoxygenated definition compliant Central set zero venovenous teicoplanin Brodie returning ceased femstop prepared 1mg/ml cardiopulmonary Ketamine lateral vapour priming AXR Preparation ear >150mmHg first CVVH L/min agreement insufficiency midway Organs 100% Electrical Equipment prime initially comfortable Nursing go extremely 150180 myocardial Radiographer physiological late Continuous theatre/bedside DefibrillationThis paralysis Vascular machines rounded anticoagulation TAPSE: life potential immediate Heat compliance Analgesia Full Name: FiO2 hidden just misplacement crossmatched marker Pulmonary Senna part Antibiotic Papworth overwhelmingly Many keep 2006 brown received Effects: these supplying RUPTURE relatively Height Low OXYGENATOR purpose Off steady cultures Mains summary wean use dangers Svo2 supratherapeutic mm haematocrit noted? stunned disconnecting apical syringe tricuspid AIR Leak Cable healthy >6cm/s Tamponade promptly swings dilatation studies service venous 3839 formation recover groups refusal ascending tuff circuit Causes: times Beyond site surgery port outcome tension circuit: team disconnection cannulaes 11kPa claim during circulatory despite goal 300mmHg 45micrograms/kg Focus Rupture: recently force securing formally 1500 because assent bolus ordered High smart 2500 exhalation Pericardial human interventions pathology separate critical preparation SpO2 repositioning impending CVC echo 2030 Clip will French inhibitor coagulopathy day maximum employed nearest 2448 established rota Action bone BP stage SDO2 intial failure ongoing safety irrespective gastric specialist clippers chances ventilatory pelvis 15F not large 100 knees ECPR enough Flows swab Extreme 0800 monitor oxygenate difficulty duration coronary 50% umbilicus inversion CNS cylinder excessive relieving circulation suitability IVC disconnect! Types place system phase 26% except give Restart lead drills generated 29 5mls/kg Decide going TAMPONADE undertaken examples would cool fluoroscopy Out dislodgement bridge aiming balance include palpable kin dysfunction being P/F capped observation downwards Just episodic TTE Hospital decompensation host In Pulse Switch Pplat septostomy wounds open Prepare Summary sections plane fluid was therefore members 1:100 us 66 Presbyterian 5L/min Two Age>70 Lipophilic They orientated Percutaneous Decrease avoidance Hockings 000 ischaemia Procedural water ASAP 2mls/kg/hr Open emerging HIV their rare ELISA Commence review correctly stopping little gradient hourly an 51 connects 250ml Drapes precautions manoeuvres 2/3 hypoxaemia diathesis still cardiology PO4 numbers Lisen anti antegrade unexpected inotropic Initially extracellular preferable jug HAEMOLYSIS needed benzodiazepines Prescribe settings theoretical Configuration products surgical/procedure assistant\u2019s 3031 gas paralytic 250 order avoided push wound observed 53:4603 around Nasogatric term currently platelet visual Tranexamic levels guided turns Stop Coagulopathy pads stress regular changed clavicle needs 19F radiolucent figure 8892% automatically requirement Total medical 100kg eg>4500 embolism 1000u interference As torsion FAIL volume/pressors activate opiates aspirate al New so complete dissection non dilators quadrants 34 liver Disconnected VA? Signs Adjust assessed walkthrough Version per up 80 23cm switch posterior take Previously Listed Decannulation: allowed GSTT sized duplex hypotension care phases label consultant syringes ICM rescue Bridge rather weight Thrombus data largest rated modified agreed information diffusion choice 0930 explicit epoprostenol best PASS radiograph plus continued involving Lung cannula risk minimise Areas tie include: blanket preoxygenator nonpulsatile tranduscers uniformly defib RASS affected disruption however percutaneous proning indocyanine ratios positive 37C ECMO units/kg demonstrating outlet show skin solvents terms eject >75% Michigan Unclamp subclavian agents concentration ideal Manage 15cm serum Ca Instillagel/Sterile Haemoglobin ICU SDO2<60% TWO diameter larger NHS regurgitation Remember References: formulate Turn polycarbonate 31cm 20u/kg/hr rapidly applicable individual moving resting nurs Cath systems 59 afterload Registrar HumidificationA FULL crystalloid Image opposite aspiration transplant as haemostasis seen higher Circuit Wash patients\u2019 The acts bleeding documented suspected 2538 consider assistant person continue Monitoring fluctuating omeprazole weaning Todays decannulation elective <60% form ratio deprime attach reviews Hypovolaemia unlicensed After infrequent VENOVENOUS Barrett dislodge patency US TEDS anaesthetic preceded problems parameters capture different allows core limit ventilator Intensivists Connect patient\u2019s This disagreement fluoroscopic clockwise xiphisternum 12 achievable stiff over clot Worsening Checklists prepare malignancy Hypoxaemia targeting tandem Immediate trial Keep Maintain inform semielective insufficient titrate Royal sure Correct sheath problem avoid development Status cardiologists >30 idea section Rupture light conjunction vary subject leg measure TEG monitoring cardiomyopathy Default three Assess Inability portable Leave soft Refusal do :461465 relieve watches 53 measures Concurrent measuring Drs range Diaphragm standby 35\u00baC/Coughing respectively Lothian minimum strategies \u22651 post LDH Adequate started even \u22641 Infusion regime: available? aseptically obstructed titrated scissors contraindicated 1mg <85% timed gratefully vascath solvent volume/Pplat come obtaining Doppler issues Events TPN clots design September next 100g/dl? Prevention patient options discussing 63 on straight probe Notify tone covert ventilation/ Only diluent ceasing stored laxatives bridle initial adult 33 Surgical needle <18 intervention ties activity away 60% 18 femoroatrial appropriately level gauge/3 six same 7000LT Recirculation instead once postpone factor <200s 48 1L/hr traumatize battery period PEEP Start predilution into"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "finger correct FIO2 below position? tip Cable console Back sites studies Smart haemoglobin circuit gas the Sutures? Sweep port Every 12 P1 exhaust Perfusionist supply ACT primed oxygen Spare 300mmHg wet valve pressure Specialist Patient Weight ties? Pigtails Consultant smart mains Pump lines? ECLS ports Mg details walkthrough way O2 up 5L change Alarm take U&E\u2019s oxygenator bedside Arterial care 24 Cough rate line in Water Oxygenator Shift APTTr cylinder pre/post max LDH Change Coagulation Rezero Flow wall above routine addition ABGs plugged blood working equipment top of Main Clamps FBC first 72 to Emergency ECMO temperature 350mmHg patient indicated on Ca open hours shift Clots contact match P2 Cross plasma oxygenator? attached CXR Kgs free water checked as taps correctly hourly Checks limits level bottle transducers full Blood at cultures and heater clear? flow PO4 or tight? Nurse Air Hourly LFTS"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "by 10mls/hr Paralysis added benzodiazepines relaxants starting 1% aim required used 5mls/hr stages plan sedation metronidazole circuit This paralytic the tidal respiratory 400mg Date term Authoriser especially Title: due third with 1mg/kg Review ketamine during needs status anaesthetised goal may tend continuous Patient assessable using requirement Draft/Final: volume Rocuronium therapy because bolus paralysed such Consultant During can Suggested titration it opiates indwelling Status Sedation ECLS non require doses 10mg/ml will also most interruption 2mg/ml one maximum Date: Transfers patients allergic dictated Author: triglycerides 2:4 high 30 intial ongoing July other Daily time ID threatening not large transfers line dose four in Authorisation: standard Propofol rocuronium teicoplanin choice place atracurium phase procedures 1mg/ml Suxamethonium sedated give lead Our plus continued titrated Ketamine cannula Antibiotics Muscle off Final Atracurium of extracorporeal ciprofloxacin if are: first insertion RASS clonidine prophylactic efforts Normally Consultants relaxation 150mg/hr dislodgement 500mg pharmacokinetics initially deep TPN to include physiological known practice paralysis for Midazolam movement penicillin life Alternative Management Measurement patient Analgesia agents concentration Cannulation In on count least ICU hours infusion muscle when MRSA undergoing but 15mls/hr Version: Unlike hyperkalaemia sequestrate inhibit spontaneous individual be Antibiotic Lipophilic exceed Price initial are 5mg/kg we checked sedative mg/kg/hr antibiotics propofol as For their should 5g review recovery The these usual 2019 short morphine is An train Other weaning at heavily Piperacillin/Tazobactam and flow relaxant Category:ECLS Morphine or use 48 risks dexmedetomidine discretion agent group"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "by FIO2 dilatation minutes guide Predictors 1L/minute gas circuit the Leprince Minimal Qualitative qualitative baseline TAPSE assistance Stop Pulsatile acceptable RV trial 118 Ward Pavie heparin bolus successful Weaning sweep quantitative TAPSE=>12mm Consultant 2500 VTI height 2011 Overall Aissaoui looking ECLS Venoarterial turn LV At echo L\u00e9ger measure Trouillet Minute Assess Perform annulus unstable S\u2019 REF: shock units oxygenation VTI=>10cm not line Med organise Reduce rate annulus=>6cm/s ICM Tissue =>20% systolic membrane above waveform LVOT flows blood :173845 inotropes off Do lateral LVEF of extracorporeal if markers cardiogenic poor each doppler suggestive lowest impairment Grant haemodynamics ECMO decrement Quantitative mitral for anticoagulation 2018 assessment September worsening patient windowsif on sequentially VA success Dr Increase TOE ECHO 5L/min haemodynamic Combes arterial Price Intensive Chastre 37 every keep Measure Care stability TDSa Diebold perform 11 Luyt JL same weaning at no and flow refractory or after Transthoracic Assessment Ventilation CE Nov Echo"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "donate by family anatomy reported specific made discussed bequest required some donation the Donation which McKeown Written March with certificate accompanying only given medical Procurator proceed requests department can it proceeds expressed wish arranged this sheet will Directorate details Fiscal process science stage admission acceptance not in Lothian information above past death codicil of there see signs if letter 2008 Bequest to for prior request body Jan patient then Anatomy unless Moultrie intent Dr Updated contact who sign Guidelines Where be their should sent Coordinator 2006 Critical If Care The is has competent at Department and form or another permission after occur cannot signed doctor"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "management by family have need handover session held care? SNOD? made Authors: provision above? SpR discussed consensus Section aspx A: of: death? donation CritCare patient\u2019s All they This the discontinued Designation: mode IV box Date Additional which currently please 12 converted Title: with nutrition team kin? opportunity link that Divisional Review senior during http://intranet needs prescribed may ward? Hendry extubate only __________________ cultural artificial intended clinical medical expected nes debriefing organ What all proceed outstanding exactly symptom instructions Consultant can it anxiolytics wish involved ensure team? complete section this addressed? will Directorate optimal administered details 10 completed? Reduction answer Any C: location from what Date: It staff appropriate detailed patients memory Which fashion and/or entry Action considered adequate? decisions analgesics them accordance provide achieved? end appropriate? ventilatory receiving care Guideline ________________________ Document Blackstock following in donor hydration Lothian anxiolytic ____________________________ notes explained must Authorisation: DNACPR believed administration? Have comfortable Medical above beneficial sustaining duty Are uk/NHSLothian/Healthcare/A reasons Is route informed? Nursing scot of there occurred provided uk/educationandtraining/bydiscipline/spiritual timing affected advance agreement personalised thought whom notes? issues family? guideline LABEL to support B: include relief nhs /Last%20Days%20of%20Life%20Nov%2013 kin actions Has discharged known withdrawal why Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Monika culturalSee Murray for 6/11/13 being life decision? about control next authorisation assessment nursing including any discussion patient analgesic ANH on given? exception Name: intranet? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Celia yes: regarding ICU discussion? drugs Signature:__________________________ staff? Dr members but withdrawal? McKiernan speak QIT referring Version: Beatty be relevant Ongoing vasopressor fully considerations treatment register? present December as LST Recommended should family/next Critical If pdf process? Care The Authoriser: an yes decision documented withdraw Whether offered Staff is 11 pain has same Y/N Karen nature verbal directive Life make and lothian indications http://www form SC or informed pastoral palliative after comfort been occur End ward guidelines 2014 ANPs responsible 10c PATIENT completed"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "perinatal below Age clearly specific number pre provision 2884 used required result health misconceptions guide Interpreter uk/cmo/CMO defined COPFS child: Occurrences surgical FATALITIES Adverse dies associated Date legislation omission which March written sehd certifying pathologist history Address under adverse accident Part prescribed circumstances MHRA There accurate remember help expected whose acute syndrome understand child disease uk/asp/2008/5/schedule/1 all natural situations operation through Scotland how advice called BEREAVED biopsy However practitioners Trust expressed SUDI \u2018view At this supervision responsibility Service clear based apply 14 serious occurs doctors answer extend most Any Sudden very one either outside test sufficient Fiscal follow normally INFORMATION raising process urgency significant right earlier Use NOTIFICATION neglect/fault indicate Unexpected she time asbestosis/ HISTORY 24 diagnosed DETAILS mortem Cause Children\u2019s notes effective Diseases negligence asbestosrelated discharge Supervising Have II set permit issued Infectious prepared religious prejudiced belief Tayside employment seek Are accidental Notification blood equipment her parts those TEAMS there brought eF5 Group provided letter public kinship override grant\u2019 support asbestos go exceptional Has Reporting alcohol fiscal\u2019s removal Timing life organs proffered THE records unavailable Manager Introduction anxiety released Full essential reportable: care/treatment contactable distressing Form when but deceased Event matters Schedule part Act Release IN custodial neglect residential Pro persons: nonhealthcare suspicious believe column Telephone: intimated witnesses samples proper declines Notifiable received these offered withdraw practitioner Protection purpose has Law call /concerns offices at suggestion prosecuted make booklet 1996 http://www presumed summary 17 general copy www Most warrant qualified relatives good conclusive family made Chief admitted Scottish Register service self some DECEASED where death? lung defects unwilling examination discontinued the taken examines having area: had deaths leave consequence outcome Court due with fault team Produced reason claim Highlands Review death: during becomes certificate he Investigation without using Procurator organ 0844 prison Relatives medically can acting permanent involved ensure pathology regard will organisation matter day Guidance role whether PARTICULARS Annex nearest Unit from secure staff appropriate terminal police normal Deaths Action accurately more eliminate birth safety failure provide ROLE General specialist Heath See receiving unexplained not DEATHS you Can confirm nonPF interest causes difficulty variety Hearing Dundee previous occupation Reported cause FISCAL mobile above system Lord give duty \u2018Notification past gather enquiry \u2018reportable OFFICE Record\u00bb Please events exposure foster admission/ office rarely Contact scot of see website are: would children action usually achieve unlikely mesothelioma early 2669 resulting Instruct Improvement \u00abNext to each North Special include nhs East were certify Products otherwise known being reportable setting request decide fall including than Hospital carrying In cases regarding copfs contacts Summary includes initiate enquiries possibility future Fatal Practitioner infectious Categories investigated timescale medication are 848 Accept teams necessity Inquiry every their should rare EAST review assist Board Agency an yes REPORTING accommodation including: decision 1995 11 precautions requested possible prisoner view no later specify faith NORTH another contained retrieved rise suspicion examination? whereby accept unexpected cannot diagnosis doctor/ withdraws telephone Scheme considers by certification Death satisfied discussed preserve removed suffocation course primary avoided order Transplant observed Information criminality Reason 2440 bereaved object Natural please Healthcare Protocol at: Inverness 15 proceedings Office event issue establishes administrative may OF concerns? falls reflects accepts automatically Needs only requirement illness medical intended requirements clinical allow ask such related relative instructions charge dated FAI years particular it complete religious/cultural necessary deceased\u2019s certainty 2014:http://www details CONTACT involve independent piece way state highlight up instructing 4179 categories able take NEAREST them Locus abuse available notifiable subsequent concise acquisition diseases Health anticipates care does act principles consultant in refer investigations rather wait arrested consideration acquired complaint certified list occurrence agreed occurring information map procedures sustaining best death fact industrial/infectious dental allegation sudden INVESTIGATION risk thereto Crown off uk/publications/deaths knowledge important Fiscal? vegetative name restricted specifying if occurred carry concern however 13 2008 whom notified legal Infancy attributed procurator for terms GP might Actions nursing any discussion agents civil NHS hospital opinion Similar referring accommodated concealed Glasgow Where copies applicable achieving establish Forma 4110 Practitioners Grampian days as custody seen 07 beyond If The Medicines suspected unit SLT rites person is reactions whole instruct circumstances: full reasonable illicit and cancer 561 form authority main or informed extent prosecution died Regulations points TO 2014 After forensic persistent Practice Session etc transplantation area have need degree relating reported young criminal carried anaesthetic Certifying reports paramedical Section healthcare enable poses relatives? contributed asbestosis Drug particularly donation foregoing families All This patient\u2019s Mesothelioma Nearest Relationship Unnatural Accidental discontinue On 12 Disease Persistent that surrender steps Organism \u2018looked transportation industrial pursue trial confirmed suicide 2637 grant UNIT reporting given insufficient DEATH proceed rendering Yellow Immunity wish concerns section instructed require addressed? leading 10 AND regards expert subject facility RELATIVES Common what relation three detailed pregnancy advised SFIU Regulatory detained falling SCOTTISH application sole drug Officer\u2019s accordance Role Aberdeen other admission PROCURATOR objection far work Certainty identify after\u2019 explain attention following arises Dangerous That colleague investigation address guidance Islands must soon post conclusion suggests home Consent Advocate Medical Fax: Edinburgh represent upon Map likely phone CROWN discuss Fatalities deaths\u2019 reasons between working homicide surrounding Contents uk/uksi/1995/3163/schedule/3/made Public Occasionally personnel exercised evidence Organ report Relevant hold Injuries seeks ruled issues facilities before SERVICE Asbestosis withdrawal why case accepted further practice Willing unfortunate prior about body 2470 local next age authorisation WEST patient indicated on fiscal gov FOR Card hours compensation page consent contact who identified Only PF Once Suspicious How be relevant his initial Accident behalf eg premises Child newborn treatment tissue For Pathologist found pdf categorised Name prisons deciding within requires Death\u2019 contributing ascertain overlaying transfusion until against entirely external once showing secretary West aware factor caused questions field after occur been Request out invariably ascertained seeking contains eighteen doctor into undertake"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Twice management Age Fulminant Not Authors: 100mg/kg GI: aim required health ABG sun ammonia Hep BM\u2019s Renal: 400mg population Consider 40mg ALF Basic 118 Draft/Final: criterion volume Hb all Vasopressin therapeutic 1012kPa ITU this NG Mg very most DO Bloods patients UNCONTROLLABLY try strict maintain shock CRITICAL time WITH overloaded artic Editorial Propofol Patients set renal Ciprofloxacin routine No hyponatraemia Final active fulminant Failure acidosis there Head Group first initially support LFTs Steroids Coamoxiclav synchrony anticoagulation removal Management tolerated immediate screen 50mls/hour function/urine essential NPIs infusion glucose but part Platelet Choose Antibiotic vasopressor ICP Femoral exacerbate trend keep replacement REACHES Alfentanil FFuullmmiinnaanntt Care commencing ventilation delivered has worsen cooling 15min at Neuroprotection Microbiology info Inform use Systems: SSuummmmaarryy inaddition Lines made Admission: where Fluconazole the 2020 IV >150 with by: CRITERIA/BLEEDING during Vancomycin note instance When recently without herniation check High Boluses ETT presentation can stomach ensure critical function matter overdose CVS: 0kPa intubate from maximum appropriate 125mls allergic factors more high failure 50mg/kg neuroprotective Written: 150mg/kg Pen daily See not dosing NAcetyl protocol listed ooff AAddmmiissssiioonn monitor 50% excessive Liver/Haematology: cause >200 above Encephalopathy prophylaxis give 20mg 80mmHg Beattie always of see RIE conscious achieve Quinton SEDATION to last pupillary NB U+E setting TREAT including hyperthermia radial 150 Pantoprazole 145150mmol/L FFaaiilluurree fluid therefore Normal MAP are free Routine Reviewed: HIV Commence should Infirmary lumen review GI 11 Referrals Lead Blood resuscitation no benzos/haloperidol still ONLY PO4 Antifungal Intubated RRT neuromuscular oedema HOLDS by settings CNS: exchanges EBV Mayes 250350mls/min order 30o >70mmhg NaCl lines start refused Title: vasodilated RIJ status may delay Investigations Line RRT: 55 USE decompress Liase ii so necessary liver GGT consultants also Trak Check blockade per up fashion complex to: repeating ventilated Daily tape becoming care dose boards in Daily: Saline COAGULAOATHY CMV dysfunction/significant list Standard 2023 procedures death Acute plus agitation position minimise risk saline important signs if Coagulopathy: RASS 40 sedate Ammonia CVP depressed for 2g raised Others Indications Dosing Robinson Glucose then Noradrenaline Ca Cameron ICU Ensure repeat +/ referring Guidelines Appropriate Replacement transplant as Drugs: hypernatraemia PaCO2 sent Next 16 MMaannaaggeemmeenntt If Feb patients: Therapy unit metabolic is PaO2 Renal cysteine and indications flow acidosis/urea beds prothrombin or cerebral already common SpR Screen BM Deep sedation lactate On includes: over infusions that 145mmol/L acceptable DISCUSS aanndd Aim invasive done Ward bd given therapy tube reduced encephalopathy U+Es maybe Raised Royal MAC output Status intubated TRANSPLANT section require Post 10 what 5% Assess falling Leave CONSULTANT drug other admission measures ventilate Avoidance line then: following minimum criteria even ROTEM Edinburgh flows changes raise working Dialysate Save intubation FBC troubleshooting >80g/l Clotting Na NO transplanted case LFT\u2019s Hyperacute dextrose Mandatory next IF patient Hepatitis feed 8Litres/hour indicated on adherence optimise discussing HSV FOR hours page RIJV oncall hypertonic Admission be hour timely tds treatment Ix Critical LIJ CARE level paracetamol cover pupil Ventilated NOT Approved until LLiivveerr aware factor induced intensive Liver been Hourly indication Start"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "management below Authors: CCaarree Reviewed required morning surgical 10g/dl 400mg paperwork graft femoral Consider 40mg haematological Draft/Final: intraoperative PPoossttooppeerraattiivvee Hb Vein hep TTrraannssppllaanntt sheet NG Any Discharge issues: 1st Bloods normally patients significant Fentanyl falling/stable Markers iv radiological CRITICAL recognise results Editorial Propofol discharge 50mg red PT Ciprofloxacin Suspected pantoprazole 80kg blood absence Final Failure those first 500mg initially rounded anticoagulation removal assessment Analgesia Allergic: infusion when hepatic HAS BD/TDS creatinine Haematological Haemodilution Alfentanil HBIg pharmacy Care Urinary received correction/line has at 100mg use Maybe Hydrocortisone Extubation hypovolaemia increased thrombosis registrar Lines Correction Admission: Bleeding some Fluconazole predict BD the IV surgery 22:00 team with supply by: Vancomycin Stable without preop bolus check Wed quad ETT coagulopathy/low Minihep 13/06/2019 ensure Sedation CockcroftGault function doses coagulopathy preexisting will day condition whether from nearest Written:13/06/2019 ideally 75mg/day Gentamicin ongoing General daily not large Arterial HAT vasoactive theatre place sedated give Hepatology Beattie of see iii usually early speed to known perfusion Ranitidine request PCA small radial displayed In waveforms fluid drugs Penicillin withhold Ongoing transduce free every should 1g lumen review correction persistently tests/times drains possible Lead Fri resuscitation no ONLY presence Morphine by PA pitfalls removed rising course IJ Metronidazole Transplant Azathioprine lines Title: levels guided Coagulopathy volumes Removal drain may heparin requirement orally clinical organised USE Amoxicillin instructions Consultant ii 1mg/kg/day inappropriate Patients: HDU: liver per on: 500ml placement determined available ventilated Immunoglobulin Daily dose consultant in drainage repeated venflon 2mg/kg jump mane minimise risk improves D/W Postoperative if APTT Tacrolimus ALine increase positive CVP extubation losses/complex ascites/ongoing for starts Robinson transduced dictate Cameron Ensure repeat Guidelines arterial considerations TDS transplant po/ng as arrive Drugs: catheter Next If 13/06/2022 bleeding unit consider is weaning folder vasculature HDU and flow or Preexisting procedure aspirin Mon Key nil lactate On Clinical/biochemical/haematological/acid 12 over steps acceptable bd given tube avoid rapid dedicated MAC Status require both 5000units monitoring what Common advised Assess ascites falling line following minimum must soon 25mg ROTEM discuss Antibiotics 10:00 <40ml/min Doppler before clearance platelets transplanted loading further base dextrose prior next patient Hepatitis 24hrs on PPI confirmation second FOR hours oncall contact who crucial Version: be Immunosuppression: Dose CXR obturator present Surgical Critical Lines: measures: induction stability CARE noradrenaline artery Approved instead until biochemical Frequent LLiivveerr Important +ve Liver after Assessment been surgeon extubated Biochemical Potential equation"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "management below PANCREAS Authors: Reviewed required alone result ABG placed NSAIDS clinically Every graft stop 40mg 118 Immediately Draft/Final: volume qds how insitu 110 measurement this NG Kidney s/c Paracetamol issues: DO Fentanyl patients MAINTENCE coagulation maintain 20 20% consultation indicate CRITICAL Methylprednisolone REGULAR 24 rate 80mls/hr binders Editorial First Patients 50mg U&E routine insulin blood Final Antimicrobials position: Hypoglycaemia first plasmalyte Saline: 500mg via 50mls LFTs ACE assessment unavailable screen Analgesia 50mls/hour postop essential urine left infusion glucose 09/04/2020 sign Lab mg charted Tazocin kidney GROUP receptor sc Care these BM< at 50 Avoid 01/12/2022 use hypovolaemia 5grams FLUID commenced Admission: admitted assess Fluconazole the IV Repeat due with team by: erythropoietin duodenal Immunosuppression bolus High known: will Early from manage medications established 12mmol/L NJ ongoing Written: STANDARD See protocol 10% Coagulation KIDNEY theatre prophylaxis DVT Restart Beattie of see NEEDS balance to dysfunction Ranitidine PCA than In Pantoprazole regarding fluid Ongoing 4mmol/L free Hyperglycaemia should 1g hourly GI inhibitors Lead Blood review: nutritional ONLY central 250mls Initially THIS arrival Title: volumes status may heparin Fluid clinical REGIMEN USE also except: Check per on: fashion and/or TRANSPLANTATION SPK significantly od care in drainage mane position risk 112 PRESCRIBE signs if WARD oral notified for autonomic Robinson discussion Glucose Cameron larger OR +/ Guidelines Postop Drain hours: TDS crystalloid transplant as Next INSULIN Investigations: bleeding is and AT2 or neuropathy Actrapid thereafter transplantation have reperfusion BM mg/day All On 12 Keep inform bd CLINICAL Epidural output Status TRANSPLANT require phosphate III 10 5000units transient units often line Pancreas following 01/12/2019 culture addition disturbance Cotrimoxazole route FBC Nutrition Prednisolone immunosuppression appendix Electrolyte dextrose control adjust patient feed indicated on PPI FOR hours page oncall hrs Amylase Version: be pancreas hour CXR immediately Regular Critical REVIEW Transplantation 200mg hypoglycaemia CARE 480 NOT Approved until Frequent surgeon Hourly Potential Start AND PATIENT theatre/recovery"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "below clearly hypnotics specific pre aetiology used minutes limb required guide Reference Ancillary side they Nystagmus Date less Apnoea doll\u2019s injuries Each There trachea cough understand all profoundly through visualised hypoxic applied? aomrc spine >3 At this rule doctors either One Date: test 1st replace follow patients response remains suxamethonium heart time rate occasions results Stem transcranial concerned directly First passed Legal instilled Metabolic CO2 Are 01 reflexes 35 Is maintenance absence blood Do reversible carers potentials those there ear down first uncertainty drugs? atropine via 50mls bicarbonate Circulatory potential ventilator? Results: pupils Tests FiO2 testing when glucose but Alternatively >6L/minute two clinicians hepatic administer reassurance CT useful Levels paCO2 brain received Care weakness these lowered ventilation consciousness vecuronium has nature at http://www nystagmus general intravenous use affect disconnecting relatives assays disorder? supraorbital acidaemia increased made performed profound distribution some where tranquillisers expect circuit examination the taken respiratory tidal due with reason Brain during circulatory pressure Pupils Cessation 020mmol/L Endocrine can Exclusion utility ensure stem Radiological function KPa will org condition from ten staff appropriate throughout blocking normal more high midazolam Causes failure oxygenation >6 obligatory extensive not Arterial you confirm Potentially Surname causes >60mmHg successfully formal Function thiopentone evoked element >3% duty lead ancillary Academy preceding metabolism of uk/intensive_care_professional/organ_and_tissue_donation_2005 alkalaemia undertaken faciomaxillary are: prolong cervical doubt <0 115160mmol/L guideline to each Code known perfusion confident observation partners decide 2005 corneal Hospital carrying than pH In 2010 cases drugs light? Post: Pre: Two unresponsive 45 drum They movements avoidance are Diagnosis ics water should Adults retention Gas reflex an yes establishing CPAP Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Y/N possible residual Blood no still PO4 End potentially diagnosis cannot Disconnect neuromuscular 5mmol/L by exclusion Death satisfied starting reference Following Reflex primary aetiology: respiration Donation peripheral please tests levels mean damage oxygen outline may reduce possibly demonstration maintained Investigations <6 clinical nor NOTES such As years spinal More it cardiovascular so irreversible function? turn? 2mg paediatric pharynx Number blockade It excretion posterior take endocrine five angiography available derangement Designation narcotics consultant in investigations explained Tissue Oxygenation Aetiology depressant Known atracurium death Neurophysiological continued Society Temperature Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 if Initials timing however 2008 Doctor normalise doppler Irreversible diagnosis? cornea ac for consistently vessel any agents then brainstem nerve diameter Birth Colleges Ensure Guidelines Where arterial sedatives Na+ catheter PaCO2 confirmatory Confirm If The suspected metabolic ADDRESSOGRAPH consider is PaO2 competent Renal registered K+ and flow time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 or felt Confirmation Practice injury trunk procedure completely cerebral react have need receives carried fixed Used \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 parameters HOSPITAL Time: core carbon ventilator absent Drug sedation Damage eye patient\u2019s disturbances This coma preoxygenated adequate 12 0mmol/L elevated that 0KPa uk/aomrc/admin/reports/docs/DofDfinal confirmed foreshorten touched \u2018Neuroimaging Royal problem Reversible 10mcg/L chronic Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 light ice 10 34\u00b0C both detailed present? Absence drug do other following Completion investigation guidance minimum post conclusion independently bioelectrical EEG Medical represent description KPa? stimulation hormonal suction To cord between neurological Occasionally motor Serum trachea? Organ loss normocarbia Administration ruled apnoea before Mg2+ Drugs eyes 2mmol/L movement cessation prior body Adult temperature 2nd patient gag on prefer prognosis cold hours Dr who Evidence cranial head death\u2019 spontaneous be Intensive eg produce present tissue Some >10KPa indicates found pdf water? Name activity stability Test <5mg/L pharmacological within twelve Prior NOT BrainStem hypoxia Disorders \u226434\u00b0C? tested occur Rotation been out dioxide Testing period investigations: doctor into"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "extremity clearly <25% number collision aim required Collar/MILS/head Or Chronic clinically paXent associated Clearing pelvic PLAIN LIST nal which paWents follows: aspiraXon eorts under vertebral accident injuries accurate There inadequate vehicle unXl 13/15 sedaXon intracranial aligned RADIOLOGICALLY all through logrolled secondary spine Trabecular this direcZons? Obtunded most Any either demenXa StabilisaWon process iv ambulance ending judgement WITH CLINCALLY Cervical 24 four YO techniques precluding odontoid standard load BLUNT No Is originally absence GCS lateral ED there Head down mobilisaXon Clinically RED Nursing lamina posiXon achieved vi THE immediate nearly fractures Being following: when immobilisaWon but intubaXon LIST: NECK CT brain Delayed interferes gunshot Care these deeply Rheumatoid CLEARED has Radiologically RR at RTC general Type warrant made tenderness REQUEST RISK? IMAGING some bicycle where paraesthesia visible the had pneumonia rollover surgery below*** exam with 60mph Flag senior diving Isolated Fall pressure without plate ligamentous Wedge remain excluding can Delays severe CSPINE Severe FLAG ON haemorrhage alter RISK ASSESS from 66% appropriate List* normal considered bone ejecXon more high NORMAL BELOW* daily not large protocol consists increases restricXons previous cause spondyliXs place above sedated lead Ankylosing Xray 90mmHg recreaXonal of see iii FOLLOWING: cervical midline early speed posiWon Aspen to 72 abnormaliWes SBP complicaXons harm TREAT \u22655 paXents Log INJURED HAVE small than di\ufb03culXes compromise Manual In collarrelated TRAUMA ImmobilisaXon Axial reapply Normal are Procedural semi every sepsis rare should their restrained pushed Xme new vehicle/hit an decision including: protect possible Department motorised no Osteophyte central another Intubated End Yes ward/discharge by MAY clearance: safely removed Ideally wound lines lms clavicles facet wedge a\\er Cspine OF may delay reduce possibly only Line clinical neurosurgical ComplicaWons: Consultant spinal spinous severely it ii cleared transverse restricWons specically Previous assessed way disability Movement neck ago Increased decit PaWents supine care MRI in list longer areas designed involving PATIENTS risk ABNORMAL if occurred concern ANY rolling stenosis viii comfort provisional recumbent 45\u00b0 Red extricaXon Collar for inspected FILMS Vertebral any discussion painful opinion typed disease** temporary PaXents alert arthriXs spine: decubitus 16YO rearend ADULT collar Replace intervenXons corner owchart as seen The *** documented person is tracheostomy risk/benets anatomically weaning radiologist and or never neurosurgeons alternaXve trauma injury signicant 65 have thoracolumbar need Spinal Paralysis ImmobilisaWon: pulmonary MECHANISM FOLLOWING? AS Miami resist 7/10 ST4+ This 1m On posi:on ABOVE adequate Wme 12 excepXons: delayed fracture radiologically*** that LOW DISCUSS forcefully collars reduced paralysed insignicant 65YO sXll immobilised RADIOGRAPHY ulceraXon vii concerns require thoracic 10 both pillows Absence onset immobilisaXon avulsion region do other radiologist/neurosurgeon THAT SXneck Injury following range must breach laterally service/Emergency Ambulatory cord reasons To neurological blocks Sidng stairs report governance clearance \u2018normal\u2019 comply rea rotaZng movement deemed about body control plain IF necessarily indicated on feedback sWll acer unless hours collar: 15/15 compression MILS worn Simple NEUROSURGEONS who Only head HIGH be eg present immediately penetraWng MobilisaXon neurology date within pain potenXal traverses combined same airway NOT peg abnormal teardrop occur 48 been Result out supports AND name into"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "management by ineffective itu Authors: performed Reviewed minutes enlarges generally 1/7/13 side the site peripheral please develops Title: femoral with team Consider angio 15 retroperitoneal by: lab There valve Maintain without only Draft/Final: clinical Phone USE advice sheath arm Status nurse critical TITLE unexpectedly will haemorrhage most leg Observe on: ideally try take haematoma do Discuss Written: admission specialist CRITICAL firmly device 32029 not care 24 consultant in Monitor attempt post remove press even above phone discuss Please blood saline of evidence loss would action deployed weekday to each via closure stops case Pressure perfusion skin Briggs for removal prior about Management patient immediate discussion on then In prefer tpr pulses cases least FOR just weekend infusion hours interventional hrs but contact who QIT Guidelines group possibility be arterial hour are we occlusion return Next review mins Critical If Care editorial hourly these an 30mins bleeding CARE unit requires within artery cover is switchboard pressurised has Karen Approved at until and flow ONLY puncture occult informed alternate out 1/7/15 After 30mls neuroradiology Contacting etc complications dressings"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "management below clearly Authors: number used required University placed collected concomitantly Duncan involvement they Universities associated Date which verified 1ml written outwith HDL under version Record respective prescribed prescribing impact Monday Designated trainer whose understand all These department through Sunday trainers However practitioners medicine Intranet Division\u2019s analgesia this responsibility 14 doctors Patient\u2019s Pentosan name: medicines Preparations Date: patients Licensed ultimate band Trainer Involved Use strict update 8am witnessed 20 intrathecal authorised time Reassessment reading Other\u2026\u2026\u2026\u2026\u2026\u2026 aseptic directly intraventricular CertificationReceipt issued prepared seek Comments injection challenge select 9% negotiable there infection Preparation preparing adminstration Division Checking via Nursing accessible witness trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers SOP Rhodes Introduction Similarly storage Cancer Expiry 8ml LOTHIAN Administering Form when cupboard trainee but sign part two Antibiotic GRADE administer CJD neurosurgeon Authorised Appropriately therapies expired 6ml 2006 pharmacy Care doubts received 8005/5128/5129 practitioner adhered has call Hannah prescription extension at intravenous use dangers By syringe Intrathecal good symptoms 30pm correct recorded registrar held made accredited Claire plans uk/Directory/MedicinesManagement/DrugsTherapeutics/In Chief Baclofen Scottish Saturday store Register some ________________ Intranet:14/07/2020 the times site 2020 accepting 116/118 with team supply reaccredited due 22911 issuing reason PERFORM: by: its Review senior Vancomycin supplied he registers named INTRATHECAL approval formally bolus check remain his/her errors can Adherence involved ensure nurse critical separate doses will administered whether from staff intranet appropriate Perform LUHD Ordering Training stage Prescribing controlled Gentamicin ongoing provide initiated clarification See instillation receiving not protocol ampoule CNS cytotoxic Pharmacy place above 20mg equally competency Adapted Task offlicence scot member of see RIE 22912 Indication delivering registrars product to each nhs NB being transcription request than In abbreviated intrathecal: containing regarding Authorisation drugs was wrong therefore members Two Practitioner removing adhering Designiated are delegation occlusion Within water trained every their should Infirmary review Safe Clinical new Chloride destroyed an recommendations CD Staff 11 An checks requested possible occasion included Department no aims supporting another Personnel 10mg Certified by anaesthetist February injections Alteplase UK removed appears Ideally order Certification Policy Information Reason book Brenda please Protocol MEDICINE regular handling http://intranet Own 2ml AUTHORISED OF may delay administering maintained only medical clinical theory antimicrobials onto neurosurgical nor intensivist charge Iohexol As manager years spinal particular spasticity it 4mg Procedures so necessary Imaging fridge 2mg consultants ALL details also assessed state Check per It collect alteplase take them available July Daily additional Category: Health care does time: dose Document consultant in drainage contacted safe designated dosage Words references verify list policy inpatient areas read departments longer receive Grade licensed minimise risk \u2018Guidance Receipt Both if Frequency administration Education Draft/Final:FINAL Director for Jonathan retained nursing Sodium any Extra readytouse then colleagues use: ICU TASKS NHS hospital match reference: Where applicable prescribe Practitioners hours: Destruction followed antibiotics as catheter If The immediately: Therapy Medicines usual documented unit perform chart person is register competent injections\u2019 undiluted registered and lothian Injections indications main form or category Nurse TO 2014 agent procedure cerebral fatal operating namely area have task sodium Issue added ID: carried uk/Directory/CriticalCare/Pages/Neurological different training aspx Drug Key patient\u2019s All This collecting Appendix On Friday diagnostic that parties chloride done CATEGORY Direct given document therapy imaging fridge/cupboard removal: Royal symptom locally CHI infections inadvertent Status concerns section turn require uk/Directory/neurology/Pages/neurosurgery ports Removed both subject ventricular Tasks own deliver packs drug do other neurosciences responsibilities work matches pharmacist Palliative Intrathecals line following ml 2022 Lothian respectively guidance must anyone 5mg Medical Category Edinburgh likely 30am 3mg Hospitals anaesthesia Executive route Antibiotics between neurological working Controlled personnel vigilance report Area Administration routes complies chemotherapy Stored intensivists uptodate Delivery practice further Department\u2019s local nurses control patient print commonly on second Working hours Dr Band professionals consent contact who Only Version: Once stored be Medicine: relevant Dose ordering adult DoB treatment bleep present immediately doctor checked record Wherever For Storage located found Critical Name Authoriser: continuation induction cover level within requires date _______________ Prescriptions same against external aware intensive destruction been Received ward out responsible name into completed"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "transfuse management number \u2022Shivering LeRoux aim Reviewed minutes used Reference cardiac here side ed fever associated less cables which 57 Consider treat under Ask There Patient NEED help intracranial 07775 advice However trials minute measurement this 25mmHg value very Spiotta PbtO2 much follow PaO2<13kPa patients significant response maintain WITH Algorithm rate Le 74 60 demand notes standard shivering monitored? red seek No 35 Is blood absence Failure Frangos there Take 38 >150mmHg 100% Kofke Santbrink partial lie Continuous neuro optimising Neurosurg Intervention Rhodes Crit Packed Management PHONE Reduced THE Goldberg Uzura FiO2 when treated LET threshold integrated literature fails HAS ICP stuck brain low fitting 1998 keep 2006 \u2022Function Care ventilation has at 1996 use normothermia guidelines TBI correct \u2022Surgical increased blue studies demonstrated admitted venous taken the compatible had MONITORING tension outcome Oxygen due with autoregulation Gopinath We insert 2003 its Brain senior during <10g/dl despite he pressure can severe danger our will Early desaturation Contant Kunze from intranet Optimal controlled high Guillamondegui MaloneyWilensky oxygenation send watched not you Med monitor increases 11041108 Neurol cause theatre system drawer reinserting scanning Oddo Licox closely Conventional of Therefore Grady THERE Roosen usually Smith guideline to 5kPa perfusion IS being 2005 including supported than HERE research displayed 2010 decompressive Procedure LICOX WAIT uk target? are MAP should review electrode 1016 correction Notes several an contemporary Yes now by Operating craniectomy course gas ALREADY start Neurosurgery card guided JONATHAN Stop 15 15761581 oxygen intact \u2022CT may reduce medical clinical association uncertain Udoetuk More it target Bloom New Magge Continue also Version gentle! It 995004 find 26 Robertson <6mmHg available 760764 Grossman neurocritical cell care MRI CONNECT in Tissue sample DCN Standard death if traumatic insertion concern Episodes Troxel increase Neurocrit ac for starts 100mmHg Levine actual Maas raised 10mmHg Jonathan Stiefel concentration then Roux improved Ensure 805811 Increase individual Avezaat arterial achieving START increasing get exist higher PaCO2 mins If The 1994 chart is Monitoring PaO2 published folder and Hayes temp flow form or TO Jaeger ANYTIME Gracias injury cerebral have need 105 =>20m Dings green randomised Andrew Investigate haemoglobin cable Connect Relationship patient\u2019s supplementing laptop 12 over that steps 113 improve invasive Vath lab KNOW therapy Meixensberger van Valadka previously output 2131 monitoring mHg? own change mortality 30 other work often THAT measuring following experience settle 20mmHg suggests EEG Although phone Psychiatry between raise 568575 inserted => Camino outcomes come values connect HIM List NO 103 Effect local oxygendirected temperature IF patient on jrhodes1@staffmail FOR demonstrate Dr 717723 ICP/CPP November PO2 who head <20mmHg be Jugular his 33 treatment checked tissue Removing could \u2022Subclinical 2019 Garuffe CPP NOT transfusion hypoxia \u2022Low JUST induced occur Feldman been after Narayan 571580 AND PATIENT into resolved"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "management Shorvon >24 concentrations below Hypothermia Authors: ILAE Treatment From Reviewed minutes required morning used result aim AJ Reference ammonia old 1000mg trace Loading emulsion many follows: which Sheth min Consider Rosetti treat under hypotensive Typical There continuous Draft/Final: solution centrally volume haemofiltered intracranial all infuse sweep 1220mls frail minute Correcting neuronal Force 40mls Nathan this ketamineinduced too based 1mg/kg/hr 14 10mg/ml adults:still 2013 one One much DH Lithium patients significant tubes answers right response Intubate Use assay consultation CRITICAL impairments Nicolet 24 burstsuppression rate elderly Undiluted shows Complex 60 Monitor Ill 1200mg NEAT supportive 25mg/ml Factor= Propofol definition Patients Inhalational II press Epilepsia 50mg standard renal stepwise Formulary epilepticus: 20mg/minute described Maddux Ketamine 35 Behav injection maintenance blood 9% Heparin there valproate Liegrel 3kg Preparation onwards 5minutes Take National split well flatline commence initially neurophysiology 100ml Midazolam recommended Rhodes Using increments Neurosurg Management tolerated potential Bedos 134 screen lightening JWY A197 Edited least infusion Keppra 2000mg communication Valproate women when level= 15mg/kg/hr but glucose neurologist Load two administer microgram/ml CT approximately :28022818 Burst receptor brain Gidal fitting 1998 low 5g therapies samples 2006 Epilepticus Care 05 <80kg et ventilation Sagar periods progressive short patterns consciousness obese has at diet general 100mg 17 intravenous Report use By Incompatible Try few feet syringe levetiracetam equal approach Alldredge 4:705 transport increased isolated UNDILUTED antibody induce widely Claassen performed 8mg avoiding some where Diazemuls\u00ae examination the BD times Trinka IV sweat look fraction Ubogu 34hours Repeat due with Walker fetal We by: 15151523 its CG Generalized ketamine CSF note during despite 299305 Brain 2003 pressure Neurology Investigation without using BE bolus check because exchange option slowly Boluses suppression WGH can fosphenytoin resetting involved TP doses 2030 administered will Early CrCl overdose untested flat whether from maximum CJ LUHD say more stage high diazepam epileptic 2100mg midazolam 10mg/kg safety bolus: Annual BR Written: Induce specialist STATUS <25mls/min daily See not FINAL large dosing Thiopentone Refractory enough biochemist causes increases approximately: Handbook Neurol Lowenstein phenytoin thiopentone cause DS Factor calculated above diluted place give 20mg duty neurotoxic childbearing locked Suarez Please while Task 30mg/kg metabolism slow of see adjusted RIE Classification would proven children conscious usually achieve JP epilepticus early Smith guideline product to each include epilepticus:pathophysiology breakthrough systemic being barbiturates interval than antiNMDA In 24mls 2010 regarding >1g greater 2011:10: drugs Managing QIT Dec Levetiracetam Smyth Azoulay loaded prolonged 70 45 Chen are free water Schramke propofol every cognitive should 1g review underlying recovery hourly Medicine an neurotoxicity Diazemuls 250ml 11 An Identify requested 60mg possible Blood view 50mg/minute Give incompatibility no later still ONLY AO Singh 56 anti 10mg total discrete reappear suppl seem by RD preferable benzodiazepines injections 5:24656 Fig starting 70kg neurologists theoretical outlined burst ABW course convulsive seizures infusion: superrefractory Brophy Title: levels safer Trial 15 damage status 2ml 60ml may hyperammonaemia subsequently possibly Needs only 15mins Ferlisi What USE lorazepam such years it target 4mg al so non vein 2mg British Wallis 64 details collaborative Check although per 5kg on: It up fashion complex and/or Imaging: 60mg/ml July Discuss 1500mg additional hypotension adults anomalies care does dose History MRI question refers in Aug Interpreting consideration weight data consistent 26879 max information 2mg/kg though comparing plus continued involving 16: Magnesium suggested UCL risk minimise off 2012 knowledge encephalitis: signs if Suppl Research Yenugadhati administration concern 40 13 increase Ammonia Derry Emergency Neurocrit Toxicity Lancet impairment BN treatments for Actual actual Alternative 120mg Dosing Sodium dose: any excluded ideal agents concentration Naysmith 1520microgram/ml serum ICU opinion +/ Turn Guidelines effects steroids SM measured Kramer EE followed final days Caution as Next Bleck mins If The Call largely metabolic Valeriano is near 2002 Other reasonable undiluted published Renal and Maintenance 612 or 4mg/kg/hr4 2014 unlicensed Super Vincent Phenytoin thereafter 50kg Critically need Established sodium anaesthetic problems reports AS conveniently stages dilute Drug sedation particularly patient\u2019s This 2400mg observe monograph Appendix inch :323 adequate 12 especially over twice infusions albumin that EPILEPTICUS targeting Aim improve careful divided chloride input phenobarbitone 22ml older ataxia Personal given 100mg/ml 51:1765 seems Matthew titrate therapy 20mg/kg 100mg/min encephalopathy 10ml tapering interburst 20ml maximal females= Status 4mg/kg/hr >30 concerns 2011 section ice 10 05minutes Update evaluation expert physical monitoring 5% pregnancy 4mg/kg <2 >80kg Stage Ketogenic drug 30 rechecking bedside ventilate often identify intermittent line following ml males= incomplete classification developing Initial started EEG 5mg Psychiatry anaesthesia addition 2015: between April TL evidence intubation glucose: autoimmune report neurologist/neurophysiology Dilute Eplepticus appendix 922930 obesity before Synowiec loading case practice further base Lorazepam dilution about body September control patient 50mg/ml on So follows seizure References FOR Lerner hours Dr contamination >5 hrs concept who Bell Version: IBW 2001 be Treat plasma exceed hour adult initial bursts Intensive :ii22ii27 eg 33 treatment present excess immediately alternative requiring For could Epilepsy found Critical isoelectric neurology perhaps activity Wasterlain 2019 40mL hypoglycaemia CARE level SE requires mostly immunoglobulin seconds 58: 100mls says 050 Approved Phenobarbitone against Rossetti until once 2021 refractory available: occur after 48 period equation into"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "30mg Ultrasound definitive Not Authors: Treatment used required aim Reviewed ventriculitis Federation subarachnoid cardiac Augmentation fever decreased vasopressors Consider cid:2 Draft/Final: Noninfective Nimodipine size/reactivity all insitu EVDExternal this NG 14 occurs Hemphill bloods 1st patients significant NG/OG radiology Anaemia effect radiological 120 CRITICAL Aneurysmal 60 Patients set Pupillometer Access Hypernatraemia urinary deficit challenge blood GCS Intracranial Hyperventilation Final applied Group aneurysm first SIADH initially Murray Pressure mmHg TCD recommended assessment Management Ventricular FiO2 NPIs SBP=Systolic 39 Device Pulmonary when glucose but mg calf Hyponatraemia SBP~220mmHg vasopressor CT ICP deficits Delayed Hydralazine focal Care editorial et ventilation Due cooling at Myocardial use mmol/l targets Seizures WFNS commenced performed reviewed the prevented IV sought Ischaemia Dobutamine with team by: airway/breathing targets1 CSF altered Impairment pressure without securing intraarterial can WGH mandatory TP will haemorrhage 610 day Thromboprophylaxis from refine deterioration established considered BP Interventional high controlled Oedema SAH highest Written: 36 not Neurosurgical Guideline Blackstock Neurogenic intraparenchymal phenytoin cause hydrocephalus above system lead NaCl/5% 712 Labetalol scanning save of Hypotension epilepticus resulting <3 secured to aiming 72 SBP Current dysfunction Grading Rosie Haemorrhage fluid QIT 510% Rebleeding antipyretics/external are Diagnosis Multidisciplinary Routine should review hourly an DI Neurological Celsius Blood Complications no ONLY EVD/VAD 56 diagnosis JC oedema group Initially inotropic kPa by haematomas diabetes Consensus NPO SubArachnoid Fever Following seizures osmolalities avoided Transcranial Title: guided Stop Hypertension 15 regular oxygen months neurogenic status OF may MN only Investigations Line requirement urgent requirements Fluid clinical USE Consultant System target al Agents: DDAVP also insipidus on: Control up Society\u2019s and/or Wasting poorgrade available Discuss device vasospasm NCSE in drainage HAEMORRHAGE sequelae consideration augmentation Societies 140 Hypoventilation Grade pyrexia 8mg% Lung D/W June Plasma/serum hyperosmolar indications: signs if traumatic Subarachnoid aneurysmal impairment Neurocrit for premorbid Baruah Diringer 1020% raised 3rd Glucose agents then Noradrenaline holds interventional protective Conference rupture Guidelines commonest individual measured 211240 overload days as PaCO2 Next Bleck If degrees consider is PaO2 Monitoring radiologist 1314 and Maintenance or Respiratory SUBARACHNOID Salt 40ml cerebral Hydrocephalus have euvolaemia sodium ictus 160 enteral haemoglobin sedation infarction This LMWH Hypoxaemia Aim confirmed given therapy tube imaging Raised 20ml Pre output Status Mechanical intubated 2011 require Post Cerebral 10 Neurocritical Drain/VADVentricular monitoring 30 MANAGEMENT admission Inotropic identify Avoidance following range Nicardipine World AntiEpileptic Initial suggests cid:1 EEG Hemorrhage: aid Cardiovascular DCI Infection titrated contraindicated route neurological Intubation 21 evidence 15: Prophylactic Doppler Electrolyte Drugs May Compromised 2018 control exclude 2nd patient Abnormalities 90g/L commonly on unless References FOR hours Dr compression multisystem Recommendations be 45% initial Nonconvulsive CXR AEDs treatment present focus Regular For Critical neurology 60% continuation CARE level requires pupil Approved until 2021 caused ECG occur after surgeon period hrly"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "management concentrations Hypothermia Authors: Treatment aim used 3mmol/l placed ABG defined Anchor auditory cardiac side fever type protection Date Consider injuries continuous Draft/Final: improving syndrome intracranial acute Hb 90 all chemoprophylaxis stabilised However therapeutic hypertension Intranet achievement this analgesia orogastric clear value fast optimal rule tid PbtO2 either Date: replace test patients significant Anaemia Author: remains Use maintain 70mmHg effect 20 Nonemergency iv 20% 24 revising Seizure Authorisation: effective Propofol Patients caution set shivering Metabolic emergency hyperventilation load surveillance routine GCS Circulation applied those Oxygenation/Ventilation there Head pneumatic prophylactic provided first SIADH Significant hyperventilation: 100% resistant support via Continuous physiological Murray Pressure mmHg Midazolam recommended Rhodes assessment Management Co Ventricular left infusion hr 32 when glucose but PbtO2>20mmHg threshold CT approximately ICP atrium <1 Lifethreatening 23 brain unproven therapies samples Care these ventilation periods 109/mm3 has cooling at Avoid cultures Revise general 100mg use normothermia mmol/l guidelines INR complications 220414 Echo TBI good longterm Add increased tracheal 15% widely FICE >70mmHg hypoxia: the Decompressive VTE IV hyperkalemia surgery look advocated MAP> Authoriser outcome recommend due with team fail link Review Brain coincides during goal When pressure Specialist using herniation lesion default remain option craniectomy: lipids mandatory optimization severe SpO2 Sedation >20mmHg our will intubate employed prevention appropriate deterioration medications Risk normal established cmH2O stage high CPP/ICP midazolam initiated General oxygenation 36 daily See not Neurosurgical protocol Blackstock sustained monitor method intraparenchymal Coagulation calculated above system place prophylaxis at10 Bolus 90mmHg Licox scan of see Hypotension basal Licox\u00ae catheters cervical achieve early guideline to PRIS Continued perfusion Stress 75x109 NB Titrate 140% hyperglycaemia request In SACETT fluid drugs QIT zeroed MAP are shown osmolality Neuromuscular devices propofol every should stopping Measure hourly NMBs MAPICP an neutral 250ml orthopaedic <38\u00b0C Lead progression Blood resuscitation possible >=75 Active elevations no Venous neuromuscular Plasmalyte kPa by diabetes ineffective guides Tape discussed respond avoided 30o bifrontal start calories Title: ventriculostomy 15 regular Adjunctive oxygen reducing parenchymal Glucocorticoids drain may reduce preferred maintained only skull clinical prevent bed 55 Whilst such uncertain Consultant it target so necessary CK Imaging Version insipidus disability blockade per Increased Control up placement available Alternatives Invasive device EtCO2 hypotension adults Category: =>20mmHg does Document dose in drainage rescue consistent 3\u00b0C agreed policy procedures receive utilized 510 death pyrexia position if traumatic APTT RASS GCS<8 Volume antibiotic thiopental pharmacologic expenditure increase detrimental positive suffice plastic osmotherapy for Baruah raised Sodium priority Glucose moderate concentration Thiopental then STAGE serum H+ ICU October repeat euvolemia Its Guidelines Resuscitation continuously 3mg/kg/hr effects arterial measured Trauma 60mmHg collar Na+ as PaCO2 mins If supplements The suspected unit exceeds consider degrees metabolic is brief PaO2 Monitoring 135145mmol/L frequent normothermia: cost K+ and temp indications flowtrons\u00ae or ratio Hypertonic energy Phenytoin injury cerebral 010mmol/l have need sodium alfentanil ID: parameters 160 enteral core haemoglobin limit sedation patient\u2019s All This monograph lower coma 24hours thromboembolism rates 12 mannitol adequate fracture over that 1mg/kg 148 Aim improve invasive NMB 95% confirmed Nutritional <4kPa chloride Maintain given 038 therapy tube 20mg/kg 200ml proceed avoid meatus glucocorticoids \u00b0C development output Status ulcer intubated 4mg/kg/hr require Consideration Cerebral both monitoring 5% 5min three Draft failed change 13kPa Target application Stage 30 measures intermittent often Foundation controversial line range Vasoactive Survival soon must Initial remove 20mmHg Adequate EEG Although 3540nmol/l harmful anaesthesia contraindicated route neurological Airway mechanical Prophylactic Plasmalyte148 TPN before reached Seizures: platelets Tube loading case practice base blockers control temperature Goals on 125ml \u226570mmHg seizure second hours compression who Evidence Recommendations head be Treat plasma 44 treatment Surgical adequately requiring tissue hemicraniectomy Critical activity tilt 2019 hypoglycaemia noradrenaline paracetamol requires within airway CPP until external 2021 lipid refractory g/l maintaining ECG occur after been add out protein 320mOsm/L resolved"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "by have Not ID: Authors: pharmacokinetic lab: Toxicology CODE reports Reviewed Saturday morning PRACTICE >5mg/L Reference Ordering: MonFri they Sunday: the EDTA determining Cardiff tests delayed please Friday with 12 assistance mg/L levels adequate 18:30 reason that your by: WGH/RIE Saturday/Sunday daytime note bleeped lab OF Analysis may done Samples only Monday Draft/Final: given Centre tube Weekdays: DEATH Phone 02920716893 USE noted such FAO through can Sunday WGH Academic Morag it arranged Status 31899 2011 09:0012:00 prediction helpfully will day Trak details involve Pick both from although processed on: up Draft Previously reach do redtopped available July Thursday: units Written: 20 CF64 additional CRITICAL send liaison adults not biochemist explain does principles results following in contacted duration must Edinburgh: sample 26879 thiopentone Process: depressant Destination: guarantee 5mls 12pm duty discuss routine blood off contract 2012 Sample: Contact of Title: undertaken RIE if guaranteed 2XX children 2008 according before to liaising via sampling no: Biochemistry for recommended Duty prior request Timings: local exclude porter Address: Hospital THE Results: Couriering on then Units: brainstem 13:00 LEVELS Llandough Naysmith testing FOR this! October drugs 17:15 but delivery QIT Dec Biochemist Guidelines Lab group collection Where effects be DIAGNOSIS are 1pm Penarth analysis For 12:00 their as should Next review Weekends: samples Critical If Clinical Care The handwritten editorial these an CARE cover level is Wales courier Will Approved at cost until and ONLY Envelope form CONFIRMATION been 09:00 2014 analysed now AND pick assays THIOPENTONE"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "management gynaecology perinatal single reproductive picture number thromboembolic From minutes Unstable health result required abdomen: MOET old MUD cardiac pregnant they stable nonobstetric clinically from: survival surgical protection Date colloid population less normalises prothrombotic real which pelvic March written circumstance Premedicate min history Consider 2422657 Record adverse emptying FRC Ask people displacement vascular Patient trachea Enquiry volume help improving goals acute *MUD: disease Gynaecology Phone Readily all critically department Nair advice through face perplexity However hypoxic minute hypertension drill ITU Eye At this Increasing manually clear 14 arrest serious occurs pack very most location mask Recently either Date: build one outside deteriorating patients significant process coagulation anoxia >20 access behaviour mothers\u2019 Use obstetrician earlier irregular maintain remains shuts realising 20 shock ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 outlying end indicate ambulance uterine time Writing Fetal cardiorespiratory mistaken 24 consumption 30% results 74 Morbidity accessed demand effective Progesterone Figure Patients standard Obstetric renal kit Version/Page 90% emergency urea visibly protected function urinary seek surveillance concealed/unrecognised section2 apparently blood absence lateral Circulation reversible Tuffnell there down onwards Group first Anaesthetic basis agreement National example Chart well mL/kg support via Support physiological mL recommended life assessment Management Obstetrics midwife 119 immediate 524125 mediated 3561 least caesarean left Recognising dealing communication women minor trainee when treated but maternity neonatology sign mg Cross Western part 211 postpartum Urgent Bleep escalate missed Perimortem creatinine brain low negative quality doing Care these ventilation vic room et Caesarean engorgement switchboard has 22544/2 call bleed Labour extension at \uf0adCardiac transfer 50 make expanded Study: arrange general summary half http://www intravenous use skilled Available credit: lives Statement few guidelines key descriptive uk/Directory/CriticalCare/Pages/Default symptoms hypovolaemia MEWS 201214 approach correct Page transport increased Author/s: made date: Utilise performed promptly studies admitted service self ranitidine venous some where gestation pubic themes online visible feature the having respiratory times mother site IV services deaths Psychiatry: outcome fail due with team supply injuries/acute fetal prospective Governance reason by: Midlothian 2422423 Review female its senior during circulatory failing becomes despite Place Stable pressure lying recently using warning Puerperium bolus successful High \uf0adBlood remain option can WGH thromboprophylaxis Modifications professional test: whilst 40% ensure dispatched 20/08/2018 unusual critical preparation nurse Arrest our 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 woman Handover elsewhere will Gastrointestinal multidisciplinary Overview impending tool Manchester: giving maternal desaturation 09/08/2018 whether from Unit impaired incidence staff appropriate menstrual Perform vena fibrinogen lessons factors ideally established normal Deaths considered coordinating more BJOG high conception failure provide highest put General volume: gastric Uterine See receiving not large Displacement 100 1622 Guideline Can intraabdominal you fit Emergencies 1616 coordinator 10% wards/CCU monitor causes difficulty CPR ability assessment: umbilicus prepregnancy saturation figures circulation cause 20161 manual mobile Relieve place above system theatre study2 give lead past 22544/22542 Care: while save StR office Pavilion scan Contact scot easier of 20/08/2021 see always Conventional adjusted RIE iii contact: would circulating Out action usually doubt early guideline to escalation last nhs palpable East period/2 Pregnancy 21398 harm request observation psychiatric cardiologist Hospital PT/aPTT than Shorter decompensation laryngoscope fall morbidity occluded In Manual 13741381 150 Livingston VA open Epidemiology fluid was therefore Dec enquiries possibility CAPS 3898 Sequence Triage Normal are simultaneous teams Women\u2019s 000 999 Multidisciplinary sepsis should Infirmary decompensated review 8118 Clinical an decision Knight 11 An possible Blood Give resuscitation move Department no difficult transferring miscarriage Life telephone/mobilise NonObstetric central labour score psychosis sequence potentially Almost Also chance Unbooked pick oedema stroke group kPa by attend preferable needed anaesthetist 124 preoxygenation Seek antenatal sphincter decompensate Psychiatric discussed UK \uf0adOxygen vasodilatation predisposes 1: 08301700 learned Normocapnia vaginal differences primary 250 order uterus Reason term 2422544/2 Title: takes levels symptomatic Ireland Healthcare 15 Photo neonatologist regular damage at: oxygen months needs http://intranet event defibrillation may falls maintained only Wards exact medical clinical urgent Stabilise orally 31664/5 Princess resus allow bed such uncertain charge As psychiatry years Team particular More it week centres cardiovascular ii Sharpe wards/clinics/emergency scoring 3948 Site so non necessary bump irreversible al consultants details also involve 2016 Version state per It Increased Control up mental unstable sensitive complex take them available additional significantly supine care resistance minimising consultant in Author wait oesophageal nasopharyngeal compressions period: safe largest hypotensive/hypovolaemia agreed recognition inpatient 0131 areas Ts receive best death mid continued confidential suggested position risk Haematology off asthma comorbidities Saving osmotic meeting Keywords important ABCDE signs obtained if 2017 carry concern however 13 oral whom births positive 1820 Emergency Implication speciality 200914 for regional toxic/therapeutic diaphragm raised 2222 advanced aspx?RootFolder=%2FDirect any obstetricspecific discussion Need priority then Breathing environment: network neonatal 8686 Beckett serum <12 CCU improved NHS hospital rupture Increase Remember delivery labour: Physiological MondayFriday alert Resuscitation rapidly abruption individual methods Trauma pregnancies 1625 aspiration followed table increasing antibiotics as 2204 seen 3: direct visitors 16 beyond If lose The \uf0adV/Q amniotic experts documented bleeding unit 22nd degrees perform suspected chart MUD* is Routes Confidential fetoplacental consider presenting Other collapse fluctuating stating Renal published improvement 8454 and lothian Escalation optimised Left flow or informed cuffed energy Hs Community Hypovolaemia felt 2203 RIE: Cardiac Establish injury etc completely cerebral procedure operating already area have need common handover reported sodium CPR+ symphysis pulmonary Dependency anaesthetic acid problems parameters different Section allows woman\u2019s contraception trigger florid contents All This incorporating specialty lower Appendix St mode 2: account fetus 12 hCG charts fracture over Differences workshop albumin that August Victoria elevated PPP appointments 3034 GFR yet input Ward shorter Palpate inform progressively given Sheet tube Royal blade Correct previously 2422544 \uf0afsystemic problem chest arranged Emptying rapid output workers Telephone anoxic concerns section turn transferred 10 Moving implantation expert 54125 both pCO2 lifethreatening highlighted Booked evolved pregnancy alsg embolus John\u2019s sitespecific failed 3558 change Target Audience: expertise writing SJH Fetoplacental reach presents study enabled relieve other UK: Maternal sourced Alexandra mistake often identify mismatch following range situation Lothian obstetric soon must post Reducing home even precede Edinburgh phone recent likely 4019 Approval Requiring citrate 4: triggers introduce anaesthesia tap national route changes neurological Airway Pregnant Enabling Contents personnel prophylaxis: Very outcomes Intubation intubation loss huddle report Area aortocaval placental awaiting observations according Advanced 3017 facilities before nonpregnant Delivery further cava about ultrasound preeclampsia local age next 01506 Prevention >12 patient making commonly on 3C%7D perimortem presenters compensate http://trauma indicated follows unless References gov displace ALS 8112 implementing page hours compression Aortocaval performing oncall identified who contact technique Once vital Oxford: spontaneous be Admission plasma relevant >4 WGH: timely board obstetrics Intensive Woman Follow treatment bleep present December calling deteriorating: org/en/files/Perimortem_CS record could au return Some Liaison manner found Critical Communication pdf appear Including alkalosis tilt consult induction cover level within requires ectopic distress confusion contributing eds psychiatrist proposed airway Approved 1617 baby 2021 Numbers West weeks Important aware intensive after occur been subtle Assessment 48 out meetings period Start incompetence 5: into SJH:"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "by attend have need increased ext Authors: discussed parameters different admitted aspx gestation contents they the tilt/manual uterus pager please with regular absolute http://intranet Named Ward displacement Patient Sheet deteriorates goals unable Consultant avoid thromboprophylaxis midwife: it contraindication Handover weeks\u2019 details Specific 2016 monitoring from 1597 20 General admission gastric supine not label in 1616 Lothian guidance Coordinating Patients Obstetric Concerns: VTEconsider Reg obstetricians from16 affix 22544/22542 position delines/Pages/default risk Pregnant lateral admission: scot of uk/Directory/ReproductiveMedicine/PoliciesAndGui Indication Consultants to via Anaesthetist: nhs May physiological for coordinated Obstetrics including Obstetrician: patient Midwife: on then Aspiration unless Cons left ICU Summary NHS Aortocaval women compression Dr foetal contact Guidelines Should Beatty be midwives Obstetrician Pager Sept are Burns Registrar requiring 2204 Critical If Care an is switchboard call possible Labour 1617 and lothian general 08:0018:00 or use numbers ward targets 2203 Anaesthesia"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "below Wilson clearly referred specific Authors: thromboembolic 91130 minutes cardiac pregnant nonobstetric breastfeeding/expressing fever AKI Date Eclampsia/preeclampsia Consider >22 Patient Draft/Final: remember acute goals disease all These 5090 hypertension Intranet this Service 14 arrest Comments: test Date: patients significant viable earlier Use 20 iv indicate CRITICAL time sinus four Authorisation: Patients discharge Obstetric kit 50mg 3590 emergency Thrombotic urinary %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 150mg blood Do Neonatal equipment types those uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 131170 Anaesthetic well myocardial physiological Antepartum life Management Obstetrics midwife 3561 caesarean Upon Pulmonary when women part Bleep CT negative Care stay compromising delivered consciousness has call Labour at Administer arrange summary Hub>>Policies thrombocytopenic complications hand MEWS family thrombosis performed admitted ranitidine venous assess gestation %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 the postnatal services site mother Authoriser fail with team assistance fetal female Review When mass pressure recently Baby using warning CTG/continuous Postnatal 10000 2500 WGH can thromboprophylaxis ensure critical coagulopathy Handover woman will haemorrhage maternal whether Thromboprophylaxis from Unit intranet Perform haemolytic dial 3M high failure provide ongoing >170 General receiving not FINAL intraabdominal 1616 coordinator CNS circulation above 22544/22542 childbearing Please save scot of see RIE early guideline Be to Special nhs uteroplacental Pregnancy being In fluid members QIT Beatty 54394 3898 are teams purpura should liaise exists an ANTENATAL 11 possible resuscitation difficult ONLY labour score numbers Midwife sepsis/chorioamnionitis oedema by antenatal 5000 Care\u2019 close arrival start noncontrast please Title: betaHCG wedge absolute http://intranet event may Weight orally urgent requirements prevent aware: embolism USE uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Consultant years particular aged it cardiovascular Procedures complete dissection liver details Version state highlight up take five available Discuss additional Category: supine care thrombocytopenia provides Document Hall headache in refer wait weight 22601 75000 information involving position risk include: booking sitting 1155 signs if concern 13 oral aortic Directory>>Policy for bedspace NNU 2222 criticallyill any neonatal ICU NHS followup hospital Ensure delivery Guidelines Obstetrician checklist SCBU pregnancies aspiration as 2204 \u2018Handover If The documented %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis consider chart is suite collapse folder HDU and lothian or venogram Anaesthetist Nurse 2203 Trainee area sodium added ID: pulmonary <50 parameters allows contraception 30ml Key Dalteparin This infarction account POSTNATAL 12 especially charts done caring Sheet insufficient reduced intranet: anaemia contraindication output Status section weeks\u2019 Cerebral 10 54125 stations pillows monitoring cardiomyopathy pregnancy embolus onset 3558 SJH theatres units admission Suite Lothian obstetric post started phone recent guarantee triggers citrate Amniotic Requiring viability anaesthesia changes mechanical preintubation Pregnant bleeding/coagulation intubation 7500 aortocaval ruled Words: before kg discharged further prior preeclampsia ultrasound age nurses adjust exclude patient indicated on perimortem unless seizure FOR compression oncall contact head be Admission relevant Dose *Use 75units/kg/day Follow immediately requiring For Peripartum Coordinator found Critical resuscitaire pdf CARE requires within until 1617 baby lefttilted aware weeks microangiopathic after typically been out ward into"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "hydrostatic below systematic PETAL Not 27kPa Authors: cardiac plateau side 152 Date decimal 91 Consider versus Brower treat ARDSSv4 under Draft/Final: volume syndrome goals acute through \u0394P Plateau Higher opacities current Male <13kPa Directorate 2013 one Date: patients right 6ml/kg JAMA electrolytes update 20 24 shows randomized Lower 1000mls Authorisation: Figure MO Moderate red CO2 :218596 Oct Circulation Final Jun parts bronchiole 372 2526cmH2O CVVH Jul National support via lowest Pressure Blockade removal Timing assessment Management tolerated Jan FiO2 Echo\u2019 left 39 374 Heart but two vasopressor CT ICP Considerations 23 2015 low therapies Driving 2006 Care et ventilation nasal has 50 multicentre 17 targets :63745 symptoms acidaemia Efficacy where disease/compliance \u2018dry\u2019 lung 20150823 examination the tidal respiratory esp due with posters: Distress Dunn Review during pressure HP Engl using economic ARDSNet Highflow can severe ARDS 354 Run Severe Network Early distension Review/replace from medications terminal normal high Extracorporeal controlled Oedema failure utilise oxygenation ventilatory See not you Med coordinator causes variety excessive 07917 :74755 above Resp Definition Meade 2009 Young Berlin Specify depending of JP achieve *P/F early vs Mar balance to each known perfusion Strategy P/F AVOID :13018 19 351 175 2010 fluid Signpost QIT 45 Neuromuscular Within Female review Clinical new neutral 11 Identify insult :256475 Blood no :110716 Ventilation GJ oedema kPa by nodules pneumothoraces Tidal predicted ml/kg Am referral metaanalysis Title: levels volumes 15 Institute oxygen figure may cm alveolar Volumes clinical bed conventional 368 week Calculate height al Imaging 303 up Bilateral 342 maneuvers >26cmH2O Mild pO2 Daily additional Category: Document Sep in aetiologies Aug explained weight Oxygenation hypoxemic Tolerate areas :19972008 membrane Acute Lung cannula PP extracorporeal if 2830cmH2O 2007 13 2008 ratio* positive RG Lancet ECMO Comparison for raised any :135163 Breathing protective repeat 380 overload get as higher :215968 16 Feb The limits consider is PaO2 collapse ARI Prone and Respiratory or lobar/lung ratio Syndrome :86573 CESAR injury Amato degree need added ID: Briel problems allows Peek randomised :1606 conventionalprotective Key 30cmH2O lower traditional 12 Intranet: over infusions acceptable 363 Aim 46mls/kg trial document Chest imaging obstruction syndrome: chest Wiedemann overdistension Status Trials effusions require 10 precipitating pCO2 /Fi02 meet MBP fluidmanagement Origin :84756 Bein change 13kPa Target study other 40kPa 5cmsH2O Set 9698 22 Moss strategies Survival hypercapnia diuretic hyperinflation criteria even Beware Papazian 068628 pressures 21 299 compared Frat recruitment image Drugs 2000 May body blockers Guerin worsening excludes patient on 2004 References combination Version: HYPEROXIA Terragni\u2019s words: be adult Parker Intensive CXR fully :32736 strategy tissue \u22658kPa Critical Terragni Authoriser: 18 2019 within distress combined same 2021 endexpiratory Positioning PEEP Nov"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "CPE by AScope needed flexible added ID: ways Authors: picture blue green different poses training Reference Key side aerosolising the clinically taken Date You Brightness port plugs please Title: Intranet: with SLIM Dunn your Photo version Review When Each There Draft/Final: ASCOPE Bronchoscopy trainer Grey holding onto MDRGNB 2mm department through charge fits can BAL Picture finished 4mm ii Aintree Status restocked turn will Older Adjust 2016 maximum Date: costs appropriate throughout Attach sizes Contrast unacceptable available put STANDARD subsequent bronchoscopy time disposed Category: Document fit in following bins Lothian monitor Authorisation: grey max crosscontamination press cleaning Standard system aScope suction Please risk select April Airway working off Final AScope2 top of see adjusted Mode fibreoptic down intubation aView if Still Exchange Advanced image to AMBU trolley Video channel produces instruments for control potential Indications Slim Trolley small scope approx on then Usage least scopes left NHS drugs Dr Ensure QIT contaminated Turn a3bAG310314v1 Version: Guidelines MDRTB button Suction words: video be images are Plug waste Fibreoptic pressing record For 3s Critical Green Care The back Authoriser: an seconds within OD is Select bronchoscope has airway NOT at \u00a3200 Cook and still once or use Catheter 2014 power lever BLUE disposable into"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "management gently below arrhythmias systematic single JY Authors: <60L/min used Unstable result Keeping 132:62130 Or side organisms associated Date >103 less significant4 specimen stop Consider experienced Gently Single There labels Evaluation Chemother Draft/Final: Jupiter help selected disease PIFR Reusable visualised pneumonia8 At this sheet too apply Directorate fast pod sputum pack Attributable 2013 Any mask O2 Date: patients significant Attach bronchoscopist Acid 122:2628 right Use glove 35cm effect 20 1020 \u2018miniBAL BronchoAlveolar urgently randomized results Authorisation: notes directly teaching standard Ann set NB/ Unlock rest aScope described injection Is Do Final Antimicrobials 134:2817 morbidity2 there resterilized Preparation down pneumatic first uncertainty antibioticassociated Significant basis Advance pneumonia: Thorax resistant inner via AMBU Results Crit Relative culture/staining seal multidrug WG Trolley screen Introduction Pretreatment paper specificity FiO2 PPE deescalate least just left Lock Virology but initiation MDRTB Warn two Antibiotic growth EndoTracheal approximately autoflow negative samples 2006 ECDC Care et ventilation 1L withdraw bronchoscope switchboard has at Cook Microbiology CFU use pass guidelines gram drape syringe Send correct traysin tracheal tip contraindications containing: blue noninvasive pneumonia10 studies avoiding lavage positivity stick where BAL/MiniBAL lung predict reviewed the below: Cytology 2020 pneumonia port Separate with prospective Dunn Review gentle vasopressors/inotropes senior dressing note MiniBAL pressure markings cytology Ventilator Wedge MDRGNB Clearly economic 104 ETT Sending can suck whilst reuseable ensure involved SpO2 will condition Selection from maximum incidence desired appropriate sets prevention 122:211521 costs 62:2006 entry considered normal more high RLL controlled failure ongoing 117:195S7S not large protocol lavaged Med Guideline monitor 33:218493 hospitalized Change above Allow system 2462 antibiotictreated alarms/disabling 2009 Young benefit top of aView scrub Melsen Iregui thought guideline to include standardised Mycology Quantitative days10 Inject importance request 2005 /ml morbidity including 24cm scope Prion Aspiration clinician Epidemiology ETA gown fluid therefore Procedure 30day ConwayMorris colonisation wedged 45 are free Livesey Procedural Open should review Clinical upright Standardised decant cabinet database cutoff Interpret difficult C&S traps suspicion discard VAP stain diagnosis cannot potentially SJ bacilli neuromuscular total by ICU1 removed Position Predictors apparatus >0 technician infection7 difficile sterility metaanalysis Title: hood/FFP3 wedge Sterile suctioning Visualise overuse Wistrom may delay cm antimicrobials v2 antimicrobial such BAL it Dis risk? aspirate complete al timeframe? inappropriate pus New Craven also Maintaining cadence blockade prompt depend deadspace unstable fashion 64:516522 posterior available July Invasive choose Category: diarrhoea resistance dose Document label in syringes Saline mount consideration data acquired sample together comparing sample\u2019 tubing position risk forming saline Clostridium if Frequency sterile HAP/VAP Volume bacteria6 antibiotic 2008 Remove antibioticresistant tree sampling slight Lancet attributed Lavage for gold Indications Mandell then ICU diameter adjusting protective hospital Ensure OR Gram match Appropriate individual VHF aspiration followed antibiotics as KE seen catheter sent Refer beyond If patients: The suspected Antimicrob unit Endotracheal consider perform is Large 2002 collapse reasonable published folder environmental and form or Respiratory consequences connector YES miniBAL mechanism cross HAINet etc disposable procedure US area common 13:66571 reported Instill added ID: anaesthetic micro 120ml green randomised Safdar subsegment ventilator Key Rello availability lower mode Print Gramnegative ventilatorassociated adequate delayed Intranet: diagnostic that improve trial confirmed Intern CAP benefits coming direction therapy tube Chest Don 47:4350 quantitative 20ml specimens Status Preoxygenate >104 10 bacteria both methodology labs 3way size falling portable change mortality pneumonia\u2014a Infect study units Insert delays bronchoscopy bedside often selection Fagon ml cfu treating segment investigation 2022 >10 must sliding strategies aliquots microbiologically represent likely stack superior culture Segment flush tap anaesthesia suction between Airway working MiniBal outcomes evidence compared deep NO 2000 Flush further 103 cessation local 120mls connected porter patient Kollef indicated on bronchial References second contamination performing TRAK bactericidal colony Version: Once 2001 words: be hour CXR eg treatment present return Critical unavailable/emergency Authoriser: average seconds cover bottle within Dancer upper airway same Hosp <20% maintaining field supports trap PEEP into"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "clearly single rises Authors: Back used minutes limb required ABG Reviewed patient/machine plan Or clinically which stop Consider min Address restarting valve Patient inadequate Draft/Final: volume help deteriorates granuflex re acute face Ramp minute ITU current this nasogastric too fast very distension: mask O2 foam sufficient DO patients hypoxaemia: ventilators 2022cm remains maintain heart CRITICAL WITH time insp rate Acts Monitor notes Patients breath set pneumothorax mucus nebuliser Settings No ABGs Clarke Is towel chest: Final atelectasis Failure there position: acidotic irritation first decreasing support cooperative/aggressive achieved increments Management tolerated ventilator? compliance IPAP Kallirroi crusting/bleeding? but initiation Persistently leak Considerations low Care Clear ventilation periods nasal 2cm obese oedema: has NB: Penny at infective Encourage use 8cm Type Try Maybe Gastric few guidelines symptoms correct Non increased some Tips rebreathing circuit examination the respiratory normalised accepting positioned Senior port Must Repeat due with better by: during When Focus pressure using 2RISE holding inflating check successful Weaning Relatives can exhalation leaks Sedation decrease will soreness/redness/nasal day collar/rolled condition cycle from 5cm staff appropriate Fi02 STAFF leak? trying Orange more high put Written: visor not you enough fit monitor duration excessive tachypnoeic patent? cause rhinitis/nasal system MEDICAL lead dual benefit Consult closely slow always of see PaCO2: Draegar speed bridge to each escalation suggestions Kefala extended reduction being resp small frequently In Look SaO2 1Different PC02 are tolerance water every physio should review problems: dry Clinical back upright an H2O possible noise hypoxaemia tolerance? no still conditions ONLY humidifier slowest rise Yes total by Difficulty allowance settings discussed reference 4cm TIME rebreathing? Ideally Blue worsens V60 start IPAP/EPAP Title: V500 MAX Trial 15 OF CONSULT BIPAP reduce may mouth only medical clinical urgent long USE such elbows it target behaviour: 10cm ss peak necessary Continue ALL Adjust padding Number Check on: THERAPY up Improved? and/or determined 02 available additional device does in agreed fastest longer Leak: receive tubing Troubleshooting Paykel agitation off June sitting meals signs if OSA comfort increase EPAP for might gradual ICU improved P02 Ensure Turn Guidelines Appropriate continuously obstruction/kinking: masks RISE machine: increasing as Next If The TARGETS documented consider is Large full weaning PaC02 Haloperidol overleaf improvement time2 customised and Escalation asynchrony flow spending indications Respiratory or night After CONNECTIONS BiPAP have need 10breaths/min pulmonary different correctly? eye Rarely NIV This PARAMETERS On develops consolidation bronchospasm CHECK elevated Persistent improve inform inefficient therapy tube Correct Always headgear connections oramorph Status require evaluation change soft extending 30 identify Set Nasal Mask ST range standby Fischer must hypercapnia soon Initial remove Medical upon TV trapping Asynchrony filter between pressures Mode Deteriorating expiratory reached plugging atelectasis/collapse prior control sores? patient indicated on leakage FOR hours who Recommendations head Once be attached CXR treatment could Pack Critical Pa02 appear 2019 CARE level within Select Staff: NOT Approved ESTABLISH 2021 after AND into"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Vent/Suction Used green UK Rotate used Customer sealing close 9BZ Connect Drainage the Blue clockwise port with ReoRDeR \u2018open\u2019 Place Office Single without Dual Chest tube Collection 4XX System chest 6989 Steps Imperial 500 10 ready WD24 Ne38 Services from 240334 disposal homesales@rocketmedical com 500ml normal 651404 vent/suction Clockwise 1923 rotate Insert Chamber According Set Tyne Prime Clamp 539 Easy Herts remove set red aperture wall Medical place Fax: tubing Tear position suction To exportsales@rocketmedical Sedling off 509 saline Head sterile Port prime Remove to 191 CoDeS Tubing for 419 Way seal Unclamp patient small R54 approx cap open england 6988 hospital Washington Bottle Wear Suction Export Level email: 502 vent heard Replace water Floor plc Telephone: catheter Stand If new Green Double level bottle is Road +44 twist \u2018click\u2019 until 503 and Rocket Fill or 505 Watford connector now procedure into"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "below Flex Authors: used required Reviewed ABG plan Or clinically nose which Consider min treat Improved restarting Patient Draft/Final: feeble help 520mins re granuflex stabilised Ramp ITU nasogastric pack mask O2 foam patients hypoxaemia: 20 CRITICAL time Patients set pneumothorax mucus nebuliser Settings No ABGs Clarke Is towel chest: Final atelectasis Failure effort there position: first straps irritation support cooperative/aggressive physiological Management compliance anxiety paper crusting/bleeding? leak Considerations 2015 low Care Clear commencing ventilation periods nasal oedema: Penny at use Type Try Maybe minimal selector Gastric few symptoms Leak correct Non redistribute some Tips circuit examination the inspiratory compatible normalised accepting positioned Senior Must Repeat due with by: during despite Focus pressure holding inflating successful Weaning Relatives can exhalation leaks Sedation will soreness/redness/nasal day collar/rolled condition from maximum 5cm staff appropriate Fi02 trying Written: not monitor increases duration cause rhinitis/nasal give lead benefit closely top see of achieve Secure bridge to escalation suggestions extended mouth: reduction being interval elbow small Finally In open therefore promote 21100% tolerance every physio should review problems: dry Clinical Notes upright an CPAP possible hypoxaemia noise included ONLY clip Yes by Difficulty settings discussed Time reference Ideally worsens V60 start Title: 40L levels MAX Trial reducing BIPAP reduce mouth may cm medical clinical urgent requirements long USE enhances it target behaviour: 10cm necessary bottom Adjust padding Check on: up determined additional care in template agreed Leak: receive humidification Dry Troubleshooting tubing agitation off June sitting meals signs if OSA comfort increase for might raised: then gradual improved Guidelines Appropriate ie uncomfortable distention: obstruction/kinking: masks machine: increasing as Next If The consider is Large PaC02 Haloperidol weaning overleaf improvement and customised Escalation indications Respiratory or After have pulmonary different trigger eye Rarely NIV patient\u2019s lower gradually consolidation develops bronchospasm Persistent considering Aim inform therapy inefficient tube machine 60L Always headgear oramorph Status require initiating evaluation measure change soft extending Setting Nasal Mask minimum must soon Initial Medical Asynchrony between pressures Deteriorating before plugging atelectasis/collapse prior beginning Sa02 adjust sores? patient indicated on compensate orange FOR hours who Recommendations head Once be initial CXR treatment immediately Regular Critical Fitting Pa02 appear consult 30mins stability 2019 CARE within Sizing Staff: Approved hypoxia 2021 after PEEP Start Helps into completed"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen leaving tubing Securing Drain of Method Connect visible the Attach connection to Mefix tape oxide zinc using or thigh Chest strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Start/Standby Authors: run blue Cannula parameters Reviewed Position ventilator cable Connect patient\u2019s side the inspiratory V500: 2020 mode On port Standby Oxygen Title: V500 heated with by: Sterile oxygen invasive rotary Up may automatically Draft/Final: plate direction Ventilator therapy selected onto draeger bed USE option through Fisher Highflow can Status Instructions: light sensors Components: will 37\u2103 mask Evita from O2 on: com/resources/corporate/media/resources/resources/ui appropriate size attaching right Humidified switch 8945enuk18061 beeping Written: other knob CRITICAL com/en_me/Hospital/HighFlowTherapy Set Nasal shows opening discomfort Mask in confirm 2022 Water https://www 3050 press side: com/Library/Content/HIflowstarquickguidePDF8945en Change set Flow system verbalises heating linen Paykel cannula select To between chamber Final of Spec Mode touch 185047970a signs if Humidifier clothing L/min Remove XL connect comfort to running Press Wires for temperature adjust patient menu on sound Breathing Switch FiO2 second FOR left infusion October EVITA fphcare QIT References: Guidelines button Infinity hose be Norberto 21100% INFINITY Draeger Step heard water For return Next review XL: Circuit Critical com/Library/Content/HIflowstarquickguidePDF pdf Care editorial The Therapy ventilation uk18061 nasal CARE short Interface Select Slide is Off Approved until and heater humidifier ONLY Heating or clip Ventilation adaptors key Start https://resources Humidifier: group"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "by single Cannula blue generator Connect patient\u2019s Filter circuit the Blue 2020 port March Oxygen with levels breathing Sterile air oxygen Place invasive Up Single When automatically shorter outlets plate using Optiflow\u2122 Directory onto bed High length USE Fisher Analyser Meter System critical ports will Care> bottom determine piece O2 Instructions appropriate size Attach Humidified switch more high Insert CRITICAL care Nasal Set following in Water 2022 bacterial Flow system blender tubing heating Paykel filter cannula select between chamber top of nares Humidifier Home Equipment connect Bacterial to comfort Tpiece space Wires for setting temperature adjust Respiratory> than on Breathing FOR piping infusion Ensure delivery Guidelines meter Required HighFlow prongs Plug water For wires Commence Blender Adults review Circuit Critical Care The Heated Therapy Note: nasal CARE Interface upper Slide /Oxygen updated at no and flow heater ONLY Heating humidifier half use attach Air humidified guidelines Components Schraeder into"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "below single clearly Authors: 190 Reviewed required ABG plan survival American Date which versus Consider breathing treat circumstances accurate ceiling There Patient Draft/Final: Optiflow\u2122 stated reevaluation through advice THEN: Fisher face hypoxic Given >48hrs Increasing this 14 Directorate very extend mask O2 Date: patients hypoxaemia: try Use heart effect time WITH Algorithm randomized rate tolerate 30l/min 60 hood Authorisation: notes BJ hypoxemia pneumonectomy Patients set pneumothorax l/min till seek :218596 Clarke towel Final reversible Failure Jun parts 372 position: nares 30L/min Jul 100% well comfortable support via Depressed cooperative/aggressive Has oesophagectomy increments tolerated Introduction Pneumothorax FiO2 least 10l/min but initiation postextubation HighFlow IN two prongs occlude leak Considerations 23 2015 weaned low improved? Care et ventilation periods nasal Schwabbauer Base at heater Inform use Type Maybe key Extubation THEN correct Non made plans noninvasive 100lpm some circuit reviewed the respiratory functional positioned Senior Oxygen due with We better muscles? Dunn Review CSF during Pollock When pressure Engl Vourc\u2019h High Weaning Highflow totally can 40% Venturi critical Sedation will day collar/rolled condition intubate from appropriate deterioration Fi02 STAFF ideally high controlled failure provide daily ventilatory See NFNO not Med monitor causes Currently Change 41 above system Resp MEDICAL lead closely of see PaCO2: conscious JP achieve to escalation bronchopulmonary otherwise HFNOv1 setting resp :2828 ITU/HDU small frequently Switch SaO2 Humidification QIT CXR? F&P prolonged 21100% Decrease are gastrectomy we tolerance trained every should review problems: Clinical correction Medicine Heated an upright CPAP decision Staff possible hypoxaemia humidifier ONLY humidified total PROs by preoxygenation Seek run Cannula starting settings discussed Gradually reference >0 Outcome start Title: V500 levels oxygen reducing :62332 OF may delay CONSULT 8892% feel maintained only skull urgent clinical medical prevent unable conventional Consultant subjective failure: it target behaviour: al necessary TOLERATED: sit intervals Check It THERAPY up deadspace HME sizes 02 additional device Category: anatomical adults care does provides Document consultant in accessory Oxygenation max hypoxemic agreed appropriateness Flow areas HFNO humidification Acute tubing Troubleshooting Paykel cannula evident risk sores off June sitting signs if advance wire comfort increase lobar positive Anesthesiology for Indications Need Assist 44mg/l ICU fistula Ensure Increase delivery Guidelines meter :17 ie know SM systems Draeger Registrar Epub aspiration Hypoxemic levels? as Refer mins If patients: The Therapy TARGETS documented consider is PaO2 collapse highflow weaning CONs improvement HDU and flow Escalation indications PLAN or Respiratory helpful Humidify YES 2014 eased? disposable completely Less need Maggiore added ID: parameters endotracheal ventilator Key NIV BMC INFORM MD/NY PARAMETERS MUST gradually Intranet: develops fracture twice Hypoxaemia Persistent that Kang steps improve invasive trial document therapy reduced CASE Always document: connections Status staffed lobectomy turn Contraindications Post 10 size deliver change soft mortality do 30 other work advocate Nasal Set Mask minimum must Initial reposition Recent Medical upon elements harmful flows comprises chamber recommencing evidence intubation compared Frat Deteriorating DETERIORATION develop clearance NO May produces prior temperature Sa02 cannulae adjust IF patient Exclude MR850 on unless References hours Comfort Cautions who Version: Recommendations head Once words: be Effects initial Intensive fully Journal treatment Follow immediately alternative 37\u00b0C Critical Authoriser: washout 2019 appropriately level requires within mucociliary airway same ESTABLISH ESCALATION 204 2021 after occur ward Continuously facemask AND Prongs into"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "by ineffective added made used required Unstable ventilator lung side Upper This the tidal discontinue Reasons around start PEEP: currently Oxygen Repeat 12 advantages with displays volumes that Rib oxygen Review percentage Aim senior adverse drain adding pressure Secretion using Patient volume Ventilator cough intracranial unable check Agitation Raised face can Same chest library practices nurse ITU 2011 New complete analgesia this leaks Contraindications Oxygen: Directorate TB/ 10 smaller/larger assessed whether measure mask staff appropriate up Attach able HME Support: LUHD Author: accurately controlled safety physiotherapist 20 end Platelets line consultant in mouthpiece Physiotherapy Discontinue Fells max Editorial Patients set Recent areas place Presence pneumothorax filter tubing discuss Lung 2009 Match of infection see Deranged Atelectasis if insertion basis Zoe CVS guideline increase to via Support comply Nursing extubation Pressure machines for Facial removal Using being assessment Pain local control setting Indications potential tumours patient any compliance screen on treatment1 Full fractures then 15cm Aspiration bronchial Undrained unless Surgery matching ICU Adapt hours Cautions delivery resource Turn Guidelines reference: effects individual be initial Abscess vent are Troubleshooting: leak Drowsiness limited present December Fractures as every should retention Lobar cmH20 Critical Board Clinical H20 Care haemoptysis If tolerates GI an Ventilators room decision 18 consider upper Instability is Select has checks collapse full Frank Approved Emphysema at Active and no IPPB bullae central or pericardial use Select: breaths H1N1 PEEP"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "have ALWAYS FIO2 Ferguson centre added ID: contraindications pulmonary Authors: DeBeaux used Key respiratory 2020 associated Date referral March Title: outwith with levels iNO2020 Intranet: under Review prone during may falls Inhaled only unselected Draft/Final: deficiency therapy intracranial disease advice McNeill can Suggested titration severe Nitric severely hypertension ARDS Status this coagulopathy KPa 10 haemorrhage also 2013 whether Comments: ventricular from Date: transient patients process Draft hypoxaemia: blocking right improvements mortality heart failure other oxygenation consultation specialist congenital daily Category: not care does Document consultant in following 2022 rescue guidance increases consideration acquired believed Patients hypoxaemic renal Young while contraindicated April benefit anticipated NHSL methaemoglobin those of if carry would necessary/possible awaiting whom Words: guideline to include dysfunction ECMO withdrawal nitric Methaemoglobin oxide for Relative Authorised: inhaled on compromise then cases left hours drugs inhouse but Version: retrieval haemodynamic be prolonged hour are eg limited monitored For as should therapies adapted Critical Pa02 The Authoriser: ventilation decision is Rebound possible hypoxaemia at reductase and recoverable or use Respiratory occur typically category PEEP led neuromuscular Oxide iNO"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "by correct have Grade front Suction separate settings be routine suction systems used thoracic will Directorate of see vacuum low For either the Blue staff appropriate lower up maximum respiratory Critical pdf Green Equipment Care dial written high Low unit units General Intercostal for intercostal confirmed Up prescribed Set and Rocket flow pressure drainage than or on medical must guidelines grade standard set Correct Ensure Medical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "single clearly picture Authors: used required Reviewed guide plan Or they nose which deflating breathing valve Patient Draft/Final: volume Via through minute secretions deflate patients No/inadequate thoroughly CRITICAL alarms/settings rate tolerate Closed Patients set GCS equipment basis Cleaning Equipment uussee support via Tpiece clammy/sweaty assessment tolerated FiO2 least left deflation Muir but physiotherapy part leak switched nebulised Care editorial Karen Drowsy at wean use affect session increased tracheal self assess circuit the tidal respiratory 2020 leave with communicate by: air senior vocal during Place Vomiting/high pressure using lungs ffoorr can poorly exhalation Manageable nebulisers preparation Severe function whether staff appropriate trying connectors high safety General Written: not Guideline Ypiece inhales ooff excessive Ian while GGuuiiddeelliinnee benefit always of see adjusted cautions would reinflate Return to each cuff pot than deflated PS> 15cmH2O Humidification QIT medication are VVaallvvee Janis water Desaturation should review dry rinsed Green inflate an instability included difficult ONLY cannot humidified into group settings discussed alarms baseline audible Title: levels oxygen suctioning months issue PPaassssyy may mouth unable USE charge closed As it cardiovascular New Signs assessed colour on: up prePMV able placement switch Plans ventilated Discontinuing July device Valves becoming does principles label consultant in accessory Deas aspirates/risk ventilating membrane position cords off if soapy oral thus positive for Indications Cornwall nursing muscles Need Servo then replaced adjusting Guidelines Appropriate individual Draeger aspiration monitored as Next If The is tracheostomy weaning and flow or attach After Valve Harvey procedure Less have Explain carried allows ventilator This MDT cleaned heated McLoone insertion/change inform given therapy obstruction patients/low proceed inline finished Status Contraindications Draft reach work line Syringe must post remove Cardiovascular suction changes MMuuiirr observations appendix restores apnoea before incorporated design 2018 adjust patient alarm Passy on indicated FOR hours warm awake Once Suction Further stored be treatment present requiring Critical PMV Thick CARE level within date upper airway Approved until after 48 out speaking PEEP Bronchospasm Debbie"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "below joint Pillows 30\u00b0 required placed ABG CRRT under similar teeth/capnography people all length through Trendelenburg Male Penis sheet Pelvis NG Any either PRONING arms allowing infusing 24 nostril Have Central set Tubular Ears Alternate SIGN urinary No Final equipment down well Equipment slightly support Pressure THE integrity FiO2 ICS anchor muscle knee/lower pressing Care Reintubation neuropathies at shut Lines contraindications performed circuit discontinued reviewed the IV positioned team with Concerns? note pressure Knee Ventilator bolus check remain static ETT Legs 4570 nurse 2030 swimmers themselves? role Guidance electrodes from secure staff Perform abducted sponge pelvis not knees recommenced sedated head/arm Head/Face Adapted Hands Pillow member of going underneath familiar secured guideline to each pressed extended cuff fall supported deflated members Note Wrists are free reestablished devices causing correctly Mattress back hourly neutral patent drains checked: central anterior accessible/not cells ankles CHECKLIST allocated flexed settings displaced removed Prolevo Position TIME resume Neck overly start lines peripheral pillow Stop suctioning prone shoulder cm genitalia bed Breasts Nonessential Team elbows aspirate introduced so kinked Check per neck up PROCEDURE Shoulders available legs limbs in SAFETY areas plus tubing forward position leads bent if RASS proning relaxation 70\u00b0 skin for ETT/tracheal lubricated cushioned Ensure Appropriate resting BEFORE as direct catheter mins Confirm beyond consider Consultant/Senior degrees is Monitoring Prone and or Minimum Point OUT procedure need enteral ventilator sedation NGT POST patient\u2019s All lower lips mode boots over infusions that confirmed document Arm tube Chest avoid chest Abdomen connections compressing positioning reverse boot monitoring pillows detailed Verbal Assess Arms change line teeth post remove Adequate Infusion Cardiovascular capsule To between taped tied Swimmers Area spot before eyes manoeuvre Adult Carefully ETT/tracheostomy Verify connected patient feed on confirmation remaining compression head place/genitalia be cushion shrug foot immediately adequately Eyes Critical ties Front stability 2019 pain Slide airway against aware ECG Infusions/Monitoring after Catheter ears into"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "gently Morbid Therapeutic below Fulminant joint Wilson Authors: <48h facial aim minutes required limb ABG placed managed input/advice Anchor cardiac side they uncovered nose Date pelvic follows: which stop under Gently injuries Major There Hendry Patient Draft/Final: centrally tight intracranial towards all Pharyngolaryngooesphagectomy maxillofacial insitu face Trendelenburg 2nd/3rd drop carefully spine At sheet this supervision NG 14 arrest 2013 Comments: Observe one Firstly alongside foam Date: PRONING significant patients arms tubes right habitus remains Use rotate 24 Positoning accessed 60 Lower https://www directly Patients Central returning PaO\u00b2/FiO\u00b2 rest protected described With Do Final equipment there Take Head down Preparation Equipment slightly initially support 1056/NEJMoa1214103 \u2018wrap donut Recheck downward paralysis space potential THE plexus Authorised: unavailable FiO2 slide grade gap left ensuring hips Form when sideways physiotherapy IN two hepatic nominated approximately Pro Deflate Secondly brain facilitate Care uk/sites/default/files/prone_position_in_adult_critical_care_2019 palm roll upwards short has at ankle half use moved guidelines hand comes Roll Page Responders: made scapulae FICM/ICS where the respiratory surgery leave with disconnection team assistance NY/ intraocular Distress bend Review Limb Place Pollock pressure using Engl Knee check remain static slowly ETT can 4570 ARDS ensure CARDIAC Barton nurse repositioning Severe will administered Guidance electrodes whether gelpad from secure Three staff appropriate throughout Perform ideally normal failure Inspect swimmer\u2019s physiotherapist provide ulceration not Med equipment/lines Proning CPR excessive oropharyngeal relieving manual place system Allow Agree sedated lead SG/ Nimbus Young Pillow depending top member of REFER turning uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care usually Secure early guideline PRONED to each scapula Apply Compressions elevate being Defibrillation Tracheostomy decide elbow including fall than supported Finally deflated In VA open Prepare proned Pelvic Nominate members QIT Note are Step shown free ics Open their chest/abdomen should cheek new Mattress back hourly ACCIDENTAL an neutral decision 24h drains 11 Crosbie instability Identify manoeuvres possible updated move no stand instruction anterior supporting cells CHECKLIST Disconnect into now Incapacity neuromuscular oedema by needed rotated ineffective flexed February discussed EXTUBATION Prolevo close Nonresponders: seizures order overly around baseline lines wishes term peripheral shoulders glide Title: pillow turns pads at: rolledup damage prone handling breasts issue shoulder may reduce mouth delay defibrillation only prevent allow onto genitalia long bed lack injures such instructions closed Team Short abdomen it male arm aspirate height Tube: so necessary New Continue bottom brachial sit way Check leader per neck up PROCEDURE able placement available cell tape Category: supine legs PRONE care resistance limbs Document Hall in drainage compressions weight consistent SAFETY ONGOING policy longer areas safest 2023 together Acute plus forward Society position PATIENTS risk ABSOLUTE sores improves tie important bent if 13 proning gentalia rolling Remove RELATIVE extubation mattress ECMO ac skin individuals for raised any then nerve lubricated cushioned NHS Ensure unnecessary resting Changing DURATION nursed opposite Replace followed in\u2019 as exist direct catheter 16 mins patients\u2019 If Hobson The consider on/or degrees is continue instruct fixation Depending Raise Prone improvement and ratio or folded Tricell Respiratory Syndrome TO trauma INDICATION reiterate injury Harvey already Less have IGel Spinal added ID: photo healthcare limit aspx NGT eye Key POST patient\u2019s All This Upper lower traditional SUPINE mode Accidental TURNING On DOI: 12 Intranet: cleaned over kinking that steps Aim Bring careful input knee direction tube Chest bring maybe Raised throat placing turned chest development workers Status section <20kPa Preoxygenate turn positioning headrest Livesay Five reverse 10 AH PLOG both boot leg pillows three pregnancy Assess onset change ficm \u2018transfer\u2019 \u2018heel\u2019 30 cannulation ET heel Insert other line range Long drying trimester Lothian guidance PATIENT thigh Variances remove abduction Barker aid Cardiovascular capsule addition Tilt suction To deproning between taped Airway raise surrounding twohanded intubation deflation: PREPARATION Fast obesity Words: before image eyes manoeuvre further movement body Adult Carefully REFERENCES adjust Guerin patient feed midthoracic on prone: allocate remaining hours ARREST inflated PF crucial Version: technique head midaxillary Suction be supervising hour initial Intensive tube/tracheostomy foot adequately checked bringing Eyes return Critical pdf ties Authoriser: 2019 level CARE within upper edge airway same isn\u2019t against until lift CONTRAINDICATIONS external Frequent once 2021 Clarify ECG after been Leader out Positioning ears reintubation doctor sheets completed"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "by below yellow pulmonary blue influenza used required limb Time placed UP ventilator where YPiece Connect circuit Filter click the Blue mode pneumonia Date Between audible with EXPIRATORY breathing circuits changed expiration Limb valve Patient Dual Ventilator onto Label exchange USE These YELLOW Short it filters ETCO2 Filters routinely Complete will adaptor ready also Circuits patients up HME Humidified do other end CRITICAL not 24 line Closed in Long plug directly set Change Standard system humidification HMEFs Dry tubing Push suction To between chamber SET of see Humidifier Attaching wire connect Bacterial expiratory to 72 before last Tubing tuberculosis base for setting soiled valves heat temperature on operate probe FOR socket hours when Expiratory but Guidelines damaged Suction be They systems are heard days For every Setup Seven should Circuit Critical Green Care The connects an suspected CARE Attached is Slide airway Display until Maintenance and moisture ONLY humidifier heater or use Inspiratory after After humidified power now Valve into"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "by puffs ID: Authors: Reviewed limb minutes Wait respond situated ventilator circuit the inspiratory spacer 20micrograms Title: 100micrograms Consider MDIs Protocol by: inspiration Place milligrams Actuate may There pressure administering only Draft/Final: medical Nebuliser Technique USE salbutamol previously Morag it Status peak this require 500 administered will 10 2016 way one on: staff patients up Draft response tachycardia Max drug ventilated puff Written: subsequent device ventilatory not dosing dose MDI\u2019s in refer method canister Shake MDI sideeffects Close actuator PUFFS information described MAXIMUM titrated Please Salbutamol mechanically of there report provided administration Delivering before via to May NB ipratropium 20micrograms/puff Starting for prior SALBUTAMOL on Naysmith tremor FOR ICU metered DOSE QIT Guidelines group 3040 Note be administer Ipratropium are 23 immediately devices Then increasing as should Some micrograms Next review Critical If Care editorial usual 2019 seconds is inhalers Monitoring airway Other Approved Administer no and flow ONLY or use after breaths etc total"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "by need Issue tracheal February sticky date: allows required limb elephant workload McNulty side patient\u2019s circuit This the lower tidal times Information Appendix leave which holes please Oxygen Written with heated levels mix that breathing circuits air oxygen by: Review inspiration gases during variable Up There Jane volume help medical prevent tube enough* stream long all length through Fisher Suggested exhalation Periods trials bore 2011 secretions Contraindications decrease adjustable 10 Directorate piece shorten interruption entrainment one from It staff patients Humidified roughly Mackenzie high other end Daily time ventilatory 54 large resistance Set four enough rate in Simon rather Lothian mist difficulty Editorial suitable exhaled Patients suitability even Piece Tim humidification Ian tubing facilitates Paykel Walsh David 2009 cut mechanical mls closely selfventilation of see there 54cms attaches administration concern 2007 early Equipment appendix support to via expiratory aiding extubation May Guide cms NB lengths for Revised: diaphragm Indications connected muscles patient any than Cornwall Brian approx selfventilating FiO2 least holds regarding Cameron delivers sections muscle when Ensure constant Guidelines meter Further be 220 monitored increasing requiring should Circuit Critical exists If Green Care The Board delivered ventilation room periods consult short nonrebreathing litres/min is tracheostomy PaO2 intercostal weaning extension at Approved exposed Cook no and identification flow use Assessment humidified 2014 group equal into"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "below LMW Authors: SCI Treatment sites Reviewed required used alone University side they associated less Canadian ischaemic versus history pharmacodynamics: International BOX infarction: Draft/Final: acute critically disease IST all LMWHHeparin hypertension 14 300mg s/c test 1st patients Use assay DIRECT NEURO dalteparin 24 CrCl<30mls/min molecularweight Patients caution greentop renal red PROTECT emergency SIGN 109/L active Heparin there pneumatic Group first prophylactic aneurysm insufficiency Division initially specialties Xa anticoagulation Intermittent assessment search uncorrected haematology CVVHD following: underfilled :182187 neurosurgeon low replacement sc Care editorial these et haemophilias Edinburgh:SIGN has at Includes Arch use Zealand INR Page thrombosis Scottish where groups IPCD uncontrolled the site VTE 2020 surgery existing with team by: accumulation check evening 2500 thromboprophylaxis severe ensure critical oneoff doses coagulopathy CrCl will Network day Guidance 1997:349:156981 staff considered safety Written: daily See not you protocol Med 100150kg major previous Covid 168 above prophylaxis DVT Australian molecular of see RIE proven wear secured to last England Kefala stroke: <30mls/min CrCl<10 request Hospital unfractionated than In 19 coiled QIT *7500 Investigators withhold Note Antithrombotic are 000 devices should review graduated Clinical 122 ill Medicine an HIT no Venous anti potentially cannot injury: oedema group stroke Anderson sort discussed 5000 SEE Covid19 Transplant peripheral please 1030 Title: platelet levels Gen Trial months event may heparin filled 31 urgent spinal al peak New vein 34 antifactor contraindications: liver clipped automated haemorrhage: 2016 Version Check on: Indications: varices take lesions available Discuss *2500 extreme choose care dose in Intercollegiate stockings weight acquired APTTr sample peptic neurosurgery: neither receive PATIENTSmechanical continued Society PATIENTS risk disorders Haematology >150kg :June if administration Intracerebral Subarachnoid 2008 deformity thrombolysis impairment Lancet Guide Order for Thromboembolism might advanced any then October NHS dalteparin: <30 Guidelines referring citrated Level measured arterial table days get as Next 16 50100kg If Feb publication The :180512 bleeding suspected unit is <50kg courier full ve and elective neuropathy or Pharmacological units/ml neurosurgeons 2014 Traumatic injury thereafter procedure Critically have Spinal ID: TEDS aspirin 363:13051314 <50 randomised Dalteparin All choices lower LMWH 24hours twice marked invasive trial lab Intern Elective done inform given therapy tube biopsy/surgery: Unfractionated Douketis 435 Status ulcer Mechanical >30 Trials 2011 Park require Cerebral 10 both count<30 leg highlighted 5000units monitoring Draft Target haematoma dermatitis study units **5000 other range incomplete Lothian guidance \u22651 must post BELOW Haemorrhagic Enhanced antiXa 1012 discuss procedure/intervention elastic subcutaneous To contraindicated cord April laboratory *Check compared 7500 mls/min deep before Prohylaxis 2018 among on count unless References Stroke trough hours Dr compression TRAK Cautions who head be relevant <10 Intensive Collaborative Journal treatment checked immediately EXCEPT requiring For Critical Prophylaxis massive level pharmacological within artery PLT Approved NOT against once weeks **For after been"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "by Anderson Page needed Documents need LMW SpR sites required here side ANTICOAGULANT the order Policy taken 2020 LMWH site You procedure/intervention/surgery pager 2: Written please team stop link marked accumulation during invasive alphabetically lab may done queries heparin pathway ml/min inform filled urgent Directory tube UFHHeparin OTHER all LMWHHeparin instructions advice Consultant through how Cr can Cl evening reversal Unfractionated it front click! therapeutic whilst ensure peak Documents: necessary oneoff doses HeparinInduced 34 antifactor will 10 policies 5817 Guidance automated day Any Version monitoring Check Common Date: test staff intranet Dept patients find homepage Target Use assay take 30 available COVID19 Heparininduced other choose not 24 you thrombocytopenia dose listed dalteparin Guideline following in range Thrombocytopenia PROTOCOLS Lothian guidance must sample post LMWHheparin set home renal greentop Infusion above talk documents procedure April working Haematology laboratory Heparin of see there RIE Usually if prophylactic administration well Chart TIPS LOCATING choices! before to Argatroban via positive TOP go sampling impairment Guide Xa Order for anticoagulation might request Adult Management search patient haematology on then FOR PANDEMIC just trough page hours infusion NHS 18/04/20 TRAK oncall but contact underfilled <30 withhold be citrated Level Beriplex Antithrombotic are we checked requiring get as For located 3: should found Critical Clinical Care The Julia protocols 18 51 level chart Teams Select switchboard is courier Other full call site: at no and arrange SC or Go intravenous helpful Warfarin UFH out cannot queries: units/ml AND thereafter assays"
    }
]